[{"Date":"Jan. 2, 2016 at 12:01 a.m. ET","Headline":"Next Week","Summary":"A Barron\u2019s calendar of key economic, business, and political events."},{"Date":"Jan. 2, 2016 at 12:01 a.m. ET","Headline":"Unused Gift Cards: Lost but Not Forgotten","Summary":""},{"Date":"Jan. 2, 2016 at 12:01 a.m. ET","Headline":"Barron\u2019s Top 10 Income Investment Ideas","Summary":""},{"Date":"Jan. 15, 2016 at 7:15 a.m. ET","Headline":"Merck to pay $830 million to settle lingering suit over Vioxx statements","Summary":"Merck & Co.  said Friday it will $800 million to settle a class action lawsuit, related to the drug maker's illegal promotion of its former painkiller Vioxx. Investors who bought Merck securities between May 21, 1999 and O..."},{"Date":"Jan. 14, 2016 at 12:01 a.m. ET","Headline":"Oversold Novartis: Juicy Yield, $9 Billion Pipeline","Summary":""},{"Date":"Jan. 21, 2016 at 4:17 a.m. ET","Headline":"Merck CEO rules out major acquisitions in 2016","Summary":"DAVOS, Switzerland--The chief executive of German pharmaceuticals giant Merck KGaA (MRK.XE) on Thursday ruled out any major mergers & acquisitions this year, saying much of the reshaping of the firm's portfolio has been co..."},{"Date":"Jan. 30, 2016 at 12:01 a.m. ET","Headline":"Conference Call: The Super Bowl and Stocks","Summary":""},{"Date":"Jan. 30, 2016 at 12:01 a.m. ET","Headline":"Conference Call: The Super Bowl and Stocks","Summary":""},{"Date":"Jan. 29, 2016 at 10:58 a.m. ET","Headline":"FDA OK\u2019s Merck\u2019s new hepatitis C drug","Summary":""},{"Date":"Feb. 1, 2016 at 11:41 a.m. ET","Headline":"Here\u2019s what the market is getting wrong about $100 billion-plus market cap stocks like Apple and Amazon","Summary":""},{"Date":"Feb. 1, 2016 at 3:11 a.m. ET","Headline":"Bernie Sanders puts GE, Verizon, Boeing on his corporate-tax hit list","Summary":""},{"Date":"Jan. 31, 2016 at 3:31 p.m. ET","Headline":"Alphabet, Exxon results to mark midpoint of ugly earnings season","Summary":""},{"Date":"Feb. 3, 2016 at 5:04 p.m. ET","Headline":"Bipolar Dow industrials ends sharply higher, reversing early tumble","Summary":"Merck & Co.  said Wednesday it had net income of $976 million, or 35 cents a share, in the fourth quarter, down from $7.3 billion, or $2.54 a share, in the year-earlier period. Adjusted per-share earnings that exclude acqu..."},{"Date":"Feb. 3, 2016 at 7:54 a.m. ET","Headline":"Which of these four scenarios is going to goose the VIX?","Summary":"Merck & Co.  said Wednesday it had net income of $976 million, or 35 cents a share, in the fourth quarter, down from $7.3 billion, or $2.54 a share, in the year-earlier period. Adjusted per-share earnings that exclude acqu..."},{"Date":"Feb. 3, 2016 at 6:56 a.m. ET","Headline":"Merck tops profit estimates, but sales fall slightly short","Summary":"Merck & Co.  said Wednesday it had net income of $976 million, or 35 cents a share, in the fourth quarter, down from $7.3 billion, or $2.54 a share, in the year-earlier period. Adjusted per-share earnings that exclude acqu..."},{"Date":"Feb. 4, 2016 at 11:12 a.m. ET","Headline":"Looking at the bright side of a bear market","Summary":""},{"Date":"Feb. 8, 2016 at 12:01 a.m. ET","Headline":"Two Biotechs to Buy During Earnings Week","Summary":""},{"Date":"Feb. 16, 2016 at 9:18 a.m. ET","Headline":"Dozens of biotech companies are \u2018free\u2019 for investors\u2019 taking","Summary":""},{"Date":"Feb. 16, 2016 at 12:01 a.m. ET","Headline":"Merck Puts the Hurt on Gilead Sciences","Summary":""},{"Date":"Feb. 13, 2016 at 12:01 a.m. ET","Headline":"Bristol-Myers\u2019 Cancer Drug Could Push the Stock 25% Higher","Summary":""},{"Date":"Feb. 27, 2016 at 12:01 a.m. ET","Headline":"9 Drug Makers That Could Boost Their Payouts","Summary":""},{"Date":"Feb. 29, 2016 at 12:01 a.m. ET","Headline":"18 Time Arbitrage Trades That Could Pay Off","Summary":""},{"Date":"Feb. 29, 2016 at 12:01 a.m. ET","Headline":"Big Pharma Has Plenty in the Pipeline","Summary":""},{"Date":"Mar. 8, 2016 at 1:30 a.m. ET","Headline":"Merck profit dented by acquisition costs","Summary":"DARMSTADT, Germany--German pharmaceuticals group Merck KGaA (MRK.XE) on Tuesday posted a 55% drop in net profit for the fourth quarter of 2015, held back by expenses related to the company's recent $17 billion acquisition ..."},{"Date":"Mar. 14, 2016 at 12:01 a.m. ET","Headline":"Agenus Stock Could Surge to $7","Summary":""},{"Date":"Mar. 21, 2016 at 4:16 a.m. ET","Headline":"China\u2019s diabetes boom promises $23 billion pot for drug makers","Summary":""},{"Date":"Mar. 30, 2016 at 10:43 a.m. ET","Headline":"Inovio\u2019s Ebola vaccine has positive results in early human trials","Summary":""},{"Date":"Mar. 29, 2016 at 12:01 a.m. ET","Headline":"Gilead Investors Shouldn\u2019t Worry About Merck Patent Dispute","Summary":""},{"Date":"Apr. 5, 2016 at 12:34 p.m. ET","Headline":"Bull trend intact, U.S. benchmarks hesitate at major resistance","Summary":""},{"Date":"Apr. 5, 2016 at 12:13 p.m. ET","Headline":"Bull trend intact, U.S. benchmarks hesitate at major resistance","Summary":""},{"Date":"Apr. 7, 2016 at 11:32 a.m. ET","Headline":"S&P, Dow back for another crack at first support","Summary":""},{"Date":"Apr. 6, 2016 at 11:28 a.m. ET","Headline":"S&P, Dow maintain well-defined technical support","Summary":""},{"Date":"Apr. 5, 2016 at 12:01 a.m. ET","Headline":"Lilly Cholesterol Data Impact Merck, Esperion","Summary":""},{"Date":"Apr. 8, 2016 at 11:20 a.m. ET","Headline":"S&P 500\u2019s bull trend absorbs latest shot across the bow","Summary":""},{"Date":"Apr. 2, 2016 at 12:01 a.m. ET","Headline":"5 Hot New Drugs","Summary":""},{"Date":"Jan. 9, 2016 at 12:01 a.m. ET","Headline":"Stock Market Could Take a Breather After China\u2019s Selloff","Summary":""},{"Date":"Apr. 11, 2016 at 11:04 a.m. ET","Headline":"S&P, Dow nail technical support, draw buyers","Summary":""},{"Date":"Apr. 13, 2016 at 11:44 a.m. ET","Headline":"U.S. benchmarks knife from major support, strengthening the bull trend","Summary":""},{"Date":"Apr. 12, 2016 at 12:21 p.m. ET","Headline":"S&P 500 holds major support, preserving the bull trend","Summary":""},{"Date":"Apr. 12, 2016 at 12:00 p.m. ET","Headline":"S&P 500 holds the trendline, preserving a bullish technical bias","Summary":""},{"Date":"Apr. 11, 2016 at 12:01 a.m. ET","Headline":"Biotech Stocks Are Back; Charts See Gains Ahead","Summary":""},{"Date":"Apr. 15, 2016 at 11:20 a.m. ET","Headline":"Bull case strengthens \u2014 again \u2014 amid U.S. technical breakouts","Summary":""},{"Date":"Apr. 14, 2016 at 11:26 a.m. ET","Headline":"Dow industrials break out, S&P 500 rattles the cage on major resistance","Summary":""},{"Date":"Apr. 13, 2016 at 12:01 a.m. ET","Headline":"A Perfect Climate for Bond-Like Stocks","Summary":""},{"Date":"Apr. 19, 2016 at 12:31 p.m. ET","Headline":"Broadening sector participation signals bull trend has room to run","Summary":""},{"Date":"Apr. 19, 2016 at 12:03 p.m. ET","Headline":"Broadening sector participation signals bull trend has room to run","Summary":""},{"Date":"Apr. 18, 2016 at 10:46 a.m. ET","Headline":"U.S. benchmarks' bull trend absorbs latest market whipsaw","Summary":""},{"Date":"Apr. 15, 2016 at 12:01 a.m. ET","Headline":"Best Bets in Biopharma","Summary":""},{"Date":"Apr. 21, 2016 at 11:50 a.m. ET","Headline":"Meet the S&P 500\u2019s new technical range","Summary":""},{"Date":"Apr. 20, 2016 at 11:35 a.m. ET","Headline":"Charting the Dow industrials\u2019 technical, and bullish, backdrop","Summary":""},{"Date":"Apr. 22, 2016 at 11:19 a.m. ET","Headline":"S&P 500\u2019s bull trend nears seasonal headwind","Summary":""},{"Date":"Apr. 25, 2016 at 11:39 a.m. ET","Headline":"S&P 500 rattles the cage on the 2,080 support","Summary":""},{"Date":"Apr. 27, 2016 at 11:41 a.m. ET","Headline":"Nasdaq presses the 200-day average amid Apple\u2019s technical downdraft","Summary":""},{"Date":"Apr. 26, 2016 at 12:27 p.m. ET","Headline":"S&P 500\u2019s bull trend is poised to buck \u2018sell in May\u2019 headwind","Summary":""},{"Date":"Apr. 26, 2016 at 12:03 p.m. ET","Headline":"S&P 500\u2019s bull trend is poised to buck \u2018sell in May\u2019 headwind","Summary":""},{"Date":"Dec. 20, 2010 at 12:01 a.m. ET","Headline":"Outlook 2011","Summary":""},{"Date":"Apr. 27, 2009 at 12:01 a.m. ET","Headline":"The Long View","Summary":""},{"Date":"Apr. 29, 2016 at 11:01 a.m. ET","Headline":"\u2018Sell in May\u2019 surfaces with major S&P support under siege","Summary":""},{"Date":"Apr. 28, 2016 at 11:14 a.m. ET","Headline":"S&P 500\u2019s bull trend absorbs central-bank induced whipsaw","Summary":""},{"Date":"Apr. 30, 2016 at 9:11 p.m. ET","Headline":"Wall Street isn\u2019t rewarding low-expectation earnings beats","Summary":""},{"Date":"Apr. 30, 2016 at 12:01 a.m. ET","Headline":"Snapchat Keeps Climbing","Summary":""},{"Date":"May. 3, 2016 at 12:48 p.m. ET","Headline":"S&P 500\u2019s bull trend meets \u2018sell-in-May\u2019 market headwind","Summary":""},{"Date":"May. 3, 2016 at 12:10 p.m. ET","Headline":"Market bears fire seasonal shot across the bow","Summary":""},{"Date":"May. 2, 2016 at 11:31 a.m. ET","Headline":"Charting a garden-variety market pullback","Summary":""},{"Date":"May. 5, 2016 at 5:03 p.m. ET","Headline":"S&P 500, Dow end little changed ahead of jobs report; Nasdaq logs a loss","Summary":"Merck & Co. Inc.'s stock  was indicated about 1% higher in premarket trade Thursday, after the drug giant reported a first-quarter profit that beat expectations and raised its outlook for the year, offsetting a sales miss...."},{"Date":"May. 5, 2016 at 11:42 a.m. ET","Headline":"S&P 500 tags major support, lifts from initial retest","Summary":"Merck & Co. Inc.'s stock  was indicated about 1% higher in premarket trade Thursday, after the drug giant reported a first-quarter profit that beat expectations and raised its outlook for the year, offsetting a sales miss...."},{"Date":"May. 5, 2016 at 9:17 a.m. ET","Headline":"How beaten-up Mr. Market still could rise up to a new high","Summary":"Merck & Co. Inc.'s stock  was indicated about 1% higher in premarket trade Thursday, after the drug giant reported a first-quarter profit that beat expectations and raised its outlook for the year, offsetting a sales miss...."},{"Date":"May. 5, 2016 at 6:59 a.m. ET","Headline":"Merck beats profit expectations, bumps up full-year guidance range","Summary":"Merck & Co. Inc.'s stock  was indicated about 1% higher in premarket trade Thursday, after the drug giant reported a first-quarter profit that beat expectations and raised its outlook for the year, offsetting a sales miss...."},{"Date":"May. 4, 2016 at 11:46 a.m. ET","Headline":"S&P 500, Nasdaq fail retest of the breakdown point","Summary":""},{"Date":"May. 6, 2016 at 11:59 a.m. ET","Headline":"S&P, Dow nail major support, important retest underway","Summary":""},{"Date":"May. 9, 2016 at 11:21 a.m. ET","Headline":"S&P, Dow survive initial retest of the 2,040 and 17,580 support","Summary":""},{"Date":"May. 11, 2016 at 11:33 a.m. ET","Headline":"Nasdaq reaches the breakdown point, retest underway","Summary":""},{"Date":"May. 11, 2016 at 8:09 a.m. ET","Headline":"If this happens, it could be a fantastic summer to own stocks","Summary":""},{"Date":"May. 10, 2016 at 6:21 p.m. ET","Headline":"Feds investigate drugmakers\u2019 ties to pharmacy-benefit managers","Summary":""},{"Date":"May. 10, 2016 at 2:30 p.m. ET","Headline":"U.S. investigates Merck, J&J and Endo over pharmacy-benefit contracts","Summary":""},{"Date":"May. 10, 2016 at 12:11 p.m. ET","Headline":"Successful technical tests preserve U.S. markets\u2019 bull trend","Summary":""},{"Date":"May. 10, 2016 at 11:46 a.m. ET","Headline":"Successful technical tests preserve U.S. markets\u2019 bull trend","Summary":""},{"Date":"May. 10, 2016 at 12:01 a.m. ET","Headline":"Three Big Pharma Stocks Headed Higher","Summary":""},{"Date":"May. 5, 2016 at 12:01 a.m. ET","Headline":"Merck: Good Time to Buy","Summary":""},{"Date":"May. 13, 2016 at 10:56 a.m. ET","Headline":"S&P 500 retests the 50-day moving average","Summary":""},{"Date":"May. 12, 2016 at 11:45 a.m. ET","Headline":"Nasdaq stalls at the breakdown point, S&P traverses the range","Summary":""},{"Date":"May. 17, 2016 at 12:26 p.m. ET","Headline":"S&P 500 traverses the May range against a bullish-leaning backdrop","Summary":""},{"Date":"May. 17, 2016 at 12:04 p.m. ET","Headline":"S&P 500 traverses the range against a bullish-leaning backdrop","Summary":""},{"Date":"May. 16, 2016 at 11:36 a.m. ET","Headline":"S&P 500 survives latest retest of the 2,040 mark","Summary":""},{"Date":"May. 19, 2016 at 12:17 p.m. ET","Headline":"U.S. benchmarks venture under major technical support","Summary":""},{"Date":"May. 18, 2016 at 11:43 a.m. ET","Headline":"S&P 500 nails the 2,040 support ahead of the Fed","Summary":""},{"Date":"May. 20, 2016 at 11:47 a.m. ET","Headline":"S&P 500\u2019s bull trend absorbs latest retest of major support","Summary":""},{"Date":"May. 23, 2016 at 11:55 a.m. ET","Headline":"Nasdaq, S&P maintain support, narrow May range intact","Summary":""},{"Date":"May. 25, 2016 at 11:08 a.m. ET","Headline":"Bull trend intact, U.S. benchmarks challenge the May peak","Summary":""},{"Date":"May. 24, 2016 at 12:57 p.m. ET","Headline":"S&P 500\u2019s range-bound May backdrop supports bullish-leaning technical bias","Summary":""},{"Date":"May. 24, 2016 at 12:39 p.m. ET","Headline":"Range-bound May backdrop supports bullish-leaning technical bias","Summary":""},{"Date":"May. 25, 2016 at 12:01 a.m. ET","Headline":"Gilead a Buy Amid a Big Management Shake-Up","Summary":""},{"Date":"May. 28, 2016 at 12:01 a.m. ET","Headline":"Paris Flea Market Turns to eBay to Find More Buyers","Summary":""},{"Date":"Jun. 6, 2016 at 1:16 p.m. ET","Headline":"Forget the Fed, recommends Goldman,and watch how the dollar trades vs. the yuan","Summary":""},{"Date":"Jun. 6, 2016 at 11:52 a.m. ET","Headline":"Charting the S&P 500's approach of major technical resistance","Summary":""},{"Date":"Jun. 8, 2016 at 11:40 a.m. ET","Headline":"S&P 500\u2019s slow-motion breakout attempt remains underway","Summary":""},{"Date":"Jun. 7, 2016 at 4:41 p.m. ET","Headline":"Judge throws out Merck\u2019s $200 million verdict over Gilead","Summary":""},{"Date":"Jun. 7, 2016 at 12:15 p.m. ET","Headline":"S&P 500 rattles the cage on major resistance","Summary":""},{"Date":"Jun. 7, 2016 at 11:54 a.m. ET","Headline":"S&P 500 rattles the cage on major resistance","Summary":""},{"Date":"Jun. 10, 2016 at 11:32 a.m. ET","Headline":"Charting a garden-variety pullback from the 2016 peak","Summary":""},{"Date":"Jun. 10, 2016 at 8:32 a.m. ET","Headline":"A summer panic is starting to brew across markets","Summary":""},{"Date":"Jun. 9, 2016 at 8:47 p.m. ET","Headline":"Merck to purchase biotech Afferent for at least $500 million","Summary":""},{"Date":"Jun. 9, 2016 at 11:22 a.m. ET","Headline":"U.S. markets\u2019 sluggish June uptrend takes a breather","Summary":""},{"Date":"Jun. 10, 2016 at 12:01 a.m. ET","Headline":"Bristol-Myers, a Top Pharmaceuticals Pick","Summary":""},{"Date":"Jun. 14, 2016 at 12:28 p.m. ET","Headline":"U.S. markets\u2019 technical backdrop softens amid Brexit overhang","Summary":""},{"Date":"Jun. 14, 2016 at 12:08 p.m. ET","Headline":"U.S. markets\u2019 technical backdrop softens amid Brexit overhang","Summary":""},{"Date":"Jun. 13, 2016 at 11:30 a.m. ET","Headline":"S&P, Dow pull in toward retest of the 50-day average","Summary":""},{"Date":"Jun. 16, 2016 at 4:52 p.m. ET","Headline":"Stocks snap 5-day losing streak; Dow reverses triple-digit loss","Summary":"Shares of Merck & Co. Inc.  surged 2.4% in premarket trade Thursday, after the drug giant said a trial investigating the use of its lung cancer treatment met its primary endpoint. Merck said Keytruda was superior to chemot..."},{"Date":"Jun. 16, 2016 at 11:38 a.m. ET","Headline":"Charting the S&P 500\u2019s approach of major technical support","Summary":"Shares of Merck & Co. Inc.  surged 2.4% in premarket trade Thursday, after the drug giant said a trial investigating the use of its lung cancer treatment met its primary endpoint. Merck said Keytruda was superior to chemot..."},{"Date":"Jun. 16, 2016 at 7:38 a.m. ET","Headline":"Merck's stock surges on positive results from cancer-treatment study","Summary":"Shares of Merck & Co. Inc.  surged 2.4% in premarket trade Thursday, after the drug giant said a trial investigating the use of its lung cancer treatment met its primary endpoint. Merck said Keytruda was superior to chemot..."},{"Date":"Jun. 15, 2016 at 11:19 a.m. ET","Headline":"Nasdaq nails the 200-day average, lifts from support","Summary":""},{"Date":"Jun. 17, 2016 at 4:04 p.m. ET","Headline":"S&P 500 posts largest weekly drop since late April","Summary":"U.S. stocks finished lower Friday, With the S&P 500 and Nasdaq Composite logging their largest weekly drops since late April, as the looming \"Brexit\" vote in the U.K. and lingering worries about the Federal Reserve's reluc..."},{"Date":"Jun. 17, 2016 at 11:27 a.m. ET","Headline":"U.S. markets\u2019 \u2018bull trend\u2019 absorbs Fed-induced volatility spike","Summary":""},{"Date":"Jun. 20, 2016 at 11:16 a.m. ET","Headline":"U.S. benchmarks knife from the June low, reclaim 50-day average","Summary":""},{"Date":"Jun. 22, 2016 at 11:29 a.m. ET","Headline":"S&P, Dow sustain breaks atop 50-day average","Summary":""},{"Date":"Jun. 21, 2016 at 12:32 p.m. ET","Headline":"S&P 500\u2019s technical backdrop remains bullish-leaning pending Brexit vote","Summary":""},{"Date":"Jun. 21, 2016 at 12:06 p.m. ET","Headline":"S&P 500\u2019s technical backdrop remains bullish-leaning pending Brexit vote","Summary":""},{"Date":"Jun. 24, 2016 at 4:39 p.m. ET","Headline":"Brexit may make health care stocks a good defensive play","Summary":"All the stocks within the Dow Jones Industrial Average  that are trading ahead of Friday's open--28 of the 30 components--are dropping sharply, as  has left global markets in disarray. Dow futures plunged 537 points, or 3%..."},{"Date":"Jun. 24, 2016 at 10:56 a.m. ET","Headline":"Charting the technical damage (or lack thereof) inflicted by Brexit","Summary":"All the stocks within the Dow Jones Industrial Average  that are trading ahead of Friday's open--28 of the 30 components--are dropping sharply, as  has left global markets in disarray. Dow futures plunged 537 points, or 3%..."},{"Date":"Jun. 24, 2016 at 7:22 a.m. ET","Headline":"All Dow stocks trading premarket are falling sharply","Summary":"All the stocks within the Dow Jones Industrial Average  that are trading ahead of Friday's open--28 of the 30 components--are dropping sharply, as  has left global markets in disarray. Dow futures plunged 537 points, or 3%..."},{"Date":"Jun. 23, 2016 at 11:19 a.m. ET","Headline":"Charting a bullish U.S. technical backdrop with Brexit vote underway","Summary":""},{"Date":"Jun. 28, 2016 at 1:09 p.m. ET","Headline":"Charting a bearish technical shift in the stock market in Brexit aftermath","Summary":""},{"Date":"Jun. 28, 2016 at 12:26 p.m. ET","Headline":"Charting a bearish technical shift amid Brexit aftermath","Summary":""},{"Date":"Jun. 27, 2016 at 11:06 a.m. ET","Headline":"S&P, Dow extend downdraft, venture under the 200-day average","Summary":""},{"Date":"Jun. 30, 2016 at 11:22 a.m. ET","Headline":"Second 9-to-1 rally places U.S. benchmarks on firmer technical ground","Summary":""},{"Date":"Jun. 29, 2016 at 11:45 a.m. ET","Headline":"S&P 500 absorbs Brexit, reclaims the 2,040 breakdown point","Summary":""},{"Date":"Jul. 2, 2016 at 12:01 a.m. ET","Headline":"Finding Quality at Columbia Dividend Income","Summary":""},{"Date":"Jul. 1, 2016 at 11:32 a.m. ET","Headline":"Brexit-rally defies gravity, S&P 500 within view of June peak","Summary":""},{"Date":"Jul. 6, 2016 at 11:26 a.m. ET","Headline":"S&P, Dow nail first support, survive initial retest","Summary":""},{"Date":"Jul. 5, 2016 at 12:41 p.m. ET","Headline":"U.S. benchmarks digest Brexit-fueled whipsaw, S&P 500 tops near major resistance","Summary":""},{"Date":"Jul. 5, 2016 at 12:18 p.m. ET","Headline":"U.S. benchmarks digest Brexit-fueled whipsaw, S&P 500 tops near major resistance","Summary":""},{"Date":"Jul. 8, 2016 at 11:26 a.m. ET","Headline":"Charting the S&P 500\u2019s approach of the 2016 peak","Summary":""},{"Date":"Jul. 7, 2016 at 11:30 a.m. ET","Headline":"S&P, Dow hold the range top ahead of U.S. jobs report","Summary":""},{"Date":"Jul. 6, 2016 at 12:01 a.m. ET","Headline":"Top U.S. Pharma Themes for the Second Half","Summary":""},{"Date":"Jul. 12, 2016 at 12:43 p.m. ET","Headline":"Charting the S&P 500\u2019s break to \u2018clear skies\u2019 territory","Summary":""},{"Date":"Jul. 12, 2016 at 12:14 p.m. ET","Headline":"Charting the S&P 500\u2019s break to \u2018clear skies\u2019 territory","Summary":""},{"Date":"Jul. 11, 2016 at 11:40 a.m. ET","Headline":"Third 9-to-1 rally fuels S&P 500 break to uncharted territory","Summary":""},{"Date":"Jul. 14, 2016 at 11:16 a.m. ET","Headline":"S&P, Dow extend the break to uncharted territory","Summary":""},{"Date":"Jul. 14, 2016 at 7:50 a.m. ET","Headline":"These 32 century-old companies pay dividends of more than 3%","Summary":""},{"Date":"Jul. 13, 2016 at 11:48 a.m. ET","Headline":"Charting the Dow industrials\u2019 break to uncharted territory","Summary":""},{"Date":"Jul. 15, 2016 at 11:14 a.m. ET","Headline":"S&P 500 vies for latest technical record","Summary":""},{"Date":"Jul. 18, 2016 at 11:18 a.m. ET","Headline":"U.S. benchmarks sustain rally to less-charted territory","Summary":"BEIJING--China's Food and Drug Administration approved GlaxoSmithKline PLC's (GSK) Cervarix, the first vaccine against human papilloma virus to be licensed for use in China for the prevention of cervical cancer."},{"Date":"Jul. 18, 2016 at 2:18 a.m. ET","Headline":"China's FDA approves GSK's Cervarix vaccine","Summary":"BEIJING--China's Food and Drug Administration approved GlaxoSmithKline PLC's (GSK) Cervarix, the first vaccine against human papilloma virus to be licensed for use in China for the prevention of cervical cancer."},{"Date":"Jul. 15, 2016 at 12:01 a.m. ET","Headline":"Big Pharma Q2 Earnings Preview","Summary":""},{"Date":"Jul. 20, 2016 at 11:17 a.m. ET","Headline":"Charting the Dow industrials\u2019 crawl to latest technical record","Summary":""},{"Date":"Jul. 19, 2016 at 12:56 p.m. ET","Headline":"Charting the S&P 500\u2019s next technical target","Summary":""},{"Date":"Jul. 19, 2016 at 12:31 p.m. ET","Headline":"Charting the S&P 500\u2019s next technical target","Summary":""},{"Date":"Jul. 16, 2016 at 12:01 a.m. ET","Headline":"Seeking Low Valuations, High Yield","Summary":""},{"Date":"Jul. 22, 2016 at 11:32 a.m. ET","Headline":"Bull trend intact, Nasdaq, Dow nail first support","Summary":""},{"Date":"Jul. 21, 2016 at 11:44 a.m. ET","Headline":"S&P, Dow hold record territory amid dwindling volume","Summary":""},{"Date":"Jul. 23, 2016 at 12:01 a.m. ET","Headline":"Columbia Large Cap Growth Takes a Long-Term View","Summary":""},{"Date":"Jul. 26, 2016 at 12:50 p.m. ET","Headline":"Bull trend intact, S&P 500 stages garden-variety pullback","Summary":""},{"Date":"Jul. 26, 2016 at 12:21 p.m. ET","Headline":"Bull trend intact, S&P 500 stages garden-variety pullback","Summary":""},{"Date":"Jul. 25, 2016 at 11:31 a.m. ET","Headline":"Dow industrials back for another crack at first support","Summary":""},{"Date":"Jul. 28, 2016 at 11:46 a.m. ET","Headline":"S&P 500 flatlines near record territory (that\u2019s bullish)","Summary":""},{"Date":"Jul. 27, 2016 at 11:28 a.m. ET","Headline":"Charting the Russell 2000\u2019s breakout attempt","Summary":""},{"Date":"Jul. 29, 2016 at 4:52 p.m. ET","Headline":"S&P 500 ends just shy of record; Dow limps lower","Summary":"Merck & Co.  reported Friday second-quarter earnings that rose to $1.21 billion, or 43 cents a share, from $687 million, or 24 cents a share, in the same period a year ago. Excluding non-recurring acquisition and divestitu..."},{"Date":"Jul. 29, 2016 at 11:30 a.m. ET","Headline":"U.S. benchmarks lay technical groundwork for the next leg higher","Summary":"Merck & Co.  reported Friday second-quarter earnings that rose to $1.21 billion, or 43 cents a share, from $687 million, or 24 cents a share, in the same period a year ago. Excluding non-recurring acquisition and divestitu..."},{"Date":"Jul. 29, 2016 at 9:21 a.m. ET","Headline":"These sorry stocks are soaring \u2014 and that\u2019s a red flag for this rally","Summary":"Merck & Co.  reported Friday second-quarter earnings that rose to $1.21 billion, or 43 cents a share, from $687 million, or 24 cents a share, in the same period a year ago. Excluding non-recurring acquisition and divestitu..."},{"Date":"Jul. 29, 2016 at 6:59 a.m. ET","Headline":"Merck's profit and revenue rise above expectations","Summary":"Merck & Co.  reported Friday second-quarter earnings that rose to $1.21 billion, or 43 cents a share, from $687 million, or 24 cents a share, in the same period a year ago. Excluding non-recurring acquisition and divestitu..."},{"Date":"Aug. 1, 2016 at 11:34 a.m. ET","Headline":"S&P 500\u2019s coiled spring strengthens near-term bullish bias","Summary":""},{"Date":"Aug. 3, 2016 at 11:55 a.m. ET","Headline":"S&P 500 violates support, back for a crack at the breakdown point","Summary":""},{"Date":"Aug. 2, 2016 at 2:59 p.m. ET","Headline":"Merck and Allergan have both expressed interest in a Biogen takeover","Summary":""},{"Date":"Aug. 2, 2016 at 12:31 p.m. ET","Headline":"Charting the S&P 500\u2019s near-term technical test","Summary":""},{"Date":"Aug. 2, 2016 at 12:09 p.m. ET","Headline":"Charting the S&P 500\u2019s near-term technical test","Summary":""},{"Date":"Aug. 2, 2016 at 12:01 a.m. ET","Headline":"8 Dividend Stocks With Pristine Balance Sheets","Summary":""},{"Date":"Aug. 5, 2016 at 4:43 p.m. ET","Headline":"S&P 500, Nasdaq ring up records after stellar jobs report","Summary":"Merck & Co. Inc.'s stock  soared $6.16, or 11%, in active premarket trade Friday, after a late-stage trial of a rival's cancer treatment failed to meet its primary endpoint. That puts the stock on track to open at the high..."},{"Date":"Aug. 5, 2016 at 11:50 a.m. ET","Headline":"U.S. jobs report does the trick \u2014 S&P 500, Nasdaq rattle cage on uncharted territory","Summary":"Merck & Co. Inc.'s stock  soared $6.16, or 11%, in active premarket trade Friday, after a late-stage trial of a rival's cancer treatment failed to meet its primary endpoint. That puts the stock on track to open at the high..."},{"Date":"Aug. 5, 2016 at 8:53 a.m. ET","Headline":"Merck's stock gives big boost to Dow futures after rival drug's disappointing trial","Summary":"Merck & Co. Inc.'s stock  soared $6.16, or 11%, in active premarket trade Friday, after a late-stage trial of a rival's cancer treatment failed to meet its primary endpoint. That puts the stock on track to open at the high..."},{"Date":"Aug. 5, 2016 at 8:53 a.m. ET","Headline":"Failed trial of lung-cancer drug sends Bristol-Myers stock plunging and Merck\u2019s shares up","Summary":""},{"Date":"Aug. 4, 2016 at 11:47 a.m. ET","Headline":"S&P 500 returns to the range, Dow industrials nail first resistance","Summary":""},{"Date":"Aug. 3, 2016 at 12:01 a.m. ET","Headline":"Potential Biogen Buyout May Not Roil Quintiles","Summary":""},{"Date":"Aug. 6, 2016 at 12:07 p.m. ET","Headline":"Why Bristol-Myers lung-cancer drug could still succeed despite stunning trial failure","Summary":""},{"Date":"Aug. 6, 2016 at 12:01 a.m. ET","Headline":"Bristol-Myers Squibb\u2019s Bad News Buoys Merck","Summary":""},{"Date":"Aug. 9, 2016 at 12:32 p.m. ET","Headline":"S&P 500, Nasdaq extend the break to \u2018clear skies\u2019 territory","Summary":"Shares of Bristol-Myers Squibb Co.  dropped 1.8% in morning trade Monday, after disappointing trial results announced last week prompted Credit Suisse to downgrade the drug giant. Analyst Vamil Divan cut his rating to neut..."},{"Date":"Aug. 9, 2016 at 12:10 p.m. ET","Headline":"S&P 500, Nasdaq extend the break to \u2018clear skies\u2019 territory","Summary":"Shares of Bristol-Myers Squibb Co.  dropped 1.8% in morning trade Monday, after disappointing trial results announced last week prompted Credit Suisse to downgrade the drug giant. Analyst Vamil Divan cut his rating to neut..."},{"Date":"Aug. 8, 2016 at 4:24 p.m. ET","Headline":"Stocks retreat from all-time high to end slightly lower","Summary":"Shares of Bristol-Myers Squibb Co.  dropped 1.8% in morning trade Monday, after disappointing trial results announced last week prompted Credit Suisse to downgrade the drug giant. Analyst Vamil Divan cut his rating to neut..."},{"Date":"Aug. 8, 2016 at 11:40 a.m. ET","Headline":"S&P 500, Nasdaq carve out latest break to record territory","Summary":"Shares of Bristol-Myers Squibb Co.  dropped 1.8% in morning trade Monday, after disappointing trial results announced last week prompted Credit Suisse to downgrade the drug giant. Analyst Vamil Divan cut his rating to neut..."},{"Date":"Aug. 8, 2016 at 10:00 a.m. ET","Headline":"Bristol-Myers' stock extends slide after downgrade, Merck upgraded","Summary":"Shares of Bristol-Myers Squibb Co.  dropped 1.8% in morning trade Monday, after disappointing trial results announced last week prompted Credit Suisse to downgrade the drug giant. Analyst Vamil Divan cut his rating to neut..."},{"Date":"Aug. 11, 2016 at 11:53 a.m. ET","Headline":"Dow industrials tag record highs, breakout attempt underway","Summary":""},{"Date":"Aug. 10, 2016 at 11:54 a.m. ET","Headline":"Charting the Dow industrials\u2019 slow-motion breakout attempt","Summary":""},{"Date":"Aug. 12, 2016 at 11:29 a.m. ET","Headline":"Charting the U.S. markets\u2019 slow-motion breakout of the millennium","Summary":""},{"Date":"Aug. 15, 2016 at 11:40 a.m. ET","Headline":"Small- and mid-caps tag new highs, breakout attempt underway","Summary":""},{"Date":"Aug. 17, 2016 at 11:51 a.m. ET","Headline":"Dow, Nasdaq challenge first support ahead of Fed minutes","Summary":""},{"Date":"Aug. 16, 2016 at 12:36 p.m. ET","Headline":"Charting the U.S. benchmarks\u2019 pulling-teeth breakout attempt","Summary":""},{"Date":"Aug. 16, 2016 at 12:06 p.m. ET","Headline":"Charting the U.S. benchmarks\u2019 slow-motion (but still bullish) summer uptrend","Summary":""},{"Date":"Aug. 16, 2016 at 12:01 a.m. ET","Headline":"Lilly and Allergan Are Large-Cap Pharma Picks","Summary":""},{"Date":"Aug. 19, 2016 at 11:48 a.m. ET","Headline":"U.S. benchmarks\u2019 slow-motion uptrend intact amid commodity, currency cross currents","Summary":""},{"Date":"Aug. 18, 2016 at 11:41 a.m. ET","Headline":"Dow industrials rally from second successful test of 18,470 support","Summary":""},{"Date":"Aug. 23, 2016 at 12:30 p.m. ET","Headline":"Bull trend intact, latest S&P 500 breakout attempt underway","Summary":""},{"Date":"Aug. 23, 2016 at 12:08 p.m. ET","Headline":"Bull trend intact, latest S&P 500 breakout attempt underway","Summary":""},{"Date":"Aug. 22, 2016 at 11:12 a.m. ET","Headline":"S&P, Dow nail first support (again), maintain the range","Summary":""},{"Date":"Aug. 25, 2016 at 11:54 a.m. ET","Headline":"VIX ticks higher, S&P 500 holds first support amid pre-Fed holding pattern","Summary":"Health-care shares tumbled Wednesday, making it the worst performing of the S&P 500 Index's  ten sectors, as pricing issues in the industry flared up again, first inflamed by an astronomical price hike of a cancer drug by ..."},{"Date":"Aug. 24, 2016 at 4:33 p.m. ET","Headline":"Stocks end at 2-week low as drop in Mylan shares punishes health care","Summary":"Health-care shares tumbled Wednesday, making it the worst performing of the S&P 500 Index's  ten sectors, as pricing issues in the industry flared up again, first inflamed by an astronomical price hike of a cancer drug by ..."},{"Date":"Aug. 24, 2016 at 3:42 p.m. ET","Headline":"Health-care sector trails broader market as pricing issues reinflamed","Summary":"Health-care shares tumbled Wednesday, making it the worst performing of the S&P 500 Index's  ten sectors, as pricing issues in the industry flared up again, first inflamed by an astronomical price hike of a cancer drug by ..."},{"Date":"Aug. 24, 2016 at 11:38 a.m. ET","Headline":"S&P, Nasdaq press the range top ahead of the Fed","Summary":""},{"Date":"Aug. 26, 2016 at 11:33 a.m. ET","Headline":"S&P 500 rattles the range, lifts from support after the Fed","Summary":""},{"Date":"Aug. 29, 2016 at 11:07 a.m. ET","Headline":"Charting a Fed-induced whipsaw, U.S. benchmarks rise from three-week lows","Summary":""},{"Date":"Aug. 31, 2016 at 3:35 p.m. ET","Headline":"How Gilead \u2018broke\u2019 Obamacare","Summary":""},{"Date":"Aug. 31, 2016 at 11:29 a.m. ET","Headline":"S&P 500 holds the range, Dow ventures lower ahead of jobs report","Summary":""},{"Date":"Aug. 30, 2016 at 12:19 p.m. ET","Headline":"Bull trend intact, U.S. benchmarks absorb Fed-related \u2018volatility\u2019","Summary":""},{"Date":"Aug. 30, 2016 at 11:58 a.m. ET","Headline":"Bull trend intact, U.S. benchmarks absorb Fed-induced \u2018volatility\u2019","Summary":""},{"Date":"Sep. 2, 2016 at 7:09 a.m. ET","Headline":"Merck scraps osteoporosis drug development on increased risk of stroke","Summary":"Merck & Co.  said Friday it is scrapping the development of osteoporosis treatment odanacatib and will no longer seek regulatory approval for its use. \"We are disappointed that the overall benefit-risk profile for odanacat..."},{"Date":"Sep. 6, 2016 at 12:43 p.m. ET","Headline":"Nasdaq nails major support, S&P 500 holds the range","Summary":""},{"Date":"Sep. 6, 2016 at 12:23 p.m. ET","Headline":"Nasdaq nails major support, S&P 500 holds the range","Summary":""},{"Date":"Sep. 8, 2016 at 11:16 a.m. ET","Headline":"Charting the small- and mid-cap benchmarks\u2019 stealth breakout attempts","Summary":""},{"Date":"Sep. 7, 2016 at 12:02 p.m. ET","Headline":"Nasdaq tags uncharted territory, S&P 500 presses the range top","Summary":""},{"Date":"Sep. 10, 2016 at 12:01 a.m. ET","Headline":"Novo Nordisk, World Leader in Diabetes Drugs, Is Set to Rally","Summary":""},{"Date":"Sep. 9, 2016 at 4:33 p.m. ET","Headline":"Would Gilead Pick Up Tesaro\u2019s PARP?","Summary":""},{"Date":"Sep. 9, 2016 at 12:29 p.m. ET","Headline":"Market bears resurface, S&P 500 ventures under major support","Summary":""},{"Date":"Sep. 12, 2016 at 11:59 a.m. ET","Headline":"Market bears fire shot across the bow, U.S. benchmarks retest major support","Summary":""},{"Date":"Sep. 14, 2016 at 11:36 a.m. ET","Headline":"S&P, Dow survive second test of major support","Summary":""},{"Date":"Sep. 13, 2016 at 1:00 p.m. ET","Headline":"S&P 500 survives major technical test, bull trend (tenuously) intact","Summary":""},{"Date":"Sep. 13, 2016 at 12:37 p.m. ET","Headline":"S&P 500 survives major technical test, bull trend (tenuously) intact","Summary":""},{"Date":"Sep. 16, 2016 at 11:39 a.m. ET","Headline":"Nasdaq reclaims the breakdown point, within view of record highs","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Thursday a Phase 3 study of ertugliflozin, an investigational oral treatment for type 2 diabetes, met its primary endpoint. The drug giants plan to submit a new drug application for ..."},{"Date":"Sep. 15, 2016 at 11:23 a.m. ET","Headline":"S&P 500 nails major support (again), rally attempt underway","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Thursday a Phase 3 study of ertugliflozin, an investigational oral treatment for type 2 diabetes, met its primary endpoint. The drug giants plan to submit a new drug application for ..."},{"Date":"Sep. 15, 2016 at 8:41 a.m. ET","Headline":"Merck and Pfizer's diabetes treatment meets primary endpoint of late-stage trial","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Thursday a Phase 3 study of ertugliflozin, an investigational oral treatment for type 2 diabetes, met its primary endpoint. The drug giants plan to submit a new drug application for ..."},{"Date":"Sep. 17, 2016 at 2:54 a.m. ET","Headline":"Seeking the Best of Both Growth and Value Stocks","Summary":""},{"Date":"Sep. 17, 2016 at 2:27 a.m. ET","Headline":"Will Bayer\u2019s Takeover of Monsanto Be a Bust?","Summary":""},{"Date":"Sep. 20, 2016 at 4:51 p.m. ET","Headline":"Stocks pare gains to end flat ahead of Fed, BOJ decisions","Summary":""},{"Date":"Sep. 20, 2016 at 12:37 p.m. ET","Headline":"Charting the S&P 500\u2019s bullish-leaning holding pattern ahead of the Fed","Summary":""},{"Date":"Sep. 20, 2016 at 12:15 p.m. ET","Headline":"Charting the S&P 500\u2019s bullish-leaning holding pattern ahead of the Fed","Summary":""},{"Date":"Sep. 19, 2016 at 4:39 p.m. ET","Headline":"Stocks end near break-even amid skittishness ahead of central-bank meetings","Summary":""},{"Date":"Sep. 19, 2016 at 11:32 a.m. ET","Headline":"Nasdaq presses uncharted territory, S&P 500 holds the range","Summary":""},{"Date":"Sep. 22, 2016 at 11:46 a.m. ET","Headline":"Nasdaq takes flight after the Fed, S&P 500 reclaims the breakdown point","Summary":""},{"Date":"Sep. 21, 2016 at 11:24 a.m. ET","Headline":"Charting a bullish technical tilt after the BOJ, and ahead of the Fed","Summary":""},{"Date":"Sep. 23, 2016 at 11:25 a.m. ET","Headline":"S&P 500 extends breakout, reclaims the 50-day average","Summary":""},{"Date":"Sep. 26, 2016 at 11:17 a.m. ET","Headline":"Charting a garden variety pullback ahead of the U.S. presidential debate","Summary":""},{"Date":"Sep. 28, 2016 at 11:45 a.m. ET","Headline":"S&P 500 whipsaws at the breakdown point, Nasdaq reclaims resistance","Summary":""},{"Date":"Sep. 27, 2016 at 12:42 p.m. ET","Headline":"Bullish bias intact, U.S. benchmarks return to the range","Summary":""},{"Date":"Sep. 27, 2016 at 12:20 p.m. ET","Headline":"Bullish bias intact, U.S. benchmarks return to the range","Summary":""},{"Date":"Sep. 30, 2016 at 1:28 p.m. ET","Headline":"Biotech stocks have plenty of catalysts around the corner","Summary":""},{"Date":"Sep. 30, 2016 at 11:53 a.m. ET","Headline":"S&P 500\u2019s \u2018bull trend\u2019 absorbs final third-quarter whipsaw","Summary":""},{"Date":"Sep. 29, 2016 at 4:26 p.m. ET","Headline":"Dow closes down nearly 200 points on Deutsche Bank, Fed concerns","Summary":""},{"Date":"Sep. 29, 2016 at 11:49 a.m. ET","Headline":"Charting a surprisingly flat September S&P 500 performance","Summary":""},{"Date":"Sep. 24, 2016 at 12:01 a.m. ET","Headline":"Pharma Shares Slump, but Payout Yields Tempt","Summary":""},{"Date":"Oct. 4, 2016 at 12:28 p.m. ET","Headline":"Charting the S&P 500\u2019s range-bound, but bullish, fourth-quarter backdrop","Summary":""},{"Date":"Oct. 4, 2016 at 12:03 p.m. ET","Headline":"Charting the S&P 500\u2019s range-bound, but bullish, fourth-quarter backdrop","Summary":""},{"Date":"Oct. 3, 2016 at 11:48 a.m. ET","Headline":"S&P, Dow rattle the near-term range","Summary":""},{"Date":"Oct. 6, 2016 at 11:27 a.m. ET","Headline":"Nasdaq tops just under record highs, S&P 500 nails the breakdown point","Summary":""},{"Date":"Oct. 5, 2016 at 11:33 a.m. ET","Headline":"S&P 500\u2019s \u2018bull trend\u2019 intact amid major sector rotation","Summary":""},{"Date":"Oct. 7, 2016 at 11:30 a.m. ET","Headline":"U.S. benchmarks\u2019 \u2018bull trend\u2019 absorbs October currency whipsaws","Summary":""},{"Date":"Oct. 10, 2016 at 4:30 p.m. ET","Headline":"Stocks close higher on oil, energy-sector gains","Summary":"Bristol-Myers Squibb  shares dropped 8.7% in premarket trade on Monday after Merck & Co.  announced positive mid\/late-stage clinical trial results for its rival lung cancer drug over the weekend. Merck said its Keytruda, w..."},{"Date":"Oct. 10, 2016 at 11:27 a.m. ET","Headline":"Nasdaq presses uncharted territory, S&P 500 challenges the 50-day average","Summary":"Bristol-Myers Squibb  shares dropped 8.7% in premarket trade on Monday after Merck & Co.  announced positive mid\/late-stage clinical trial results for its rival lung cancer drug over the weekend. Merck said its Keytruda, w..."},{"Date":"Oct. 10, 2016 at 9:23 a.m. ET","Headline":"Bristol-Myers stock drops nearly 9% after Merck announces positive lung cancer drug results","Summary":"Bristol-Myers Squibb  shares dropped 8.7% in premarket trade on Monday after Merck & Co.  announced positive mid\/late-stage clinical trial results for its rival lung cancer drug over the weekend. Merck said its Keytruda, w..."},{"Date":"Oct. 12, 2016 at 12:02 p.m. ET","Headline":"Brexit-related aftershock stirs U.S. market technical cross currents","Summary":"U.S. stocks closed sharply lower Tuesday after Alcoa Inc. results started earnings season off on a dour note while oil prices fell and the dollar rose. The Dow Jones Industrial Average  fell 200.38 points, or 1.1%, to clos..."},{"Date":"Oct. 11, 2016 at 5:20 p.m. ET","Headline":"The Health-Care Sector Is Anything but Healthy","Summary":"U.S. stocks closed sharply lower Tuesday after Alcoa Inc. results started earnings season off on a dour note while oil prices fell and the dollar rose. The Dow Jones Industrial Average  fell 200.38 points, or 1.1%, to clos..."},{"Date":"Oct. 11, 2016 at 4:05 p.m. ET","Headline":"U.S. stocks close sharply lower on earnings concerns, oil retreat","Summary":"U.S. stocks closed sharply lower Tuesday after Alcoa Inc. results started earnings season off on a dour note while oil prices fell and the dollar rose. The Dow Jones Industrial Average  fell 200.38 points, or 1.1%, to clos..."},{"Date":"Oct. 11, 2016 at 1:18 p.m. ET","Headline":"Market bears resurface, S&P 500 ventures under near-term support","Summary":""},{"Date":"Oct. 11, 2016 at 12:54 p.m. ET","Headline":"Market bears resurface, S&P 500 ventures under near-term support","Summary":""},{"Date":"Oct. 11, 2016 at 7:03 a.m. ET","Headline":"How a Merck cancer breakthrough caused Bristol-Myers\u2019 stock to plunge","Summary":""},{"Date":"Oct. 14, 2016 at 11:59 a.m. ET","Headline":"Charting the S&P 500\u2019s bullish hammer at major support","Summary":""},{"Date":"Oct. 14, 2016 at 6:04 a.m. ET","Headline":"Aerie Stock Hits Record High, Holder Sells $2 Million","Summary":""},{"Date":"Oct. 13, 2016 at 11:50 a.m. ET","Headline":"S&P 500, Dow industrials rattle the cage on major support: S&P 2,117, and Dow 18,000","Summary":""},{"Date":"Oct. 18, 2016 at 12:32 p.m. ET","Headline":"Bull \u2018trend\u2019 intact, S&P 500 challenges the breakdown point","Summary":""},{"Date":"Oct. 18, 2016 at 12:11 p.m. ET","Headline":"Bull \u2018trend\u2019 intact, S&P 500 challenges the breakdown point","Summary":""},{"Date":"Oct. 17, 2016 at 11:48 a.m. ET","Headline":"S&P 500\u2019s bullish reversal stalls at the breakdown point","Summary":""},{"Date":"Oct. 20, 2016 at 11:02 a.m. ET","Headline":"S&P 500, Nasdaq balk (again) at first resistance","Summary":"Merck & Co.  said Wednesday morning that its investigational antiviral medicine met its primary endpoint in a phase 3 trial. The treatment, letermovir, is being tested to prevent infection in stem cell transplant recipient..."},{"Date":"Oct. 19, 2016 at 11:23 a.m. ET","Headline":"S&P 500, Nasdaq back for latest crack at the breakdown point","Summary":"Merck & Co.  said Wednesday morning that its investigational antiviral medicine met its primary endpoint in a phase 3 trial. The treatment, letermovir, is being tested to prevent infection in stem cell transplant recipient..."},{"Date":"Oct. 19, 2016 at 7:33 a.m. ET","Headline":"Merck says its antiviral medicine met late-stage primary endpoint","Summary":"Merck & Co.  said Wednesday morning that its investigational antiviral medicine met its primary endpoint in a phase 3 trial. The treatment, letermovir, is being tested to prevent infection in stem cell transplant recipient..."},{"Date":"Oct. 22, 2016 at 12:01 a.m. ET","Headline":"Lanxess Shares Could Rise 25% or More","Summary":""},{"Date":"Oct. 22, 2016 at 12:01 a.m. ET","Headline":"10 Top Dividend Payers for the Long Haul","Summary":""},{"Date":"Oct. 22, 2016 at 12:01 a.m. ET","Headline":"After a Bumpy Week, Stocks End Up 0.4%","Summary":""},{"Date":"Oct. 21, 2016 at 11:49 a.m. ET","Headline":"Nasdaq challenges the breakdown point, S&P 500 traverses the range","Summary":""},{"Date":"Oct. 24, 2016 at 12:51 p.m. ET","Headline":"These investors, many with religious ties, are calling for drug price transparency","Summary":""},{"Date":"Oct. 24, 2016 at 11:38 a.m. ET","Headline":"The market in a minute: It\u2019s not time to step on the gas yet","Summary":""},{"Date":"Oct. 24, 2016 at 11:09 a.m. ET","Headline":"S&P 500 ventures atop resistance, within view of 50-day average","Summary":""},{"Date":"Oct. 26, 2016 at 12:43 p.m. ET","Headline":"Apple\u2019s stock is the biggest drag on the Dow","Summary":"U.S. stocks closed lower on Tuesday, pressured as the latest corporate results raised new concerns about whether the market's levels were justified given the pace of economic activity. Both 3M Co. [S: MMM] and Whirlpool Co..."},{"Date":"Oct. 26, 2016 at 11:14 a.m. ET","Headline":"Small- and mid-cap benchmarks survive (another) retest of major support","Summary":"U.S. stocks closed lower on Tuesday, pressured as the latest corporate results raised new concerns about whether the market's levels were justified given the pace of economic activity. Both 3M Co. [S: MMM] and Whirlpool Co..."},{"Date":"Oct. 25, 2016 at 4:37 p.m. ET","Headline":"Stock market ends lower after lackluster earnings, drop in consumer confidence","Summary":"U.S. stocks closed lower on Tuesday, pressured as the latest corporate results raised new concerns about whether the market's levels were justified given the pace of economic activity. Both 3M Co. [S: MMM] and Whirlpool Co..."},{"Date":"Oct. 25, 2016 at 4:02 p.m. ET","Headline":"U.S. stocks close lower as earnings, data weigh","Summary":"U.S. stocks closed lower on Tuesday, pressured as the latest corporate results raised new concerns about whether the market's levels were justified given the pace of economic activity. Both 3M Co. [S: MMM] and Whirlpool Co..."},{"Date":"Oct. 25, 2016 at 2:30 p.m. ET","Headline":"Gardasil propelled Merck to a strong third quarter \u2014 but don\u2019t expect that to last","Summary":"Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company reported net income of $2.2 billion, or 78 cents per share, up from $1.8 billion, or 64 cents..."},{"Date":"Oct. 25, 2016 at 12:46 p.m. ET","Headline":"S&P 500\u2019s bull \u2018trend\u2019 intact ahead of the best six months seasonally","Summary":"Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company reported net income of $2.2 billion, or 78 cents per share, up from $1.8 billion, or 64 cents..."},{"Date":"Oct. 25, 2016 at 12:24 p.m. ET","Headline":"S&P 500\u2019s bull \u2018trend\u2019 intact ahead of the best six months seasonally","Summary":"Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company reported net income of $2.2 billion, or 78 cents per share, up from $1.8 billion, or 64 cents..."},{"Date":"Oct. 25, 2016 at 9:20 a.m. ET","Headline":"A long-term gold bull wants to see this happen before he buys more","Summary":"Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company reported net income of $2.2 billion, or 78 cents per share, up from $1.8 billion, or 64 cents..."},{"Date":"Oct. 25, 2016 at 6:56 a.m. ET","Headline":"Merck shares climb 3% after third-quarter earnings beat","Summary":"Shares of Merck & Co. Inc.  were up 3% in premarket trade Tuesday after the company beat third-quarter expectations. The company reported net income of $2.2 billion, or 78 cents per share, up from $1.8 billion, or 64 cents..."},{"Date":"Oct. 28, 2016 at 11:42 a.m. ET","Headline":"S&P 500 holds the range, Russell 2000 continues to press major support","Summary":""},{"Date":"Oct. 27, 2016 at 11:47 a.m. ET","Headline":"Russell 2000 challenges major support amid 10-year yield\u2019s breakout","Summary":""},{"Date":"Oct. 29, 2016 at 12:36 a.m. ET","Headline":"This Year, the Market\u2019s Going to the Dogs","Summary":""},{"Date":"Nov. 3, 2016 at 9:18 a.m. ET","Headline":"The stocks that say buy me, this election is already over","Summary":""},{"Date":"Nov. 4, 2016 at 7:30 a.m. ET","Headline":"Merck\u2019s Alzheimer\u2019s drug data fuel hopes for new treatment","Summary":""},{"Date":"Nov. 6, 2016 at 7:26 a.m. ET","Headline":"Drug companies spend $109 million to block vote to lower drug prices","Summary":""},{"Date":"Nov. 9, 2016 at 2:12 p.m. ET","Headline":"\u2018The unthinkable has happened\u2019: President-elect Trump sends drug stocks up and other players tumbling","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 10:09 a.m. ET","Headline":"Trump\u2019s victory is just the beginning of the shocks for stocks","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 6:56 a.m. ET","Headline":"Drug stocks rally premarket, while health insurers and hospital operators slide","Summary":"Health care stocks were mixed in premarket trade Wednesday, with drug stocks benefiting from expectations that a Trump administration will take a less harsh view on drug pricing, while health insurers fell on expectations ..."},{"Date":"Nov. 9, 2016 at 6:56 a.m. ET","Headline":"Dow stocks tumble as tech leads losers, but healthcare gains","Summary":"Dow Jones Industrial Average  futures are plunging, but the feeling isn't unanimously bearish about D. Of the 29 Dow stocks that are trading premarket, 24 are selling off, with 21 down at least 1%. The most-active decliner..."},{"Date":"Nov. 11, 2016 at 7:10 a.m. ET","Headline":"Fearing changes under President-elect Trump, women are getting IUDs and stockpiling Plan B","Summary":""},{"Date":"Nov. 10, 2016 at 4:25 p.m. ET","Headline":"Dow rallies to record close as investors reposition for Trump presidency","Summary":""},{"Date":"Nov. 10, 2016 at 11:26 a.m. ET","Headline":"The death of Obamacare will bring new opportunities for investors","Summary":""},{"Date":"Nov. 10, 2016 at 9:46 a.m. ET","Headline":"President-elect Trump puts Obamacare\u2019s future up in the air","Summary":""},{"Date":"Nov. 12, 2016 at 12:01 a.m. ET","Headline":"Pharma M&A Is on the Way","Summary":""},{"Date":"Nov. 15, 2016 at 12:36 p.m. ET","Headline":"European stocks rise as oil boosts energy shares","Summary":"FRANKFURT--German pharmaceuticals and chemicals company Merck KGaA (MRK.XE) on Tuesday reported a 25.5% rise in net profit for the third quarter of 2016 and raised its guidance for the full year. Net profit for the period ..."},{"Date":"Nov. 15, 2016 at 1:42 a.m. ET","Headline":"Merck KGaA net income rises 25.5%","Summary":"FRANKFURT--German pharmaceuticals and chemicals company Merck KGaA (MRK.XE) on Tuesday reported a 25.5% rise in net profit for the third quarter of 2016 and raised its guidance for the full year. Net profit for the period ..."},{"Date":"Nov. 14, 2016 at 8:56 a.m. ET","Headline":"5 big hurdles to repealing Obamacare","Summary":""},{"Date":"Nov. 17, 2016 at 9:28 a.m. ET","Headline":"10 biotech companies ripe for a buyout, courtesy of Donald Trump","Summary":""},{"Date":"Nov. 23, 2016 at 11:58 a.m. ET","Headline":"Bull trend broadens: Charting the break atop Dow 19,000, S&P 2,200","Summary":""},{"Date":"Nov. 22, 2016 at 2:34 p.m. ET","Headline":"Share buybacks will rise 30% to $780 billion next year, says Goldman Sachs","Summary":""},{"Date":"Nov. 25, 2016 at 7:09 a.m. ET","Headline":"What Eli Lilly\u2019s hard fall in Alzheimer\u2019s treatment race means for its competitors","Summary":""},{"Date":"Nov. 26, 2016 at 12:01 a.m. ET","Headline":"Global Dividend Growth Takes a Few Steps Back","Summary":""},{"Date":"Nov. 29, 2016 at 12:24 p.m. ET","Headline":"Bull trend intact:  Charting the S&P 500\u2019s garden-variety pullback","Summary":""},{"Date":"Nov. 29, 2016 at 11:57 a.m. ET","Headline":"Bull trend intact:  Charting the S&P 500\u2019s garden-variety pullback","Summary":""},{"Date":"Nov. 28, 2016 at 11:18 a.m. ET","Headline":"Bull trend pauses, U.S. benchmarks pull in from record highs","Summary":""},{"Date":"Nov. 28, 2016 at 11:15 a.m. ET","Headline":"Amazon\u2019s cloud services bloom, fed by demand from big clients","Summary":""},{"Date":"Nov. 28, 2016 at 9:45 a.m. ET","Headline":"Biogen in promising but risky limelight after Eli Lilly\u2019s Alzheimer\u2019s drug fails","Summary":""},{"Date":"Dec. 1, 2016 at 11:50 a.m. ET","Headline":"Charting a December divergence, Nasdaq plunges to 50-day average","Summary":""},{"Date":"Dec. 1, 2016 at 6:11 a.m. ET","Headline":"Three Biotechs With Bullish Insider Buying","Summary":""},{"Date":"Nov. 30, 2016 at 11:21 a.m. ET","Headline":"Closing out November, U.S. benchmarks sustain the technical breakout","Summary":""},{"Date":"Dec. 3, 2016 at 12:01 a.m. ET","Headline":"How to Invest in 2017: Don\u2019t Chase Trump Stocks","Summary":""},{"Date":"Dec. 2, 2016 at 11:47 a.m. ET","Headline":"S&P 500 nails the 2,190 breakout point, survives initial retest","Summary":""},{"Date":"Dec. 5, 2016 at 11:32 a.m. ET","Headline":"Dow extends break to uncharted territory, S&P holds the 2,190 breakout point","Summary":""},{"Date":"Dec. 7, 2016 at 11:24 a.m. ET","Headline":"Charting the S&P 500\u2019s latest slow-motion breakout attempt","Summary":""},{"Date":"Dec. 6, 2016 at 12:28 p.m. ET","Headline":"Bull trend intact:  S&P 500 rallies from the breakout point","Summary":""},{"Date":"Dec. 6, 2016 at 12:04 p.m. ET","Headline":"Bull trend intact:  S&P 500 rallies from the breakout point","Summary":""},{"Date":"Dec. 9, 2016 at 12:55 p.m. ET","Headline":"Biogen gains on new Eli Lilly Alzheimer\u2019s data, as beta-amyloid hypothesis \u2018lives to see another day\u2019","Summary":""},{"Date":"Dec. 8, 2016 at 3:06 p.m. ET","Headline":"Would Gilead Buy BioMarin?","Summary":""},{"Date":"Dec. 8, 2016 at 7:28 a.m. ET","Headline":"Stocks close at new heights as investors shake off Trump-inspired health-care woes","Summary":""},{"Date":"Dec. 10, 2016 at 12:01 a.m. ET","Headline":"A Top Dividend Fund\u2019s Newest Favorites","Summary":""},{"Date":"Dec. 10, 2016 at 12:01 a.m. ET","Headline":"Get Ready for Dow 20,000","Summary":""},{"Date":"Dec. 15, 2016 at 5:35 p.m. ET","Headline":"Gilead shares slip as jury sides with Merck in patent lawsuit","Summary":"Shares of Gilead Sciences Inc.  slipped while Merck & Co.  rose in the extended session Thursday after a jury awarded Merck billions in royalties over a hepatitis C drug dispute. In a patent lawsuit against Gilead, a feder..."},{"Date":"Dec. 21, 2016 at 1:46 p.m. ET","Headline":"What Gilead\u2019s True Believers Should Do Now","Summary":""},{"Date":"Dec. 20, 2016 at 11:19 a.m. ET","Headline":"Pharma Picks as Fundamentals Weaken","Summary":""},{"Date":"Dec. 23, 2016 at 10:53 a.m. ET","Headline":"11 tax-loss stocks to pick up before the end of the year","Summary":""},{"Date":"Jan. 2, 2017 at 12:01 a.m. ET","Headline":"Where to Find Yield","Summary":""},{"Date":"Jan. 7, 2017 at 12:01 a.m. ET","Headline":"Stockpicker\u2019s Delight","Summary":""},{"Date":"Jan. 10, 2017 at 5:01 p.m. ET","Headline":"Merck shares rise after hours on priority review lung cancer drug application","Summary":"Merck & Co.  shares advanced in the extended session Tuesday after the drug maker said the Food and Drug Administration will grant a priority review for one of its lung cancer treatments. Merck shares rose 2.2% to $61.25 a..."},{"Date":"Jan. 10, 2017 at 4:55 p.m. ET","Headline":"Nasdaq closes at 4th straight record\u2014marks best such streak since 1999","Summary":""},{"Date":"Jan. 9, 2017 at 5:41 p.m. ET","Headline":"Five unpopular, but prudent, things for investors to do near Dow 20,000","Summary":""},{"Date":"Jan. 9, 2017 at 4:35 p.m. ET","Headline":"The Best Dow Stocks As 20,000 Looms","Summary":""},{"Date":"Jan. 11, 2017 at 4:27 p.m. ET","Headline":"Dow moves within 50 points of 20,000 after Trump news conference","Summary":"U.S. stocks rebounded to close higher Wednesday following President-elect Donald Trump's press conference, with the Nasdaq notching its fifth straight record close in a row. The Dow Jones Industrial Average  rose 98.75 poi..."},{"Date":"Jan. 11, 2017 at 4:06 p.m. ET","Headline":"Nasdaq closes at fifth straight record as stocks finish higher","Summary":"U.S. stocks rebounded to close higher Wednesday following President-elect Donald Trump's press conference, with the Nasdaq notching its fifth straight record close in a row. The Dow Jones Industrial Average  rose 98.75 poi..."},{"Date":"Jan. 11, 2017 at 3:14 p.m. ET","Headline":"What pharma investors ought to do after Donald Trump fires a salvo","Summary":""},{"Date":"Jan. 14, 2017 at 12:01 a.m. ET","Headline":"Don\u2019t Fear the Tweeter","Summary":""},{"Date":"Jan. 13, 2017 at 11:01 a.m. ET","Headline":"Drug Pricing May Linger Over Biotech in 2017","Summary":""},{"Date":"Jan. 20, 2017 at 4:16 p.m. ET","Headline":"Merck will pay $625 million and royalties to settle Keytruda patent litigation with Bristol-Myers Squibb and Ono Pharma","Summary":"Merck & Co. Inc.  will pay $625 million and royalties to Bristol-Myers Squibb Co.  and Ono Pharmaceutical Co. Ltd. to settle patent litigation over Merck's cancer drug Keytruda, the companies said Friday afternoon. As part..."},{"Date":"Jan. 20, 2017 at 11:11 a.m. ET","Headline":"Bristol-Myers\u2019 tight-lipped pass on accelerated lung cancer drug approval leaves field wide open for Merck","Summary":"Bristol-Myers Squibb Co.  shares sunk 7.2% in pre-market trade Friday after the company said it wouldn't try for accelerated approval in first-line lung cancer for its combination of Opdivo and Yervoy. The company said the..."},{"Date":"Jan. 20, 2017 at 7:48 a.m. ET","Headline":"Bristol-Myers Squibb stock sinks 7.2% after it says it won't pursue accelerated approval for lung cancer combination treatment","Summary":"Bristol-Myers Squibb Co.  shares sunk 7.2% in pre-market trade Friday after the company said it wouldn't try for accelerated approval in first-line lung cancer for its combination of Opdivo and Yervoy. The company said the..."},{"Date":"Jan. 19, 2017 at 4:06 p.m. ET","Headline":"U.S. stocks close lower ahead of Trump inauguration","Summary":"U.S. stocks finished lower Thursday with the Dow industrials falling a fifth straight session as investors exercised caution ahead of President-elect Donald Trump's inauguration on Friday. The Dow Jones Industrial Average ..."},{"Date":"Jan. 21, 2017 at 12:01 a.m. ET","Headline":"5 Drug Stocks With Rising Dividends and Yields Up to 4.1%","Summary":""},{"Date":"Jan. 24, 2017 at 10:23 a.m. ET","Headline":"Health care sector ETF falls for sixth-straight day, longest such streak in 16 months","Summary":"The SPDR Health Care Select Sector ETF  is shedding 1% in morning trade, putting it on track for a sixth-straight loss, amid uncertainty over the fallout from President Donald Trump's intent to repeal the Affordable Care A..."},{"Date":"Jan. 23, 2017 at 3:21 p.m. ET","Headline":"We\u2019re in the year of the biotech buyout, and here are five prime targets","Summary":""},{"Date":"Jan. 26, 2017 at 8:14 a.m. ET","Headline":"Dow\u2019s road to 20,000 paved by Goldman, Boeing, and IBM","Summary":""},{"Date":"Jan. 25, 2017 at 9:38 a.m. ET","Headline":"The Trump factor: Should investors be bullish or bearish \u2014 or neither?","Summary":""},{"Date":"Dec. 3, 2016 at 12:01 a.m. ET","Headline":"Top 10 Stock Picks for 2017","Summary":""},{"Date":"Jan. 28, 2017 at 7:58 a.m. ET","Headline":"Outlooks for the Age of Trump are top focus of earnings season","Summary":""},{"Date":"Jan. 27, 2017 at 11:48 a.m. ET","Headline":"Two things are happening in the U.S. stock market for the first time since 1900","Summary":""},{"Date":"Jan. 27, 2017 at 9:48 a.m. ET","Headline":"Merck will release average drug price increases to \u2018provide greater transparency\u2019","Summary":""},{"Date":"Jan. 28, 2017 at 12:01 a.m. ET","Headline":"Barron\u2019s 2017 Roundtable, Part 3: 17 Picks From Three Pros","Summary":""},{"Date":"Feb. 1, 2017 at 7:00 a.m. ET","Headline":"President Trump says he wants to bring down drug prices \u2014 and uses aspirin as an example","Summary":""},{"Date":"Jan. 31, 2017 at 4:23 p.m. ET","Headline":"Trump Today: President backs Obama LGBTQ workforce rule but cyber order delayed","Summary":""},{"Date":"Jan. 31, 2017 at 8:07 a.m. ET","Headline":"Why Trump\u2019s immigration order could spark a brain drain that hurts the U.S. economy","Summary":""},{"Date":"Feb. 3, 2017 at 7:38 a.m. ET","Headline":"Above the rise of Merck\u2019s Gardasil vaccine, a specter is looming","Summary":"Merck & Co. Inc.  shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer drug beat expectations. But on the company's earnings call, management sai..."},{"Date":"Feb. 3, 2017 at 5:55 a.m. ET","Headline":"Hunting down the year\u2019s 5 hottest M&A targets","Summary":"Merck & Co. Inc.  shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer drug beat expectations. But on the company's earnings call, management sai..."},{"Date":"Feb. 2, 2017 at 11:21 a.m. ET","Headline":"The 10 cheapest, fastest-growing and most beloved Dow stocks","Summary":"Merck & Co. Inc.  shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer drug beat expectations. But on the company's earnings call, management sai..."},{"Date":"Feb. 2, 2017 at 9:14 a.m. ET","Headline":"Dan Loeb\u2019s playbook for investment home runs in the Trump era","Summary":"Merck & Co. Inc.  shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer drug beat expectations. But on the company's earnings call, management sai..."},{"Date":"Feb. 2, 2017 at 8:32 a.m. ET","Headline":"Merck earnings stock gains give way after Keytruda revenue turns out to be a miss","Summary":"Merck & Co. Inc.  shares surged as much as 1.4% in pre-market trade after company earnings numbers appeared to show its blockbuster Keytruda cancer drug beat expectations. But on the company's earnings call, management sai..."},{"Date":"Feb. 2, 2017 at 7:00 a.m. ET","Headline":"Merck matches profit expectations but sales come up a bit short","Summary":"Merck & Co. Inc.  reported Thursday fourth-quarter earnings that rose to $1.18 billion, or 42 cents a share, from $976 million, or 35 cents a share, in the same period a year ago. Excluding non-recurring items, the health ..."},{"Date":"Feb. 4, 2017 at 8:33 a.m. ET","Headline":"$16 billion Thornburg fund goes shopping globally for dividend stocks","Summary":""},{"Date":"Feb. 7, 2017 at 4:42 p.m. ET","Headline":"Drug stocks dip after Spicer affirms Trump\u2019s stance on cutting costs","Summary":""},{"Date":"Feb. 7, 2017 at 1:15 p.m. ET","Headline":"Biotech executives say President Trump\u2019s \u2018misguided\u2019 travel ban will harm the industry","Summary":""},{"Date":"Feb. 7, 2017 at 2:50 a.m. ET","Headline":"All eyes will be on Gilead\u2019s hepatitis C franchise as it reports fourth-quarter earnings","Summary":""},{"Date":"Feb. 9, 2017 at 6:44 p.m. ET","Headline":"Bristol-Myers Squibb Stock in Bargain Bin","Summary":""},{"Date":"Feb. 15, 2017 at 6:04 p.m. ET","Headline":"Stock market notches best record run in quarter century","Summary":"Shares of Merck & Co.  gave up their regular session gains after hours Tuesday when the drugmaker said it was halting a study of an Alzheimer's drug because it did not appear to be working. Merck shares fell 1.5% to $64.69..."},{"Date":"Feb. 14, 2017 at 5:15 p.m. ET","Headline":"Merck shares slip after hours as Alzheimer's study halted","Summary":"Shares of Merck & Co.  gave up their regular session gains after hours Tuesday when the drugmaker said it was halting a study of an Alzheimer's drug because it did not appear to be working. Merck shares fell 1.5% to $64.69..."},{"Date":"Feb. 23, 2017 at 5:50 p.m. ET","Headline":"Merck to take $2.9 billion charge on hepatitis C drug","Summary":"Merck & Co.  said late Thursday it will book a pre-tax charge of $2.9 billion for a hepatitis C drug candidate. Merck said recent changes to its product profile and expectations for pricing caused it to evaluate the drug c..."},{"Date":"Feb. 23, 2017 at 4:01 p.m. ET","Headline":"Shares of manufacturers whose CEOs met Trump today are slumping, led by U.S. Steel","Summary":""},{"Date":"Feb. 23, 2017 at 2:11 p.m. ET","Headline":"Doubts persist about tax timing as Trump meets with CEOs","Summary":""},{"Date":"Feb. 24, 2017 at 8:44 a.m. ET","Headline":"Only 1 of 30 Dow stocks is trading higher premarket","Summary":"The early selloff in the Dow Jones Industrial Average  Friday is nearly unanimous, with the shares of 29 of 30 components declining in premarket trade. Among the biggest percentage declines ahead of the open, shares of Gol..."},{"Date":"Mar. 1, 2017 at 5:29 p.m. ET","Headline":"The Dow\u2019s 21,000 rally was powered by Apple\u2019s 15% rally since Jan. 25","Summary":""},{"Date":"Mar. 1, 2017 at 5:20 p.m. ET","Headline":"Top drugmakers to ignore investor calls to explain price hikes","Summary":""},{"Date":"Mar. 3, 2017 at 4:10 p.m. ET","Headline":"Stocks extend weekly winning streaks as rate hike looms","Summary":"U.S. stocks finished higher for the week Friday and fractionally higher for the session as Federal Reserve Chairwoman Janet Yellen signaled a March rate hike was likely appropriate. The Dow Jones Industrial Average  advanc..."},{"Date":"Mar. 7, 2017 at 8:24 p.m. ET","Headline":"Investors face three deadly mistakes after Trump claims he was wiretapped by Obama","Summary":"Shares of Dynavax Technologies Corp.  reversed premarket losses to trade flat at the open Monday, after the biotech reported findings from an early-stage trial of its SD-101 treatment for metastatic melanoma in combination..."},{"Date":"Mar. 6, 2017 at 9:33 a.m. ET","Headline":"UPDATE: Dynavax shares reverse premarket losses to open flat","Summary":"Shares of Dynavax Technologies Corp.  reversed premarket losses to trade flat at the open Monday, after the biotech reported findings from an early-stage trial of its SD-101 treatment for metastatic melanoma in combination..."},{"Date":"Mar. 9, 2017 at 12:29 p.m. ET","Headline":"Bank stocks help European markets end higher as Draghi plays down deflationary risks","Summary":"FRANKFURT--German pharmaceuticals and chemicals group Merck KGaA (MRK.XE) said Thursday that net profit had more than doubled in the fourth quarter of 2016, boosted by growth at the health-care division and by the integrat..."},{"Date":"Mar. 9, 2017 at 8:59 a.m. ET","Headline":"Pharma says high prices fund drug development \u2014 but this study finds otherwise","Summary":"FRANKFURT--German pharmaceuticals and chemicals group Merck KGaA (MRK.XE) said Thursday that net profit had more than doubled in the fourth quarter of 2016, boosted by growth at the health-care division and by the integrat..."},{"Date":"Mar. 9, 2017 at 4:09 a.m. ET","Headline":"Trump\u2019s \u2018Obamacare Lite\u2019 presents opportunities and perils for investors","Summary":"FRANKFURT--German pharmaceuticals and chemicals group Merck KGaA (MRK.XE) said Thursday that net profit had more than doubled in the fourth quarter of 2016, boosted by growth at the health-care division and by the integrat..."},{"Date":"Mar. 9, 2017 at 2:24 a.m. ET","Headline":"Merck Q4 profit rises 15%, beating forecasts","Summary":"FRANKFURT--German pharmaceuticals and chemicals group Merck KGaA (MRK.XE) said Thursday that net profit had more than doubled in the fourth quarter of 2016, boosted by growth at the health-care division and by the integrat..."},{"Date":"Mar. 13, 2017 at 4:05 p.m. ET","Headline":"U.S. stocks little changed ahead of expected rate hike","Summary":"U.S. stocks were little changed Monday, with the Dow industrials closing slightly lower ahead of a widely expected rate hike from the Federal Reserve this Wednesday. The Dow Jones Industrial Average  closed down 21.50 poin..."},{"Date":"Mar. 15, 2017 at 10:34 a.m. ET","Headline":"The Dogs of the Dow are falling behind in the 2017 rally","Summary":""},{"Date":"Mar. 17, 2017 at 3:21 p.m. ET","Headline":"Republican health-care bill would be credit negative for hospitals, pharma and medical device makers in 2020: Moody\u2019s","Summary":""},{"Date":"Mar. 16, 2017 at 4:31 p.m. ET","Headline":"Stock market ends lower as health care, utilities slump","Summary":""},{"Date":"Mar. 24, 2017 at 12:57 p.m. ET","Headline":"European stocks end week lower, as traders mull implications of U.S. health-care vote","Summary":""},{"Date":"Mar. 28, 2017 at 7:42 a.m. ET","Headline":"Trumpcare\u2019s collapse creates some certainty for health-care stocks","Summary":""},{"Date":"Apr. 4, 2017 at 9:48 a.m. ET","Headline":"NewLink Genetics Corp. stock drops 28% on mid-stage results for melanoma drug","Summary":"NewLink Genetics Corp.  shares dropped as much as 27.7% in morning trade Tuesday after the company released interim results for a phase 2 trial for advanced melanoma. The company's indoximod was being tested in combination..."},{"Date":"Apr. 3, 2017 at 3:33 p.m. ET","Headline":"Bristol-Myers May Be Hedging on IO","Summary":""},{"Date":"Apr. 7, 2017 at 7:56 a.m. ET","Headline":"Merck receives FDA Complete Response Letter for medicines using sitagliptin","Summary":"Merck & Co. Inc. shares  fell 1.5% in premarket trade Friday, after the company said it received a Complete Response Letter from the U.S. Food and Drug Administration regarding its application to include data on cardiovasc..."},{"Date":"Apr. 10, 2017 at 4:06 p.m. ET","Headline":"Stocks finish fractionally higher led by energy gains","Summary":"Stocks closed fractionally higher Monday, but well off session highs as investors cautiously approached the beginning of earnings season. The Dow Jones Industrial Average closed up 1.92 points at 20,658.02, led by gains in..."},{"Date":"Apr. 8, 2017 at 12:33 a.m. ET","Headline":"Hersh Cohen Shares His Top Dividend Picks","Summary":""},{"Date":"Apr. 12, 2017 at 11:25 a.m. ET","Headline":"Celgene, Biogen to Gain From Higher Prices","Summary":""},{"Date":"Apr. 12, 2017 at 8:08 a.m. ET","Headline":"Incyte: Why This Biotech Beauty Can Stay Hot","Summary":""},{"Date":"Apr. 13, 2017 at 3:31 p.m. ET","Headline":"Big Pharma Earnings: What to Watch","Summary":""},{"Date":"Apr. 18, 2017 at 3:20 a.m. ET","Headline":"Johnson & Johnson earnings: Expect a slow first quarter due to drug segment challenges","Summary":""},{"Date":"Apr. 24, 2017 at 7:11 a.m. ET","Headline":"PDL BioPharma to be paid $19.5 million by Merck to settle Keytruda patent suit","Summary":"Shares of PDL BioPharma Inc.  were indicated up over 2% in premarket trade Monday, after the marketer of biopharmaceutical products said it will be paid a one-time lump sum of $19.5 million by Merck & Co. Inc.  to settle a..."},{"Date":"Apr. 26, 2017 at 3:34 p.m. ET","Headline":"Four Biotech Picks Ahead of Earnings","Summary":"FRANKFURT--German healthcare company Fresenius SE & Co. KGaA (FRE.XE) late Monday announced two acquisitions worth combined more than $5 billion to strengthen the generic drug business of its Fresenius Kabi clinical nutrit..."},{"Date":"Apr. 25, 2017 at 3:28 a.m. ET","Headline":"Fresenius makes 2 buys to boost Kabi clinical unit","Summary":"FRANKFURT--German healthcare company Fresenius SE & Co. KGaA (FRE.XE) late Monday announced two acquisitions worth combined more than $5 billion to strengthen the generic drug business of its Fresenius Kabi clinical nutrit..."},{"Date":"Apr. 29, 2017 at 8:00 a.m. ET","Headline":"Fed, jobs data and Apple earnings will keep stock-market investors busy","Summary":""},{"Date":"May. 2, 2017 at 4:30 p.m. ET","Headline":"Stocks eke out gains as Nasdaq closes at record for second day","Summary":"Shares of Merck & Co. Inc.  rallied 2% in premarket trade Tuesday, after the drug giant reported first-quarter profit and sales that rose above expectations, and lifted its full-year outlook. Net income increased to $1.55 ..."},{"Date":"May. 2, 2017 at 9:16 a.m. ET","Headline":"Here\u2019s the \u2018last remaining cheap asset\u2019 as the Fed pumps up prices for everything else","Summary":"Shares of Merck & Co. Inc.  rallied 2% in premarket trade Tuesday, after the drug giant reported first-quarter profit and sales that rose above expectations, and lifted its full-year outlook. Net income increased to $1.55 ..."},{"Date":"May. 2, 2017 at 7:18 a.m. ET","Headline":"Gilead earnings: Lowered expectations could help when company reports first-quarter results","Summary":"Shares of Merck & Co. Inc.  rallied 2% in premarket trade Tuesday, after the drug giant reported first-quarter profit and sales that rose above expectations, and lifted its full-year outlook. Net income increased to $1.55 ..."},{"Date":"May. 2, 2017 at 6:55 a.m. ET","Headline":"Merck's stock jumps after profit and sales beat, raised guidance","Summary":"Shares of Merck & Co. Inc.  rallied 2% in premarket trade Tuesday, after the drug giant reported first-quarter profit and sales that rose above expectations, and lifted its full-year outlook. Net income increased to $1.55 ..."},{"Date":"May. 3, 2017 at 5:51 a.m. ET","Headline":"Four Small Biotechs See Bullish April Stock Buys","Summary":""},{"Date":"May. 5, 2017 at 7:40 a.m. ET","Headline":"Big Sales by Biogen CFO Don\u2019t Deter Buying","Summary":""},{"Date":"May. 12, 2017 at 4:06 p.m. ET","Headline":"Dow industrials, S&P 500 snap 3-week win streak","Summary":"The Dow industrials and S&P 500 both snapped a streak of three weeks of gains Friday, closing lower for the session and week, while the Nasdaq finished higher for a fourth week of gains. President Donald Trump's firing of ..."},{"Date":"May. 11, 2017 at 8:10 a.m. ET","Headline":"Merck stock rises 2.4% after new Keytruda lung cancer approval","Summary":"Merck & Co. Inc.  shares surged 2.4% in premarket trade Thursday after the company's Keytruda was approved in combination with chemotherapy for first-line lung cancer. The approval is key because the approval applies regar..."},{"Date":"May. 16, 2017 at 11:31 a.m. ET","Headline":"Three Top Picks in U.S. Big Pharma","Summary":""},{"Date":"May. 18, 2017 at 4:17 p.m. ET","Headline":"Merck's Keytruda gets two bladder cancer approvals from FDA","Summary":"Merck & Co. Inc.  said Thursday late afternoon that its key cancer drug Keytruda has received two approvals for bladder cancer from the Food and Drug Administration. Keytruda has been approved for initial treatment of a ty..."},{"Date":"May. 18, 2017 at 2:47 a.m. ET","Headline":"Merck profit falls 12%","Summary":"FRANKFURT--German chemicals and pharmaceuticals company Merck KGaA (MRK.XE) reported a 12% decline in net profit for the first quarter of 2017. Net profit for the period ended March 31 fell to EUR521 million ($580.4 millio..."},{"Date":"May. 17, 2017 at 12:01 p.m. ET","Headline":"Most Dow stocks are below their 50-day moving averages","Summary":"As the Dow Jones Industrial Average  slips Wednesday  (MA), which many technicians use to define the short-term trend, 17 of its 30 components are also below their respective 50-day MAs. Of that total, shares of Boeing Co...."},{"Date":"Jun. 3, 2017 at 3:58 p.m. ET","Headline":"Cancer drug prices could double or triple thanks to this popular but unproven drug trend","Summary":"Merck & Co. Inc.  said premarket Friday that a late-stage clinical trial comparing its cancer drug Keytruda to Bristol-Myers Squibb's [: BMY] cancer drug Yervoy found patients on Keytruda had better results. The trial, whi..."},{"Date":"Jun. 2, 2017 at 7:49 a.m. ET","Headline":"Merck reports positive results for late-stage trial comparing its Keytruda against Bristol-Myers' Yervoy","Summary":"Merck & Co. Inc.  said premarket Friday that a late-stage clinical trial comparing its cancer drug Keytruda to Bristol-Myers Squibb's [: BMY] cancer drug Yervoy found patients on Keytruda had better results. The trial, whi..."},{"Date":"Jun. 6, 2017 at 4:24 p.m. ET","Headline":"Beyond tech: How other sectors are driving the stock market","Summary":""},{"Date":"Jun. 8, 2017 at 4:06 p.m. ET","Headline":"Nasdaq closes at record, stocks finish slightly higher after Comey testimony","Summary":"The tech-heavy Nasdaq finished at a record Thursday as other benchmarks closed slightly higher following former Federal Bureau of Investigation director James Comey's testimony in front of senators and ahead of U.K. electi..."},{"Date":"Jun. 8, 2017 at 8:56 a.m. ET","Headline":"NewLink Genetics' stock plunges as Genentech plans to returns rights cancer treatment candidate","Summary":"Shares of NewLink Genetics Corp.  plunged 31% in premarket trade Thursday, putting them on track to open at a more-than 5-year low, after the biopharmaceutical company said Genentech planned to return the the rights to New..."},{"Date":"Jun. 13, 2017 at 7:24 a.m. ET","Headline":"GE\u2019s stock is the worst Dow performer since Immelt took charge","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker announced its was pausing enrollment in studies of a cancer treatment at the recommendation of a data monitoring committee. Merck shares decli..."},{"Date":"Jun. 12, 2017 at 4:30 p.m. ET","Headline":"Merck shares slip as blood cancer drug study enrollment paused","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker announced its was pausing enrollment in studies of a cancer treatment at the recommendation of a data monitoring committee. Merck shares decli..."},{"Date":"Jun. 14, 2017 at 11:12 a.m. ET","Headline":"JNJ Diabetes Data Benefit Lilly, Hurt Merck","Summary":""},{"Date":"Jun. 19, 2017 at 5:37 p.m. ET","Headline":"Three must-own cancer stocks for your biotechnology portfolio","Summary":""},{"Date":"Jun. 23, 2017 at 11:32 a.m. ET","Headline":"Nasdaq presses two-week highs as FAANG-fueled key reversal fades","Summary":"The Dow industrials and the S&P 500 on Thursday logged their third straight finish in the red, despite crude-oil prices gaining after a recent sell-off, and as health-care stocks lured buyers. Still, sharp gains in the hea..."},{"Date":"Jun. 22, 2017 at 4:09 p.m. ET","Headline":"Dow, S&P 500 book 3rd straight loss, even as oil and health care rally","Summary":"The Dow industrials and the S&P 500 on Thursday logged their third straight finish in the red, despite crude-oil prices gaining after a recent sell-off, and as health-care stocks lured buyers. Still, sharp gains in the hea..."},{"Date":"Jun. 27, 2017 at 4:03 p.m. ET","Headline":"Merck Cholesterol Drug Could Help Unlock Value","Summary":""},{"Date":"Jun. 27, 2017 at 12:47 p.m. ET","Headline":"Charting the S&P 500\u2019s stealth breakout attempt as FAANG-fueled downturn fades","Summary":""},{"Date":"Jun. 27, 2017 at 12:16 p.m. ET","Headline":"Charting the S&P 500\u2019s stealth breakout attempt as FAANG-fueled downturn fades","Summary":""},{"Date":"Jun. 26, 2017 at 11:32 a.m. ET","Headline":"S&P 500 hesitates near record territory, Dow industrials nail the bottom of the gap","Summary":""},{"Date":"Jun. 29, 2017 at 11:55 a.m. ET","Headline":"Nasdaq Composite ventures under the 50-day average, retest underway","Summary":""},{"Date":"Jun. 28, 2017 at 11:15 a.m. ET","Headline":"S&P 500, Dow nail near-term support, absorb ECB-fueled June downdraft","Summary":""},{"Date":"Jun. 28, 2017 at 3:25 a.m. ET","Headline":"Massive cyberattack hits scores of companies as it rampages across the globe","Summary":""},{"Date":"Jul. 1, 2017 at 2:21 a.m. ET","Headline":"Bristol-Myers Could Return 40% in Two to Three Years","Summary":""},{"Date":"Jun. 30, 2017 at 11:26 a.m. ET","Headline":"S&P 500 nails the 2,405 support amid volatile second-quarter conclusion","Summary":""},{"Date":"Jul. 5, 2017 at 4:50 p.m. ET","Headline":"Merck shares slip as 3 blood-cancer drug studies halted by FDA","Summary":"Merck & Co.  shares declined in the extended session Wednesday after the drugmaker said the Food and Drug Administration halted three clinical studies of a blood cancer drug because of deaths in the studies. Merck shares d..."},{"Date":"Jul. 5, 2017 at 11:33 a.m. ET","Headline":"Nasdaq maintains last-ditch support (again), Dow industrials pull in from record high","Summary":""},{"Date":"Jul. 7, 2017 at 11:53 a.m. ET","Headline":"S&P 500 maintains the 2,405 breakout point (again), lifts on solid jobs report","Summary":"The EU antitrust watchdog has opened formal probes into General Electric Co. , Merck KGaA , Sigma-Aldrich and Canon Inc. ,  in recent acquisitions. The EU competition commission said General Electric, and Merck and Sigma-A..."},{"Date":"Jul. 6, 2017 at 12:00 p.m. ET","Headline":"Nasdaq challenges major support amid geopolitical tensions, S&P 500 nails 50-day average","Summary":"The EU antitrust watchdog has opened formal probes into General Electric Co. , Merck KGaA , Sigma-Aldrich and Canon Inc. ,  in recent acquisitions. The EU competition commission said General Electric, and Merck and Sigma-A..."},{"Date":"Jul. 6, 2017 at 9:01 a.m. ET","Headline":"\u2018Run very far away\u2019 from Tesla\u2019s stock, warns this chart","Summary":"The EU antitrust watchdog has opened formal probes into General Electric Co. , Merck KGaA , Sigma-Aldrich and Canon Inc. ,  in recent acquisitions. The EU competition commission said General Electric, and Merck and Sigma-A..."},{"Date":"Jul. 6, 2017 at 6:10 a.m. ET","Headline":"EU opens formal probe into GE, Merck KGaA, Sigma-Aldrich and Canon, says they breached merger rules","Summary":"The EU antitrust watchdog has opened formal probes into General Electric Co. , Merck KGaA , Sigma-Aldrich and Canon Inc. ,  in recent acquisitions. The EU competition commission said General Electric, and Merck and Sigma-A..."},{"Date":"Jul. 10, 2017 at 11:16 a.m. ET","Headline":"Nasdaq presses familiar resistance amid sluggish third-quarter start","Summary":""},{"Date":"Jul. 20, 2017 at 4:14 p.m. ET","Headline":"Trump Today: President won\u2019t say if he has  confidence in Sessions","Summary":""},{"Date":"Jul. 23, 2017 at 9:58 a.m. ET","Headline":"Stocks brace for volatility in earnings deluge; Fed meeting looms","Summary":""},{"Date":"Jul. 27, 2017 at 8:43 a.m. ET","Headline":"AstraZeneca\u2019s late-stage trial failure sends its shares down 16% and Bristol-Myers, Merck stocks seesawing","Summary":"AstraZeneca PLC  shares plummeted as much as 16% in premarket trade Thursday after the company said its cancer drug combination failed to meet its primary endpoint in a late-stage clinical trial. In the AstraZeneca late-st..."},{"Date":"Jul. 27, 2017 at 8:07 a.m. ET","Headline":"AstraZeneca shares plummet 16% on late-stage trial failure; Bristol-Myers shares fall 6% and Merck shares rise 5%","Summary":"AstraZeneca PLC  shares plummeted as much as 16% in premarket trade Thursday after the company said its cancer drug combination failed to meet its primary endpoint in a late-stage clinical trial. In the AstraZeneca late-st..."},{"Date":"Jul. 29, 2017 at 8:03 a.m. ET","Headline":"Biotech companies lose $21 billion in research funds amid political squabbling","Summary":"U.S. stock benchmarks opened modestly lower on Friday after a key measure of U.S. economic growth showed improvement, but also highlighted stubbornly low inflation. A second-quarter reading on gross domestic product rose 2..."},{"Date":"Jul. 28, 2017 at 4:33 p.m. ET","Headline":"S&P 500, Nasdaq finish lower after Amazon disappointment; Dow closes at record","Summary":"U.S. stock benchmarks opened modestly lower on Friday after a key measure of U.S. economic growth showed improvement, but also highlighted stubbornly low inflation. A second-quarter reading on gross domestic product rose 2..."},{"Date":"Jul. 28, 2017 at 9:44 a.m. ET","Headline":"A case for buying the freakin\u2019 dip with Amazon, as the Mooch might now say","Summary":"U.S. stock benchmarks opened modestly lower on Friday after a key measure of U.S. economic growth showed improvement, but also highlighted stubbornly low inflation. A second-quarter reading on gross domestic product rose 2..."},{"Date":"Jul. 28, 2017 at 9:38 a.m. ET","Headline":"Stock market opens lower as Wall Street resumes tech selling","Summary":"U.S. stock benchmarks opened modestly lower on Friday after a key measure of U.S. economic growth showed improvement, but also highlighted stubbornly low inflation. A second-quarter reading on gross domestic product rose 2..."},{"Date":"Jul. 28, 2017 at 8:44 a.m. ET","Headline":"Merck expects June cyberattack to affect company's 2017 financial performance","Summary":"Merck & Co. Inc.  said Friday that a network cyberattack in late June caused it to issue conservative 2017 guidance. The June 27 cyberattack disrupted the company's global operations, including manufacturing, research and ..."},{"Date":"Jul. 28, 2017 at 6:59 a.m. ET","Headline":"Merck profit and sales rise, beat expectations amid big jump in Keytruda sales","Summary":"Merck & Co.  reported Friday a second-quarter net profit that rose to $1.95 billion, or 71 cents a share, from $1.21 billion, or 43 cents a share, in the same period a year ago. Excluding non-recurring items, the drug gian..."},{"Date":"Aug. 1, 2017 at 3:57 p.m. ET","Headline":"Investing icon Burton Malkiel talks Trump, valuations, and the ETFs he\u2019s bullish on","Summary":""},{"Date":"Aug. 3, 2017 at 7:29 a.m. ET","Headline":"How each Dow stock contributed to the 22,000 milestone","Summary":""},{"Date":"Aug. 6, 2017 at 10:37 a.m. ET","Headline":"AbbVie\u2019s new, cheaper hepatitis C drug could launch the drug world\u2019s own Hunger Games","Summary":""},{"Date":"Aug. 8, 2017 at 4:38 p.m. ET","Headline":"Stocks close lower as Dow snaps streak of records","Summary":""},{"Date":"Aug. 11, 2017 at 10:27 a.m. ET","Headline":"More than half of women who got an abortion last year were using contraception","Summary":""},{"Date":"Aug. 14, 2017 at 4:33 p.m. ET","Headline":"U.S. stocks gain 1% for the first time in 3 months as geopolitical fears ebb","Summary":"U.S. stock benchmarks rallied Monday, as a recent aversion to assets considered risky on the back of fears about tensions between the U.S. and North Korea receded somewhat. The Dow Jones Industrial Average  closed up by 0...."},{"Date":"Aug. 14, 2017 at 4:28 p.m. ET","Headline":"Trump Today: President denounces white supremacists two days after Charlottesville violence","Summary":"U.S. stock benchmarks rallied Monday, as a recent aversion to assets considered risky on the back of fears about tensions between the U.S. and North Korea receded somewhat. The Dow Jones Industrial Average  closed up by 0...."},{"Date":"Aug. 14, 2017 at 4:07 p.m. ET","Headline":"Dow closes up 135 points as North Korea tensions ease","Summary":"U.S. stock benchmarks rallied Monday, as a recent aversion to assets considered risky on the back of fears about tensions between the U.S. and North Korea receded somewhat. The Dow Jones Industrial Average  closed up by 0...."},{"Date":"Aug. 14, 2017 at 1:55 p.m. ET","Headline":"Trump says \u2018racism is evil\u2019 after criticism over initial Charlottesville response","Summary":"Merck & Co. Inc.  Chief Executive Kenneth Frazier said early Monday, two days after Saturday's deadly violence at a white supremacist rally in Charlottesville, Va., that he is resigning from the President's American Manufa..."},{"Date":"Aug. 14, 2017 at 9:25 a.m. ET","Headline":"Merck CEO to resign from President's American Manufacturing Council two days after Charlottesville violence","Summary":"Merck & Co. Inc.  Chief Executive Kenneth Frazier said early Monday, two days after Saturday's deadly violence at a white supremacist rally in Charlottesville, Va., that he is resigning from the President's American Manufa..."},{"Date":"Aug. 16, 2017 at 4:18 p.m. ET","Headline":"Trump Today: President says he\u2019s pulling plug on business councils as he faces CEO defections","Summary":"A popular gauge of the dollar reversed course on Wednesday, turning negative, following afternoon news that a pair of advisory council's to President Donald Trump was being disbanded amid a wave of high-profile CEO departu..."},{"Date":"Aug. 16, 2017 at 3:31 p.m. ET","Headline":"Bristol-Myers Can Overcome Market\u2019s Pessimism","Summary":"A popular gauge of the dollar reversed course on Wednesday, turning negative, following afternoon news that a pair of advisory council's to President Donald Trump was being disbanded amid a wave of high-profile CEO departu..."},{"Date":"Aug. 16, 2017 at 2:38 p.m. ET","Headline":"Trump business councils disband amid wave of CEO exits","Summary":"A popular gauge of the dollar reversed course on Wednesday, turning negative, following afternoon news that a pair of advisory council's to President Donald Trump was being disbanded amid a wave of high-profile CEO departu..."},{"Date":"Aug. 16, 2017 at 2:32 p.m. ET","Headline":"Dollar takes it on the chin as Trump dissolves business advisory panels","Summary":"A popular gauge of the dollar reversed course on Wednesday, turning negative, following afternoon news that a pair of advisory council's to President Donald Trump was being disbanded amid a wave of high-profile CEO departu..."},{"Date":"Aug. 16, 2017 at 11:59 a.m. ET","Headline":"McConnell says there are \u2018no good neo-Nazis\u2019 after Trump\u2019s \u2018very fine people\u2019 comment","Summary":"A fourth individual stepped down from President Donald Trump's manufacturing advisory council on Tuesday in the wake of his response to violence in Charlottesville, Va. The latest to exit is Scott Paul, head of the Allianc..."},{"Date":"Aug. 15, 2017 at 8:48 p.m. ET","Headline":"AFL-CIO leader quits Trump\u2019s manufacturing council in disgust","Summary":"A fourth individual stepped down from President Donald Trump's manufacturing advisory council on Tuesday in the wake of his response to violence in Charlottesville, Va. The latest to exit is Scott Paul, head of the Allianc..."},{"Date":"Aug. 15, 2017 at 4:50 p.m. ET","Headline":"Trump Today: President bashes \u2018grandstanders\u2019 after more leaders quit manufacturing council","Summary":"A fourth individual stepped down from President Donald Trump's manufacturing advisory council on Tuesday in the wake of his response to violence in Charlottesville, Va. The latest to exit is Scott Paul, head of the Allianc..."},{"Date":"Aug. 15, 2017 at 12:15 p.m. ET","Headline":"Merck CEO quits presidential council after Charlottesville violence \u2018as a matter of personal conscience,\u2019 and Trump attacks him","Summary":"A fourth individual stepped down from President Donald Trump's manufacturing advisory council on Tuesday in the wake of his response to violence in Charlottesville, Va. The latest to exit is Scott Paul, head of the Allianc..."},{"Date":"Aug. 15, 2017 at 11:54 a.m. ET","Headline":"Fourth leader steps down from Trump's manufacturing council","Summary":"A fourth individual stepped down from President Donald Trump's manufacturing advisory council on Tuesday in the wake of his response to violence in Charlottesville, Va. The latest to exit is Scott Paul, head of the Allianc..."},{"Date":"Aug. 15, 2017 at 11:48 a.m. ET","Headline":"Larry Summers asks why all CEOs aren\u2019t quitting Trump\u2019s councils","Summary":""},{"Date":"Aug. 15, 2017 at 11:18 a.m. ET","Headline":"Merck, Allergan, Lilly: Top Pharma Picks","Summary":""},{"Date":"Aug. 15, 2017 at 9:22 a.m. ET","Headline":"It\u2019s these other factors that really matter to investors so don\u2019t flinch, strategist says","Summary":""},{"Date":"Aug. 15, 2017 at 7:21 a.m. ET","Headline":"CEOs of Intel, Under Armour quit Trump\u2019s manufacturing council","Summary":""},{"Date":"Aug. 18, 2017 at 3:01 p.m. ET","Headline":"This market leader was the most-purchased stock by hedge funds last quarter","Summary":"Rep. Elijah Cummings (D-Md.) and Rep. Peter Welch (D-Vt.) said Thursday morning that they are launching an investigation into multiple sclerosis drug prices, and have sent letters to seven pharmaceutical companies about th..."},{"Date":"Aug. 17, 2017 at 12:59 p.m. ET","Headline":"Reps. Cummings, Welch to launch investigation into multiple sclerosis drug prices","Summary":"Rep. Elijah Cummings (D-Md.) and Rep. Peter Welch (D-Vt.) said Thursday morning that they are launching an investigation into multiple sclerosis drug prices, and have sent letters to seven pharmaceutical companies about th..."},{"Date":"Aug. 17, 2017 at 11:36 a.m. ET","Headline":"Barack Obama\u2019s tweet is the most \u2018liked\u2019, 4th most retweeted, in Twitter\u2019s history","Summary":""},{"Date":"Aug. 17, 2017 at 8:05 a.m. ET","Headline":"This is the lesson the stock market has learned from Charlottesville","Summary":""},{"Date":"Aug. 21, 2017 at 11:07 a.m. ET","Headline":"JNJ, Merck to Take the Stage at ESC","Summary":""},{"Date":"Aug. 21, 2017 at 7:08 a.m. ET","Headline":"16-member White House arts committee is the latest group to quit Trump","Summary":""},{"Date":"Jul. 15, 2017 at 12:01 a.m. ET","Headline":"\u201cA Great Time\u201d to Invest in the Health-Care Sector","Summary":""},{"Date":"Aug. 24, 2017 at 11:58 a.m. ET","Headline":"Why it\u2019s time for CEOs to tell Trump: \u2018You\u2019re fired!\u2019","Summary":""},{"Date":"Aug. 25, 2017 at 11:03 a.m. ET","Headline":"Down With Teva, Up With Portola","Summary":"Merck KGaA (MRK.XE) said Friday the European Commission has approved its drug Mavenclad for the treatment of multiple sclerosis. The German pharmaceuticals company said it expects the drug to become available in Germany an..."},{"Date":"Aug. 25, 2017 at 4:37 a.m. ET","Headline":"Merck gets EU approval for multiple sclerosis drug","Summary":"Merck KGaA (MRK.XE) said Friday the European Commission has approved its drug Mavenclad for the treatment of multiple sclerosis. The German pharmaceuticals company said it expects the drug to become available in Germany an..."},{"Date":"Aug. 29, 2017 at 5:34 a.m. ET","Headline":"High-Quality Value Stocks Priced to Buy","Summary":""},{"Date":"Aug. 31, 2017 at 5:01 p.m. ET","Headline":"Surprise: Those \u2018great\u2019 companies generally turn out to be meh ... or duds","Summary":""},{"Date":"Sep. 5, 2017 at 11:57 a.m. ET","Headline":"European stocks end choppy day lower at North Korea worries persist","Summary":"Shares of Merck KGaA  climbed 2% in Frankfurt on Tuesday after the German pharmaceutical major put its consumer health business up for sale. In a statement the company said it's \"preparing strategic options\" for the unit, ..."},{"Date":"Sep. 5, 2017 at 9:27 a.m. ET","Headline":"September stinks for stocks? No, this month actually looks like yet another winner","Summary":"Shares of Merck KGaA  climbed 2% in Frankfurt on Tuesday after the German pharmaceutical major put its consumer health business up for sale. In a statement the company said it's \"preparing strategic options\" for the unit, ..."},{"Date":"Sep. 5, 2017 at 3:42 a.m. ET","Headline":"Merck rises 2% after health business is put up for sale","Summary":"Shares of Merck KGaA  climbed 2% in Frankfurt on Tuesday after the German pharmaceutical major put its consumer health business up for sale. In a statement the company said it's \"preparing strategic options\" for the unit, ..."},{"Date":"Sep. 7, 2017 at 7:52 a.m. ET","Headline":"Celgene shares drop 1% on news that FDA has placed six trials on partial or full clinical hold","Summary":"Celgene Corp.  shares dropped 1% in premarket trade Thursday after the company said that the Food and Drug Administration has placed a partial clinical hold on five clinical trials and a full clinical hold on one trial. Al..."},{"Date":"Sep. 6, 2017 at 12:28 p.m. ET","Headline":"Merck to buy privately-held biotech Rigontec for 115 mln euros upfront","Summary":"Merck & Co.  said Wednesday that it will acquire privately-held biotech Rigontec for \u20ac115 million ($137 million) upfront to Rigontec's shareholders and up to \u20ac349 million ($416 million) in additional milestone-contingent p..."},{"Date":"Sep. 8, 2017 at 11:07 a.m. ET","Headline":"Merck Tops JNJ, Allergan","Summary":""},{"Date":"Sep. 11, 2017 at 2:38 p.m. ET","Headline":"Health-Care Stocks Poised for More Gains","Summary":""},{"Date":"Sep. 13, 2017 at 1:35 p.m. ET","Headline":"Bristol-Myers Stock May Be Fully Valued","Summary":""},{"Date":"Sep. 13, 2017 at 12:02 p.m. ET","Headline":"Star-studded #HandinHand hurricane telethon pulls in $44 million so far","Summary":""},{"Date":"Sep. 14, 2017 at 12:23 p.m. ET","Headline":"What you don\u2019t know about Martin Shkreli \u2014 his investing tips and strategies","Summary":""},{"Date":"Sep. 27, 2017 at 1:16 p.m. ET","Headline":"Gilead\u2019s China Entrance Looks Crowded","Summary":""},{"Date":"Sep. 29, 2017 at 7:09 a.m. ET","Headline":"Merck discontinues development program for a Hep-C treatment","Summary":"Merck & Co.  said Friday it would discontinue the development of the investigational combination regimens MK-3682B and MK-3682C for the treatment of chronic hepatitis C, after a review of available Phase 2 efficacy data. T..."},{"Date":"Oct. 1, 2017 at 5:07 p.m. ET","Headline":"Merck Hepatitis C exit could lift the space\u2019s two remaining drugmakers","Summary":""},{"Date":"Oct. 4, 2017 at 11:51 a.m. ET","Headline":"6 Top Pharma Picks for Q4","Summary":""},{"Date":"Oct. 6, 2017 at 3:58 a.m. ET","Headline":"A breakout in this cheap, forgotten stock is powering the Dow Jones Industrial Average","Summary":""},{"Date":"Oct. 9, 2017 at 10:28 a.m. ET","Headline":"Lilly Patent Win Preserves Sales Guidance","Summary":""},{"Date":"Oct. 10, 2017 at 4:43 p.m. ET","Headline":"Dow logs 47th record finish for 2017 as stock market ends higher","Summary":""},{"Date":"Oct. 10, 2017 at 8:36 a.m. ET","Headline":"12 Dividend-Paying Stocks for the Long Run","Summary":""},{"Date":"Oct. 14, 2017 at 7:49 a.m. ET","Headline":"Here are the actual tax rates the biggest companies in America pay","Summary":""},{"Date":"Oct. 16, 2017 at 12:15 p.m. ET","Headline":"Lost beneath headlines of five-figure drug costs \u2014 pharmaceutical price growth is weakening","Summary":""},{"Date":"Oct. 16, 2017 at 7:53 a.m. ET","Headline":"Bristol-Myers Gets a Boost","Summary":""},{"Date":"Oct. 20, 2017 at 5:51 p.m. ET","Headline":"Merck to lay off about 1,800 U.S. sales reps in cost-cutting move","Summary":""},{"Date":"Oct. 23, 2017 at 12:52 p.m. ET","Headline":"Byron Wien Measures China\u2019s Tech Success","Summary":""},{"Date":"Oct. 25, 2017 at 2:38 p.m. ET","Headline":"U.S. Committee backs Glaxo's shingles vaccine","Summary":"GlaxoSmithKline PLC (GSK.LN) on Wednesday said that a U.S. advisory committee has recommended its Shingrix product as the preferred vaccine to prevent shingles in adults aged 50 and over. The FTSE 100-listed pharmaceutical..."},{"Date":"Oct. 25, 2017 at 9:53 a.m. ET","Headline":"What to watch in Bayer earnings: Monsanto deal","Summary":"German pharmaceutical and chemical company Bayer AG (BAYN.XE) is scheduled to report third-quarter earnings on Wednesday. Here's what you need to know: EARNINGS FORECAST: Forecasts peg net income at around EUR1.18 billion ..."},{"Date":"Oct. 24, 2017 at 12:12 p.m. ET","Headline":"EarningsWatch: Amazon, Alphabet and AMD form tech\u2019s A list","Summary":""},{"Date":"Oct. 24, 2017 at 11:50 a.m. ET","Headline":"These stocks have popped more than 75% since Trump was elected","Summary":""},{"Date":"Oct. 28, 2017 at 12:01 a.m. ET","Headline":"No Tax Cut? No Worry for Wall Street","Summary":"Merck & Co.  shares fell in the extended session Friday after the drug maker said it was no longer pursuing market approval for a lung cancer drug in Europe. Merck shares declined 2.3% to $56.91 after hours, adding to a 6...."},{"Date":"Oct. 27, 2017 at 5:58 p.m. ET","Headline":"Merck shares fall deeper into red as European lung-cancer marketing application pulled","Summary":"Merck & Co.  shares fell in the extended session Friday after the drug maker said it was no longer pursuing market approval for a lung cancer drug in Europe. Merck shares declined 2.3% to $56.91 after hours, adding to a 6...."},{"Date":"Oct. 27, 2017 at 5:09 p.m. ET","Headline":"Nasdaq books biggest blowout victory against the Dow industrials in 15 years","Summary":"Investors shouldn't give credit to the surging in shares of Intel Corp.  and Microsoft Corp. , after both tech-sector heavyweights reported better-than-expected earnings, for the Dow Jones Industrial Average's  gain, they ..."},{"Date":"Oct. 27, 2017 at 4:38 p.m. ET","Headline":"S&P 500, Nasdaq end at records as tech rally powers gains","Summary":"Investors shouldn't give credit to the surging in shares of Intel Corp.  and Microsoft Corp. , after both tech-sector heavyweights reported better-than-expected earnings, for the Dow Jones Industrial Average's  gain, they ..."},{"Date":"Oct. 27, 2017 at 3:41 p.m. ET","Headline":"Apple's stock rally stands out for the Dow","Summary":"Investors shouldn't give credit to the surging in shares of Intel Corp.  and Microsoft Corp. , after both tech-sector heavyweights reported better-than-expected earnings, for the Dow Jones Industrial Average's  gain, they ..."},{"Date":"Oct. 27, 2017 at 2:09 p.m. ET","Headline":"Nasdaq on track for best daily point rise in more than 2 years as tech sector powers record rally","Summary":"The Nasdaq Composite Index was on pace to book its best single-session point gains in more than 2 years on Friday as tech shares soared. The Nasdaq Composite Index  was surging 145 points, or 2.2%, toward a fresh all-time ..."},{"Date":"Oct. 27, 2017 at 10:29 a.m. ET","Headline":"Microsoft's record stock rally delivers more than 45-point tailwind to Dow industrials","Summary":"The Dow Jones Industrial Average was struggling to take flight on Friday, with shares of Microsoft Corp. rallying to a record high after better-than-expected earnings, providing a boost to the average. Shares of Microsoft ..."},{"Date":"Oct. 27, 2017 at 10:05 a.m. ET","Headline":"Dow dragged lower by Chevron, Merck; Nasdaq sets fresh intraday record on tech earnings","Summary":"U.S. stock benchmarks opened mostly higher on Friday, supported by data showing the U.S. economy expanded at a solid 3% annual pace for a second straight quarter despite damages from two hurricanes. A strong spate of quart..."},{"Date":"Oct. 27, 2017 at 8:52 a.m. ET","Headline":"How high can Amazon go? Legendary trader sees 10% pop on top of today\u2019s surge","Summary":"Shares of Merck & Co. Inc.  surged 1.8% in premarket trade Friday, after the drug giant beat profit expectations and raised its outlook. The company swung to a third-quarter net loss of $56 million, or 2 cents a share, fro..."},{"Date":"Oct. 27, 2017 at 7:02 a.m. ET","Headline":"Merck's stock rallies after profit beat, raised outlook offset sales miss","Summary":"Shares of Merck & Co. Inc.  surged 1.8% in premarket trade Friday, after the drug giant beat profit expectations and raised its outlook. The company swung to a third-quarter net loss of $56 million, or 2 cents a share, fro..."},{"Date":"Oct. 26, 2017 at 3:46 p.m. ET","Headline":"Apple and Nike show that stock performance is linked to how CEOs invest money","Summary":""},{"Date":"Oct. 26, 2017 at 3:01 p.m. ET","Headline":"EarningsWatch: Celgene tanks and Twitter spikes ahead of Amazon, Alphabet reports","Summary":""},{"Date":"Oct. 30, 2017 at 4:44 p.m. ET","Headline":"Stocks finish lower as doubts over pace of tax cuts weigh on sentiment","Summary":"U.S. stocks closed lower on Monday following a report that the House of Representatives was considering phasing in a cut to corporate taxes, rather than enacting them immediately, as investors had been hoping. The Dow Jone..."},{"Date":"Oct. 30, 2017 at 4:01 p.m. ET","Headline":"U.S. stocks close lower on disappointment over possible pace of tax cuts","Summary":"U.S. stocks closed lower on Monday following a report that the House of Representatives was considering phasing in a cut to corporate taxes, rather than enacting them immediately, as investors had been hoping. The Dow Jone..."},{"Date":"Oct. 30, 2017 at 2:43 p.m. ET","Headline":"Merck's stock suffering biggest 2-day selloff since February 2009","Summary":"Shares of Merck & Co. Inc.  tumbled 5.8% in active afternoon trade Monday, putting them on track for a sixth straight loss to a 5 1\/2-month low, after the health care and consumer products company was downgraded at SunTrus..."},{"Date":"Nov. 1, 2017 at 11:10 a.m. ET","Headline":"Big, old companies drive the Dow\u2019s outperformance","Summary":"Merck (MRK.XE) said on Wednesday that it has signed a memorandum of understanding with Samsung Biologics (207940.SE) that extends an agreement to supply raw materials for biopharmaceutical manufacturing."},{"Date":"Nov. 1, 2017 at 3:38 a.m. ET","Headline":"Merck, Samsung Biologics extend partnership","Summary":"Merck (MRK.XE) said on Wednesday that it has signed a memorandum of understanding with Samsung Biologics (207940.SE) that extends an agreement to supply raw materials for biopharmaceutical manufacturing."},{"Date":"Nov. 9, 2017 at 2:36 a.m. ET","Headline":"Merck net profit rises","Summary":"Merck KGaA (MRK.XE) said on Thursday that its third-quarter net profit was up 41% compared to the same period a year earlier. The German chemicals and pharmaceuticals company reported a third-quarter net profit of 645 mill..."},{"Date":"Nov. 15, 2017 at 12:22 p.m. ET","Headline":"GE's stock bounces sharply to pace Dow gainers","Summary":"General Electric Co.'s  stock bounced sharply off earlier lows to rally 1.5% on heavy volume, enough to pace the gainers within the Dow Jones Industrial Average . The stock was down as much as 2.2% at its intraday low of $..."},{"Date":"Nov. 18, 2017 at 12:01 a.m. ET","Headline":"What\u2019s Next for ETFs","Summary":""},{"Date":"Nov. 21, 2017 at 8:30 a.m. ET","Headline":"Six promising stocks to buy for the biotech rebound ahead","Summary":""},{"Date":"Nov. 21, 2017 at 6:41 a.m. ET","Headline":"How to avoid the next GE \u2014 and find industrial winners of the future","Summary":""},{"Date":"Nov. 28, 2017 at 2:42 p.m. ET","Headline":"Merck announces $10 billion share buyback","Summary":"Merck & Co. Inc.  announced on Tuesday a $10 billion share buyback program. The company also said that it has increased the quarterly dividend to 48 cents per outstanding share, up one cent from the prior quarter. The divi..."},{"Date":"Nov. 28, 2017 at 8:50 a.m. ET","Headline":"Merck KGaA,  Pfizer's Avelumab fails to meet goal","Summary":"Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Tuesday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase 3 trial in patients with certain gastric cancers. The trial assessed avelumab a..."},{"Date":"Nov. 28, 2017 at 8:12 a.m. ET","Headline":"Pfizer, Germany's Merck cancer treatment trial misses primary endpoint","Summary":"Pfizer Inc.  and German-based Merck KGaA  said Tuesday a phase 3 trial of a cancer treatment did not meet its primary endpoint of superior overall survival. Pfizer's stock slipped 0.9% in premarket trade. The trial tested ..."},{"Date":"Dec. 2, 2017 at 12:01 a.m. ET","Headline":"Payouts Grew Globally in Third Quarter","Summary":""},{"Date":"Dec. 9, 2017 at 12:01 a.m. ET","Headline":"How We Did in 2017: Stock Picks Topped the Market","Summary":""},{"Date":"Dec. 18, 2017 at 7:13 a.m. ET","Headline":"If you\u2019re bargain shopping for U.S. stocks, start here","Summary":""},{"Date":"Dec. 16, 2017 at 12:01 a.m. ET","Headline":"Hungry for Income? The Best\u2014and Worst\u2014Yield Plays for 2018","Summary":""},{"Date":"Dec. 20, 2017 at 8:26 a.m. ET","Headline":"Republican tax bill makes big winners of Amgen, Gilead and other drugmakers","Summary":""},{"Date":"Dec. 19, 2017 at 3:04 p.m. ET","Headline":"These 55 stocks have at least doubled since Trump was elected","Summary":""},{"Date":"Dec. 22, 2017 at 7:15 a.m. ET","Headline":"Merck and Pfizer diabetes drug approved by the FDA","Summary":"Merck & Co. Inc.  and Pfizer Inc.  said Friday that the Food and Drug Administration has approved diabetes drug Steglatro tablets, and the fixed-dose combination Steglujan tablets. Steglatro (ertugliflozin) is indicated, a..."},{"Date":"Jan. 3, 2018 at 6:59 a.m. ET","Headline":"Biggest Dow winners and losers in 2017: Boeing soars to record levels, GE slumps","Summary":""},{"Date":"Dec. 30, 2017 at 12:01 a.m. ET","Headline":"Corning Shares Could Gain More Than 25%","Summary":""},{"Date":"Jan. 4, 2018 at 1:53 p.m. ET","Headline":"Boeing\u2019s stock leads the charge to Dow 25,000, adding about 150 points","Summary":""},{"Date":"Jan. 6, 2018 at 11:09 a.m. ET","Headline":"10 favorite stocks for 2018 from top-ranked stock newsletter writers","Summary":""},{"Date":"Jan. 14, 2018 at 2:17 p.m. ET","Headline":"Here\u2019s what all 30 companies that make up the Dow industrials think about the tax cuts","Summary":""},{"Date":"Jan. 16, 2018 at 4:33 p.m. ET","Headline":"Dow ends lower in sharp one-day reversal","Summary":"Merck & Co. Inc. shares  jumped almost 7% Tuesday, after the company announced positive results in a late-stage lung cancer trial. The New Jersey-based drug company said the Phase 3 trial of Keytruda in combination with pe..."},{"Date":"Jan. 16, 2018 at 12:31 p.m. ET","Headline":"Here\u2019s what all 30 companies that make up the Dow industrials think about blockchain","Summary":"Merck & Co. Inc. shares  jumped almost 7% Tuesday, after the company announced positive results in a late-stage lung cancer trial. The New Jersey-based drug company said the Phase 3 trial of Keytruda in combination with pe..."},{"Date":"Jan. 16, 2018 at 11:00 a.m. ET","Headline":"UPDATE: Merck shares jump 7% on news of positive results from lung cancer trial","Summary":"Merck & Co. Inc. shares  jumped almost 7% Tuesday, after the company announced positive results in a late-stage lung cancer trial. The New Jersey-based drug company said the Phase 3 trial of Keytruda in combination with pe..."},{"Date":"Jan. 16, 2018 at 9:31 a.m. ET","Headline":"Apple\u2019s stock just broke out from a 2-month hibernation","Summary":""},{"Date":"Jan. 19, 2018 at 4:10 a.m. ET","Headline":"AstraZeneca says 2 new drugs get approval in Japan","Summary":"AstraZeneca PLC (AZN.LN) said Friday that two new drugs, its Lynparza tablets for advanced ovarian cancer and its Fasenra treatment for bronchial asthma, have received approval from Japanese authorities."},{"Date":"Jan. 21, 2018 at 12:25 p.m. ET","Headline":"Merck leaps past rivals with latest lung cancer drug results","Summary":""},{"Date":"Jan. 28, 2018 at 1:22 p.m. ET","Headline":"The next phase of artificial intelligence will replace inventors","Summary":""},{"Date":"Jan. 31, 2018 at 10:44 a.m. ET","Headline":"CDC director quits after report about tobacco-stock trades","Summary":"Brenda Fitzgerald, President Donald Trump's director of the Centers for Disease Control and Prevention, bought and sold shares in a tobacco company after taking office last year, , posing a potentially serious conflict of ..."},{"Date":"Jan. 31, 2018 at 9:03 a.m. ET","Headline":"5 Dow stocks have fallen 4% or more over the past week","Summary":"Brenda Fitzgerald, President Donald Trump's director of the Centers for Disease Control and Prevention, bought and sold shares in a tobacco company after taking office last year, , posing a potentially serious conflict of ..."},{"Date":"Jan. 30, 2018 at 8:12 p.m. ET","Headline":"CDC chief bought tobacco stock after taking office: report","Summary":"Brenda Fitzgerald, President Donald Trump's director of the Centers for Disease Control and Prevention, bought and sold shares in a tobacco company after taking office last year, , posing a potentially serious conflict of ..."},{"Date":"Feb. 2, 2018 at 8:44 a.m. ET","Headline":"\u2018Google is at Apple\u2019s mercy\u2019 \u2014 the trouble in Alphabet\u2019s earnings","Summary":"Merck & Co. Inc.  shares rose 0.7% in premarket trade Friday after the company reported a fourth-quarter profit beat and revenue miss. The company reported a loss of $872 million, or a loss of 32 cents per share, after a l..."},{"Date":"Feb. 2, 2018 at 7:08 a.m. ET","Headline":"Merck shares rise after Q4 profit beat, revenue miss","Summary":"Merck & Co. Inc.  shares rose 0.7% in premarket trade Friday after the company reported a fourth-quarter profit beat and revenue miss. The company reported a loss of $872 million, or a loss of 32 cents per share, after a l..."},{"Date":"Feb. 1, 2018 at 1:38 p.m. ET","Headline":"Fast-growing Amazon should replace sluggish GE in the Dow","Summary":""},{"Date":"Feb. 1, 2018 at 7:29 a.m. ET","Headline":"Pharmaceutical stocks drop after drug price mention in Trump\u2019s State of the Union","Summary":""},{"Date":"Feb. 6, 2018 at 9:09 a.m. ET","Headline":"Bristol-Myers touts lung cancer breakthrough, but critics cry foul","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its fourth-quarter results on Wednesday at 1200 GMT. Here's what to expect: CORE OPERATING PROFIT: The U.K. pharmaceutical group is expected to report a core operating profit of 2 billi..."},{"Date":"Feb. 6, 2018 at 6:26 a.m. ET","Headline":"Here are the biggest losers among Dow and S&P 500 stocks in Monday\u2019s rout","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its fourth-quarter results on Wednesday at 1200 GMT. Here's what to expect: CORE OPERATING PROFIT: The U.K. pharmaceutical group is expected to report a core operating profit of 2 billi..."},{"Date":"Feb. 6, 2018 at 5:43 a.m. ET","Headline":"What to watch in GlaxoSmithKline earnings","Summary":"GlaxoSmithKline PLC (GSK.LN) reports its fourth-quarter results on Wednesday at 1200 GMT. Here's what to expect: CORE OPERATING PROFIT: The U.K. pharmaceutical group is expected to report a core operating profit of 2 billi..."},{"Date":"Feb. 5, 2018 at 7:24 a.m. ET","Headline":"Bristol-Myers surges 5.6% on advanced lung cancer trial results, Q4 earnings","Summary":"Bristol-Myers Squibb Co.  shares surged 5.6% in premarket trade on Monday after the company reported positive results for its Opdivo and Yervoy cancer drug combination in a late-stage clinical trial, along with fourth-quar..."},{"Date":"Feb. 7, 2018 at 6:48 a.m. ET","Headline":"These U.S. stocks rose as much as 15% Tuesday as the market bounced back","Summary":""},{"Date":"Feb. 10, 2018 at 7:22 a.m. ET","Headline":"Dow Jones Industrial Average rebounds, powered by Nike and Microsoft","Summary":""},{"Date":"Feb. 9, 2018 at 6:23 a.m. ET","Headline":"These Dow and S&P 500 stocks have taken the worst beatings","Summary":""},{"Date":"Feb. 14, 2018 at 7:56 p.m. ET","Headline":"U.K. blames Russia for crippling cyberattack in June","Summary":""},{"Date":"Feb. 14, 2018 at 8:21 a.m. ET","Headline":"Pimco\u2019s Big Buys: Apple, Intel, Merck, Pfizer, GE","Summary":""},{"Date":"Feb. 13, 2018 at 10:04 a.m. ET","Headline":"3 Biotechs That Could Benefit From an M&A Frenzy","Summary":""},{"Date":"Feb. 9, 2018 at 8:31 a.m. ET","Headline":"Selling CVS, Chipotle, Costco and Qualcomm","Summary":""},{"Date":"Feb. 16, 2018 at 1:11 p.m. ET","Headline":"Big Stock Buys in GE, Citi, DowDuPont, Merck","Summary":"(Adds Merck KGaA comment and additional avelumab trial in seventh paragraph.) Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Thursday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase ..."},{"Date":"Feb. 15, 2018 at 10:38 a.m. ET","Headline":"Merck KGaA and Pfizer's Avelumab fails in trial","Summary":"(Adds Merck KGaA comment and additional avelumab trial in seventh paragraph.) Merck KGaA (MRK.XE) and Pfizer Inc. PFE said on Thursday that avelumab, a cancer immunotherapy, failed to meet the primary objective of a phase ..."},{"Date":"Feb. 15, 2018 at 7:02 a.m. ET","Headline":"This might be the time when you can finally get quality stocks on sale","Summary":""},{"Date":"Feb. 20, 2018 at 10:19 a.m. ET","Headline":"Merck shares dip after surprise patent loss to Gilead","Summary":"Merck & Co. Inc.  shares dipped 1.6% in morning trade Tuesday after the company lost a patent case to Gilead Sciences Inc. . Gilead shares rose 0.4% in morning trade. The case, which involves alleged patent infringement by..."},{"Date":"Feb. 19, 2018 at 7:21 a.m. ET","Headline":"Here\u2019s what the 30 companies that make up the Dow industrials are doing to address sexual-harassment claims","Summary":""},{"Date":"Feb. 27, 2018 at 4:39 p.m. ET","Headline":"Stock market ends lower as Powell\u2019s testimony stokes fresh inflation, rate-hike fears","Summary":""},{"Date":"Mar. 2, 2018 at 6:45 a.m. ET","Headline":"These Dow and S&P 500 stocks took the biggest hits on fears of a Trump trade war","Summary":""},{"Date":"Mar. 1, 2018 at 6:36 a.m. ET","Headline":"These Dow stocks were clobbered in February \u2014 but there were winners too","Summary":""},{"Date":"Mar. 8, 2018 at 1:46 a.m. ET","Headline":"Merck KGaA's profit up on sales growth, tax reform","Summary":"Merck KGaA (MRK.XE) said Thursday that net profit increased markedly in the fourth quarter, driven by organic sales growth in its healthcare and life-science divisions, and by exceptional income related to the U.S. tax ref..."},{"Date":"Mar. 7, 2018 at 1:17 p.m. ET","Headline":"Here\u2019s what the 30 Dow industrials companies say about a potential trade war","Summary":"Germany's Merck KGaA (MRK.XE) is scheduled to report fourth-quarter results on Thursday. Here's what to look for: REVENUE: Merck is expected to post sales of 3.8 billion euros ($4.7 billion) in the fourth quarter, accordin..."},{"Date":"Mar. 7, 2018 at 10:58 a.m. ET","Headline":"What to watch in Merck earnings: Consumer health","Summary":"Germany's Merck KGaA (MRK.XE) is scheduled to report fourth-quarter results on Thursday. Here's what to look for: REVENUE: Merck is expected to post sales of 3.8 billion euros ($4.7 billion) in the fourth quarter, accordin..."},{"Date":"Mar. 7, 2018 at 9:31 a.m. ET","Headline":"Merck KGaA's evobrutinib has positive MS trial","Summary":"Merck KGaA (MRK.XE) said on Wednesday that a study of evobrutinib in relapsing multiple sclerosis has yielded positive results. The phase 2b study demonstrated that patients who received evobrutinib had a clinically meanin..."},{"Date":"Mar. 7, 2018 at 9:00 a.m. ET","Headline":"Here\u2019s a trick for getting access to hot IPO shares in Spotify and Dropbox","Summary":""},{"Date":"Mar. 14, 2018 at 4:22 p.m. ET","Headline":"As stocks recover, Goldman sees \u2018lowered bar\u2019 for volatility\u2019s return","Summary":""},{"Date":"Mar. 20, 2018 at 7:05 a.m. ET","Headline":"The Dow is now down for 2018, but it still has plenty of winners","Summary":""},{"Date":"Mar. 23, 2018 at 7:01 a.m. ET","Headline":"Here are the biggest Dow and S&P 500 stock losers in March","Summary":""},{"Date":"Mar. 29, 2018 at 3:02 p.m. ET","Headline":"3M Co.'s stock has been the biggest drag on the Dow in the first quarter of 2018","Summary":"The Dow Jones Industrial Average on Thursday was on track to snap a quarterly win streak, and the biggest contributor the end of that successful run has been 3M Co. Shares of 3M Co.  have fallen 6.4%, sapping 129 points fr..."},{"Date":"Mar. 29, 2018 at 12:06 p.m. ET","Headline":"FDA push for cheaper \u2018biosimilar\u2019 drugs could challenge pharma\u2019s biggest blockbusters","Summary":""},{"Date":"Mar. 29, 2018 at 9:18 a.m. ET","Headline":"Here\u2019s why stock volatility likely won\u2019t end in April","Summary":""},{"Date":"Apr. 3, 2018 at 10:36 a.m. ET","Headline":"AstraZeneca submits drugs for U.S., Europe review","Summary":"Update includes extra information, analyst sales forecast and updated share price AstraZeneca PLC (AZN.LN) said Tuesday that regulators in Europe and the U.S. have accepted applications for cancer treatments Lynparza and M..."},{"Date":"Apr. 3, 2018 at 6:57 a.m. ET","Headline":"Intel, Amazon and Tesla lead tech stocks lower on the first trading day of April","Summary":""},{"Date":"Apr. 7, 2018 at 7:43 a.m. ET","Headline":"Here are Friday\u2019s worst stocks as trade conflict and a weak jobs report disappoint investors","Summary":"NewLink Genetics Corp.  plans to review its clinical programs after the failure of a similar drug in a Merck  and Incyte  clinical trial. NewLink noted that the mechanism of its drug, an IDO pathway inhibitor called indoxi..."},{"Date":"Apr. 6, 2018 at 4:35 p.m. ET","Headline":"Stock market ends sharply lower on renewed trade war fears","Summary":"NewLink Genetics Corp.  plans to review its clinical programs after the failure of a similar drug in a Merck  and Incyte  clinical trial. NewLink noted that the mechanism of its drug, an IDO pathway inhibitor called indoxi..."},{"Date":"Apr. 6, 2018 at 3:14 p.m. ET","Headline":"NewLink will review clinical programs after Merck, Incyte trial failure","Summary":"NewLink Genetics Corp.  plans to review its clinical programs after the failure of a similar drug in a Merck  and Incyte  clinical trial. NewLink noted that the mechanism of its drug, an IDO pathway inhibitor called indoxi..."},{"Date":"Apr. 6, 2018 at 9:14 a.m. ET","Headline":"NewLink Genetics shares plummet 39% after Merck, Incyte trial failure","Summary":"NewLink Genetics Corp.  shares plummeted 39.2% in premarket trade Friday after Merck  and Incyte Corp.  said their trial testing a combination including a type of cancer drug called an IDO inhibitor  NewLink has focused it..."},{"Date":"Apr. 6, 2018 at 8:04 a.m. ET","Headline":"Incyte's stock plunges, Merck shares fall after disappointing study results of melanoma treatment","Summary":"Shares of Incyte Corp.  plunged 19% in premarket trade Friday, and Merck & Co. Inc.'s stock  dropped 1.9%, after the companies said an external data monitoring committee (eDMC) determined that results from a phase 3 study ..."},{"Date":"Apr. 6, 2018 at 7:57 a.m. ET","Headline":"All Dow stocks trading premarket are seeing red","Summary":"All 29 of the Dow Jones Industrial Average  components trading in the premarket are declining, as  with China has sent Dow futures  tumbling. Only DowDuPont Inc.'s stock  is still inactive ahead of the open. Among the bigg..."},{"Date":"Apr. 9, 2018 at 4:53 p.m. ET","Headline":"Stocks relinquish gains in late trade to end slightly higher","Summary":"Shares of Merck & Co. Inc.  surged 2.6% in premarket trade Monday, after the drug maker said its cancer treatment Keytruda met the primary endpoint of a phase 3 trial evaluating the Keytruda as monotherapy for the first-li..."},{"Date":"Apr. 9, 2018 at 7:00 a.m. ET","Headline":"Merck's stock surges after positive Keytruda trial results","Summary":"Shares of Merck & Co. Inc.  surged 2.6% in premarket trade Monday, after the drug maker said its cancer treatment Keytruda met the primary endpoint of a phase 3 trial evaluating the Keytruda as monotherapy for the first-li..."},{"Date":"Apr. 14, 2018 at 10:20 a.m. ET","Headline":"A shingles vaccine can improve your health \u2014 especially if you\u2019re over 50","Summary":""},{"Date":"Apr. 17, 2018 at 8:46 a.m. ET","Headline":"All 30 Dow stock rise premarket, led by UnitedHealth","Summary":"Shares of all 30 Dow Jones Industrial Average  components were trading higher, as the three companies reporting earnings gave investors reason to cheer. The gainers were leb by the 2.3% jump in .'s stock  after the insurer..."},{"Date":"Apr. 17, 2018 at 6:58 a.m. ET","Headline":"Merck shares surge anew on lung cancer advance, while Bristol-Myers stock plummets","Summary":"Shares of Merck & Co. rose on Monday, providing an outsize boost to the Dow Jones Industrial Average in early trading. The stock  rose 2.4%, by far the biggest gainer among the blue-chip average's 30 components. The rally ..."},{"Date":"Apr. 17, 2018 at 2:27 a.m. ET","Headline":"Stocks end higher as focus turns to earnings","Summary":"Shares of Merck & Co. rose on Monday, providing an outsize boost to the Dow Jones Industrial Average in early trading. The stock  rose 2.4%, by far the biggest gainer among the blue-chip average's 30 components. The rally ..."},{"Date":"Apr. 16, 2018 at 10:18 a.m. ET","Headline":"Merck leads Dow industrials higher","Summary":"Shares of Merck & Co. rose on Monday, providing an outsize boost to the Dow Jones Industrial Average in early trading. The stock  rose 2.4%, by far the biggest gainer among the blue-chip average's 30 components. The rally ..."},{"Date":"Apr. 16, 2018 at 10:12 a.m. ET","Headline":"Merck shares rise after beating rivals' lung cancer results","Summary":"In a fierce rivalry to prove cancer drug combinations work better for advanced lung cancer, Merck & Co.  drew ahead of rivals on Monday, releasing late-stage results showing that a cancer drug combination using its Keytrud..."},{"Date":"Apr. 16, 2018 at 8:48 a.m. ET","Headline":"NewLink shares fall on late-stage trial changes","Summary":"NewLink Genetics Corp.  shares fell as much as 15% in premarket trade Monday after the company said it won't proceed as planned with a late-stage trial of its indoximod for advanced melanoma. The company will instead look ..."},{"Date":"Apr. 19, 2018 at 4:27 p.m. ET","Headline":"Stock market ends with losses as tech and consumer staples skid","Summary":"The Dow Jones Industrial Average on Thursday were slumping, pushing the blue-chip gauge into the red for the year and threatening a second straight decline as consumer-staples shares declined. Most recently, the Dow  was o..."},{"Date":"Apr. 19, 2018 at 1:03 p.m. ET","Headline":"Dow's stumble drives blue chips back into negative territory for 2018","Summary":"The Dow Jones Industrial Average on Thursday were slumping, pushing the blue-chip gauge into the red for the year and threatening a second straight decline as consumer-staples shares declined. Most recently, the Dow  was o..."},{"Date":"Apr. 19, 2018 at 9:31 a.m. ET","Headline":"Watch for \u2018violent selloff\u2019 to thwart Saudis\u2019 wish for $100 oil","Summary":"Eli Lilly & Co.  shares fell 1.8% premarket and Incyte Corp.  shares dropped 4.5% premarket on Thursday after a Food and Drug Administration briefing document raised issues with their rheumatoid arthritis drug baricitinib...."},{"Date":"Apr. 19, 2018 at 9:10 a.m. ET","Headline":"Eli Lilly, Incyte shares fall after FDA cites issues with rheumatoid arthritis drug","Summary":"Eli Lilly & Co.  shares fell 1.8% premarket and Incyte Corp.  shares dropped 4.5% premarket on Thursday after a Food and Drug Administration briefing document raised issues with their rheumatoid arthritis drug baricitinib...."},{"Date":"Apr. 23, 2018 at 2:04 p.m. ET","Headline":"Merck's stock surges to lead Dow's gainers after Goldman turns bullish","Summary":"Shares of Merck & Co. Inc.  ran up $1.61, or 2.7%, to a near three-month high in afternoon trade Monday, enough to pace the Dow Jones Industrial Average's  gainers, after Goldman Sachs turned bullish on the drugmaker, citi..."},{"Date":"Apr. 23, 2018 at 10:00 a.m. ET","Headline":"How the 2018 election will affect your money","Summary":"Merck KGaA (MRK.XE) said Monday that it has received a patent for its CRISPR genome-editing technology in China. The CRISPR technology allows for precise chromosome modification in living cells, said Merck. Its application..."},{"Date":"Apr. 23, 2018 at 9:29 a.m. ET","Headline":"Merck receives patent for CRISPR tech in China","Summary":"Merck KGaA (MRK.XE) said Monday that it has received a patent for its CRISPR genome-editing technology in China. The CRISPR technology allows for precise chromosome modification in living cells, said Merck. Its application..."},{"Date":"Apr. 28, 2018 at 12:01 a.m. ET","Headline":"In This Earnings Season, The Beats Roll On","Summary":""},{"Date":"May. 1, 2018 at 4:24 p.m. ET","Headline":"Tech rally lifts S&P 500, Nasdaq; Dow falls for 3rd straight session","Summary":"Merck & Co. Inc.  reported a first-quarter profit beat and sales miss early Tuesday. Merck shares rose 1.1% in premarket trade. Earnings for the latest quarter declined to $736 million, or 27 cents per share, from $1.55 bi..."},{"Date":"May. 1, 2018 at 8:58 a.m. ET","Headline":"Billionaire Sam Zell warns on stocks and real estate: \u2018Where\u2019s the beef?\u2019","Summary":"Merck & Co. Inc.  reported a first-quarter profit beat and sales miss early Tuesday. Merck shares rose 1.1% in premarket trade. Earnings for the latest quarter declined to $736 million, or 27 cents per share, from $1.55 bi..."},{"Date":"May. 1, 2018 at 7:14 a.m. ET","Headline":"Merck shares lift after Q1 profit beat, sales miss","Summary":"Merck & Co. Inc.  reported a first-quarter profit beat and sales miss early Tuesday. Merck shares rose 1.1% in premarket trade. Earnings for the latest quarter declined to $736 million, or 27 cents per share, from $1.55 bi..."},{"Date":"Apr. 30, 2018 at 7:07 a.m. ET","Headline":"Merck has submitted Keytruda combination for FDA approval","Summary":"Merck & Co. Inc.  said early Monday that it has submitted a supplemental application with the Food and Drug Administration for the cancer drug Keytruda in combination with chemotherapy, a combination that recently showed i..."},{"Date":"May. 2, 2018 at 8:00 a.m. ET","Headline":"L.A. Capital Management Slashes GE, Merck Stakes","Summary":""},{"Date":"May. 11, 2018 at 2:41 p.m. ET","Headline":"Drug stocks slip, then swing back even higher after Trump unveils drug cost cutting plan","Summary":"Healthcare stocks dipped after President Donald Trump started presenting his plan to cut prescription drug costs, then bounced sharply to trade even higher than pre-speech levels. The SPDR Health Care Select Sector ETF  wa..."},{"Date":"May. 11, 2018 at 2:30 p.m. ET","Headline":"Dow tips higher, but knocked around, after Trump proposes sweeping change to health-care policy","Summary":"The Dow Jones Industrial Average briefly turned negative Friday afternoon, as President Donald Trump announced a series of changes intended to overhaul health-care policy in the U.S. At last check, the Dow  was up 51 point..."},{"Date":"May. 15, 2018 at 12:20 p.m. ET","Headline":"European stocks inch higher with data, earnings deluge in focus","Summary":"Merck KGaA (MRK.XE) shares fell by as much as 4.8% in early trade Tuesday after the company said that, despite organic growth, its first-quarter sales declined, dragged by currency headwinds and continuing market-share dec..."},{"Date":"May. 15, 2018 at 5:11 a.m. ET","Headline":"Merck KGaA sales hurt by currency, China headwinds","Summary":"Merck KGaA (MRK.XE) shares fell by as much as 4.8% in early trade Tuesday after the company said that, despite organic growth, its first-quarter sales declined, dragged by currency headwinds and continuing market-share dec..."},{"Date":"May. 15, 2018 at 1:41 a.m. ET","Headline":"Merck KGaA's sales hit by currency headwinds","Summary":"Merck KGaA (MRK.XE) said Tuesday that despite attaining organic growth its first-quarter sales declined, dragged down by currency headwinds. The company reported a 4.4% sales decline to 3.69 billion euros ($4.41 billion), ..."},{"Date":"May. 14, 2018 at 1:43 p.m. ET","Headline":"Why Trump\u2019s drug-price pitch makes no sense","Summary":""},{"Date":"May. 19, 2018 at 12:01 a.m. ET","Headline":"Stocks That Could Rise on Sports Betting","Summary":""},{"Date":"May. 23, 2018 at 7:30 a.m. ET","Headline":"Merck\u2019s experimental and unlicensed Ebola vaccine is being used in latest outbreak","Summary":""},{"Date":"May. 24, 2018 at 1:44 p.m. ET","Headline":"A Dozen Safe and Solid Dividend Stocks","Summary":""},{"Date":"Jun. 4, 2018 at 7:41 a.m. ET","Headline":"Merck announces positive results for Keytruda in melanoma trial","Summary":"Merck & Co. Inc.  said Monday its Keytruda drug showed positive results in a late-stage trial as a treatment for advanced melanoma. The company said a new analysis of four-year data for Keytruda from a Phase 3 study showed..."},{"Date":"Jun. 5, 2018 at 8:14 a.m. ET","Headline":"Merck\u2019s Keytruda still leading cancer drug research after major cancer conference","Summary":""},{"Date":"May. 26, 2018 at 12:01 a.m. ET","Headline":"World\u2019s Best CEOs: Growth Leaders","Summary":""},{"Date":"Jun. 13, 2018 at 2:17 a.m. ET","Headline":"Merck KGaA to stick with Crispr gene-editing tech","Summary":"Merck KGaA (MRK.XE) said late Tuesday that it has no plans to change its position with regards to Crispr technologies, after the publication of two studies on Monday that led to a sharp fall in shares of companies in the s..."},{"Date":"Jun. 20, 2018 at 4:26 p.m. ET","Headline":"What GE\u2019s stock being replaced by Walgreens in the Dow Jones Industrial Average may mean","Summary":"Merck KGaA (MRK.XE) said Wednesday that it signed a collaboration agreement with Alibaba Health Information Technology Ltd. (0241.HK) to provide healthcare services in China. The partnership will focus on drug the track an..."},{"Date":"Jun. 20, 2018 at 2:33 a.m. ET","Headline":"Merck KGaA partners with Alibaba Health in China","Summary":"Merck KGaA (MRK.XE) said Wednesday that it signed a collaboration agreement with Alibaba Health Information Technology Ltd. (0241.HK) to provide healthcare services in China. The partnership will focus on drug the track an..."},{"Date":"Jun. 22, 2018 at 11:58 a.m. ET","Headline":"Dow vies to avoid longest losing streak since 1978, Nasdaq digests break to record territory","Summary":""},{"Date":"Jun. 21, 2018 at 12:14 p.m. ET","Headline":"Charting a market divergence, Dow industrials violate 50-day average","Summary":""},{"Date":"Jun. 26, 2018 at 1:09 p.m. ET","Headline":"Charting market cross currents: Dow industrials whipsaw at the 200-day average","Summary":""},{"Date":"Jun. 26, 2018 at 12:26 p.m. ET","Headline":"Charting market cross currents, Dow industrials whipsaw at the 200-day average","Summary":""},{"Date":"Jun. 25, 2018 at 11:47 a.m. ET","Headline":"Major support under siege, Dow industrials violate 200-day average","Summary":""},{"Date":"Jun. 28, 2018 at 11:49 a.m. ET","Headline":"Charting cracks in the technical backdrop, S&P 500 fails retest of breakdown point","Summary":"AstraZeneca PLC (AZN.LN) said Wednesday that a phase 3 trial of its cancer drug Lynparza showed that the treatment was successful in improving progression-free survival for women with advanced ovarian cancer with a mutatio..."},{"Date":"Jun. 27, 2018 at 11:33 a.m. ET","Headline":"S&P 500 rallies to retest the breakdown point (2,742) from underneath","Summary":"AstraZeneca PLC (AZN.LN) said Wednesday that a phase 3 trial of its cancer drug Lynparza showed that the treatment was successful in improving progression-free survival for women with advanced ovarian cancer with a mutatio..."},{"Date":"Jun. 27, 2018 at 2:35 a.m. ET","Headline":"AstraZeneca says Lynparza trial data is positive","Summary":"AstraZeneca PLC (AZN.LN) said Wednesday that a phase 3 trial of its cancer drug Lynparza showed that the treatment was successful in improving progression-free survival for women with advanced ovarian cancer with a mutatio..."},{"Date":"Jun. 29, 2018 at 11:53 a.m. ET","Headline":"S&P 500 holds major support, back for second crack at 2,742 breakdown point","Summary":""},{"Date":"Jul. 2, 2018 at 11:26 a.m. ET","Headline":"S&P 500 capped by major resistance, extended retest of 50-day average underway","Summary":"AstraZeneca PLC (AZN.LN) said Monday that its Lynparza and Imfinzi cancer drugs have been approved in Japan. The Anglo-Swedish pharmaceutical major said Lynparza--which was developed together with Merck & Co. (MRK) -- has ..."},{"Date":"Jul. 2, 2018 at 2:26 a.m. ET","Headline":"AstraZeneca cancer drugs approved in Japan","Summary":"AstraZeneca PLC (AZN.LN) said Monday that its Lynparza and Imfinzi cancer drugs have been approved in Japan. The Anglo-Swedish pharmaceutical major said Lynparza--which was developed together with Merck & Co. (MRK) -- has ..."},{"Date":"Jul. 3, 2018 at 12:54 p.m. ET","Headline":"Charting the S&P 500\u2019s new range amid early third-quarter cross currents","Summary":""},{"Date":"Jul. 3, 2018 at 12:09 p.m. ET","Headline":"Charting the S&P 500\u2019s new range amid early third-quarter cross currents","Summary":""},{"Date":"Jul. 3, 2018 at 11:45 a.m. ET","Headline":"Charting the S&P 500\u2019s new range amid early third-quarter cross currents","Summary":""},{"Date":"Jul. 5, 2018 at 11:49 a.m. ET","Headline":"Dow industrials nail 200-day average, Nasdaq capped by the range top","Summary":""},{"Date":"Jul. 10, 2018 at 12:24 p.m. ET","Headline":"Charting a bullish Q3 start, S&P 500 challenges major resistance","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 10, 2018 at 11:51 a.m. ET","Headline":"Charting a bullish technical tilt, S&P 500 challenges major resistance","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 6:08 p.m. ET","Headline":"Trump slams Pfizer in tweet over drug prices, but stock still ends day up","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 1:28 p.m. ET","Headline":"Pfizer shares rise after President Trump attacks its drug price hikes","Summary":"President Donald Trump criticized pharmaceutical giant Pfizer Inc.  in a Monday tweet for recently increasing the prices of many of its prescription drugs. In the , which referred to Pfizer and unspecified \"others,\" Trump ..."},{"Date":"Jul. 9, 2018 at 11:11 a.m. ET","Headline":"Bull \u2018trend\u2019 strengthens:  S&P 500, Nasdaq reclaim the breakdown point","Summary":""},{"Date":"Jul. 7, 2018 at 12:01 a.m. ET","Headline":"Charting the Market","Summary":""},{"Date":"Jul. 12, 2018 at 11:40 a.m. ET","Headline":"Charting the S&P 500\u2019s pulling-teeth breakout attempt","Summary":""},{"Date":"Jul. 11, 2018 at 11:44 a.m. ET","Headline":"S&P 500 nails the range top, balks at major resistance","Summary":""},{"Date":"May. 19, 2018 at 12:01 a.m. ET","Headline":"Why Coke, PepsiCo, and P&G Look Like Bargains","Summary":""},{"Date":"Jul. 13, 2018 at 11:42 a.m. ET","Headline":"S&P 500 nails major resistance, breakout attempt (still) underway","Summary":""},{"Date":"Jul. 16, 2018 at 2:18 p.m. ET","Headline":"Johnson & Johnson earnings: Time to talk about drug prices","Summary":""},{"Date":"Jul. 16, 2018 at 11:39 a.m. ET","Headline":"S&P 500 nudges the range top, major resistance under siege","Summary":""},{"Date":"Jul. 18, 2018 at 12:01 p.m. ET","Headline":"Charting a modest July breakout, S&P 500 escapes jagged range","Summary":""},{"Date":"Jul. 17, 2018 at 12:26 p.m. ET","Headline":"S&P 500 ventures atop major resistance, slow-motion breakout attempt underway","Summary":""},{"Date":"Jul. 17, 2018 at 11:54 a.m. ET","Headline":"S&P 500 ventures atop major resistance, slow-motion breakout attempt underway","Summary":""},{"Date":"Jul. 17, 2018 at 7:08 a.m. ET","Headline":"Trade war, tariffs and inflation will be the big worries this earnings season","Summary":""},{"Date":"Jul. 20, 2018 at 11:49 a.m. ET","Headline":"S&P 500 nails the 2,802 breakout point, successful retest strengthens bull case","Summary":"Merck & Co. Inc.  said Thursday it is adopting a 'responsible' pricing policy and will cut the prices of certain products, while committing to increasing the average price of its drugs by no more than the annual inflation ..."},{"Date":"Jul. 19, 2018 at 3:03 p.m. ET","Headline":"Merck to lower price of Hep C treatment Zepatier by 60%, commits to 'responsible' pricing","Summary":"Merck & Co. Inc.  said Thursday it is adopting a 'responsible' pricing policy and will cut the prices of certain products, while committing to increasing the average price of its drugs by no more than the annual inflation ..."},{"Date":"Jul. 19, 2018 at 11:31 a.m. ET","Headline":"S&P 500, Nasdaq pull in to the breakout point, initial retest underway","Summary":""},{"Date":"Jul. 24, 2018 at 12:34 p.m. ET","Headline":"Bull trend strengthens:  S&P 500, Nasdaq extend July technical breakouts","Summary":""},{"Date":"Jul. 24, 2018 at 12:07 p.m. ET","Headline":"Bull trend strengthens:  S&P 500, Nasdaq extend July technical breakouts","Summary":""},{"Date":"Jul. 24, 2018 at 7:35 a.m. ET","Headline":"Earnings Watch: 35% of S&P 500 companies set to report in a crazy week","Summary":""},{"Date":"Jul. 23, 2018 at 11:34 a.m. ET","Headline":"Nasdaq, S&P 500 tag the breakout point, latest slow-motion retest underway","Summary":""},{"Date":"Jul. 26, 2018 at 11:48 a.m. ET","Headline":"Charting market rotation: S&P 500 and Dow industrials take flight","Summary":""},{"Date":"Jul. 25, 2018 at 12:00 p.m. ET","Headline":"Charting market cross currents, Nasdaq absorbs bearish single-day reversal","Summary":""},{"Date":"Jul. 28, 2018 at 10:30 a.m. ET","Headline":"Drugmakers sure are eager to talk about drug prices lately","Summary":""},{"Date":"Jul. 27, 2018 at 4:33 p.m. ET","Headline":"Stock market ends lower after disappointing results from Twitter, bellwethers","Summary":""},{"Date":"Jul. 27, 2018 at 11:42 a.m. ET","Headline":"Dow industrials extend July breakout, Nasdaq pulls in to major support","Summary":""},{"Date":"Jul. 27, 2018 at 11:26 a.m. ET","Headline":"Azar says HHS will create more open market for prescription drugs","Summary":""},{"Date":"Jul. 27, 2018 at 8:45 a.m. ET","Headline":"Carmaggedon? Big hits to GM, Ford and Fiat Chrysler\u2019s stocks are \u2018rattling nerves\u2019","Summary":""},{"Date":"Jul. 27, 2018 at 8:37 a.m. ET","Headline":"Merck touts a 60% price cut, but the drug is outdated and on the way out","Summary":""},{"Date":"Jul. 30, 2018 at 11:56 a.m. ET","Headline":"Nasdaq violates major support, rattles cage on 50-day average","Summary":"The U.S. Food and Drug Administration has accepted Merck KGaA's (MRK.XE) resubmission for approval of a drug used to treat multiple sclerosis, the company said Monday. The move to review cladribine, which trades globally u..."},{"Date":"Jul. 30, 2018 at 7:38 a.m. ET","Headline":"FDA to review Merck KGaA's MS drug again","Summary":"The U.S. Food and Drug Administration has accepted Merck KGaA's (MRK.XE) resubmission for approval of a drug used to treat multiple sclerosis, the company said Monday. The move to review cladribine, which trades globally u..."},{"Date":"Aug. 1, 2018 at 11:41 a.m. ET","Headline":"S&P 500 holds the breakout point, Nasdaq maintains key trendline ahead of Fed","Summary":""},{"Date":"Aug. 3, 2018 at 11:29 a.m. ET","Headline":"Charting a bullish reversal, Nasdaq knifes to the breakdown point","Summary":""},{"Date":"Aug. 2, 2018 at 11:57 a.m. ET","Headline":"Nasdaq nails trendline support (again), bullish intraday reversal underway","Summary":""},{"Date":"Aug. 7, 2018 at 12:21 p.m. ET","Headline":"Charting a bullish technical tilt:  S&P 500, Nasdaq rise within view of record territory","Summary":""},{"Date":"Aug. 7, 2018 at 11:48 a.m. ET","Headline":"Charting a bullish technical tilt:  S&P 500, Nasdaq rise within view of record territory","Summary":""},{"Date":"Aug. 6, 2018 at 11:30 a.m. ET","Headline":"S&P 500 extends rally from major support, Nasdaq reclaims the breakdown point","Summary":""},{"Date":"Aug. 9, 2018 at 11:18 a.m. ET","Headline":"Charting a bull trend holding pattern, U.S. benchmarks maintain first support","Summary":"Merck KGaA (MRK.XE) backed its yearly forecast for sales Thursday after second-quarter group sales edged up slightly, despite being slowed down by currency headwinds. The company reported second-quarter sales of 3.71 billi..."},{"Date":"Aug. 9, 2018 at 1:32 a.m. ET","Headline":"Merck KGaA sales edge up, 2018 outlook confirmed","Summary":"Merck KGaA (MRK.XE) backed its yearly forecast for sales Thursday after second-quarter group sales edged up slightly, despite being slowed down by currency headwinds. The company reported second-quarter sales of 3.71 billi..."},{"Date":"Aug. 8, 2018 at 11:23 a.m. ET","Headline":"Charting the Nasdaq\u2019s slow-motion approach of record territory","Summary":""},{"Date":"Aug. 8, 2018 at 8:43 a.m. ET","Headline":"5 smart trades that will get you away from pricey tech stocks","Summary":""},{"Date":"Aug. 8, 2018 at 7:58 a.m. ET","Headline":"Merck\u2019s 60% price cut for hepatitis C drug nets company a big sales opportunity","Summary":""},{"Date":"Aug. 10, 2018 at 11:44 a.m. ET","Headline":"S&P 500 ventures under the breakout point amid currency cross currents","Summary":""},{"Date":"Aug. 13, 2018 at 11:40 a.m. ET","Headline":"Charting a bull-trend whipsaw, S&P 500 absorbs Turkey-fueled downdraft","Summary":""},{"Date":"Aug. 13, 2018 at 8:11 a.m. ET","Headline":"There\u2019s new evidence that the dominant approach to Alzheimer\u2019s may be completely wrong","Summary":""},{"Date":"Aug. 15, 2018 at 11:39 a.m. ET","Headline":"S&P 500 nails the 2,802 breakout point, Dow industrials venture under key trendline","Summary":""},{"Date":"Aug. 14, 2018 at 12:27 p.m. ET","Headline":"Bull trend absorbs shot across bow, Dow industrials maintain trendline support","Summary":""},{"Date":"Aug. 14, 2018 at 11:54 a.m. ET","Headline":"Bull trend absorbs shot across bow, Dow industrials maintain trendline support","Summary":""},{"Date":"Aug. 21, 2018 at 12:36 p.m. ET","Headline":"Charting an August breakout attempt, S&P 500 approaches record territory","Summary":""},{"Date":"Aug. 21, 2018 at 11:50 a.m. ET","Headline":"Charting an August breakout attempt, S&P 500 approaches record territory","Summary":""},{"Date":"Aug. 20, 2018 at 12:14 p.m. ET","Headline":"Charting a bullish reversal:  S&P 500 extends rally from major support","Summary":""},{"Date":"Aug. 23, 2018 at 11:54 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 hesitates at major resistance","Summary":""},{"Date":"Aug. 22, 2018 at 11:57 a.m. ET","Headline":"S&P 500 briefly tags fractional record high, extended breakout attempt underway","Summary":""},{"Date":"Aug. 24, 2018 at 11:46 a.m. ET","Headline":"S&P 500, Nasdaq edge to uncharted territory, headline breakout attempt underway","Summary":""},{"Date":"Aug. 24, 2018 at 8:44 a.m. ET","Headline":"The 15 U.S. companies that are investing the most in tomorrow\u2019s big ideas","Summary":""},{"Date":"Aug. 27, 2018 at 11:35 a.m. ET","Headline":"S&P 500, Nasdaq take flight, extend August rally to uncharted territory","Summary":""},{"Date":"Aug. 29, 2018 at 11:32 a.m. ET","Headline":"Charting a runaway gap:  S&P 500, Nasdaq extend break to uncharted territory","Summary":""},{"Date":"Aug. 29, 2018 at 7:30 a.m. ET","Headline":"Portola Pharmaceuticals Director Scores With Stock Purchase","Summary":""},{"Date":"Aug. 28, 2018 at 12:38 p.m. ET","Headline":"Charting the break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq tag record highs","Summary":""},{"Date":"Aug. 28, 2018 at 11:52 a.m. ET","Headline":"Charting the break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq tag record highs","Summary":""},{"Date":"Aug. 24, 2018 at 7:25 p.m. ET","Headline":"Why Health Care\u2019s Rally May Be Just Getting Started","Summary":""},{"Date":"Aug. 31, 2018 at 11:32 a.m. ET","Headline":"S&P 500, Nasdaq digest two standard deviation August breakout","Summary":""},{"Date":"Aug. 30, 2018 at 7:28 p.m. ET","Headline":"FDA approves pair of Merck drugs to treat HIV","Summary":""},{"Date":"Aug. 30, 2018 at 11:20 a.m. ET","Headline":"S&P 500 and Nasdaq register powerful spike atop 20-day volatility bands","Summary":""},{"Date":"Sep. 4, 2018 at 12:36 p.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 digests rally atop 20-day volatility bands","Summary":""},{"Date":"Sep. 4, 2018 at 11:50 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 digests rally atop 20-day volatility bands","Summary":""},{"Date":"Sep. 6, 2018 at 11:38 a.m. ET","Headline":"Nasdaq ventures under major support, S&P 500 back for second crack at 2,873 breakout point","Summary":""},{"Date":"Sep. 5, 2018 at 11:40 a.m. ET","Headline":"S&P 500 pulls in to the breakout point (2,873), initial retest underway","Summary":""},{"Date":"Sep. 7, 2018 at 11:59 a.m. ET","Headline":"Charting a garden-variety pullback, S&P 500 maintains the breakout point","Summary":""},{"Date":"Sep. 10, 2018 at 11:26 a.m. ET","Headline":"Nasdaq maintains key trendline support, S&P 500 nails the breakout point","Summary":""},{"Date":"Sep. 12, 2018 at 11:35 a.m. ET","Headline":"S&P 500 rallies from the breakout point, Nasdaq holds key trendline","Summary":""},{"Date":"Sep. 11, 2018 at 12:51 p.m. ET","Headline":"Charting a bullish September backdrop:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Sep. 11, 2018 at 12:16 p.m. ET","Headline":"Charting a bullish September backdrop:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Sep. 14, 2018 at 11:37 a.m. ET","Headline":"Charting the Dow industrials\u2019 bull-flag breakout attempt","Summary":""},{"Date":"Sep. 13, 2018 at 11:44 a.m. ET","Headline":"Charting a successful technical test: S&P 500 rallies from major support","Summary":""},{"Date":"Sep. 12, 2018 at 4:07 p.m. ET","Headline":"Rate Hikes Could Hurt These High-Yielding Sectors","Summary":""},{"Date":"Sep. 18, 2018 at 2:57 p.m. ET","Headline":"Health care ETF surges toward record in a broad sector rally","Summary":"The SPDR Health Care Select Sector ETF  rose 0.7% toward a record high in afternoon trade Tuesday, with 55 of its 63 equity components gaining ground. Among the ETF's (XLV) members which are also Dow Jones Industrial Avera..."},{"Date":"Sep. 18, 2018 at 12:47 p.m. ET","Headline":"Charting a bull-flag breakout attempt:  Dow industrials challenge seven-month highs","Summary":""},{"Date":"Sep. 18, 2018 at 12:11 p.m. ET","Headline":"Charting a bull-flag breakout attempt:  Dow industrials challenge seven-month highs","Summary":""},{"Date":"Sep. 17, 2018 at 11:32 a.m. ET","Headline":"S&P 500 traverses the September range as trade-policy tensions persist","Summary":""},{"Date":"Sep. 17, 2018 at 9:06 a.m. ET","Headline":"Billionaire health-care investor Phillip Frost charged by SEC with pump-and-dump schemes","Summary":""},{"Date":"Sep. 20, 2018 at 11:51 a.m. ET","Headline":"Charting a break to \u2018clear skies\u2019 territory:  S&P 500, Dow industrials tag record highs","Summary":"Galectin Therapeutics Inc.  shares surged 15% in Thursday premarket trade after the company said that combining its therapy, GR-MD-02, with Keytruda, Merck & Co.'s  leading cancer therapy, appeared to have better results f..."},{"Date":"Sep. 20, 2018 at 8:25 a.m. ET","Headline":"Galectin stock lifts 15% premarket on early cancer combination trial results","Summary":"Galectin Therapeutics Inc.  shares surged 15% in Thursday premarket trade after the company said that combining its therapy, GR-MD-02, with Keytruda, Merck & Co.'s  leading cancer therapy, appeared to have better results f..."},{"Date":"Sep. 19, 2018 at 11:50 a.m. ET","Headline":"Dow industrials extend technical breakout, rise within view of record highs","Summary":""},{"Date":"Sep. 22, 2018 at 3:35 p.m. ET","Headline":"Here\u2019s how all 30 Dow Jones Industrial Average stocks performed as the benchmark set another record","Summary":""},{"Date":"Sep. 21, 2018 at 11:59 a.m. ET","Headline":"Alzheimer\u2019s and dementia are expected to grow, and could affect minority groups more","Summary":""},{"Date":"Sep. 21, 2018 at 11:42 a.m. ET","Headline":"S&P 500, Dow industrials knife to uncharted territory, close atop 20-day volatility bands","Summary":""},{"Date":"Sep. 21, 2018 at 7:13 a.m. ET","Headline":"These Dow Jones Industrial Average stocks have been left behind as the index hits a record","Summary":""},{"Date":"Sep. 24, 2018 at 11:36 a.m. ET","Headline":"S&P 500 pulls in to the breakout point (2,916), initial retest underway","Summary":""},{"Date":"Sep. 26, 2018 at 11:16 a.m. ET","Headline":"S&P 500 nails the breakout point (again) amid garden-variety pullback","Summary":""},{"Date":"Sep. 25, 2018 at 12:38 p.m. ET","Headline":"Bull trend pauses:  S&P 500 holds the breakout point (2,916) ahead of the Fed","Summary":""},{"Date":"Sep. 25, 2018 at 12:00 p.m. ET","Headline":"Bull trend pauses:  S&P 500 holds the breakout point (2,916) ahead of the Fed","Summary":""},{"Date":"Sep. 28, 2018 at 11:16 a.m. ET","Headline":"Closing out a bullish third quarter, Nasdaq rattles the cage on a breakout","Summary":""},{"Date":"Sep. 27, 2018 at 12:04 p.m. ET","Headline":"Charting market rotation, bull trend absorbs Fed-fueled volatility","Summary":""},{"Date":"Oct. 2, 2018 at 12:34 p.m. ET","Headline":"Charting a bullish Q4 start, S&P 500 rises to challenge record close","Summary":""},{"Date":"Oct. 2, 2018 at 12:08 p.m. ET","Headline":"Charting a bullish Q4 start, S&P 500 rises to challenge record close","Summary":""},{"Date":"Oct. 1, 2018 at 11:39 a.m. ET","Headline":"Charting a trade-fueled breakout attempt, S&P 500 challenges record close","Summary":""},{"Date":"Oct. 4, 2018 at 12:04 p.m. ET","Headline":"Market bears resurface as Treasury yields spike, S&P 500 nails major resistance","Summary":""},{"Date":"Oct. 3, 2018 at 11:35 a.m. ET","Headline":"Charting the approach of Dow 27,000 as technical divergence persists","Summary":""},{"Date":"Oct. 5, 2018 at 11:57 a.m. ET","Headline":"Charting fourth-quarter cross currents, Nasdaq violates key trendline support","Summary":""},{"Date":"Oct. 8, 2018 at 12:03 p.m. ET","Headline":"October downturn accelerates, placing major S&P 500 support (2,873) under siege","Summary":""},{"Date":"Oct. 10, 2018 at 11:35 a.m. ET","Headline":"Charting a bearish technical tilt, S&P 500 violates major support","Summary":""},{"Date":"Oct. 9, 2018 at 12:51 p.m. ET","Headline":"5 Reasons Investors Should Take a Fresh Look at Big Pharma","Summary":""},{"Date":"Oct. 9, 2018 at 12:49 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 nails major support","Summary":""},{"Date":"Oct. 9, 2018 at 12:11 p.m. ET","Headline":"Cracks surface in the bull trend, S&P 500 nails major support","Summary":""},{"Date":"Oct. 12, 2018 at 11:56 a.m. ET","Headline":"Charting a dead-cat bounce, S&P 500 retests 200-day average from underneath","Summary":""},{"Date":"Oct. 12, 2018 at 5:30 a.m. ET","Headline":"The Stock Market Was Scary This Week. Here Are 5 Mutual Funds for Income Investors","Summary":""},{"Date":"Oct. 11, 2018 at 12:24 p.m. ET","Headline":"Bearish momentum accelerates, 10-to-1 down day inflicts technical damage","Summary":""},{"Date":"Oct. 11, 2018 at 6:47 a.m. ET","Headline":"These stocks in the Dow Jones Industrial Average, S&P 500 and Nasdaq declined the most on Wednesday","Summary":""},{"Date":"Oct. 16, 2018 at 12:54 p.m. ET","Headline":"Charting a corrective bounce, S&P 500 reclaims 200-day average","Summary":"Merck KGaA (MRK.XE) expects to return to profitable growth as of next year, with its pharmaceuticals pipeline unfolding its full potential, the company said Tuesday after its capital markets day. The company acknowledged 2..."},{"Date":"Oct. 16, 2018 at 12:25 p.m. ET","Headline":"Charting a corrective bounce, S&P 500 reclaims 200-day average","Summary":"Merck KGaA (MRK.XE) expects to return to profitable growth as of next year, with its pharmaceuticals pipeline unfolding its full potential, the company said Tuesday after its capital markets day. The company acknowledged 2..."},{"Date":"Oct. 16, 2018 at 2:09 a.m. ET","Headline":"Merck KGaA sees return to profit in 2019","Summary":"Merck KGaA (MRK.XE) expects to return to profitable growth as of next year, with its pharmaceuticals pipeline unfolding its full potential, the company said Tuesday after its capital markets day. The company acknowledged 2..."},{"Date":"Oct. 15, 2018 at 11:49 a.m. ET","Headline":"S&P 500 nails the 200-day average, initial retest from underneath still underway","Summary":""},{"Date":"Oct. 18, 2018 at 11:39 a.m. ET","Headline":"Charting a fragile recovery attempt, S&P 500 digests initial technical progress","Summary":""},{"Date":"Oct. 17, 2018 at 11:42 a.m. ET","Headline":"Charting a market recovery attempt:  S&P 500, Nasdaq venture atop 200-day average","Summary":""},{"Date":"Oct. 19, 2018 at 11:58 a.m. ET","Headline":"Charting October volatility:  S&P 500, Nasdaq whipsaw at the 200-day average","Summary":""},{"Date":"Oct. 22, 2018 at 11:49 a.m. ET","Headline":"S&P 500, Nasdaq nail 200-day average amid lackluster recovery attempt","Summary":"Bristol-Myers Squibb Co.  shares dropped nearly 6% in extremely heavy Monday morning trade after the company said that, because of new information from a cancer clinical trial, the U.S. Food and Drug Administration is exte..."},{"Date":"Oct. 22, 2018 at 10:36 a.m. ET","Headline":"Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug","Summary":"Bristol-Myers Squibb Co.  shares dropped nearly 6% in extremely heavy Monday morning trade after the company said that, because of new information from a cancer clinical trial, the U.S. Food and Drug Administration is exte..."},{"Date":"Oct. 24, 2018 at 12:25 p.m. ET","Headline":"Charting a second corrective bounce, S&P 500 lifts from four-month lows","Summary":""},{"Date":"Oct. 23, 2018 at 12:49 p.m. ET","Headline":"Charting an ominous technical tilt, S&P 500 plunges from the 200-day average","Summary":""},{"Date":"Oct. 23, 2018 at 12:18 p.m. ET","Headline":"Charting an ominous technical tilt, S&P 500 plunges from the 200-day average","Summary":""},{"Date":"Oct. 23, 2018 at 10:46 a.m. ET","Headline":"Here are Tuesday\u2019s biggest stock-market losers","Summary":""},{"Date":"Oct. 23, 2018 at 10:29 a.m. ET","Headline":"Caterpillar Tanks, 3M Slumps Because Trade Woes Are Not Just for China Anymore","Summary":""},{"Date":"Oct. 26, 2018 at 11:47 a.m. ET","Headline":"Bearish momentum intact, S&P 500 tags the 10% correction mark","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 4:42 p.m. ET","Headline":"Dow stages 400-point comeback; S&P snaps six-day losing streak","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 3:57 p.m. ET","Headline":"Trump Today: President blames media for \u2018anger\u2019 after bombs sent to Democrats","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 2:59 p.m. ET","Headline":"Merck and Walgreens Are Boosting Their Dividends in a Big Way","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 12:34 p.m. ET","Headline":"Charting a primary trend shift, October downdraft inflicts extensive damage","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 11:44 a.m. ET","Headline":"Merck and Bristol-Myers Squibb Are Seeing Rising Sales of Their Cancer Drugs","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 9:38 a.m. ET","Headline":"A \u2018lost decade\u2019 for stocks may have just arrived, says this adviser","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 7:17 a.m. ET","Headline":"Merck's profit falls short, lowers guidance","Summary":"Merck & Co.'s MRK third-quarter earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, turning around from a loss of $56 million a y..."},{"Date":"Oct. 25, 2018 at 6:55 a.m. ET","Headline":"Merck's profit and revenue fall short","Summary":"Merck & Co.'s MRK earnings rose from the comparable quarter a year ago but not to where analysts were expecting. The company reported net income of $1.95 billion, up from a loss of $56 million for the comparable quarter a ..."},{"Date":"Oct. 25, 2018 at 6:51 a.m. ET","Headline":"Merck raises quarterly dividend by 15% to 55 cents a share, unveils $10 billion buyback","Summary":"Merck & Co. Inc.  said Thursday it is raising its quarterly dividend by 15% to 55 cents a share. The new dividend will be paid Jan. 8 to shareholders of record as of Dec. 17. The board has also approved a share buyback pro..."},{"Date":"Oct. 28, 2018 at 7:32 a.m. ET","Headline":"Here are this week\u2019s worst stocks in the Dow Jones Industrial Average, S&P 500 and Nasdaq","Summary":""},{"Date":"Oct. 30, 2018 at 12:42 p.m. ET","Headline":"Charting a second dead-cat bounce, S&P 500 rises from 10% correction mark","Summary":"Novartis AG (NOVN.EB) and Pfizer Inc. (PFE) are teaming up to target a complex type of liver disease, underscoring the growing willingness of drug makers to work with rivals to tackle difficult-to-treat conditions."},{"Date":"Oct. 30, 2018 at 12:07 p.m. ET","Headline":"Charting a second dead-cat bounce, S&P 500 rises from 10% correction mark","Summary":"Novartis AG (NOVN.EB) and Pfizer Inc. (PFE) are teaming up to target a complex type of liver disease, underscoring the growing willingness of drug makers to work with rivals to tackle difficult-to-treat conditions."},{"Date":"Oct. 29, 2018 at 11:54 a.m. ET","Headline":"S&P 500 lifts to the breakdown point (2,710), latest retest underway","Summary":"Novartis AG (NOVN.EB) and Pfizer Inc. (PFE) are teaming up to target a complex type of liver disease, underscoring the growing willingness of drug makers to work with rivals to tackle difficult-to-treat conditions."},{"Date":"Oct. 29, 2018 at 2:54 a.m. ET","Headline":"Novartis, Pfizer team up on liver-disease drugs","Summary":"Novartis AG (NOVN.EB) and Pfizer Inc. (PFE) are teaming up to target a complex type of liver disease, underscoring the growing willingness of drug makers to work with rivals to tackle difficult-to-treat conditions."},{"Date":"Nov. 1, 2018 at 11:40 a.m. ET","Headline":"Charting a shooting star, S&P 500 nails the breakdown point (2,710)","Summary":""},{"Date":"Oct. 31, 2018 at 11:59 a.m. ET","Headline":"Closing out a damaging October plunge, U.S. benchmarks rise from multi-month lows","Summary":""},{"Date":"Nov. 2, 2018 at 11:44 a.m. ET","Headline":"Market bears resurface as major U.S. benchmarks tag next resistance","Summary":""},{"Date":"Nov. 5, 2018 at 11:43 a.m. ET","Headline":"Charting a near-term holding pattern, S&P 500 asserts the range","Summary":""},{"Date":"Nov. 7, 2018 at 11:47 a.m. ET","Headline":"Charting November follow-through, S&P 500 ventures atop 200-day average","Summary":""},{"Date":"Nov. 6, 2018 at 12:33 p.m. ET","Headline":"Charting the S&P 500\u2019s November bounce ahead of U.S. midterms","Summary":""},{"Date":"Nov. 6, 2018 at 12:03 p.m. ET","Headline":"Charting the S&P 500\u2019s November bounce ahead of U.S. midterms","Summary":""},{"Date":"Nov. 6, 2018 at 8:35 a.m. ET","Headline":"How Trump could rescue Apple\u2019s fast-sinking stock","Summary":""},{"Date":"Nov. 9, 2018 at 11:52 a.m. ET","Headline":"S&P 500 nails the range top (2,817), stalls at well-defined resistance","Summary":"Endo International PLC  shares rose 6% in Thursday premarket trade after the company reported third-quarter adjusted profit and revenue beats and upbeat 2018 guidance. The company reported a net loss of $173.2 million, or ..."},{"Date":"Nov. 8, 2018 at 12:09 p.m. ET","Headline":"Bull case strengthens:  S&P 500, Nasdaq knife atop 200-day average","Summary":"Endo International PLC  shares rose 6% in Thursday premarket trade after the company reported third-quarter adjusted profit and revenue beats and upbeat 2018 guidance. The company reported a net loss of $173.2 million, or ..."},{"Date":"Nov. 8, 2018 at 7:31 a.m. ET","Headline":"Drug stocks rise after midterm elections, with one analyst calling outcome a \u2018best-case scenario\u2019","Summary":"Endo International PLC  shares rose 6% in Thursday premarket trade after the company reported third-quarter adjusted profit and revenue beats and upbeat 2018 guidance. The company reported a net loss of $173.2 million, or ..."},{"Date":"Nov. 8, 2018 at 7:28 a.m. ET","Headline":"Endo stock rises 6% after Q3 beats and upbeat 2018 guidance","Summary":"Endo International PLC  shares rose 6% in Thursday premarket trade after the company reported third-quarter adjusted profit and revenue beats and upbeat 2018 guidance. The company reported a net loss of $173.2 million, or ..."},{"Date":"Nov. 8, 2018 at 5:34 a.m. ET","Headline":"Here are the post-election stock-market winners in the Dow, S&P 500 and Nasdaq","Summary":""},{"Date":"Nov. 13, 2018 at 1:07 p.m. ET","Headline":"Charting a post-election downdraft, S&P 500 returns to mini-crash range","Summary":""},{"Date":"Nov. 13, 2018 at 12:38 p.m. ET","Headline":"Charting a post-election downdraft, S&P 500 returns to mini-crash range","Summary":""},{"Date":"Nov. 13, 2018 at 11:21 a.m. ET","Headline":"Just How Gender-Equity Focused Is That Fund, Anyway?","Summary":""},{"Date":"Nov. 12, 2018 at 11:57 a.m. ET","Headline":"Charting a failed technical test:  S&P 500, Nasdaq violate 200-day average","Summary":""},{"Date":"Nov. 14, 2018 at 12:23 p.m. ET","Headline":"Charting persistent November volatility, Dow industrials challenge 200-day average","Summary":"(Adds CEO quote, details on currency effects and outlook, context for net profit decline.) Merck KGaA (MRK.XE) said Wednesday that third-quarter net profit fell, but it raised its full-year organic sales growth expectation..."},{"Date":"Nov. 14, 2018 at 2:17 a.m. ET","Headline":"Merck KGaA profit falls, but lifts sales view","Summary":"(Adds CEO quote, details on currency effects and outlook, context for net profit decline.) Merck KGaA (MRK.XE) said Wednesday that third-quarter net profit fell, but it raised its full-year organic sales growth expectation..."},{"Date":"Nov. 19, 2018 at 12:00 p.m. ET","Headline":"Bearish momentum persists:  S&P 500, Nasdaq stall at well-defined resistance","Summary":"Merck KGaA (MRK.XE) and Palantir Technologies Inc. PLTCI.XX plan to form a joint venture whose brand name will be Syntropy, the company said Monday. The joint venture will offer data integration and analytics technology fo..."},{"Date":"Nov. 19, 2018 at 8:16 a.m. ET","Headline":"Merck KGaA, Palantir to form joint venture","Summary":"Merck KGaA (MRK.XE) and Palantir Technologies Inc. PLTCI.XX plan to form a joint venture whose brand name will be Syntropy, the company said Monday. The joint venture will offer data integration and analytics technology fo..."},{"Date":"Nov. 21, 2018 at 12:21 p.m. ET","Headline":"S&P 500 tags negative YTD territory, back for initial crack at the breakdown point","Summary":""},{"Date":"Nov. 20, 2018 at 12:46 p.m. ET","Headline":"Bearish momentum accelerates, S&P 500 ventures under major support","Summary":""},{"Date":"Nov. 20, 2018 at 12:06 p.m. ET","Headline":"Bearish momentum accelerates, S&P 500 ventures under major support","Summary":""},{"Date":"Nov. 27, 2018 at 1:02 p.m. ET","Headline":"Bristol-Myers Squibb Stock Dips on Failed Lung-Cancer Trial","Summary":""},{"Date":"Nov. 27, 2018 at 12:36 p.m. ET","Headline":"S&P 500 nails the breakdown point (2,673), pulling-teeth retest underway","Summary":""},{"Date":"Nov. 27, 2018 at 12:07 p.m. ET","Headline":"S&P 500 nails the breakdown point (2,673), pulling-teeth retest underway","Summary":""},{"Date":"Nov. 26, 2018 at 11:46 a.m. ET","Headline":"Charting a bull-bear technical test:  S&P 500 nails the breakdown point (2,673)","Summary":""},{"Date":"Nov. 29, 2018 at 12:16 p.m. ET","Headline":"Charting a Fed-fueled nearly 8-to-1 up day, S&P 500 spikes to major resistance","Summary":""},{"Date":"Nov. 29, 2018 at 7:10 a.m. ET","Headline":"Here are the stocks that powered the Dow after the Fed\u2019s Powell soothed investors","Summary":""},{"Date":"Nov. 28, 2018 at 11:52 a.m. ET","Headline":"S&P 500 extends bounce ahead of the Fed, reclaims first resistance","Summary":""},{"Date":"Nov. 30, 2018 at 11:57 a.m. ET","Headline":"S&P 500 nails major resistance (2,742), sustains initial Fed-fueled gains","Summary":""},{"Date":"Dec. 3, 2018 at 4:39 p.m. ET","Headline":"Here are the best-performing U.S. stocks in Monday\u2019s rally","Summary":""},{"Date":"Dec. 3, 2018 at 11:58 a.m. ET","Headline":"Charting a trade-fueled rally attempt, S&P 500 reclaims 200-day average","Summary":""},{"Date":"Dec. 4, 2018 at 1:21 p.m. ET","Headline":"Market bears resurface:  S&P 500 nails major resistance amid flattening yield curve","Summary":""},{"Date":"Dec. 4, 2018 at 12:51 p.m. ET","Headline":"Market bears resurface:  S&P 500 nails major resistance amid flattening yield curve","Summary":""},{"Date":"Dec. 7, 2018 at 12:02 p.m. ET","Headline":"Charting a bearish market whipsaw, S&P 500 asserts wide December range","Summary":""},{"Date":"Dec. 6, 2018 at 12:00 p.m. ET","Headline":"Charting an aggressive December downdraft amid S&P 500\u2019s pending death cross","Summary":""},{"Date":"Dec. 6, 2018 at 10:29 a.m. ET","Headline":"Bristol-Myers Stock Is Rising on an Analyst Upgrade","Summary":""},{"Date":"Dec. 6, 2018 at 7:06 a.m. ET","Headline":"Here are the worst-performing stocks on \u2018Tariff Man\u2019 Tuesday","Summary":""},{"Date":"Dec. 11, 2018 at 12:44 p.m. ET","Headline":"Charting a December bounce:  S&P 500 nails major support","Summary":""},{"Date":"Dec. 11, 2018 at 12:09 p.m. ET","Headline":"Charting a December bounce:  S&P 500 nails major support","Summary":""},{"Date":"Dec. 10, 2018 at 11:31 a.m. ET","Headline":"Bearish momentum accelerates:  S&P 500 ventures under major support","Summary":""},{"Date":"Dec. 10, 2018 at 6:57 a.m. ET","Headline":"These stocks suffered the biggest losses of the week","Summary":""},{"Date":"Dec. 13, 2018 at 2:48 p.m. ET","Headline":"Look to these stock market sectors in 2019 instead of FAANGs and tech","Summary":"Merck & Co. Inc.  said Wednesday it is working with Brazilian non-profit Instituto Butantan to develop vaccines to protect against the mosquito-borne virus dengue. The pair have licensed rights from National Institute of A..."},{"Date":"Dec. 13, 2018 at 11:36 a.m. ET","Headline":"S&P 500 balks at major resistance as December bounce fades","Summary":"Merck & Co. Inc.  said Wednesday it is working with Brazilian non-profit Instituto Butantan to develop vaccines to protect against the mosquito-borne virus dengue. The pair have licensed rights from National Institute of A..."},{"Date":"Dec. 12, 2018 at 12:43 p.m. ET","Headline":"Merck to develop dengue vaccine with Brazilian nonprofit","Summary":"Merck & Co. Inc.  said Wednesday it is working with Brazilian non-profit Instituto Butantan to develop vaccines to protect against the mosquito-borne virus dengue. The pair have licensed rights from National Institute of A..."},{"Date":"Dec. 12, 2018 at 11:15 a.m. ET","Headline":"S&P 500 extends corrective bounce, major resistance (2,673) under siege","Summary":""},{"Date":"Dec. 14, 2018 at 11:17 a.m. ET","Headline":"Charting a failed technical test, S&P 500 traverses negative YTD territory","Summary":"Merck & Co. Inc.  said Friday it has reached agreement to acquire privately held French company Antelliq for 2.1 billion euros in cash, and the assumption of EUR1.15 billion in debt. Antelliq specializes in digital animal ..."},{"Date":"Dec. 14, 2018 at 6:58 a.m. ET","Headline":"Merck to acquire France's Intelliq for 2.1 billion euros in cash, assumption of debt","Summary":"Merck & Co. Inc.  said Friday it has reached agreement to acquire privately held French company Antelliq for 2.1 billion euros in cash, and the assumption of EUR1.15 billion in debt. Antelliq specializes in digital animal ..."},{"Date":"Dec. 17, 2018 at 11:42 a.m. ET","Headline":"S&P 500 reaches less-charted territory, second test of major support (2,581) underway","Summary":""},{"Date":"Dec. 17, 2018 at 7:00 a.m. ET","Headline":"Merck Insiders Stepped Up Stock Sales in a Big Way This Year","Summary":""},{"Date":"Dec. 16, 2018 at 10:36 a.m. ET","Headline":"These are the U.S. stock market\u2019s biggest losers this week","Summary":""},{"Date":"Dec. 19, 2018 at 2:59 p.m. ET","Headline":"Eli Lilly Forecast Points to a Strong Year","Summary":""},{"Date":"Dec. 19, 2018 at 11:40 a.m. ET","Headline":"S&P 500 establishes near-term floor, bounces modestly ahead of Fed","Summary":""},{"Date":"Dec. 18, 2018 at 12:42 p.m. ET","Headline":"Charting a falling-knife backdrop, S&P 500 confirms primary downtrend","Summary":""},{"Date":"Dec. 18, 2018 at 12:07 p.m. ET","Headline":"Charting a falling-knife backdrop, S&P 500 confirms primary downtrend","Summary":""},{"Date":"Dec. 21, 2018 at 3:14 p.m. ET","Headline":"Perrigo Tumbles 27% After Getting Slapped With a $1.8 Billion Tax Bill","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 21, 2018 at 12:05 p.m. ET","Headline":"Charting the December carnage, S&P 500 tags the 2,450 target","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 20, 2018 at 11:57 a.m. ET","Headline":"Falling-knife backdrop persists, S&P 500 extends to less-charted territory","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 20, 2018 at 9:55 a.m. ET","Headline":"Eli Lilly and Pfizer Are Boosting Dividends","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 20, 2018 at 6:48 a.m. ET","Headline":"Powell party pooper: Here are the worst-performing stocks after the Fed wrecks the market","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 20, 2018 at 3:08 a.m. ET","Headline":"AstraZeneca: Ovarian cancer drug meets first goals","Summary":"AstraZeneca PLC's (AZN.LN) Lynparza drug met its primary goal in a clinical trial for treatment of relapsed ovarian cancer, the pharmaceutical company said Thursday. Lynparza, which AstraZeneca is developing in collaborati..."},{"Date":"Dec. 23, 2018 at 1:59 p.m. ET","Headline":"There will be \u2018plenty of opportunity\u2019 for investors in 2019, says manager of $74 billion Franklin Income Fund","Summary":""},{"Date":"Dec. 25, 2018 at 9:00 a.m. ET","Headline":"Chevron Stock\u2019s Strong Start This Year Couldn\u2019t Survive the Dive in Oil Prices","Summary":""},{"Date":"Dec. 29, 2018 at 10:00 a.m. ET","Headline":"Verizon Stock Left Its Competitors in the Dust in 2018","Summary":""},{"Date":"Dec. 29, 2018 at 9:00 a.m. ET","Headline":"Coca-Cola Stock Staged a 2018 Comeback","Summary":""},{"Date":"Dec. 29, 2018 at 7:00 a.m. ET","Headline":"McDonald\u2019s Stock Was a Slow and Steady Winner in 2018","Summary":""},{"Date":"Dec. 28, 2018 at 8:00 a.m. ET","Headline":"Walt Disney Stock Went Nowhere in 2018","Summary":""},{"Date":"Dec. 24, 2018 at 11:21 a.m. ET","Headline":"Caterpillar Stock Is Slumping Despite Earnings Growth","Summary":""},{"Date":"Dec. 31, 2018 at 9:57 a.m. ET","Headline":"Countdown to 2019: Lessons From the Dow\u2019s Painful Year","Summary":""},{"Date":"Dec. 31, 2018 at 6:30 a.m. ET","Headline":"Merck Stock Was the Best in the Dow in 2018 \u2014 by Far","Summary":""},{"Date":"Dec. 31, 2018 at 5:30 a.m. ET","Headline":"Pfizer Stock Withstood a Health Care Sector Stumble to Be a 2018 Winner","Summary":""},{"Date":"Dec. 31, 2018 at 5:00 a.m. ET","Headline":"Microsoft Stock Was the Dow\u2019s Top Tech Performer in 2018","Summary":""},{"Date":"Dec. 30, 2018 at 12:00 p.m. ET","Headline":"Cisco Stock Rose in 2018 by Avoiding Drama","Summary":""},{"Date":"Dec. 30, 2018 at 11:00 a.m. ET","Headline":"UnitedHealth Stock Rose in 2018 Because Stability Paid Off","Summary":""},{"Date":"Dec. 30, 2018 at 8:00 a.m. ET","Headline":"Look for Boeing Stock to Stay Strong in 2019","Summary":""},{"Date":"Jan. 2, 2019 at 2:46 p.m. ET","Headline":"Biotech Stocks in 2019 May Be Facing Another Tough Year","Summary":""},{"Date":"Jan. 2, 2019 at 12:07 p.m. ET","Headline":"Charting a \u2018near-term\u2019 rally attempt, S&P 500 rises amid major technical damage","Summary":""},{"Date":"Jan. 2, 2019 at 10:48 a.m. ET","Headline":"Bausch Stock Is Soaring After an Analyst Upgrade","Summary":""},{"Date":"Jan. 2, 2019 at 8:37 a.m. ET","Headline":"Dow Futures Drop 350 Points Because a Slowing China Is Scarier Than a Government Shutdown","Summary":""},{"Date":"Dec. 28, 2018 at 8:00 a.m. ET","Headline":"Procter & Gamble Stock Survived a Brutal Year for Consumer Staples","Summary":""},{"Date":"Dec. 28, 2018 at 7:00 a.m. ET","Headline":"It Was a Bad Year for Walgreens to Join the Dow","Summary":""},{"Date":"Dec. 28, 2018 at 5:00 a.m. ET","Headline":"Intel Stock Got Hammered This Year. Is It Finally Cheap Enough?","Summary":""},{"Date":"Dec. 27, 2018 at 2:46 p.m. ET","Headline":"Johnson & Johnson Stock Had a Baby Powder Problem in 2018","Summary":""},{"Date":"Dec. 27, 2018 at 6:30 a.m. ET","Headline":"American Express Had a Better Year Than It Looks. That Could Be Bad News in 2019","Summary":""},{"Date":"Dec. 27, 2018 at 5:30 a.m. ET","Headline":"What Happened With Apple Stock in 2018 and What\u2019s Next","Summary":""},{"Date":"Dec. 26, 2018 at 9:00 a.m. ET","Headline":"JPMorgan Was Humming Along in 2018. The Stock Wasn\u2019t.","Summary":""},{"Date":"Dec. 26, 2018 at 8:00 a.m. ET","Headline":"Travelers Stock Had a Tough 2018 and the Pressure Won\u2019t Ease Up Soon","Summary":""},{"Date":"Dec. 26, 2018 at 7:00 a.m. ET","Headline":"Home Depot Stock Was Hammered in 2018","Summary":""},{"Date":"Dec. 26, 2018 at 6:00 a.m. ET","Headline":"United Technologies Stock Spent 2018 Stuck in Limbo","Summary":""},{"Date":"Dec. 25, 2018 at 8:00 a.m. ET","Headline":"3M Stock Had a Rough 2018 Amid Weakness in the Industrial Sector","Summary":""},{"Date":"Dec. 25, 2018 at 7:00 a.m. ET","Headline":"Exxon Mobil Stock Rode the Plunge in Oil Prices Down in 2018","Summary":""},{"Date":"Jan. 4, 2019 at 11:37 a.m. ET","Headline":"S&P 500 back for second crack at resistance (2,520) amid Fed-fueled rally attempt","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 4, 2019 at 7:21 a.m. ET","Headline":"These are the top stock picks for 2019 among Wall Street analysts","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 3, 2019 at 11:56 a.m. ET","Headline":"S&P 500 nails resistance (2,520), pulls in amid Apple-fueled volatility","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 3, 2019 at 9:27 a.m. ET","Headline":"The best and worst stocks of 2018","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 3, 2019 at 8:44 a.m. ET","Headline":"Dow Futures Drop 248 Points as Big Biotech Deal Overshadowed by Apple Tumble","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 3, 2019 at 6:53 a.m. ET","Headline":"Merck's Keytruda wins 5 new approvals in Japan","Summary":"Merck & Co. Inc.  said Thursday it has received five new approvals from the Japanese regulator for its Keytruda treatment, including three expanded uses in advanced non-small lung cancer, one in melanoma and a new indicati..."},{"Date":"Jan. 5, 2019 at 12:10 p.m. ET","Headline":"The biggest stock-market winners and losers on the best day for jobs news in 10 months","Summary":""},{"Date":"Jan. 8, 2019 at 12:23 p.m. ET","Headline":"Charting a bull-bear battleground:  S&P 500, Nasdaq nail major resistance","Summary":"Shares of Moderna Inc.  rallied 7.7% in premarket trade Tuesday, after the biotechnology company provided details on recent progress made on its immuno-oncology programs. The company, which became the largest biotech initi..."},{"Date":"Jan. 8, 2019 at 11:57 a.m. ET","Headline":"Charting a bull-bear battleground:  S&P 500, Nasdaq nail major resistance","Summary":"Shares of Moderna Inc.  rallied 7.7% in premarket trade Tuesday, after the biotechnology company provided details on recent progress made on its immuno-oncology programs. The company, which became the largest biotech initi..."},{"Date":"Jan. 8, 2019 at 8:48 a.m. ET","Headline":"Moderna's stock jumps after progress report on cancer treatments","Summary":"Shares of Moderna Inc.  rallied 7.7% in premarket trade Tuesday, after the biotechnology company provided details on recent progress made on its immuno-oncology programs. The company, which became the largest biotech initi..."},{"Date":"Jan. 7, 2019 at 11:39 a.m. ET","Headline":"Second 20-to-1 up day strengthens S&P 500\u2019s \u2018near-term\u2019 recovery attempt","Summary":""},{"Date":"Jan. 10, 2019 at 11:58 a.m. ET","Headline":"Charting a bullish divergence:  Nasdaq reclaims the breakdown point","Summary":""},{"Date":"Jan. 9, 2019 at 11:31 a.m. ET","Headline":"2 Consumer-Staples Stocks That Could Break Out","Summary":""},{"Date":"Jan. 9, 2019 at 11:29 a.m. ET","Headline":"Charting a bull-bear stalemate:  S&P 500 hesitates at major resistance (2,581)","Summary":""},{"Date":"Jan. 11, 2019 at 4:43 p.m. ET","Headline":"Here are the best Dow and S&P stocks so far in 2019","Summary":""},{"Date":"Jan. 11, 2019 at 11:51 a.m. ET","Headline":"S&P 500 edges atop major resistance (2,581) amid persistent January rally attempt","Summary":""},{"Date":"Jan. 14, 2019 at 11:19 a.m. ET","Headline":"Charting a near-term holding pattern, S&P 500 digests January gains","Summary":""},{"Date":"Jan. 16, 2019 at 11:51 a.m. ET","Headline":"Bull case strengthens, Nasdaq reclaims the 50-day average","Summary":""},{"Date":"Jan. 15, 2019 at 5:50 p.m. ET","Headline":"The Dow Climbs 156 Points as China Gives a Reason to Hope","Summary":""},{"Date":"Jan. 15, 2019 at 4:48 p.m. ET","Headline":"Here\u2019s your guide to the upcoming biotechnology takeover wave","Summary":""},{"Date":"Jan. 15, 2019 at 12:18 p.m. ET","Headline":"Charting a bull flag:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Jan. 15, 2019 at 11:46 a.m. ET","Headline":"Charting a bull flag:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Jan. 18, 2019 at 11:50 a.m. ET","Headline":"Bull case strengthens (again), S&P 500 signals intermediate-term \u2018trend\u2019 shift","Summary":""},{"Date":"Jan. 17, 2019 at 11:44 a.m. ET","Headline":"Charting a persistent rally attempt, S&P 500 nails major resistance","Summary":""},{"Date":"Jan. 22, 2019 at 1:05 p.m. ET","Headline":"S&P 500 reaches firmer technical ground, pulls in from major resistance","Summary":""},{"Date":"Jan. 22, 2019 at 12:32 p.m. ET","Headline":"S&P 500 reaches firmer technical ground, pulls in from major resistance","Summary":""},{"Date":"Jan. 24, 2019 at 11:11 a.m. ET","Headline":"Charting a successful technical test, S&P 500 maintains major support","Summary":"Shares of Merck & Co Inc.  were down 1.2% on Wednesday after BMO Capital Markets downgraded the company's rating to market perform from outperform, citing Merck's \"over-dependence on Keytruda\" and upcoming trials that coul..."},{"Date":"Jan. 23, 2019 at 4:25 p.m. ET","Headline":"Big Pharma Stocks Were Downgraded by Analysts Today","Summary":"Shares of Merck & Co Inc.  were down 1.2% on Wednesday after BMO Capital Markets downgraded the company's rating to market perform from outperform, citing Merck's \"over-dependence on Keytruda\" and upcoming trials that coul..."},{"Date":"Jan. 23, 2019 at 12:01 p.m. ET","Headline":"S&P 500 retests major support (2,631) as first January selling pressure surfaces","Summary":"Shares of Merck & Co Inc.  were down 1.2% on Wednesday after BMO Capital Markets downgraded the company's rating to market perform from outperform, citing Merck's \"over-dependence on Keytruda\" and upcoming trials that coul..."},{"Date":"Jan. 23, 2019 at 11:33 a.m. ET","Headline":"BMO downgrades Merck to market perform","Summary":"Shares of Merck & Co Inc.  were down 1.2% on Wednesday after BMO Capital Markets downgraded the company's rating to market perform from outperform, citing Merck's \"over-dependence on Keytruda\" and upcoming trials that coul..."},{"Date":"Jan. 23, 2019 at 8:23 a.m. ET","Headline":"IBM, P&G, United Technologies Earnings Lift Dow Above a Sea of Troubles","Summary":"Merck KGaA (MRK.XE) said Wednesday that it has signed a strategic collaboration agreement with Tencent Holdings Ltd. (0700.HK) to develop digital healthcare services in China. The German company said it will work with the ..."},{"Date":"Jan. 23, 2019 at 1:43 a.m. ET","Headline":"Merck, Tencent to collaborate on China healthcare","Summary":"Merck KGaA (MRK.XE) said Wednesday that it has signed a strategic collaboration agreement with Tencent Holdings Ltd. (0700.HK) to develop digital healthcare services in China. The German company said it will work with the ..."},{"Date":"Jan. 25, 2019 at 11:27 a.m. ET","Headline":"Bull \u2019trend\u2019 persists, S&P 500 back for second crack at major resistance (2,673)","Summary":""},{"Date":"Jan. 28, 2019 at 11:30 a.m. ET","Headline":"Charting a market whipsaw, S&P 500 pulls in to major support (2,631)","Summary":""},{"Date":"Jan. 28, 2019 at 10:54 a.m. ET","Headline":"Don\u2019t worry, Mr. President, the media is about to pay a lot more attention to earnings","Summary":""},{"Date":"Jan. 30, 2019 at 8:30 p.m. ET","Headline":"Here are the biggest stock winners on the day the Fed went soft on interest rates","Summary":""},{"Date":"Jan. 30, 2019 at 11:12 a.m. ET","Headline":"Charting a breakout attempt:  Dow industrials rattle cage on major resistance (24,876)","Summary":""},{"Date":"Jan. 29, 2019 at 12:16 p.m. ET","Headline":"Charting a garden-variety pullback, S&P 500 asserts near-term range","Summary":""},{"Date":"Jan. 29, 2019 at 11:47 a.m. ET","Headline":"Charting a garden-variety pullback, S&P 500 asserts near-term range","Summary":""},{"Date":"Jan. 29, 2019 at 10:40 a.m. ET","Headline":"Pfizer\u2019s \u2018Promising Outlook\u2019 Still Shines for Analysts After Earnings Report","Summary":""},{"Date":"Jan. 29, 2019 at 9:37 a.m. ET","Headline":"An earnings tsunami \u2014 with 113 S&P 500 components \u2014 marks \u2018pivot point\u2019 for stock market","Summary":""},{"Date":"Jan. 25, 2019 at 8:52 p.m. ET","Headline":"An Exclusive Look at the Companies Most Exposed to Climate Change Risk \u2014 and What They\u2019re Doing About It","Summary":""},{"Date":"Feb. 1, 2019 at 4:25 p.m. ET","Headline":"Stocks close mostly higher after blockbuster January jobs report","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings before the open were accounting for nearly half of the Dow's 83-point gain in morning trade. Shares of Chevron Corp.  rose ..."},{"Date":"Feb. 1, 2019 at 12:00 p.m. ET","Headline":"S&P 500 confirms bull trend, rises to nail next resistance (2,710)","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings before the open were accounting for nearly half of the Dow's 83-point gain in morning trade. Shares of Chevron Corp.  rose ..."},{"Date":"Feb. 1, 2019 at 11:35 a.m. ET","Headline":"The Dow Rises 142 Points Because Jobs Data Went to Work on Stocks","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings before the open were accounting for nearly half of the Dow's 83-point gain in morning trade. Shares of Chevron Corp.  rose ..."},{"Date":"Feb. 1, 2019 at 9:44 a.m. ET","Headline":"Dow's 3 earnings reporters adding nearly 40 points to the rally","Summary":"Shares of the three Dow Jones Industrial Average  components that reported fourth-quarter earnings before the open were accounting for nearly half of the Dow's 83-point gain in morning trade. Shares of Chevron Corp.  rose ..."},{"Date":"Feb. 1, 2019 at 9:33 a.m. ET","Headline":"Merck Stock Gains Because Cancer Drug Brings Rising Earnings","Summary":"Merck & Co.  said Friday it had net income of $1.827 billion, or 69 cents a share, in the fourth quarter, after a loss of $1.046 billion, or 39 cents a share, in the year-earlier quarter. The year-earlier number reflects a..."},{"Date":"Feb. 1, 2019 at 9:30 a.m. ET","Headline":"Amazon and Apple earnings \u2014 is this where it all goes wrong for the stock market?","Summary":"Merck & Co.  said Friday it had net income of $1.827 billion, or 69 cents a share, in the fourth quarter, after a loss of $1.046 billion, or 39 cents a share, in the year-earlier quarter. The year-earlier number reflects a..."},{"Date":"Feb. 1, 2019 at 6:57 a.m. ET","Headline":"Merck tops profit and sales estimates in latest quarter","Summary":"Merck & Co.  said Friday it had net income of $1.827 billion, or 69 cents a share, in the fourth quarter, after a loss of $1.046 billion, or 39 cents a share, in the year-earlier quarter. The year-earlier number reflects a..."},{"Date":"Jan. 31, 2019 at 11:57 a.m. ET","Headline":"Bull trend accelerates, S&P 500 reclaims major resistance (2,673) after the Fed","Summary":""},{"Date":"Jan. 28, 2019 at 8:42 a.m. ET","Headline":"Climate Change Could Hit These Companies Hardest","Summary":""},{"Date":"Feb. 2, 2019 at 2:17 p.m. ET","Headline":"Pricing Pressure a Hard Pill for Pharma to Swallow","Summary":""},{"Date":"Feb. 2, 2019 at 10:35 a.m. ET","Headline":"Oil earnings fuel rally after Exxon, Chevron results","Summary":""},{"Date":"Feb. 5, 2019 at 12:59 p.m. ET","Headline":"Bull trend strengthens, S&P 500 approaches 200-day average","Summary":""},{"Date":"Feb. 5, 2019 at 12:16 p.m. ET","Headline":"Bull trend strengthens, S&P 500 approaches 200-day average","Summary":""},{"Date":"Feb. 5, 2019 at 9:35 a.m. ET","Headline":"Stock forecaster who called 2018 \u2018panic event\u2019 says get ready for the next one","Summary":""},{"Date":"Feb. 4, 2019 at 11:34 a.m. ET","Headline":"Charting a bullish February start, Dow industrials sustain slight break atop 200-day average","Summary":""},{"Date":"Feb. 7, 2019 at 12:21 p.m. ET","Headline":"Charting a failed technical test: S&P 500 balks at 200-day average amid trade concerns","Summary":""},{"Date":"Feb. 6, 2019 at 1:48 p.m. ET","Headline":"Eli Lilly Stock Falls Because 2019 Isn\u2019t 2018","Summary":""},{"Date":"Feb. 6, 2019 at 11:33 a.m. ET","Headline":"Charting a slow-motion breakout attempt, S&P 500 hesitates at 200-day average","Summary":""},{"Date":"Feb. 6, 2019 at 7:04 a.m. ET","Headline":"GlaxoSmithKline and Merck KGaA strike immunotherapy deal worth up to $4 billion","Summary":""},{"Date":"Feb. 8, 2019 at 12:14 p.m. ET","Headline":"Charting limited technical damage (so far), S&P 500 extends pullback from resistance","Summary":""},{"Date":"Feb. 8, 2019 at 11:20 a.m. ET","Headline":"Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health","Summary":""},{"Date":"Feb. 8, 2019 at 8:45 a.m. ET","Headline":"5 things to know about Gossamer Bio, a biotech with a surprisingly diverse pipeline","Summary":""},{"Date":"Feb. 8, 2019 at 5:00 a.m. ET","Headline":"Buying the Dow Stocks With the Highest Dividends Is a Winning Strategy","Summary":""},{"Date":"Feb. 11, 2019 at 11:43 a.m. ET","Headline":"Bull trend intact, S&P 500 absorbs downturn from 200-day average","Summary":""},{"Date":"Feb. 11, 2019 at 6:00 a.m. ET","Headline":"Big Pharma Wants to Borrow Cash for M&A, but Could Run Into Credit Downgrades","Summary":""},{"Date":"Feb. 13, 2019 at 11:50 a.m. ET","Headline":"Nasdaq nails 200-day average, S&P 500 extends break atop major resistance","Summary":""},{"Date":"Feb. 13, 2019 at 7:03 a.m. ET","Headline":"Here are the stock market\u2019s biggest winners as Washington (apparently) avoids another shutdown","Summary":""},{"Date":"Feb. 12, 2019 at 1:53 p.m. ET","Headline":"The Biotech Stock Rally May Just Be Getting Started","Summary":""},{"Date":"Feb. 12, 2019 at 12:32 p.m. ET","Headline":"Bull trend strengthens, S&P 500 rattles cage on 200-day average","Summary":""},{"Date":"Feb. 12, 2019 at 11:57 a.m. ET","Headline":"Bull trend strengthens, S&P 500 rattles cage on 200-day average","Summary":""},{"Date":"Feb. 12, 2019 at 11:16 a.m. ET","Headline":"7 stocks that prove bigger is better in 2019","Summary":""},{"Date":"Feb. 15, 2019 at 11:47 a.m. ET","Headline":"S&P 500 extends break atop 200-day average, rises to nail next resistance (2,773)","Summary":""},{"Date":"Feb. 14, 2019 at 1:08 p.m. ET","Headline":"Zoetis Stock Gains Because People Keep Spending on Their Pets","Summary":""},{"Date":"Feb. 14, 2019 at 11:58 a.m. ET","Headline":"Charting a jagged breakout attempt:  S&P 500 whipsaws at major resistance","Summary":""},{"Date":"Feb. 19, 2019 at 4:29 p.m. ET","Headline":"Merck stock falls in late trading on cancer study","Summary":"Merck & Co. Inc.  shares declined in after-hours trading Tuesday after the company  that a study of its Keytruda drug did not meet its goals. The company said that a study on the effectiveness of the drug for patients with..."},{"Date":"Feb. 19, 2019 at 12:36 p.m. ET","Headline":"Charting a primary trend shift:  S&P 500, Nasdaq reclaim 200-day average","Summary":""},{"Date":"Feb. 19, 2019 at 12:04 p.m. ET","Headline":"Charting a primary trend shift:  S&P 500, Nasdaq reclaim 200-day average","Summary":""},{"Date":"Feb. 18, 2019 at 6:00 a.m. ET","Headline":"Big Pharma Can\u2019t Resist Big Mergers. Here\u2019s Why.","Summary":""},{"Date":"Feb. 21, 2019 at 12:08 p.m. ET","Headline":"Charting a bull-trend pullback: Nasdaq, Dow industrials hesitate at major resistance","Summary":""},{"Date":"Feb. 20, 2019 at 11:50 a.m. ET","Headline":"Nasdaq nails major resistance, slow-motion breakout attempt underway","Summary":""},{"Date":"Feb. 22, 2019 at 11:37 a.m. ET","Headline":"Charting a tandem breakout attempt:  Nasdaq, Dow industrials clear major resistance","Summary":""},{"Date":"Feb. 25, 2019 at 12:00 p.m. ET","Headline":"Dow\u2019s Best-Performing Stock in 2018 Gets Vote of Confidence","Summary":""},{"Date":"Feb. 25, 2019 at 11:58 a.m. ET","Headline":"Bull trend strengthens, S&P 500 ventures atop major resistance (2,802)","Summary":""},{"Date":"Feb. 7, 2019 at 11:43 a.m. ET","Headline":"4 Health-Care Stocks With Hefty Dividends","Summary":""},{"Date":"Feb. 27, 2019 at 12:08 p.m. ET","Headline":"Charting a garden-variety pullback, Nasdaq nails major support (7,486)","Summary":"Germany's Merck KGaA  said Wednesday it is offering to acquire Versum Materials Inc.  in an all-cash deal with an enterprise value of $5.9 billion. Merck is offering to pay $48 per Versum share, which is equal to a 51.7% p..."},{"Date":"Feb. 27, 2019 at 8:10 a.m. ET","Headline":"Merck KGaA offers to buy Versum Materials in all-cash deal valued at $5.9 billion","Summary":"Germany's Merck KGaA  said Wednesday it is offering to acquire Versum Materials Inc.  in an all-cash deal with an enterprise value of $5.9 billion. Merck is offering to pay $48 per Versum share, which is equal to a 51.7% p..."},{"Date":"Feb. 26, 2019 at 2:48 p.m. ET","Headline":"Drugmakers\u2019 CEOs clash with senators in hearing on drug price hikes","Summary":""},{"Date":"Feb. 26, 2019 at 12:46 p.m. ET","Headline":"Charting a V-shaped reversal, S&P 500 hesitates at major resistance","Summary":""},{"Date":"Feb. 26, 2019 at 12:17 p.m. ET","Headline":"Charting a V-shaped reversal, S&P 500 hesitates at major resistance","Summary":""},{"Date":"Feb. 26, 2019 at 10:34 a.m. ET","Headline":"The $1 reason to keep buying one of the S&P\u2019s hottest stocks: Netflix","Summary":""},{"Date":"Feb. 26, 2019 at 9:45 a.m. ET","Headline":"Drugmakers\u2019 CEOs set to get grilled at Senate hearing on rising drug prices","Summary":""},{"Date":"Feb. 26, 2019 at 8:22 a.m. ET","Headline":"Curtain rises on 3 days of Michael Cohen drama | Republican senator says he\u2019ll vote against Trump\u2019s border emergency","Summary":""},{"Date":"Feb. 1, 2019 at 8:00 p.m. ET","Headline":"Corning Stock Still Looks Like a Buy, on Strong 2019 Outlook","Summary":""},{"Date":"Jan. 11, 2019 at 8:00 p.m. ET","Headline":"Why Bristol-Myers Squibb Can Be a Sweet Pill for Investors","Summary":""},{"Date":"Mar. 1, 2019 at 3:43 p.m. ET","Headline":"Versum Is Sticking With Entegris and Spurning Germany\u2019s Merck\u2013For Now","Summary":""},{"Date":"Mar. 1, 2019 at 11:24 a.m. ET","Headline":"S&P 500 rallies toward major resistance, pulling-teeth retest underway","Summary":""},{"Date":"Feb. 28, 2019 at 11:58 a.m. ET","Headline":"Bull trend pauses:  Nasdaq, Dow industrials maintain major support","Summary":""},{"Date":"Feb. 28, 2019 at 11:44 a.m. ET","Headline":"Stock market just can\u2019t break through this key resistance level","Summary":""},{"Date":"Mar. 5, 2019 at 12:59 p.m. ET","Headline":"Charting a bull-trend pullback:  S&P 500 absorbs March shot across the bow","Summary":"Merck KGaA (MRK.XE) on Tuesday said it remained committed to pursuing its acquisition of Versum Materials Inc. (VSM) after receiving a formal rejection from Versum's board of directors last week, about a month after Entegr..."},{"Date":"Mar. 5, 2019 at 12:27 p.m. ET","Headline":"Charting a bull-trend pullback:  S&P 500 weathers March shot across the bow","Summary":"Merck KGaA (MRK.XE) on Tuesday said it remained committed to pursuing its acquisition of Versum Materials Inc. (VSM) after receiving a formal rejection from Versum's board of directors last week, about a month after Entegr..."},{"Date":"Mar. 5, 2019 at 11:49 a.m. ET","Headline":"GM and Other \u2018Goldilocks\u2019 Stocks Popular With Fund Managers","Summary":"Merck KGaA (MRK.XE) on Tuesday said it remained committed to pursuing its acquisition of Versum Materials Inc. (VSM) after receiving a formal rejection from Versum's board of directors last week, about a month after Entegr..."},{"Date":"Mar. 5, 2019 at 7:05 a.m. ET","Headline":"Merck KGaA says Versum board declines talks","Summary":"Merck KGaA (MRK.XE) on Tuesday said it remained committed to pursuing its acquisition of Versum Materials Inc. (VSM) after receiving a formal rejection from Versum's board of directors last week, about a month after Entegr..."},{"Date":"Mar. 4, 2019 at 11:43 a.m. ET","Headline":"S&P 500 nails the range top (2,817), modest selling pressure resurfaces","Summary":""},{"Date":"Mar. 7, 2019 at 11:59 a.m. ET","Headline":"S&P 500 ventures under 200-day average, pulls in to nail major support (2,742)","Summary":"German multinational Merck KGaA (MRK.XE) said Thursday that its fourth-quarter net profit more than doubled as sales rose in its three business sectors. Net income was 2.45 billion euros ($2.77 billion), up from EUR1.01 bi..."},{"Date":"Mar. 7, 2019 at 1:55 a.m. ET","Headline":"Merck KGaA profit rises on sales growth","Summary":"German multinational Merck KGaA (MRK.XE) said Thursday that its fourth-quarter net profit more than doubled as sales rose in its three business sectors. Net income was 2.45 billion euros ($2.77 billion), up from EUR1.01 bi..."},{"Date":"Mar. 6, 2019 at 12:08 p.m. ET","Headline":"Bull-bear stalemate persists, S&P 500 extends pullback from major resistance","Summary":""},{"Date":"Mar. 8, 2019 at 12:16 p.m. ET","Headline":"Charting near-term technical damage:  S&P 500 and Nasdaq violate 200-day average","Summary":""},{"Date":"Mar. 11, 2019 at 12:04 p.m. ET","Headline":"S&P 500 pulls rabbit from hat, rallies after barely holding major support (2,742)","Summary":""},{"Date":"Mar. 13, 2019 at 12:27 p.m. ET","Headline":"A Merck Cancer Treatment Has a Big Opportunity in China, Analyst Says","Summary":""},{"Date":"Mar. 13, 2019 at 11:30 a.m. ET","Headline":"Charting a headline breakout attempt, S&P 500 challenges major resistance (2,817)","Summary":""},{"Date":"Mar. 12, 2019 at 12:52 p.m. ET","Headline":"Charting a bullish reversal, S&P 500 spikes from major support (2,742)","Summary":""},{"Date":"Mar. 12, 2019 at 12:49 p.m. ET","Headline":"Prescription drug prices aren\u2019t rising \u2014 they\u2019re falling for the first time in 47 years","Summary":""},{"Date":"Mar. 12, 2019 at 12:16 p.m. ET","Headline":"Charting a bullish reversal, S&P 500 spikes from major support (2,742)","Summary":""},{"Date":"Mar. 12, 2019 at 8:10 a.m. ET","Headline":"Want to ride the health-care stock wave? Here are 19 companies growing sales rapidly","Summary":""},{"Date":"Mar. 12, 2019 at 7:53 a.m. ET","Headline":"Here are Monday\u2019s stock-market winners after five-day losing streak is broken","Summary":""},{"Date":"Mar. 15, 2019 at 11:30 a.m. ET","Headline":"S&P 500 nails the range top, Nasdaq ventures atop major resistance (7,670)","Summary":""},{"Date":"Mar. 14, 2019 at 11:59 a.m. ET","Headline":"Charting an extended breakout attempt, S&P 500 nails resistance amid Boeing headwind","Summary":""},{"Date":"Feb. 27, 2019 at 12:32 p.m. ET","Headline":"Entegris May Lose A Bidding War for Versum, but Don\u2019t Give Up on the Stock Yet","Summary":""},{"Date":"Mar. 19, 2019 at 12:36 p.m. ET","Headline":"Charting a break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq reclaim major resistance","Summary":""},{"Date":"Mar. 19, 2019 at 12:07 p.m. ET","Headline":"Charting a break to \u2018clear skies\u2019 territory:  S&P 500, Nasdaq reclaim major resistance","Summary":""},{"Date":"Mar. 18, 2019 at 11:43 a.m. ET","Headline":"Slow-motion breakout underway:  S&P 500, Nasdaq venture atop major resistance","Summary":""},{"Date":"Mar. 21, 2019 at 11:59 a.m. ET","Headline":"S&P 500, Nasdaq nail the breakout point, sustain break to \u2018clear skies\u2019 territory","Summary":"Merck KGaA, Darmstadt, Germany (MRK.XE), and Pfizer Inc. PFE said Wednesday they discontinued the Phase III JAVELIN Ovarian PARP 100 study. The study was evaluating avelumab in combination with chemotherapy followed by mai..."},{"Date":"Mar. 20, 2019 at 4:32 p.m. ET","Headline":"Eli Lilly Stock Is Up Because UBS Sees Reasons to Be Bullish","Summary":"Merck KGaA, Darmstadt, Germany (MRK.XE), and Pfizer Inc. PFE said Wednesday they discontinued the Phase III JAVELIN Ovarian PARP 100 study. The study was evaluating avelumab in combination with chemotherapy followed by mai..."},{"Date":"Mar. 20, 2019 at 12:55 p.m. ET","Headline":"Merck KGaA, Pfizer end ovarian cancer trial","Summary":"Merck KGaA, Darmstadt, Germany (MRK.XE), and Pfizer Inc. PFE said Wednesday they discontinued the Phase III JAVELIN Ovarian PARP 100 study. The study was evaluating avelumab in combination with chemotherapy followed by mai..."},{"Date":"Mar. 20, 2019 at 11:36 a.m. ET","Headline":"S&P 500 pulls in to the breakout point (2,817) ahead of the Fed","Summary":""},{"Date":"Mar. 22, 2019 at 11:56 a.m. ET","Headline":"Market bears resurface:  S&P 500, Nasdaq venture under major support","Summary":""},{"Date":"Mar. 25, 2019 at 12:17 p.m. ET","Headline":"Charting a 7-to-1 down day:  S&P 500 ventures under support amid yield-curve headwind","Summary":""},{"Date":"Mar. 24, 2019 at 9:25 a.m. ET","Headline":"Stocks took a big hit Friday, and these shares fell the most","Summary":""},{"Date":"Mar. 27, 2019 at 11:48 a.m. ET","Headline":"Charting a bull-bear stalemate:  S&P 500 whipsaws at the breakout point","Summary":""},{"Date":"Mar. 27, 2019 at 10:25 a.m. ET","Headline":"Pfizer Stock Will Gain Because Its Pipeline Has Promise, Analyst Says","Summary":""},{"Date":"Mar. 26, 2019 at 12:40 p.m. ET","Headline":"Bull trend survives shot across bow, S&P 500 narrowly holds major support","Summary":""},{"Date":"Mar. 26, 2019 at 12:03 p.m. ET","Headline":"Bull trend survives shot across bow, S&P 500 narrowly holds major support","Summary":""},{"Date":"Mar. 26, 2019 at 10:59 a.m. ET","Headline":"Merck KGaA Isn\u2019t Giving Up on a Versum Takeover. It\u2019s Going Hostile.","Summary":""},{"Date":"Mar. 26, 2019 at 8:15 a.m. ET","Headline":"Apple Streams, Boeing\u2019s Airworthiness, and More To Know About Stocks for Tuesday","Summary":""},{"Date":"Mar. 29, 2019 at 11:36 a.m. ET","Headline":"Closing the first quarter on a bullish note, S&P 500 rallies from the breakout point","Summary":""},{"Date":"Mar. 28, 2019 at 11:53 a.m. ET","Headline":"Bull-bear stalemate persists:  S&P 500, Nasdaq press major support","Summary":""},{"Date":"Mar. 29, 2019 at 8:34 p.m. ET","Headline":"There Are Animal Spirits in This Health-Care Business","Summary":""},{"Date":"Apr. 2, 2019 at 12:38 p.m. ET","Headline":"Charting a bullish second-quarter start, S&P 500 nails major resistance (2,873)","Summary":""},{"Date":"Apr. 2, 2019 at 12:07 p.m. ET","Headline":"Charting a bullish second-quarter start, S&P 500 nails major resistance (2,873)","Summary":""},{"Date":"Apr. 2, 2019 at 11:15 a.m. ET","Headline":"AstraZeneca May Not Have the Cash Flow to Pull Off Its Big Expansion","Summary":""},{"Date":"Apr. 1, 2019 at 11:45 a.m. ET","Headline":"S&P 500 spikes from the breakout point, rises to challenge next resistance (2,860)","Summary":""},{"Date":"Apr. 4, 2019 at 11:48 a.m. ET","Headline":"Charting a belated breakout attempt, Dow industrials clear five-month range top","Summary":""},{"Date":"Apr. 3, 2019 at 11:42 a.m. ET","Headline":"Bull trend strengthens:  S&P 500, Nasdaq extend April breakout","Summary":""},{"Date":"Apr. 5, 2019 at 11:47 a.m. ET","Headline":"Charting the escape from mini-crash territory:  S&P 500 approaches 2,900 mark","Summary":""},{"Date":"Apr. 8, 2019 at 11:32 a.m. ET","Headline":"Bull trend pauses, S&P 500 digests decisive April breakout","Summary":"Versum Materials Inc. (VSM) on Monday said Merck KGaA (MRK.XE) has offered to acquire the company for $53 a share, or about $5.78 billion, and that its board determined that the bid constitutes a superior proposal to its p..."},{"Date":"Apr. 8, 2019 at 9:07 a.m. ET","Headline":"GE Stock Slides, Zillow Rises, and 3 More Monday Movers","Summary":"Versum Materials Inc. (VSM) on Monday said Merck KGaA (MRK.XE) has offered to acquire the company for $53 a share, or about $5.78 billion, and that its board determined that the bid constitutes a superior proposal to its p..."},{"Date":"Apr. 8, 2019 at 6:18 a.m. ET","Headline":"Versum gets superior $53\/shr bid via German Merck","Summary":"Versum Materials Inc. (VSM) on Monday said Merck KGaA (MRK.XE) has offered to acquire the company for $53 a share, or about $5.78 billion, and that its board determined that the bid constitutes a superior proposal to its p..."},{"Date":"Apr. 10, 2019 at 11:22 a.m. ET","Headline":"Charting a garden-variety pullback, S&P 500 nails first support (2,873)","Summary":"AstraZeneca PLC (AZN.LN) and Merck & Co. Inc. (MRK) said Wednesday that the European Commission has approved Lynparza as a monotherapy for the treatment of germline BRCA-mutated metastatic breast cancer."},{"Date":"Apr. 10, 2019 at 2:34 a.m. ET","Headline":"AstraZeneca: EU approves breast-cancer treatment","Summary":"AstraZeneca PLC (AZN.LN) and Merck & Co. Inc. (MRK) said Wednesday that the European Commission has approved Lynparza as a monotherapy for the treatment of germline BRCA-mutated metastatic breast cancer."},{"Date":"Apr. 9, 2019 at 12:28 p.m. ET","Headline":"Charting the S&P 500\u2019s approach of the 2,900 mark","Summary":""},{"Date":"Apr. 9, 2019 at 12:00 p.m. ET","Headline":"Charting the S&P 500\u2019s approach of the 2,900 mark","Summary":""},{"Date":"Apr. 12, 2019 at 11:19 p.m. ET","Headline":"Stocks With the Biggest Dividend Yields Can Be Dangerous. Here\u2019s a Safer Way to Find Equity Income.","Summary":"Merck KGaA  said Friday it has signed a definitive agreement to acquire Versum Materials Inc.  in a deal with an enterprise value of 5.8 billion euros ($6.6 billion). Merck will pay $53 per Versum share in cash to create a..."},{"Date":"Apr. 12, 2019 at 11:38 a.m. ET","Headline":"S&P 500 extends April breakout, Nasdaq approaches 8,000 mark","Summary":"Merck KGaA  said Friday it has signed a definitive agreement to acquire Versum Materials Inc.  in a deal with an enterprise value of 5.8 billion euros ($6.6 billion). Merck will pay $53 per Versum share in cash to create a..."},{"Date":"Apr. 12, 2019 at 8:26 a.m. ET","Headline":"Merck KGaA to buy Versum in all-cash deal valued at 5.8 billion euros","Summary":"Merck KGaA  said Friday it has signed a definitive agreement to acquire Versum Materials Inc.  in a deal with an enterprise value of 5.8 billion euros ($6.6 billion). Merck will pay $53 per Versum share in cash to create a..."},{"Date":"Apr. 12, 2019 at 8:00 a.m. ET","Headline":"Dividend-Growth Stocks Like McDonald\u2019s Could Be Winners in the Post-Post-Crisis Market","Summary":""},{"Date":"Apr. 11, 2019 at 2:57 p.m. ET","Headline":"What \u2018Medicare for All\u2019 would do to the  health-care sector","Summary":""},{"Date":"Apr. 11, 2019 at 11:38 a.m. ET","Headline":"Charting a bull flag, S&P 500 digests rally to six-month highs","Summary":""},{"Date":"Apr. 11, 2019 at 7:05 a.m. ET","Headline":"Depressed by low yields? Earn higher investment income with a \u2018building\u2019 strategy","Summary":""},{"Date":"Apr. 16, 2019 at 12:38 p.m. ET","Headline":"Charting the S&P 500\u2019s slow-motion approach of record territory","Summary":""},{"Date":"Apr. 16, 2019 at 11:58 a.m. ET","Headline":"Charting the S&P 500\u2019s slow-motion approach of record territory","Summary":""},{"Date":"Apr. 15, 2019 at 11:37 a.m. ET","Headline":"Charting a bull-flag breakout, S&P 500 (almost) tags next target","Summary":""},{"Date":"Apr. 15, 2019 at 7:41 a.m. ET","Headline":"Chevron Wants to Buy Anadarko Petroleum. Don\u2019t Be Surprised If a Bidding War Ensues.","Summary":""},{"Date":"Apr. 18, 2019 at 7:26 a.m. ET","Headline":"5 things to know about Hookipa Pharma ahead of its IPO","Summary":""},{"Date":"Apr. 18, 2019 at 7:20 a.m. ET","Headline":"Health-care stocks keep getting hammered \u2014 Wall Street says this is why","Summary":""},{"Date":"Apr. 20, 2019 at 7:45 a.m. ET","Headline":"You can capture a dividend above 5% and still enjoy stock-market growth","Summary":""},{"Date":"Apr. 19, 2019 at 9:27 a.m. ET","Headline":"Health-care drama has now spread to biopharma stocks","Summary":""},{"Date":"Apr. 24, 2019 at 1:50 p.m. ET","Headline":"AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Here\u2019s what to expect","Summary":""},{"Date":"Apr. 26, 2019 at 8:31 a.m. ET","Headline":"Merck's Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results","Summary":"Merck & Co. Inc.  said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemothera..."},{"Date":"Apr. 30, 2019 at 4:22 p.m. ET","Headline":"S&P 500 ekes out third straight record close; Nasdaq retreats after Google revenue miss","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 10:24 a.m. ET","Headline":"GE\u2019s free-cash improvement might not be all that, Apple still has a China problem","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 10:20 a.m. ET","Headline":"Merck and Pfizer Stock Rise but Eli Lilly Slips as Big Pharma Earnings Roll in","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 9:52 a.m. ET","Headline":"Fed and tech stocks could crack the market rally, warns Wall Street strategist","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 8:06 a.m. ET","Headline":"General Electric Stock Is Soaring, Google Is Down, and More to Know for Tuesday","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 7:02 a.m. ET","Headline":"Merck shares rise premarket as earnings top estimates","Summary":"Merck & Co. Inc. shares  rose 2.6% in premarket trade Tuesday, after the drug company posted stronger-than-expected earnings for the first quarter and raised guidance for the full year. The company said it had net income o..."},{"Date":"Apr. 30, 2019 at 5:32 a.m. ET","Headline":"Today Is Earnings Day for Big Pharma. Here\u2019s What to Watch.","Summary":""},{"Date":"Apr. 29, 2019 at 4:45 p.m. ET","Headline":"Insulin-maker Eli Lilly is scheduled to report earnings Tuesday. Here\u2019s what to expect","Summary":""},{"Date":"Apr. 29, 2019 at 1:42 p.m. ET","Headline":"Beaten-down health-care companies join Apple and Google in earnings parade","Summary":""},{"Date":"Apr. 29, 2019 at 1:41 p.m. ET","Headline":"Merck is reporting earnings on Tuesday. Here\u2019s what to expect","Summary":""},{"Date":"Apr. 29, 2019 at 11:35 a.m. ET","Headline":"Sen. Tina Smith Sells Entire Abbott Stock Investment","Summary":""},{"Date":"Apr. 29, 2019 at 9:51 a.m. ET","Headline":"Ingersoll-Rand Could Make a Deal With Gardner, Avengers Sets a Record, and More for Stocks on Monday","Summary":""},{"Date":"Sep. 10, 2018 at 5:04 p.m. ET","Headline":"SEC Charges Against Phillip Frost Might Just Be the Tip of the Iceberg","Summary":""},{"Date":"May. 2, 2019 at 1:21 p.m. ET","Headline":"These 6 biotech stocks are promising takeover targets","Summary":""},{"Date":"Apr. 30, 2019 at 8:19 a.m. ET","Headline":"Berkshire Hathaway and 14 Other Steady Stocks to Buy Before Market Volatility Picks Up","Summary":""},{"Date":"May. 3, 2019 at 1:08 p.m. ET","Headline":"Bristol-Myers\u2019 Acquisition of Celgene Is a Prescription for Success, One Analyst Says","Summary":""},{"Date":"May. 6, 2019 at 10:43 a.m. ET","Headline":"Here are the biggest stock-market losers after Trump threatens more tariffs","Summary":""},{"Date":"May. 9, 2019 at 1:10 p.m. ET","Headline":"Here are this week\u2019s biggest stock-market losers as Trump\u2019s trade war on China continues","Summary":""},{"Date":"May. 9, 2019 at 7:46 a.m. ET","Headline":"These 3 revolutionary genomics companies are changing lives for patients \u2014 and investors","Summary":""},{"Date":"May. 14, 2019 at 10:07 a.m. ET","Headline":"Here are the stocks to buy if an all-out U.S.-China trade war erupts, says Goldman","Summary":"Merck KGaA (MRK.XE) said Tuesday that first-quarter sales increased, while its net profit fell sharply and backed its targets for the year. Sales for the quarter came in at 3.75 billion euros ($4.21 billion), up 7.5% from ..."},{"Date":"May. 14, 2019 at 7:08 a.m. ET","Headline":"Here are Monday\u2019s worst stock-market performers as U.S.-China trade dispute escalates","Summary":"Merck KGaA (MRK.XE) said Tuesday that first-quarter sales increased, while its net profit fell sharply and backed its targets for the year. Sales for the quarter came in at 3.75 billion euros ($4.21 billion), up 7.5% from ..."},{"Date":"May. 14, 2019 at 2:37 a.m. ET","Headline":"Merck KGaA backs 2019 target after sales rise","Summary":"Merck KGaA (MRK.XE) said Tuesday that first-quarter sales increased, while its net profit fell sharply and backed its targets for the year. Sales for the quarter came in at 3.75 billion euros ($4.21 billion), up 7.5% from ..."},{"Date":"May. 20, 2019 at 5:08 p.m. ET","Headline":"Merck shares slip as Keytruda fails another clinical trial","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker said its cancer treatment Keytruda failed to meet clinical endpoints in another late-stage study. Merck shares declined 0.7% after hours, foll..."},{"Date":"May. 20, 2019 at 12:31 p.m. ET","Headline":"Drugmakers\u2019 lobbying spending at 10-year high as Washington targets soaring prices","Summary":""},{"Date":"May. 22, 2019 at 5:30 a.m. ET","Headline":"A Bicycle IPO Is Coming, But It\u2019s Probably Not the One You\u2019re Thinking Of","Summary":"Merck & Co. Inc.  said Tuesday it has reached an agreement to acquire Peloton Therapeutics Inc.  for an upfront payment of $1.05 billion in cash. Peloton, a clinical-stage biotech focused on cancer treatments,  The biotech..."},{"Date":"May. 21, 2019 at 5:07 p.m. ET","Headline":"Merck Snaps Up Cancer Drugmaker Peloton Therapeutics","Summary":"Merck & Co. Inc.  said Tuesday it has reached an agreement to acquire Peloton Therapeutics Inc.  for an upfront payment of $1.05 billion in cash. Peloton, a clinical-stage biotech focused on cancer treatments,  The biotech..."},{"Date":"May. 21, 2019 at 4:26 p.m. ET","Headline":"Dow logs 200-point gain as demand for tech, energy stocks overshadow trade angst","Summary":"Merck & Co. Inc.  said Tuesday it has reached an agreement to acquire Peloton Therapeutics Inc.  for an upfront payment of $1.05 billion in cash. Peloton, a clinical-stage biotech focused on cancer treatments,  The biotech..."},{"Date":"May. 21, 2019 at 6:55 a.m. ET","Headline":"Merck to acquire Peloton Therapeutics for upfront payment of $1.05 billion in cash","Summary":"Merck & Co. Inc.  said Tuesday it has reached an agreement to acquire Peloton Therapeutics Inc.  for an upfront payment of $1.05 billion in cash. Peloton, a clinical-stage biotech focused on cancer treatments,  The biotech..."},{"Date":"May. 24, 2019 at 9:28 p.m. ET","Headline":"A Bicycle IPO Is Coming, but It\u2019s Probably Not the One You\u2019re Thinking","Summary":""},{"Date":"May. 29, 2019 at 7:45 a.m. ET","Headline":"Pfizer, Eli Lilly, Bristol-Myer and J&J initiated with buy ratings by Goldman Sachs","Summary":""},{"Date":"Jun. 3, 2019 at 2:58 a.m. ET","Headline":"AstraZeneca Lynparza trial results 'unprecedented'","Summary":"AstraZeneca PLC (AZN.LN) on Monday said phase 3 results from a trial of its Lynparza cancer treatment, developed with Merck & Co. Inc. (MRK), demonstrated that the drug nearly doubled the time patients lived without diseas..."},{"Date":"Jun. 10, 2019 at 4:28 p.m. ET","Headline":"Dow logs 6-day winning streak as U.S.-Mexico trade tensions recede","Summary":"Merck & Co. Inc.  said Monday it was buying privately held biopharmaceutical company Tilos Therapeutics, in a deal that could be valued at up to $773 million. The deal includes an upfront payment and contingent milestone p..."},{"Date":"Jun. 10, 2019 at 7:02 a.m. ET","Headline":"Merck to buy cancer-treatment biotech Tilos Therapeutics for up to $773 million","Summary":"Merck & Co. Inc.  said Monday it was buying privately held biopharmaceutical company Tilos Therapeutics, in a deal that could be valued at up to $773 million. The deal includes an upfront payment and contingent milestone p..."},{"Date":"Jun. 13, 2019 at 4:12 p.m. ET","Headline":"Amgen, Biogen, Gilead and Novo Nordisk have \u2018very high\u2019 capacity for M&A, says Moody\u2019s","Summary":""},{"Date":"Jun. 14, 2019 at 6:11 p.m. ET","Headline":"Drugmakers file lawsuit to block rule requiring drug prices in TV ads","Summary":""},{"Date":"Jun. 14, 2019 at 10:07 a.m. ET","Headline":"Merck Plans Its First Investor Day in 5 Years. Here\u2019s What to Watch.","Summary":""},{"Date":"Jun. 18, 2019 at 12:01 p.m. ET","Headline":"Here are the best-performing U.S. stocks as S&P 500 nears record level","Summary":""},{"Date":"Jun. 18, 2019 at 7:09 a.m. ET","Headline":"Shares of cancer-therapy companies skyrocket after Pfizer acquisition news","Summary":""},{"Date":"Jun. 21, 2019 at 9:57 a.m. ET","Headline":"Merck Signals Stability at Rare Investor Day. Wall Street Wants More Information.","Summary":""},{"Date":"Jun. 25, 2019 at 10:20 a.m. ET","Headline":"AbbVie\u2019s Bid for Allergan Has Specialty Drugmaker Stocks Rallying","Summary":""},{"Date":"Jun. 27, 2019 at 9:52 a.m. ET","Headline":"First Democratic Debate Eases Worry Over a Health-Insurance Overhaul","Summary":""},{"Date":"Jul. 1, 2019 at 1:46 p.m. ET","Headline":"Here are the stock market\u2019s winners and losers in the first half of 2019","Summary":""},{"Date":"Jul. 5, 2019 at 8:53 p.m. ET","Headline":"The Stock Market May Be Pointing to Trump\u2019s Reelection","Summary":""},{"Date":"Jul. 4, 2019 at 7:00 a.m. ET","Headline":"Attorney General Bill Barr Sold Millions in AT&T Stock","Summary":""},{"Date":"Jul. 4, 2019 at 5:05 a.m. ET","Headline":"The \u2018Dogs of the Dow\u2019 Are Neck and Neck With the Stock Market","Summary":""},{"Date":"Jul. 6, 2019 at 7:29 a.m. ET","Headline":"The July Fourth Weekend vegan barbecue from hell: Fly-larvae hot dogs and locust ice cream","Summary":""},{"Date":"Jul. 9, 2019 at 3:14 p.m. ET","Headline":"Elanco Could Merge With Bayer\u2019s Animal-Health Business. Here\u2019s What It Means for the Sector.","Summary":""},{"Date":"Jul. 9, 2019 at 11:15 a.m. ET","Headline":"Merck, Amgen, and Eli Lilly Get a Drug Pricing Win in Court","Summary":""},{"Date":"Jul. 8, 2019 at 5:00 a.m. ET","Headline":"Stocks Are Winners When Wall Street Agrees","Summary":""},{"Date":"Jul. 11, 2019 at 4:05 p.m. ET","Headline":"The Dow components that drove the blue-chip stock index to a 27,000 milestone","Summary":""},{"Date":"Jul. 11, 2019 at 1:58 p.m. ET","Headline":"UnitedHealth Is the Top Dow Stock, Merck Is the Worst. See, Markets Are Efficient.","Summary":""},{"Date":"Jul. 11, 2019 at 1:35 p.m. ET","Headline":"Drug Stocks Are Falling Because Trump\u2019s Next Move on Pricing Could Be Trouble","Summary":""},{"Date":"Jul. 11, 2019 at 1:02 p.m. ET","Headline":"Weight Watchers Stock Is Soaring and the Dow Is Jumping","Summary":""},{"Date":"Jul. 11, 2019 at 10:42 a.m. ET","Headline":"Stocks of drug distributors and PBM-owners surge after Trump administration pulls rebate proposal","Summary":""},{"Date":"Jul. 13, 2019 at 7:26 a.m. ET","Headline":"Health care is one of the stock market\u2019s healthiest sectors right now","Summary":""},{"Date":"Jul. 15, 2019 at 6:58 a.m. ET","Headline":"Health companies start reporting earnings next week: Here are 3 things to keep in mind","Summary":""},{"Date":"Jul. 17, 2019 at 7:23 a.m. ET","Headline":"Merck stock up slightly after FDA approves Recarbrio for new indication","Summary":"Shares of Merck & Co Inc.  ticked up 0.5% in premarket trade Wednesday after the company said the U.S. Food and Drug Administration had approved its antibacterial Recarbrio injection for use in treating complicated urinary..."},{"Date":"Jul. 19, 2019 at 9:16 a.m. ET","Headline":"Merck Could Be a Big Winner in the HIV Prevention Market, Analysts Say","Summary":""},{"Date":"Jul. 25, 2019 at 11:16 a.m. ET","Headline":"Bristol-Myers earnings beat boosts stock","Summary":""},{"Date":"Jul. 25, 2019 at 8:53 a.m. ET","Headline":"Bristol-Myers Squibb Stock Is Hit by Drug-Trial Data, but Earnings Could Still Triumph","Summary":""},{"Date":"Jul. 29, 2019 at 1:52 p.m. ET","Headline":"Two dividend stock income ideas as the Fed works against you","Summary":""},{"Date":"Jul. 29, 2019 at 8:14 a.m. ET","Headline":"The earnings menu: Beyond Meat, Apple and a big bag of chips","Summary":""},{"Date":"Jul. 29, 2019 at 7:29 a.m. ET","Headline":"Is the stock market set up for another late-year nose dive?","Summary":""},{"Date":"Jul. 28, 2019 at 3:00 p.m. ET","Headline":"Apple, GE, Qualcomm and More Stocks to Watch This Week","Summary":""},{"Date":"Jul. 30, 2019 at 4:28 p.m. ET","Headline":"Stocks end lower as China trade deal hopes wane and corporate earnings come in mixed","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Jul. 30, 2019 at 1:52 p.m. ET","Headline":"Gilead and Amgen will report second-quarter earnings after the closing bell. Here\u2019s what to expect","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Jul. 30, 2019 at 9:44 a.m. ET","Headline":"There\u2019s a generational shift in the Fed\u2019s thinking, and here\u2019s what it means for stocks","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Jul. 30, 2019 at 9:30 a.m. ET","Headline":"Merck tops earnings expectations, thanks to strong cancer-drug sales","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Jul. 30, 2019 at 9:21 a.m. ET","Headline":"Merck Delivers on Earnings as Sales of Cancer Drug Keytruda Soar","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Jul. 30, 2019 at 7:05 a.m. ET","Headline":"Merck shares climb 3.7% after earnings blow past estimates","Summary":"Merck & Co. Inc. shares  jumped almost 5% in premarket trade Tuesday, after the drug company trounced earnings estimates for the second quarter and raised its guidance. Kenilworth, N.J.-based Merck said it had net income o..."},{"Date":"Aug. 5, 2019 at 4:47 p.m. ET","Headline":"These stocks have plunged the most since Powell and Trump crashed investors\u2019 party","Summary":""},{"Date":"Aug. 8, 2019 at 3:38 a.m. ET","Headline":"Europe stocks climb in early action, led by pharmas","Summary":"Led by pharmaceuticals including Novo Nordisk and Merck KGaA , European stocks traded higher on Thursday, with the Stoxx 600 Europe  rising 0.8% in early action. U.S. stocks finished off lows on Wednesday, and the markets ..."},{"Date":"Aug. 7, 2019 at 3:33 a.m. ET","Headline":"AstraZeneca: Lynparza effective in prostate cancer","Summary":"AstraZeneca PLC (AZN.LN) said Wednesday that cancer drug Lynparza met its primary objective in a clinical trial, making it the only drug in its class with positive phase 3 study results for prostate cancer."},{"Date":"Aug. 9, 2019 at 7:27 a.m. ET","Headline":"20 companies, including Amazon and Chipotle, that are getting more profitable as sales improve","Summary":""},{"Date":"Aug. 12, 2019 at 4:45 p.m. ET","Headline":"Dow closes 390 points lower, loses grip on 26,000 as 10-year Treasury hits 1.64%","Summary":""},{"Date":"Aug. 14, 2019 at 8:03 a.m. ET","Headline":"These stocks rose the most as Trump backed off (a bit) from tariffs","Summary":""},{"Date":"Aug. 9, 2019 at 11:36 p.m. ET","Headline":"The Market Is Getting Strange. 8 Stocks to Ride It Out.","Summary":""},{"Date":"Aug. 16, 2019 at 9:14 a.m. ET","Headline":"Buy Merck Stock Because Its Immunotherapy Drug Is a Game-Changer, Analyst Says","Summary":""},{"Date":"Aug. 15, 2019 at 8:28 a.m. ET","Headline":"Here are the worst stock performers as the Dow drops 800 points","Summary":""},{"Date":"Aug. 30, 2019 at 6:59 p.m. ET","Headline":"How to Invest in MRNA Technology","Summary":""},{"Date":"Aug. 30, 2019 at 6:57 p.m. ET","Headline":"2 Biotech Companies Are Chasing the Next Frontier in Treating Disease. But Will It Work?","Summary":""},{"Date":"Aug. 30, 2019 at 7:08 a.m. ET","Headline":"Here are 2019\u2019s biggest stock market winners and losers in the Dow, S&P 500 and Nasdaq","Summary":""},{"Date":"Aug. 30, 2019 at 7:23 p.m. ET","Headline":"Expect Modest Gains for Stocks and Bonds This Fall \u2014 at Best","Summary":""},{"Date":"Sep. 5, 2019 at 12:52 p.m. ET","Headline":"Podcast: Why Big Pharma Is Betting on a New Biotech Therapy","Summary":""},{"Date":"Sep. 17, 2019 at 6:55 a.m. ET","Headline":"Merck's V920 Ebola treatment granted priority review by the FDA","Summary":"Merck & Co. Inc.  said Tuesday the Food and Drug Administration has accepted the biologics license application (BLA) for its V920 investigational vaccine for Ebola Zaire virus. The drugmaker said the FDA also granted prior..."},{"Date":"Sep. 16, 2019 at 2:46 p.m. ET","Headline":"This low-volatility dividend-stock strategy can give you peace of mind","Summary":""},{"Date":"Sep. 19, 2019 at 9:10 a.m. ET","Headline":"Pfizer Is Spinning Off Upjohn. What\u2019s Left Will Be No Bargain, Analyst Says","Summary":""},{"Date":"Sep. 18, 2019 at 10:12 a.m. ET","Headline":"Merck Won \u2018Groundbreaking\u2019 Approval for Cancer Treatment in 3 Countries at Once","Summary":""},{"Date":"Sep. 20, 2019 at 12:56 p.m. ET","Headline":"Drug stocks pacing the Dow's gainers Senate GOP leaders dismiss Democrats' drug-pricing plan","Summary":"The health care sector was Friday's best performer, as drug stocks got a lift after reports that Senate Republican leaders said the unveiled by House Speaker Nancy Pelosi and other top Democrats would be dead on arrival. T..."},{"Date":"Sep. 20, 2019 at 9:49 a.m. ET","Headline":"Merck KGaA, Pfizer' Bavencio gets positive opinion","Summary":"Merck KGaA's (MRK.XE) EMD Serono biopharmaceutical unit and Pfizer Inc. (PFE) on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use recommended approval of Bavencio in combination wi..."},{"Date":"Sep. 27, 2019 at 10:50 a.m. ET","Headline":"Atara Biotherapeutics Stock Falls After Goldman Downgrade","Summary":""},{"Date":"Sep. 26, 2019 at 8:59 a.m. ET","Headline":"Five points every investor ought to consider about the Trump impeachment inquiry","Summary":""},{"Date":"Sep. 30, 2019 at 2:07 p.m. ET","Headline":"Seattle Genetics, Merck, Bristol-Myers Unveil Upbeat Treatment Data at Cancer Conference","Summary":""},{"Date":"Sep. 26, 2019 at 10:46 a.m. ET","Headline":"A Big Cancer Conference Starts Tomorrow. Here\u2019s What It Means for Merck, Bristol-Myers and Other Drug Stocks.","Summary":""},{"Date":"Oct. 3, 2019 at 7:00 a.m. ET","Headline":"Amgen, Merck and Others Highlighted Cancer-Drug Developments in Barcelona","Summary":""},{"Date":"Oct. 2, 2019 at 11:21 a.m. ET","Headline":"Here are the stocks that have soared and sunk the most in 2019","Summary":""},{"Date":"Oct. 4, 2019 at 11:55 a.m. ET","Headline":"Merck\u2019s Keytruda Will Become Best-Selling Drug Worldwide, Research Group Says","Summary":""},{"Date":"Oct. 11, 2019 at 7:28 a.m. ET","Headline":"Low-Volatility Stocks Are Riskier Than You Might Think. Here\u2019s a Better Way to Play Them.","Summary":""},{"Date":"Oct. 10, 2019 at 9:40 a.m. ET","Headline":"Merck Stock Has Beaten Its Rivals This Year. It\u2019s Still \u2018Highly Inexpensive.\u2019","Summary":""},{"Date":"Oct. 23, 2019 at 4:13 p.m. ET","Headline":"U.S. stocks end with a flourish higher in bumpy trade framed by a mixed bag of corporate earnings","Summary":"U.S. stocks closed higher Wednesday, with the major indexes managing to shake off weakness from corporate quarterly results from the country's biggest names. The Dow Jones Industrial Average  closed up 45 points, or 0.2%, ..."},{"Date":"Oct. 24, 2019 at 11:47 a.m. ET","Headline":"How to invest in biotech stocks like a Nobel Prize winner","Summary":""},{"Date":"Oct. 24, 2019 at 9:35 a.m. ET","Headline":"Why your best stock bets for the next 10 years are Disney and Target, says this CEO","Summary":""},{"Date":"Oct. 26, 2019 at 6:00 a.m. ET","Headline":"Merck\u2019s Earnings Are on Tuesday. Here\u2019s What to Expect.","Summary":""},{"Date":"Oct. 29, 2019 at 5:15 p.m. ET","Headline":"The Dow Slipped 19 Points Because the Fed Could Play Trick or Treat","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 4:19 p.m. ET","Headline":"S&P 500 retreats from record high; Google miss weighs on tech shares","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 10:12 a.m. ET","Headline":"Merck and Pfizer Stocks Are on a Roll as Earnings Beat Forecasts, Raise Hope About Big Pharma","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 10:06 a.m. ET","Headline":"A bear-market catalyst is lying in wait for stocks, warns UBS","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 9:00 a.m. ET","Headline":"The Dow Is Edging Lower as Grubhub Gets Drubbed After a Big Earnings Miss","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 8:31 a.m. ET","Headline":"Merck, Pfizer stock gains on earnings beats would add 23 points to the Dow's price","Summary":"Shares of Merck & Co. Inc.  and Pfizer Inc.  rallied in premarket trading Tuesday after earnings beats, and were the best performers among Dow Jones Industrial Average  components, but not enough to lift the Dow into posit..."},{"Date":"Oct. 29, 2019 at 6:57 a.m. ET","Headline":"Merck's stock rallies after profit and sales rise above expectations, full-year outlook raised","Summary":"Shares of Merck & Co. Inc.  rallied 2.2% in premarket trading Tuesday, after the health care company reported a third-quarter profit and revenue that rose above expectations, and lifted its full-year outlook. Net income wa..."},{"Date":"Oct. 28, 2019 at 8:40 a.m. ET","Headline":"Starbucks, Merck, and Cintas Are Expected to Raise Dividends This Week","Summary":""},{"Date":"Oct. 28, 2019 at 7:48 a.m. ET","Headline":"Apple, Facebook and Exxon are about to lead a big test of the earnings recession","Summary":""},{"Date":"Oct. 30, 2019 at 12:17 p.m. ET","Headline":"U.S. lobbying for U.K. drug price rise prompts Johnson, Corbyn clash over post-Brexit trade pact","Summary":""},{"Date":"Oct. 30, 2019 at 11:21 a.m. ET","Headline":"Why would the Fed cut interest rates a 3rd time in a row even as stocks near records? Investors may soon find out","Summary":""},{"Date":"Nov. 9, 2019 at 11:50 a.m. ET","Headline":"Quit being fooled by fast-growing companies claiming to be tech firms when they just use technology","Summary":""},{"Date":"Nov. 9, 2019 at 11:44 a.m. ET","Headline":"Marine algae keys Chinese claim to Alzheimer\u2019s breakthrough","Summary":""},{"Date":"Nov. 9, 2019 at 10:14 a.m. ET","Headline":"This simple stock investing strategy combines value, quality and dividends into a winning formula","Summary":""},{"Date":"Nov. 11, 2019 at 1:37 p.m. ET","Headline":"NextCure Stock Collapses After New Cancer Drug Data","Summary":""},{"Date":"Nov. 14, 2019 at 2:19 a.m. ET","Headline":"Merck posts higher profit and revenue as it lifts sales forecast","Summary":"Merck said it now expects to report overall sales of between EUR15.7 billion and EUR16.3 billion for 2019, from between EUR15.3 billion and EUR15.9 billion."},{"Date":"Nov. 18, 2019 at 3:44 p.m. ET","Headline":"Retirement Savers Are Turning to Dividend Stocks for Income. Here\u2019s How to Use Them in Your Portfolio.","Summary":""},{"Date":"Nov. 18, 2019 at 10:24 a.m. ET","Headline":"Beyond Meat Is Shaking Up the Meat Industry. Animal-Health Stocks Could Take a Hit, Too.","Summary":""},{"Date":"Nov. 18, 2019 at 7:29 a.m. ET","Headline":"How to Generate Retirement Income With a \u2018Total Return\u2019 Strategy","Summary":""},{"Date":"Nov. 20, 2019 at 11:01 a.m. ET","Headline":"Your three-stock survival kit for 2020 \u2014 packed by Nuveen\u2019s top stock-market strategist","Summary":"Shares of Merck & Co. Inc.  were up 0.3% in midday trading Tuesday, after the health care company said it will raise its quarterly dividend by 11%. The company will pay a dividend of 61 cents a share, up from 55 cents a sh..."},{"Date":"Nov. 20, 2019 at 7:08 a.m. ET","Headline":"U.S. Stocks Set to Fall Because China Is Irritated Over a Hong Kong Democracy Bill","Summary":"Shares of Merck & Co. Inc.  were up 0.3% in midday trading Tuesday, after the health care company said it will raise its quarterly dividend by 11%. The company will pay a dividend of 61 cents a share, up from 55 cents a sh..."},{"Date":"Nov. 19, 2019 at 12:59 p.m. ET","Headline":"Merck raises quarterly dividend, to yield more than peers and the S&P 500","Summary":"Shares of Merck & Co. Inc.  were up 0.3% in midday trading Tuesday, after the health care company said it will raise its quarterly dividend by 11%. The company will pay a dividend of 61 cents a share, up from 55 cents a sh..."},{"Date":"Nov. 23, 2019 at 8:00 a.m. ET","Headline":"Agilent Technologies, Merck, M&T Bank Announced Dividend Hikes","Summary":""},{"Date":"Nov. 30, 2019 at 12:03 p.m. ET","Headline":"Here\u2019s the real difference between women and men when it comes to stock-market investing","Summary":""},{"Date":"Dec. 2, 2019 at 8:57 a.m. ET","Headline":"Merck Stock Gains as FDA Accelerates Review of New Use for Blockbuster Cancer Drug","Summary":""},{"Date":"Dec. 3, 2019 at 12:27 p.m. ET","Headline":"Here are the worst-performing U.S. stocks on Tuesday","Summary":""},{"Date":"Nov. 23, 2019 at 3:41 p.m. ET","Headline":"Pfizer Is the Dow\u2019s Worst Stock. A New Strategy Makes It Worth Another Look.","Summary":""},{"Date":"Dec. 6, 2019 at 11:46 a.m. ET","Headline":"Bullish reversal accelerates, S&P 500 knifes toward record peak (3,154) on jobs report","Summary":""},{"Date":"Dec. 5, 2019 at 11:40 a.m. ET","Headline":"Charting a bull-bear stalemate:  S&P 500, Nasdaq maintain major support","Summary":""},{"Date":"Dec. 10, 2019 at 12:30 p.m. ET","Headline":"Bull trend intact:  S&P 500 absorbs December whipsaw","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 10, 2019 at 12:00 p.m. ET","Headline":"Bull trend intact:  S&P 500 absorbs December whipsaw","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 10, 2019 at 7:14 a.m. ET","Headline":"Drug manufacturers have spent a record $342 billion on M&A in 2019","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 5:23 p.m. ET","Headline":"The Dow Fell 105 Points Because Trump\u2019s China Tariffs Can Kick In Next Week","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 4:45 p.m. ET","Headline":"U.S. stock market snaps 3-day win streak as China tariff deadline comes in focus","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 4:44 p.m. ET","Headline":"Sanofi\u2019s New CEO Is Aiming for a Narrower Focus in Drug Development","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 11:44 a.m. ET","Headline":"S&P 500 digests bullish reversal as December volatility spike fades","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 9:42 a.m. ET","Headline":"Merck and Sanofi Are Both Acquiring Cancer-Drug Developers","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 8:42 a.m. ET","Headline":"No News Is Bad News for the Dow on Monday Morning","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 9, 2019 at 6:56 a.m. ET","Headline":"Merck to acquire ArQule for $20 per share in cash or about $2.7 billion","Summary":"Merck & Co. Inc.  said Monday it has entered an agreement to acquire ArQule Inc.  for $20 a share in cash or an equity value of about $2.7 billion. The deal is expected to close in the first quarter of 2020 and to boost Me..."},{"Date":"Dec. 12, 2019 at 11:58 a.m. ET","Headline":"Charting a trade-fueled breakout, S&P 500 knifes to latest record high","Summary":"Shares of Amneal Pharmaceuticals  jumped 33% in premarket trading after the generic drugmaker said Thursday that it has started selling EluRyng, the first generic version of Merck's  birth-control NuvaRing. The NuvaRing br..."},{"Date":"Dec. 12, 2019 at 9:05 a.m. ET","Headline":"Amneal stock jumps on launch of first generic NuvaRing","Summary":"Shares of Amneal Pharmaceuticals  jumped 33% in premarket trading after the generic drugmaker said Thursday that it has started selling EluRyng, the first generic version of Merck's  birth-control NuvaRing. The NuvaRing br..."},{"Date":"Dec. 12, 2019 at 9:04 a.m. ET","Headline":"Big Pharma\u2019s Coming Back in 2020. Don\u2019t Hold Your Breath for Generic Drug Stocks","Summary":""},{"Date":"Dec. 12, 2019 at 7:34 a.m. ET","Headline":"Investors shift attention to next generation of CAR-T, new sickle cell treatments at major hematology meeting","Summary":""},{"Date":"Dec. 11, 2019 at 12:08 p.m. ET","Headline":"There\u2019s More Bad News for the Worst Stock in the Dow This Year","Summary":""},{"Date":"Dec. 11, 2019 at 11:28 a.m. ET","Headline":"Charting the S&P 500\u2019s bullish holding pattern ahead of the Fed","Summary":""},{"Date":"Dec. 14, 2019 at 4:47 p.m. ET","Headline":"Biotech stocks are producing outsized gains \u2014 here\u2019s how to get your share","Summary":""},{"Date":"Dec. 14, 2019 at 8:59 a.m. ET","Headline":"These are Wall Street\u2019s top dividend stock picks for 2020","Summary":""},{"Date":"Dec. 14, 2019 at 8:48 a.m. ET","Headline":"Here\u2019s the one Dow stock to buy now if you believe that what goes down must come up","Summary":""},{"Date":"Dec. 13, 2019 at 11:40 a.m. ET","Headline":"Charting bull-flag breakouts:  S&P 500, Nasdaq reach record territory","Summary":""},{"Date":"Dec. 16, 2019 at 11:04 a.m. ET","Headline":"S&P 500 extends break to uncharted territory, spikes from first support","Summary":""},{"Date":"Dec. 15, 2019 at 7:06 p.m. ET","Headline":"There\u2019s more upside for biotech even after 24% gains in two months","Summary":""},{"Date":"Dec. 18, 2019 at 3:55 p.m. ET","Headline":"Merck Nears Approval of New Use for Blockbuster Cancer Drug Keytruda","Summary":""},{"Date":"Dec. 18, 2019 at 11:50 a.m. ET","Headline":"Bull trend persists:  S&P 500 notches consecutive closes atop 20-day volatility bands","Summary":""},{"Date":"Dec. 17, 2019 at 12:25 p.m. ET","Headline":"Bull trend confirmed:  S&P 500, Nasdaq extend decisive late-year breakouts","Summary":""},{"Date":"Dec. 17, 2019 at 11:55 a.m. ET","Headline":"Bull trend confirmed:  S&P 500, Nasdaq extend decisive late-year breakouts","Summary":""},{"Date":"Dec. 20, 2019 at 12:09 p.m. ET","Headline":"Bull trend takes flight: S&P 500 extends break to \u2018clear skies\u2019 territory","Summary":""},{"Date":"Dec. 19, 2019 at 11:48 a.m. ET","Headline":"Charting (another) bull-flag breakout attempt, S&P 500 tags 3,200 mark","Summary":""},{"Date":"Dec. 23, 2019 at 12:08 p.m. ET","Headline":"Charting a bullish finish to the 2010s:  S&P 500 sustains decisive breakout","Summary":""},{"Date":"Dec. 28, 2019 at 4:18 p.m. ET","Headline":"Top stock picks for 2020: The best of the biggest","Summary":""},{"Date":"Dec. 30, 2019 at 11:09 a.m. ET","Headline":"Here are the best and worst Dow and S&P 500 stocks of 2019","Summary":"Share of Myriad Genetics Inc.  shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to identify pa..."},{"Date":"Dec. 30, 2019 at 11:06 a.m. ET","Headline":"AstraZeneca and Merck Get a Boost as FDA Approves New Use for Cancer Drug","Summary":"Share of Myriad Genetics Inc.  shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to identify pa..."},{"Date":"Dec. 30, 2019 at 8:41 a.m. ET","Headline":"Nio Stock Is Soaring, Myriad Genetics Jumps, as the Dow Holds Its Ground","Summary":"Share of Myriad Genetics Inc.  shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to identify pa..."},{"Date":"Dec. 30, 2019 at 7:45 a.m. ET","Headline":"Myriad Genetics's stock surges after FDA approval of diagnostic test for pancreatic cancer","Summary":"Share of Myriad Genetics Inc.  shot up 8.3% in premarket trading Monday, after the molecular diagnostics company said its BRACAnalysis CDx was approved by the Food and Drug Administration as a companion test to identify pa..."},{"Date":"Dec. 30, 2019 at 7:00 a.m. ET","Headline":"Merck Stock Leveled Out in 2019. It Could Return to its Glory Days Next Year.","Summary":""},{"Date":"Dec. 31, 2019 at 5:14 p.m. ET","Headline":"The Best\u2014and Worst\u2014Company Stocks in the Dow This Year","Summary":""},{"Date":"Dec. 31, 2019 at 10:08 a.m. ET","Headline":"Three Things I Learned Picking Stocks in 2019 and One New Year Investing Resolution","Summary":""},{"Date":"Jan. 3, 2020 at 11:59 a.m. ET","Headline":"Charting market cross currents:  Strong 2020 start vies with geopolitical headwinds","Summary":""},{"Date":"Jan. 2, 2020 at 12:01 p.m. ET","Headline":"Charting a bullish 2020 start:  S&P 500 vies for latest record close","Summary":""},{"Date":"Dec. 31, 2019 at 4:25 p.m. ET","Headline":"Dogs of the Dow Stock-Picking Strategy Was a Winner for the Decade","Summary":""},{"Date":"Jan. 7, 2020 at 12:48 p.m. ET","Headline":"Charting a jagged 2020 start, S&P 500 nails first support","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0.9% after hours, followi..."},{"Date":"Jan. 7, 2020 at 12:20 p.m. ET","Headline":"Charting a jagged 2020 start, S&P 500 maintains first support","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0.9% after hours, followi..."},{"Date":"Jan. 7, 2020 at 9:17 a.m. ET","Headline":"It\u2019s Time to Buy Bristol-Myers Stock, According to 1 Analyst. Here\u2019s Why.","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0.9% after hours, followi..."},{"Date":"Jan. 6, 2020 at 4:37 p.m. ET","Headline":"Merck stock slides as lung-cancer drug misses a study endpoint","Summary":"Merck & Co.  shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0.9% after hours, followi..."},{"Date":"Jan. 6, 2020 at 11:56 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 nails first support (3,215)","Summary":""},{"Date":"Jan. 9, 2020 at 12:02 p.m. ET","Headline":"Bull trend takes flight, charting the approach of Dow 29,000","Summary":""},{"Date":"Jan. 8, 2020 at 11:44 a.m. ET","Headline":"Bull trend absorbs jagged 2020 start, Nasdaq lifts to latest record high","Summary":""},{"Date":"Jan. 10, 2020 at 12:07 p.m. ET","Headline":"Charting the latest bull-flag breakout, S&P 500 tags another record high","Summary":""},{"Date":"Jan. 10, 2020 at 10:01 a.m. ET","Headline":"S&P 5,000? Why one fund manager says that milestone may be reached sooner than you would expect","Summary":""},{"Date":"Jan. 13, 2020 at 11:48 a.m. ET","Headline":"Bull trend intact, S&P 500 digests latest breakout","Summary":""},{"Date":"Jan. 15, 2020 at 12:05 p.m. ET","Headline":"Charting a trade-fueled breakout, S&P 500 tags record high amid market rotation","Summary":""},{"Date":"Jan. 14, 2020 at 12:39 p.m. ET","Headline":"Charting a bullish 2020 start: S&P 500 extends break to record territory","Summary":""},{"Date":"Jan. 14, 2020 at 12:10 p.m. ET","Headline":"Charting a bullish 2020 start: S&P 500 extends break to record territory","Summary":""},{"Date":"Jan. 17, 2020 at 12:04 p.m. ET","Headline":"Charting bullish momentum:  Small- and mid-caps clear 20-day volatility bands","Summary":""},{"Date":"Jan. 16, 2020 at 12:00 p.m. ET","Headline":"Charting market rotation:  Bull trend strengthens as small- and mid-caps take flight","Summary":""},{"Date":"Jan. 21, 2020 at 12:54 p.m. ET","Headline":"Bull trend persists, S&P 500 digests powerful rally atop 20-day volatility bands","Summary":""},{"Date":"Jan. 21, 2020 at 12:24 p.m. ET","Headline":"Bull trend persists, S&P 500 digests powerful rally atop 20-day volatility bands","Summary":""},{"Date":"Jan. 23, 2020 at 11:47 a.m. ET","Headline":"Charting a bull-trend pullback, S&P 500 retests gap support","Summary":""},{"Date":"Jan. 22, 2020 at 11:59 a.m. ET","Headline":"Charting successful technical tests:  S&P 500, Nasdaq rally from first support","Summary":""},{"Date":"Jan. 25, 2020 at 8:50 a.m. ET","Headline":"Value stocks are making a comeback, and here\u2019s how to get in early","Summary":""},{"Date":"Jan. 24, 2020 at 11:50 a.m. ET","Headline":"Charting a bullish holding pattern, S&P 500 nails gap support","Summary":""},{"Date":"Jan. 27, 2020 at 2:09 p.m. ET","Headline":"These U.S. stocks are down the most as the coronavirus spreads","Summary":""},{"Date":"Jan. 31, 2020 at 10:52 a.m. ET","Headline":"Some Drugmakers Are Racing to Develop a Coronavirus Vaccine. Why Big Pharma Isn\u2019t Rushing In.","Summary":""},{"Date":"Feb. 1, 2020 at 10:56 a.m. ET","Headline":"Bernie Sanders\u2019 surge in the polls could hit the S&P 500 with Iowa Caucus vote due this week, analysts warn","Summary":""},{"Date":"Feb. 1, 2020 at 10:02 a.m. ET","Headline":"Disney and Alphabet could put an end to the earnings recession","Summary":""},{"Date":"Feb. 4, 2020 at 7:30 a.m. ET","Headline":"Merck Reports Earnings Tomorrow. Here\u2019s What to Expect.","Summary":""},{"Date":"Feb. 6, 2020 at 5:01 a.m. ET","Headline":"Why Merck Is Spinning Off 3 Divisions, and Two More Numbers to Know","Summary":"Merck & Co. Inc.'s stock  sank 4.3% in premarket trading Wednesday, and was the only Dow Jones Industrial Average  component losing ground, after the health care and drugs company reported . Given that Merck's stock is one..."},{"Date":"Feb. 5, 2020 at 4:20 p.m. ET","Headline":"S&P 500, Nasdaq close at records amid upbeat data, easing coronavirus fears","Summary":"Merck & Co. Inc.'s stock  sank 4.3% in premarket trading Wednesday, and was the only Dow Jones Industrial Average  component losing ground, after the health care and drugs company reported . Given that Merck's stock is one..."},{"Date":"Feb. 5, 2020 at 9:22 a.m. ET","Headline":"Merck Is Spinning Off 3 Divisions to Focus on \u2018Key Growth Drivers,\u2019 CEO Ken Frazier Said","Summary":"Merck & Co. Inc.'s stock  sank 4.3% in premarket trading Wednesday, and was the only Dow Jones Industrial Average  component losing ground, after the health care and drugs company reported . Given that Merck's stock is one..."},{"Date":"Feb. 5, 2020 at 9:11 a.m. ET","Headline":"Merck's stock is the only Dow member losing ground, after earnings and spinoff news","Summary":"Merck & Co. Inc.'s stock  sank 4.3% in premarket trading Wednesday, and was the only Dow Jones Industrial Average  component losing ground, after the health care and drugs company reported . Given that Merck's stock is one..."},{"Date":"Feb. 5, 2020 at 8:42 a.m. ET","Headline":"Ford Motor Stock, Snap Are Sliding, but Hope About Coronavirus Is Lifting the Dow","Summary":"Merck & Co. Inc.  announced Wednesday that it was spinning off its Women's Health, Trusted Legacy Brands and Biosimilar Products businesses into a separate publicly traded company, while also reporting a fourth-quarter pro..."},{"Date":"Feb. 5, 2020 at 7:05 a.m. ET","Headline":"Merck announces spinoffs, reports profit beat but sales miss; stock falls","Summary":"Merck & Co. Inc.  announced Wednesday that it was spinning off its Women's Health, Trusted Legacy Brands and Biosimilar Products businesses into a separate publicly traded company, while also reporting a fourth-quarter pro..."},{"Date":"Feb. 7, 2020 at 4:57 p.m. ET","Headline":"An Expert\u2019s Advice for Cutting Your Tax Bill","Summary":""},{"Date":"Feb. 7, 2020 at 3:07 p.m. ET","Headline":"How Big a Hit? Health-Care Companies Try to Gauge the Costs of Coronavirus.","Summary":""},{"Date":"Feb. 24, 2020 at 4:56 p.m. ET","Headline":"Here are the worst-performing stocks Monday as investors panic over the coronavirus","Summary":""},{"Date":"Feb. 25, 2020 at 4:44 p.m. ET","Headline":"These U.S. stocks skidded the most Tuesday as the market slides for the fourth straight day","Summary":""},{"Date":"Feb. 28, 2020 at 6:46 p.m. ET","Headline":"How the Coronavirus Will Challenge the Health-Care Industry","Summary":""},{"Date":"Feb. 28, 2020 at 9:07 a.m. ET","Headline":"FDA Reports First Drug Shortage Due to Coronavirus, Far Earlier Than Expected","Summary":""},{"Date":"Feb. 28, 2020 at 7:28 a.m. ET","Headline":"Here\u2019s how the 30 Dow industrials companies are prepping for the impact of the coronavirus","Summary":""},{"Date":"Mar. 3, 2020 at 4:48 p.m. ET","Headline":"These stocks took the biggest hit after the Fed\u2019s interest-rate cut sent markets reeling","Summary":""},{"Date":"Mar. 3, 2020 at 6:46 a.m. ET","Headline":"These are the 10 biggest stock winners Monday as the market rebounds from coronavirus rout","Summary":""},{"Date":"Mar. 2, 2020 at 5:08 p.m. ET","Headline":"The Dow Gains Nearly 1,300 Points as Investors Bet on the Fed","Summary":""},{"Date":"Mar. 2, 2020 at 9:09 a.m. ET","Headline":"Gilead Stock Is Rising Because a Deal Will Expand Its Cancer-Drug Pipeline","Summary":""},{"Date":"Mar. 5, 2020 at 6:36 a.m. ET","Headline":"These stocks soared the most after Biden burned Bernie on Super Tuesday","Summary":""},{"Date":"Mar. 7, 2020 at 9:21 a.m. ET","Headline":"Here are Friday\u2019s worst stock-market performers as oil takes the market down","Summary":""},{"Date":"Mar. 9, 2020 at 3:19 p.m. ET","Headline":"Eli Lilly and 2 More Drug Stocks That Could Ride Out the Coronavirus Crisis, According to J.P. Morgan","Summary":""},{"Date":"Mar. 8, 2020 at 7:00 a.m. ET","Headline":"A Financial Giant Doubles Down on Bank of America and Apple Stock.","Summary":""},{"Date":"Mar. 7, 2020 at 10:31 a.m. ET","Headline":"Coronavirus Outbreak Could Disrupt Drug Companies\u2019 Clinical Trials","Summary":""},{"Date":"Mar. 13, 2020 at 5:47 a.m. ET","Headline":"These stocks sank the most during Thursday\u2019s rout, with declines of up to 53%","Summary":""},{"Date":"Mar. 12, 2020 at 6:56 a.m. ET","Headline":"These U.S. stocks fell the most after the coronavirus was upgraded to a pandemic","Summary":""},{"Date":"Mar. 21, 2020 at 11:19 a.m. ET","Headline":"Market Experts Say the Coronavirus Selloff Is \u2018Worse Than Anything We\u2019ve Seen Since 1929.\u2019 Here\u2019s How Bad It Could Get.","Summary":""},{"Date":"Mar. 22, 2020 at 11:02 a.m. ET","Headline":"These low-volatility stocks have outperformed during the coronavirus crash","Summary":""},{"Date":"Mar. 27, 2020 at 6:43 a.m. ET","Headline":"Here are Thursday\u2019s best-performing stocks as the Dow Jones Industrial Average produces a three-day gain of 21%","Summary":""},{"Date":"Mar. 30, 2020 at 10:36 a.m. ET","Headline":"S&P 500 Dividends Will Fall 25% This Year, Analysts Say","Summary":""},{"Date":"Mar. 27, 2020 at 9:18 p.m. ET","Headline":"12 Stocks That Kept the Cash Flowing During the Financial Crisis and Could Be Worth Buying Now","Summary":""},{"Date":"Apr. 2, 2020 at 3:13 p.m. ET","Headline":"Will companies in the Dow report earnings as usual despite COVID-19 disruptions, or delay them because they can?","Summary":""},{"Date":"Apr. 2, 2020 at 8:00 a.m. ET","Headline":"Thousands of U.S. Factories May Be Able to Be Retooled to Fight Coronavirus, According to a New Survey","Summary":""},{"Date":"Apr. 2, 2020 at 5:15 a.m. ET","Headline":"These U.S. stocks fell the most April 1 after Trump turned grim on coronavirus forecast","Summary":""},{"Date":"Apr. 1, 2020 at 6:36 a.m. ET","Headline":"Only one stock in the Dow rose during the first quarter \u2014 and it was up by only one penny","Summary":""},{"Date":"Apr. 4, 2020 at 1:31 p.m. ET","Headline":"Here are the best bets for investors seeking income, according to Goldman Sachs","Summary":""},{"Date":"Apr. 3, 2020 at 5:24 p.m. ET","Headline":"3 S&P sectors climbed this week \u2014 here are the stocks that rose and fell the most","Summary":""},{"Date":"Mar. 13, 2020 at 8:24 p.m. ET","Headline":"18 Stocks to Buy Amid the Coronavirus Carnage, According to Barron\u2019s Roundtable Experts","Summary":""},{"Date":"Apr. 6, 2020 at 5:16 p.m. ET","Headline":"Here are the biggest stock-market winners April 6, as major indexes jump at least 7%","Summary":""},{"Date":"Apr. 8, 2020 at 5:15 p.m. ET","Headline":"These stocks rose the most Wednesday, as laggards from previous trading sessions bounced back","Summary":""},{"Date":"Apr. 11, 2020 at 11:35 a.m. ET","Headline":"Three stocks to buy during the coronavirus crash \u2014 besides the usual suspects","Summary":""},{"Date":"Apr. 20, 2020 at 6:58 a.m. ET","Headline":"The next 45 days are the \u2018most critical period in U.S. financial history,\u2019 says stock-market expert who profited in 1987 and 2008 crises","Summary":""},{"Date":"Apr. 17, 2020 at 7:20 p.m. ET","Headline":"In a Pandemic, Pharma\u2019s Strengths Emerge: Pipelines With Essential Drugs","Summary":""},{"Date":"Apr. 21, 2020 at 8:44 p.m. ET","Headline":"Here are Tuesday\u2019s worst stocks as the S&P 500 posts the biggest decline in three weeks","Summary":""},{"Date":"Apr. 24, 2020 at 11:07 a.m. ET","Headline":"Big Pharma Will Turn to Mergers After Crisis, Says RBC","Summary":""},{"Date":"Apr. 26, 2020 at 3:00 p.m. ET","Headline":"Tesla, Amazon, Boeing, and Other Stocks for Investors to Watch This Week","Summary":""},{"Date":"Apr. 28, 2020 at 4:49 p.m. ET","Headline":"U.S. stocks end lower as investors weigh earnings reports and prospects for reopening economy","Summary":"The U.S. stock market lost ground Tuesday morning, turning negative as the benchmarks were weighed by declines in shares of health-care names and those linked to information technology. The Dow Jones Industrial Average  wa..."},{"Date":"Apr. 28, 2020 at 3:04 p.m. ET","Headline":"Coronavirus update: German infection rate ticks higher after reopening moves, offers lesson to U.S. governors","Summary":"The U.S. stock market lost ground Tuesday morning, turning negative as the benchmarks were weighed by declines in shares of health-care names and those linked to information technology. The Dow Jones Industrial Average  wa..."},{"Date":"Apr. 28, 2020 at 12:57 p.m. ET","Headline":"One Biotech Stock Is Up 57% After Presenting at a Big Cancer Conference. Here\u2019s Why.","Summary":"The U.S. stock market lost ground Tuesday morning, turning negative as the benchmarks were weighed by declines in shares of health-care names and those linked to information technology. The Dow Jones Industrial Average  wa..."},{"Date":"Apr. 28, 2020 at 11:36 a.m. ET","Headline":"Regeneron Stock Has Hit Its Peak, Says Citi","Summary":"The U.S. stock market lost ground Tuesday morning, turning negative as the benchmarks were weighed by declines in shares of health-care names and those linked to information technology. The Dow Jones Industrial Average  wa..."},{"Date":"Apr. 28, 2020 at 11:05 a.m. ET","Headline":"Dow erases 380-point gain Tuesday morning as tech-related and health-care shares drag stock market lower","Summary":"The U.S. stock market lost ground Tuesday morning, turning negative as the benchmarks were weighed by declines in shares of health-care names and those linked to information technology. The Dow Jones Industrial Average  wa..."},{"Date":"Apr. 28, 2020 at 10:31 a.m. ET","Headline":"Good News on Oxford Vaccine Is Bright Spot in Somber Covid-19 Landscape","Summary":"The four components of the Dow Jones Industrial Average  that reported first-quarter earnings Tuesday are providing a net boost of about 47 points to the Dow's price, with 3M Co.'s stock  adding the most and .'s stock  the..."},{"Date":"Apr. 28, 2020 at 9:25 a.m. ET","Headline":"Dow's earnings reporters add nearly a net 50 points to the Dow's price, led by 3M's stock rally","Summary":"The four components of the Dow Jones Industrial Average  that reported first-quarter earnings Tuesday are providing a net boost of about 47 points to the Dow's price, with 3M Co.'s stock  adding the most and .'s stock  the..."},{"Date":"Apr. 28, 2020 at 9:16 a.m. ET","Headline":"Pfizer and Merck Earnings Were Good. Here\u2019s Why Their Stocks Are Going In Opposite Directions.","Summary":"Shares of Merck & Co. Inc.  rose 1% in premarket trading Tuesday, after the drug giant reported first-quarter profit and sales that beat expectations, but provided a downbeat full-year outlook. Net income rose to $3.22 bil..."},{"Date":"Apr. 28, 2020 at 7:01 a.m. ET","Headline":"Merck's stock gains after profit and sales beat, but outlook is downbeat","Summary":"Shares of Merck & Co. Inc.  rose 1% in premarket trading Tuesday, after the drug giant reported first-quarter profit and sales that beat expectations, but provided a downbeat full-year outlook. Net income rose to $3.22 bil..."},{"Date":"Apr. 27, 2020 at 4:08 p.m. ET","Headline":"Coronavirus update: Optimism over phased reopenings only slightly tempered by continued concerns over inadequate testing for COVID-19 virus","Summary":"Shares of Merck & Co. Inc.  gained 1.9% in premarket trading on Monday after the drugmaker announced a COVID-19 collaboration with the Institute for Systems Biology (IBS), a research organization. The aim, they said, is to..."},{"Date":"Apr. 27, 2020 at 7:27 a.m. ET","Headline":"Shares of Merck gain on COVID-19 research collaboration","Summary":"Shares of Merck & Co. Inc.  gained 1.9% in premarket trading on Monday after the drugmaker announced a COVID-19 collaboration with the Institute for Systems Biology (IBS), a research organization. The aim, they said, is to..."},{"Date":"Apr. 27, 2020 at 2:35 a.m. ET","Headline":"New York trial tests heartburn medication against COVID-19","Summary":"A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, . Pepcid, a generic drug marketed by Merck  and Johnson & Johnson , is being tested on 187 COVID-19 patients in critica..."},{"Date":"Apr. 30, 2020 at 7:28 a.m. ET","Headline":"Shareholder returns will fall 40% this year, Goldman says. Here are some safe dividend plays","Summary":""},{"Date":"Apr. 29, 2020 at 5:15 p.m. ET","Headline":"Here are the stock market\u2019s biggest winners on Wednesday as investors see new hope","Summary":""},{"Date":"May. 2, 2020 at 9:17 a.m. ET","Headline":"ServiceNow CEO: $10 billion in annual revenue is next goal","Summary":""},{"Date":"May. 2, 2020 at 9:06 a.m. ET","Headline":"Money Managers See More Covid Pain for Stocks in 2020 \u2014 but Better Days in 2021","Summary":""},{"Date":"May. 2, 2020 at 7:18 a.m. ET","Headline":"Here are Friday\u2019s biggest stock-market losers, driven lower by disappointing earnings and a shrinking manufacturing sector","Summary":""},{"Date":"May. 1, 2020 at 8:52 p.m. ET","Headline":"Banks and Corporations Pull Back From Buybacks. Big Tech Feels Differently.","Summary":""},{"Date":"May. 6, 2020 at 1:46 p.m. ET","Headline":"These 10 Stocks Have Healthy Dividends and Low Default Risk","Summary":""},{"Date":"May. 5, 2020 at 12:49 p.m. ET","Headline":"ICE partners with Amazon, 3M and Pfizer to identify counterfeit coronavirus gear","Summary":""},{"Date":"May. 11, 2020 at 4:51 p.m. ET","Headline":"Dow ends 100 points lower, leaving stock benchmarks mixed amid skepticism over re-openings","Summary":"Exchange-traded funds that track the health care sector pushed higher Monday as investors watched for progress on coronavirus treatments. The Select Sector SPDR ETF that tracks health care, often known by its ticker, XLV, ..."},{"Date":"May. 11, 2020 at 1:12 p.m. ET","Headline":"Health-care ETFs rise as coronavirus treatments take center stage","Summary":"Exchange-traded funds that track the health care sector pushed higher Monday as investors watched for progress on coronavirus treatments. The Select Sector SPDR ETF that tracks health care, often known by its ticker, XLV, ..."},{"Date":"May. 14, 2020 at 2:15 p.m. ET","Headline":"8 Dividend Stocks That Split the Difference Between Yield and Safety","Summary":""},{"Date":"May. 14, 2020 at 10:46 a.m. ET","Headline":"Merck, Roche, Amgen Stocks React to Release of Cancer-Drug Data","Summary":""},{"Date":"May. 13, 2020 at 12:31 p.m. ET","Headline":"Exxon Mobil Faces New Climate Challenge From Shareholder","Summary":""},{"Date":"May. 16, 2020 at 9:15 a.m. ET","Headline":"Merck, Medtronic, and Other Health-Care Stocks Widely Owned by ESG Funds Outperform","Summary":""},{"Date":"May. 18, 2020 at 5:01 p.m. ET","Headline":"Here are Monday\u2019s best stock-market performers as airlines and cruise lines shine","Summary":""},{"Date":"May. 20, 2020 at 9:23 a.m. ET","Headline":"Here are the \u2018hot dogs\u2019 that hedge funds have used to outperform this year","Summary":"Shares of AstraZeneca  gained 0.7% and Merck & Co. Inc.'s stock  was up 0.7% in premarket trading on Wednesday after the companies said the Food and Drug Administration had approved their cancer drug Lynparza for certain p..."},{"Date":"May. 20, 2020 at 7:58 a.m. ET","Headline":"AstraZeneca and Merck's Lynparza gets FDA approval for prostate cancer","Summary":"Shares of AstraZeneca  gained 0.7% and Merck & Co. Inc.'s stock  was up 0.7% in premarket trading on Wednesday after the companies said the Food and Drug Administration had approved their cancer drug Lynparza for certain p..."},{"Date":"May. 26, 2020 at 5:02 p.m. ET","Headline":"The Dow Rose 530 Points Because a Coronavirus Vaccine Could Cure the Economy","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 4:58 p.m. ET","Headline":"Merck CEO Warns a Covid-19 Vaccine Could Take Longer Than 18 Months. Moderna Stock Tumbles.","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 4:42 p.m. ET","Headline":"Dow closes up 500 points, tests 25,000 level, on recovery hopes and vaccine news","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 4:34 p.m. ET","Headline":"Global Stocks Rally on Recovery Hopes and Vaccine News","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 2:45 p.m. ET","Headline":"Coronavirus update: Global case tally crosses 5.5 million as WHO warns of risk of \u2018second peak\u2019 in current infection wave","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 11:43 a.m. ET","Headline":"GE Is an Industrial Stock but a Covid-19 Vaccine Is the Remedy It Needs","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 9:54 a.m. ET","Headline":"Dow surges 600 points, S&P 500 punches above key technical level as stock-market investors focus on Novovax, Merck vaccine candidates","Summary":"U.S. stock benchmarks rallied Tuesday morning after Memorial Day weekend, as investors seized on fresh coronavirus vaccine news and signs that global economy was slowly starting to emerge from shutdowns induced by the vira..."},{"Date":"May. 26, 2020 at 9:53 a.m. ET","Headline":"Covid-19 and Vaccine News Drive Boeing Stock Now. But Don\u2019t Forget the MAX.","Summary":""},{"Date":"May. 26, 2020 at 9:33 a.m. ET","Headline":"The Dow Is Rising Because Vaccines Are In the News Again","Summary":""},{"Date":"May. 26, 2020 at 8:17 a.m. ET","Headline":"Vaccines Are All That Matter for the Market and 5 More Things to Know","Summary":""},{"Date":"May. 26, 2020 at 7:24 a.m. ET","Headline":"Merck does deals to develop coronavirus vaccines, drug","Summary":""},{"Date":"May. 27, 2020 at 1:06 p.m. ET","Headline":"Boeing Lays Off Thousands. More Cuts Are Coming.","Summary":""},{"Date":"May. 26, 2020 at 10:13 a.m. ET","Headline":"Merck Dives Into Covid-19 Fray With Two Vaccines and One Antiviral","Summary":""},{"Date":"Jun. 1, 2020 at 12:17 p.m. ET","Headline":"Pfizer\u2019s Breast Cancer Treatment Fails in an Advanced Trial. The Stock Is Falling.","Summary":""},{"Date":"Jun. 1, 2020 at 9:07 a.m. ET","Headline":"Moderna\u2019s Covid-19 Vaccine Enters Next Phase of Testing. Goldman Sachs Is Upbeat.","Summary":""},{"Date":"Jun. 1, 2020 at 6:42 a.m. ET","Headline":"These stocks performed best in May as the market rally continued","Summary":""},{"Date":"Jun. 2, 2020 at 9:16 a.m. ET","Headline":"Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive","Summary":""},{"Date":"Jun. 4, 2020 at 11:38 a.m. ET","Headline":"Gates Pledges $1.6 Billion for Vaccines. What That Means for Covid-19 and Other Diseases.","Summary":""},{"Date":"Jun. 6, 2020 at 3:38 p.m. ET","Headline":"These stocks rose by double digits Friday as underperforming sectors bounced back","Summary":""},{"Date":"Jun. 6, 2020 at 12:03 p.m. ET","Headline":"Buy this, not that \u2014 5 stocks to trade into now and 5 to avoid","Summary":""},{"Date":"Jun. 9, 2020 at 4:44 p.m. ET","Headline":"Merck's Keytruda doesn't meet goals in bladder cancer study","Summary":"Merck Inc.  said late Tuesday that its drug Keytruda did not reach its goals in a late-stage clinical study for the treatment of bladder cancer. The drug maker said bladder cancer patients given Keytruda in a Phase 3 clini..."},{"Date":"Jun. 10, 2020 at 4:53 p.m. ET","Headline":"Dow closes 280 points lower, Nasdaq above 10,000 after Fed says it\u2019ll keep buying bonds and interest rates near zero","Summary":""},{"Date":"Jun. 12, 2020 at 6:49 a.m. ET","Headline":"These U.S. stocks led the market\u2019s brutal decline Thursday","Summary":""},{"Date":"Jun. 17, 2020 at 2:32 p.m. ET","Headline":"Coronavirus update: U.S. death toll edges above 117,000; Oklahoma is one of 9 states that are still setting case records","Summary":"Merck & Co. Inc.  priced a $4.5 billion, four-part bond offering on Wednesday, joining the many companies issuing debt to bolster liquidity during the coronavirus pandemic. The company sold $1 billion of 0.750% notes due 2..."},{"Date":"Jun. 17, 2020 at 8:41 a.m. ET","Headline":"Merck prices four-part bond offering","Summary":"Merck & Co. Inc.  priced a $4.5 billion, four-part bond offering on Wednesday, joining the many companies issuing debt to bolster liquidity during the coronavirus pandemic. The company sold $1 billion of 0.750% notes due 2..."},{"Date":"Jun. 20, 2020 at 8:45 p.m. ET","Headline":"Here are the best and worst stocks during the first 100 days of the coronavirus pandemic","Summary":""},{"Date":"Jun. 24, 2020 at 6:00 a.m. ET","Headline":"Flawed models for police rules and unions are at root of brutality","Summary":""},{"Date":"Jun. 29, 2020 at 9:36 a.m. ET","Headline":"Covid Changed the Definition of Corporate Leadership. Meet Barron\u2019s New Top CEOs.","Summary":""},{"Date":"Jun. 29, 2020 at 7:47 a.m. ET","Headline":"These 6 health-care stocks are \u2018buys\u2019 because they can thrive under either Trump or Biden","Summary":""},{"Date":"Jun. 30, 2020 at 6:40 a.m. ET","Headline":"High volatility is here to stay in 2020. Goldman names 31 stocks to deliver the best returns amid the turbulence","Summary":""},{"Date":"Jun. 29, 2020 at 8:07 a.m. ET","Headline":"Covid Cases Are Rising Faster Than Ever in the U.S.","Summary":""},{"Date":"Jul. 4, 2020 at 11:20 a.m. ET","Headline":"These stocks, including Tesla and Apple, are the real winners for the second quarter of 2020","Summary":""},{"Date":"Jul. 8, 2020 at 7:38 a.m. ET","Headline":"Merck, Eisai to put experimental cancer combination in new clinical trial","Summary":"Shares of Merck & Co. Inc.  gained 0.1% in premarket trading on Wednesday after it received a complete response letter from the Food and Drug Administration for an application to approve Keytruda in combination with Eisai ..."},{"Date":"Jul. 17, 2020 at 6:30 a.m. ET","Headline":"5 Biopharma Stocks That Are Affordable And Growing","Summary":""},{"Date":"Jul. 21, 2020 at 4:09 p.m. ET","Headline":"Lawmaker Presses Drugmakers on Covid-19 Vaccine Pricing","Summary":""},{"Date":"Jul. 21, 2020 at 11:16 a.m. ET","Headline":"Vaccine Makers Tell Congress They Are Hopeful, but Challenges Remain","Summary":""},{"Date":"Jul. 20, 2020 at 7:00 a.m. ET","Headline":"A Big Contrarian Investor Sold Walmart, Merck and Pfizer Stock. Here\u2019s What It Bought.","Summary":""},{"Date":"Jul. 22, 2020 at 9:47 a.m. ET","Headline":"Pfizer Will Charge the U.S. $19.50 a Dose for Its Covid-19 Vaccine. The Stock Jumps.","Summary":""},{"Date":"Jul. 22, 2020 at 6:37 a.m. ET","Headline":"Democratic lawmakers signal concern about coronavirus vaccine pricing, speed of development","Summary":""},{"Date":"Jul. 25, 2020 at 12:01 p.m. ET","Headline":"How Much Will Drugmakers Charge for Covid-19 Vaccines? Questions About Pricing Arise.","Summary":""},{"Date":"Jul. 24, 2020 at 8:07 p.m. ET","Headline":"Even as Indy Goes Autonomous, the Race to True Self-Driving Has Been Long","Summary":""},{"Date":"Jul. 24, 2020 at 7:07 p.m. ET","Headline":"Trump Signs 4 Executive Orders Aimed at Lowering Drug Prices. What to Know.","Summary":""},{"Date":"Jul. 27, 2020 at 10:53 a.m. ET","Headline":"Big Tech\u2019s big test arrives in the busiest week of earnings season","Summary":""},{"Date":"Jul. 27, 2020 at 6:00 a.m. ET","Headline":"Only 4% of Companies Reveal the Racial Makeup of Their Employee Base. Investors Are Pushing to Change That.","Summary":""},{"Date":"Jul. 26, 2020 at 6:27 p.m. ET","Headline":"Amazon, Apple,\u00a0Boeing, Starbucks, Visa and Other Stocks to Watch This Week","Summary":""},{"Date":"Jul. 28, 2020 at 4:36 p.m. ET","Headline":"Pfizer CEO Says Companies Should Make Profit On Covid-19 Vaccines","Summary":""},{"Date":"Jul. 31, 2020 at 12:49 p.m. ET","Headline":"Stocks Are Split as Tech Takes Center Stage","Summary":"Shares of Merck & Co. Inc.  rallied 3.4% in premarket trading Friday, after the drug giant reported second-quarter profit and sales that beat expectations, while pharmaceutical sales fell from the effects of the COVID-19 p..."},{"Date":"Jul. 31, 2020 at 11:28 a.m. ET","Headline":"Coronavirus update: Pandemic will continue for some time, experts tell Congress as U.S. case tally nears 4.5 million","Summary":"Shares of Merck & Co. Inc.  rallied 3.4% in premarket trading Friday, after the drug giant reported second-quarter profit and sales that beat expectations, while pharmaceutical sales fell from the effects of the COVID-19 p..."},{"Date":"Jul. 31, 2020 at 9:46 a.m. ET","Headline":"Merck Stock Climbs on Earnings Beat as Keytruda Sales Jump","Summary":"Shares of Merck & Co. Inc.  rallied 3.4% in premarket trading Friday, after the drug giant reported second-quarter profit and sales that beat expectations, while pharmaceutical sales fell from the effects of the COVID-19 p..."},{"Date":"Jul. 31, 2020 at 7:00 a.m. ET","Headline":"Merck's stock rallies after profit and sales beats, raised outlook","Summary":"Shares of Merck & Co. Inc.  rallied 3.4% in premarket trading Friday, after the drug giant reported second-quarter profit and sales that beat expectations, while pharmaceutical sales fell from the effects of the COVID-19 p..."},{"Date":"Aug. 1, 2020 at 9:33 a.m. ET","Headline":"Stocks stage a late-day comeback to end higher one day after a Big Tech earnings blowout","Summary":""},{"Date":"Aug. 3, 2020 at 1:16 p.m. ET","Headline":"Stocks Climb to Start the Month as New Virus Cases Fall","Summary":""},{"Date":"Aug. 3, 2020 at 10:47 a.m. ET","Headline":"Buy Merck for Its Unappreciated Pipeline, Says Goldman","Summary":""},{"Date":"Aug. 5, 2020 at 11:18 a.m. ET","Headline":"The stock market will be flying high in a year \u2014 for 2 simple reasons","Summary":""},{"Date":"Aug. 8, 2020 at 1:11 p.m. ET","Headline":"Should you volunteer for a COVID-19 vaccine trial? Who qualifies, and what are the side effects?","Summary":"The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s  remdesivir with Merck KGaA's  interferon beta-1a as a treatment for COVID-19 p..."},{"Date":"Aug. 7, 2020 at 1:14 p.m. ET","Headline":"Coronavirus update: Global case tally climbs above 19 million; U.S. death toll moves above 160,000 after 11 straight days with 1,000-plus fatalities","Summary":"The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s  remdesivir with Merck KGaA's  interferon beta-1a as a treatment for COVID-19 p..."},{"Date":"Aug. 7, 2020 at 9:11 a.m. ET","Headline":"NIH to test remdesivir with Merck KGaA's interferon therapy as a COVID-19 treatment","Summary":"The National Institutes of Health said it will conduct a randomized, controlled clinical trial testing a combination of Gilead Sciences Inc.'s  remdesivir with Merck KGaA's  interferon beta-1a as a treatment for COVID-19 p..."},{"Date":"Aug. 9, 2020 at 7:00 a.m. ET","Headline":"A Big Pension Bought GE, Merck, and Intel Stock. It Sold This Biotech.","Summary":""},{"Date":"Aug. 12, 2020 at 8:38 a.m. ET","Headline":"Russia\u2019s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential","Summary":""},{"Date":"Aug. 11, 2020 at 9:27 a.m. ET","Headline":"After 150 days of the COVID-19 pandemic, here are the best- and worst-performing stocks","Summary":""},{"Date":"Aug. 12, 2020 at 6:00 a.m. ET","Headline":"Why a Winning Dividend Fund Likes Home Depot, Target, and Walmart","Summary":""},{"Date":"Aug. 17, 2020 at 8:35 a.m. ET","Headline":"Merck Is Barron\u2019s Stock Pick This Week. Here\u2019s Why.","Summary":""},{"Date":"Aug. 20, 2020 at 5:25 p.m. ET","Headline":"The Dow Finished the Day Higher. Individual Stocks Got Hammered. What That Might Mean.","Summary":""},{"Date":"Aug. 21, 2020 at 7:27 p.m. ET","Headline":"Tech, Tesla, and Apple Star as Stocks Keep Rising","Summary":""},{"Date":"Aug. 21, 2020 at 3:44 p.m. ET","Headline":"5 New Stocks That Are Hedge Funds\u2019 Favorites","Summary":""},{"Date":"Aug. 26, 2020 at 9:27 a.m. ET","Headline":"Pfizer Got Kicked Out of the Dow Just as Things Were Looking Up","Summary":""},{"Date":"Aug. 25, 2020 at 4:57 p.m. ET","Headline":"Forget the Dow Shake-Up. A Tesla Addition to the S&P 500 Would Really Matter.","Summary":""},{"Date":"Aug. 27, 2020 at 7:58 a.m. ET","Headline":"Interest Rates Will Remain Low for Years. These High-Quality Stocks Might Offer the Income You Need.","Summary":""},{"Date":"Sep. 1, 2020 at 9:56 a.m. ET","Headline":"Here are the big winners among U.S. stocks during a sizzling August","Summary":""},{"Date":"Sep. 3, 2020 at 2:19 p.m. ET","Headline":"Is 30 too old to work in media? This advertising boss has been forced to apologize after ageism row","Summary":""},{"Date":"Sep. 4, 2020 at 6:11 a.m. ET","Headline":"Here are the biggest stock-market losers on Thursday as the tech sector tanks","Summary":""},{"Date":"Sep. 9, 2020 at 9:18 a.m. ET","Headline":"AstraZeneca\u2019s Vaccine-Trial Pause Won\u2019t Slow Its Rivals","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 9, 2020 at 7:43 a.m. ET","Headline":"Tech Stocks Are Bouncing Back. It Doesn\u2019t Mean Anything Yet.","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 8, 2020 at 3:59 p.m. ET","Headline":"Coronavirus update: Global case tally tops 27.3 million, and U.S. accounts for a quarter, as 9 drug-company CEOs pledge to \u2018stand with science\u2019 in vaccine development","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 8, 2020 at 12:05 p.m. ET","Headline":"Under Pressure to Deliver, 9 Covid-19 Vaccine Developers Promise Safety First","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 8, 2020 at 9:11 a.m. ET","Headline":"Sell Moderna Stock, Analyst Says, Because Covid Vaccine Competition Is Fierce","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 8, 2020 at 6:44 a.m. ET","Headline":"Group of 9 drug company CEOs pledge to make sure COVID-19 vaccine follows full regulatory path","Summary":"A group of nine drug company chief executives said Tuesday they have signed a pledge to make the safety and well-being of vaccinated individuals the top priority in developing the first COVID-19 vaccine. The CEOs of AstraZ..."},{"Date":"Sep. 11, 2020 at 10:20 a.m. ET","Headline":"U.S. Drug Stocks Look Cheap. Here\u2019s Why, According to One Analyst.","Summary":""},{"Date":"Sep. 10, 2020 at 8:21 a.m. ET","Headline":"AstraZeneca\u2019s coronavirus vaccine setback shows why Big Pharma prefers to be safe than sorry. Which is good news","Summary":""},{"Date":"Sep. 15, 2020 at 1:47 p.m. ET","Headline":"Bill Gates questions FDA, says only one drugmaker has a chance to deliver a coronavirus vaccine by next month","Summary":"Shares of Seattle Genetics  rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck & Co. Inc. . Shares of Merck were up 0.6%. The first deal allows Merck to co-develop and commercialize ..."},{"Date":"Sep. 14, 2020 at 6:11 p.m. ET","Headline":"The Dow Gained 327 Points, but the Nasdaq 100\u2019s Rise Might Have Been More Important","Summary":"Shares of Seattle Genetics  rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck & Co. Inc. . Shares of Merck were up 0.6%. The first deal allows Merck to co-develop and commercialize ..."},{"Date":"Sep. 14, 2020 at 11:15 a.m. ET","Headline":"Merck\u2019s Partnership With Seattle Genetics Is a Bet on a New Anticancer Strategy","Summary":"Shares of Seattle Genetics  rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck & Co. Inc. . Shares of Merck were up 0.6%. The first deal allows Merck to co-develop and commercialize ..."},{"Date":"Sep. 14, 2020 at 8:01 a.m. ET","Headline":"Shares of Seattle Genetics jump as Merck makes up to $4.2 billion investment","Summary":"Shares of Seattle Genetics  rallied 9.3% in premarket trading on Monday after it announced two cancer deals with Merck & Co. Inc. . Shares of Merck were up 0.6%. The first deal allows Merck to co-develop and commercialize ..."},{"Date":"Sep. 14, 2020 at 7:51 a.m. ET","Headline":"Merger Monday Is Back","Summary":""},{"Date":"Sep. 17, 2020 at 5:23 p.m. ET","Headline":"Moderna Shares the Latest on its Coronavirus Vaccine Trial and Other Research Advances","Summary":""},{"Date":"Sep. 22, 2020 at 4:07 p.m. ET","Headline":"Merck\u2019s Lung Cancer Drug Is a Blockbuster. Other Companies Are Starting to Challenge Its Dominance.","Summary":"Shares of Vaccinex Inc.  tumbled 61.6% in premarket trading on Tuesday after the preclinical biotechnology company said an experimental Huntington's disease treatment, pepinemab, did not meet the primary endpoints in a Pha..."},{"Date":"Sep. 22, 2020 at 12:32 p.m. ET","Headline":"Stock-market \u2018anxiety will only intensify over the next 60-90 days\u2019 warns expert who profited in 1987 and 2008 crises","Summary":"Shares of Vaccinex Inc.  tumbled 61.6% in premarket trading on Tuesday after the preclinical biotechnology company said an experimental Huntington's disease treatment, pepinemab, did not meet the primary endpoints in a Pha..."},{"Date":"Sep. 22, 2020 at 8:40 a.m. ET","Headline":"Vaccinex's stock falls after investigational drug fails Huntington's disease study","Summary":"Shares of Vaccinex Inc.  tumbled 61.6% in premarket trading on Tuesday after the preclinical biotechnology company said an experimental Huntington's disease treatment, pepinemab, did not meet the primary endpoints in a Pha..."},{"Date":"Sep. 25, 2020 at 3:16 p.m. ET","Headline":"Everything you need to know about what it would take for the FDA to approve a COVID-19 vaccine","Summary":""},{"Date":"Sep. 25, 2020 at 1:30 p.m. ET","Headline":"Why Covid-19 Vaccine Prices May Be Unexpectedly Low","Summary":""},{"Date":"Sep. 28, 2020 at 7:27 a.m. ET","Headline":"There are four coronavirus vaccines in late-stage studies \u2014 here\u2019s how they differ","Summary":""},{"Date":"Oct. 1, 2020 at 3:18 p.m. ET","Headline":"In These Election Scenarios, Managed Care Wins, Biotech Loses","Summary":""},{"Date":"Sep. 30, 2020 at 9:13 a.m. ET","Headline":"Regeneron\u2019s Good News on Covid Antibodies Is Positive for Vaccines, Too","Summary":""},{"Date":"Oct. 3, 2020 at 3:08 p.m. ET","Headline":"Here are the biggest winners in a solid third quarter for U.S. stocks","Summary":""},{"Date":"Sep. 28, 2020 at 8:56 a.m. ET","Headline":"10 Stocks to Buy as the Health-Care Revolution Races Ahead, According to Experts","Summary":""},{"Date":"Oct. 12, 2020 at 9:11 a.m. ET","Headline":"Trump raised 5 times as much money from America\u2019s top CEOs as Biden","Summary":""},{"Date":"Oct. 19, 2020 at 9:50 a.m. ET","Headline":"Bristol Myers Stock Skeptic Upgrades to a Buy. Here\u2019s Why.","Summary":""},{"Date":"Oct. 21, 2020 at 6:52 a.m. ET","Headline":"U.S. and allies take on Russia for \u2018malicious\u2019 military intelligence cyberattacks on Olympics and elections","Summary":""},{"Date":"Oct. 20, 2020 at 8:57 a.m. ET","Headline":"Misery Loves Company: Behind the Boom in Oil Stock M&A","Summary":""},{"Date":"Oct. 22, 2020 at 12:04 p.m. ET","Headline":"Glaxo Vaccines Target Another Viral Threat","Summary":""},{"Date":"Oct. 27, 2020 at 4:31 p.m. ET","Headline":"Dow books back-to-back loss as Wall Street struggles to rebound from Monday selloff","Summary":"U.S. stocks on Tuesday finished mostly lower, but technology-related stocks ended in the green, as investors appeared to try and position their portfolios with less than a week until the Nov. 3 election between President D..."},{"Date":"Oct. 27, 2020 at 4:05 p.m. ET","Headline":"Dow ends nearly 900 points lower in 2-day skid ahead of presidential election but tech stocks rally","Summary":"U.S. stocks on Tuesday finished mostly lower, but technology-related stocks ended in the green, as investors appeared to try and position their portfolios with less than a week until the Nov. 3 election between President D..."},{"Date":"Oct. 27, 2020 at 9:36 a.m. ET","Headline":"Merck Stock Is Rising After an Earnings Beat and a Rosier Forecast","Summary":""},{"Date":"Oct. 27, 2020 at 7:29 a.m. ET","Headline":"As markets gyrate over second-wave fears, here are 2 consumer staple stocks to ride for the long run, from Barclays","Summary":""},{"Date":"Oct. 26, 2020 at 7:59 a.m. ET","Headline":"Ready for another Big Tech hearing\/earnings doubleheader?","Summary":""},{"Date":"Oct. 29, 2020 at 10:00 a.m. ET","Headline":"This Is How Big Honeywell\u2019s Quantum Computing Business Could Be","Summary":""},{"Date":"Oct. 28, 2020 at 5:34 p.m. ET","Headline":"Here are Wednesday\u2019s biggest losers in the stock market as 97% of S&P 500 companies dropped","Summary":""},{"Date":"Oct. 30, 2020 at 5:14 p.m. ET","Headline":"These are the worst-performing stocks in October as Big Tech slumps","Summary":""},{"Date":"Nov. 4, 2020 at 5:18 p.m. ET","Headline":"These stocks rose the most Wednesday as investors cheered a divided government following the elections","Summary":"Shares of UnitedHealth Group Inc.  soared 10.2% in morning trading, enough to pace the Dow Jones Industrial Average's  gainers, as the . The stock's price gain of $32.65 was adding about 215 points to the Dow's price, whil..."},{"Date":"Nov. 4, 2020 at 2:20 p.m. ET","Headline":"What the Best and Worst Performing Stocks in the Dow Say About the Election","Summary":"Shares of UnitedHealth Group Inc.  soared 10.2% in morning trading, enough to pace the Dow Jones Industrial Average's  gainers, as the . The stock's price gain of $32.65 was adding about 215 points to the Dow's price, whil..."},{"Date":"Nov. 4, 2020 at 11:23 a.m. ET","Headline":"Health care stocks soar, add more than 350 points to the Dow's price","Summary":"Shares of UnitedHealth Group Inc.  soared 10.2% in morning trading, enough to pace the Dow Jones Industrial Average's  gainers, as the . The stock's price gain of $32.65 was adding about 215 points to the Dow's price, whil..."},{"Date":"Nov. 5, 2020 at 3:04 p.m. ET","Headline":"These 7 \u2018deeply out of favor stocks\u2019 are worth a look right now, says contrarian manager","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to cl..."},{"Date":"Nov. 5, 2020 at 12:30 p.m. ET","Headline":"6 S&P 500 Dividend Payers With Safe Yields Above 2%","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to cl..."},{"Date":"Nov. 5, 2020 at 10:49 a.m. ET","Headline":"Merck Just Bet Billions on Antibody-Drug Cancer Combos. Here\u2019s Why.","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to cl..."},{"Date":"Nov. 5, 2020 at 9:10 a.m. ET","Headline":"Bristol Myers Stock Is Rising Because the Celgene Drugs It Acquired Boosted Earnings","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to cl..."},{"Date":"Nov. 5, 2020 at 6:40 a.m. ET","Headline":"Merck to buy VelosBio for $2.75 billion to bolster oncology pipeline","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker announced a deal to buy privately held biopharmaceutical company VelosBio Inc. for $2.75 billion in cash. The deal is expected to cl..."},{"Date":"Jul. 13, 2020 at 2:12 p.m. ET","Headline":"37 Stocks Poised to Emerge Even Stronger After the Crisis, According to Barron\u2019s Investing Experts","Summary":""},{"Date":"Nov. 9, 2020 at 8:30 a.m. ET","Headline":"Trump\u2019s vaccine czar says the first vaccine should be submitted for emergency authorization around Thanksgiving","Summary":""},{"Date":"Nov. 16, 2020 at 5:57 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Confirms Apple Stock Sale, Buys of Pfizer, Merck","Summary":""},{"Date":"Nov. 16, 2020 at 8:23 a.m. ET","Headline":"A Covid Vaccine Is Coming. Here\u2019s What It Means for the Stock Market.","Summary":""},{"Date":"Nov. 17, 2020 at 11:12 a.m. ET","Headline":"Why Did Warren Buffett\u2019s Berkshire Hathaway Fall Out of Love With JPMorgan?","Summary":""},{"Date":"Nov. 20, 2020 at 4:04 p.m. ET","Headline":"Trump announces rules to lower drug prices","Summary":""},{"Date":"Nov. 21, 2020 at 8:30 a.m. ET","Headline":"Nike and 6 Other Companies That Raised Their Dividend This Week","Summary":""},{"Date":"Nov. 24, 2020 at 10:14 a.m. ET","Headline":"Be Like Buffett and Wager on Pfizer. Here\u2019s How to Do It With Options.","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 24, 2020 at 7:30 a.m. ET","Headline":"Why Now May Be the Time to Buy Health Care Stocks","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 23, 2020 at 4:30 p.m. ET","Headline":"Dow ends 327 point higher after Janet Yellen reported as Biden\u2019s Treasury Secretary pick","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 23, 2020 at 2:58 p.m. ET","Headline":"U.S. coronavirus case tally tops 12 million amid growing fears that Thanksgiving travel will spark another surge of infections","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 23, 2020 at 10:38 a.m. ET","Headline":"Regeneron Is Allowed to Sell the Covid Antibody It Served Trump and the Stock Is Rising","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 23, 2020 at 6:56 a.m. ET","Headline":"Merck to pay $425 million upfront to buy COVID-19 treatment developer OncoImmune","Summary":"Shares of Merck & Co. Inc.  surged 3.1% in premarket trading Monday, after the drug maker announced a deal to buy clinical-stage biopharmaceutical company OncoImmune for an upfront payment of $425 million in cash. OncoImmu..."},{"Date":"Nov. 28, 2020 at 1:15 p.m. ET","Headline":"These 5 stocks will profit  from the dollar\u2019s continuing decline","Summary":""},{"Date":"Nov. 28, 2020 at 7:57 a.m. ET","Headline":"30 dividend stocks selected for value as the U.S. economy gathers steam","Summary":""},{"Date":"Dec. 2, 2020 at 9:17 a.m. ET","Headline":"Moderna Stock Dips After Merck Announces It Sold Its Stake","Summary":""},{"Date":"Dec. 1, 2020 at 4:55 p.m. ET","Headline":"Activist Shareholders Press Pfizer, J&J, and Other Pharma Companies on Covid Vaccine Price and Access","Summary":""},{"Date":"Dec. 3, 2020 at 12:24 p.m. ET","Headline":"Warren Buffett\u2019s Woodstock for Capitalists Going Virtual Again in 2021","Summary":""},{"Date":"Dec. 10, 2020 at 5:35 p.m. ET","Headline":"CEOs of Big Companies Pledge $100 Million for Initiative to Hire 1 Million Black Workers","Summary":""},{"Date":"Dec. 9, 2020 at 11:10 a.m. ET","Headline":"Moderna Will Succeed, but Its Stock Already Reflects That, Says Needham","Summary":""},{"Date":"Dec. 18, 2020 at 4:25 p.m. ET","Headline":"908 Devices Stock More Than Doubles in Market Debut","Summary":""},{"Date":"Dec. 16, 2020 at 9:09 a.m. ET","Headline":"Dogs of the Dow Stock-Picking Strategy Didn\u2019t Work This Year. It Could in 2021.","Summary":""},{"Date":"Dec. 22, 2020 at 8:00 a.m. ET","Headline":"Better Returns With Less Risk? Goldman Has a Basket of Stocks for That.","Summary":""},{"Date":"Dec. 21, 2020 at 8:07 a.m. ET","Headline":"Stimulus Is on Its Way\u2014and the Stock Market Asks \u201cWhat Have You Done for Me Lately?\u201d","Summary":""},{"Date":"Dec. 23, 2020 at 2:37 p.m. ET","Headline":"U.S. COVID-19 deaths surge back to more than 3,000 a day as hospitalizations spike to another record","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Wednesday after the drugmaker said it signed a deal with the U.S. government to develop, manufacture, and distribute an experimental COVID-19 therapy. The $35..."},{"Date":"Dec. 23, 2020 at 11:05 a.m. ET","Headline":"New U.S. Covid-19 Vaccine Deal Gives Pfizer $2 Billion More in Sales","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Wednesday after the drugmaker said it signed a deal with the U.S. government to develop, manufacture, and distribute an experimental COVID-19 therapy. The $35..."},{"Date":"Dec. 23, 2020 at 7:32 a.m. ET","Headline":"Merck signs $356 million deal with U.S. government for experimental COVID-19 therapy","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Wednesday after the drugmaker said it signed a deal with the U.S. government to develop, manufacture, and distribute an experimental COVID-19 therapy. The $35..."},{"Date":"Dec. 30, 2020 at 12:04 p.m. ET","Headline":"Merck Had a Disappointing 2020. Why Its Strategy Could Pay Off in 2021.","Summary":""},{"Date":"Dec. 29, 2020 at 5:06 p.m. ET","Headline":"The Dow Fell 68 Points Because Stocks Needed a Breather","Summary":""},{"Date":"Jan. 1, 2021 at 4:00 a.m. ET","Headline":"Merck Is One of Barron\u2019s Top Stock Picks for the New Year. Here\u2019s Why.","Summary":""},{"Date":"Dec. 31, 2020 at 7:15 a.m. ET","Headline":"Is the Stock Market Open Today? Here Are the Hours for New Year\u2019s Eve and Day.","Summary":""},{"Date":"Jan. 2, 2021 at 8:17 a.m. ET","Headline":"These are the best performing Nasdaq and S&P 500 stocks of 2020","Summary":""},{"Date":"Jan. 2, 2021 at 6:30 a.m. ET","Headline":"The Dow Trailed the S&P 500 in 2020. It Was the Blue Chips\u2019 Worst Relative Performance Since 1998.","Summary":""},{"Date":"Jan. 5, 2021 at 10:23 a.m. ET","Headline":"Merck Stock Is Deeply Undervalued, Says Citi. It Could Surge in 2021.","Summary":""},{"Date":"Jan. 4, 2021 at 7:41 a.m. ET","Headline":"Here Are Barron\u2019s 10 Top Stocks for the New Year","Summary":""},{"Date":"Jan. 4, 2021 at 7:25 a.m. ET","Headline":"Here Are Barron\u2019s Best Income Investments for the New Year","Summary":""},{"Date":"Jan. 6, 2021 at 7:05 a.m. ET","Headline":"Biden\u2019s defense and economic teams aren\u2019t ready to battle China","Summary":""},{"Date":"Jan. 11, 2021 at 3:42 p.m. ET","Headline":"Illumina CEO Says Business Is Bouncing Back. The Gene Sequencer Sees New Opportunities.","Summary":""},{"Date":"Jan. 11, 2021 at 6:30 a.m. ET","Headline":"A Start-Up That Wants to Undersell the Drug Industry Raises Another $500 Million","Summary":""},{"Date":"Jan. 12, 2021 at 4:56 p.m. ET","Headline":"Bristol Myers Looks to Its Drug Pipeline to Turbocharge Growth","Summary":""},{"Date":"Jan. 19, 2021 at 1:50 p.m. ET","Headline":"2 Reasons This Will Be Gilead\u2019s Year, Says Morgan Stanley","Summary":""},{"Date":"Jan. 19, 2021 at 8:05 a.m. ET","Headline":"Eli Lilly Stock Is Still Pricey. Why It Might Be a Buy.","Summary":""},{"Date":"Jan. 19, 2021 at 6:00 a.m. ET","Headline":"The Dogs of the Dow and Other High Yielders Keep Roaring Into 2021","Summary":""},{"Date":"Jan. 25, 2021 at 4:52 p.m. ET","Headline":"S&P 500, Nasdaq log record closes as stock market kicks off jam-packed week","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 3:17 p.m. ET","Headline":"It Was a Grim Morning in the Covid-19 Fight. The Market Is Looking to Johnson & Johnson for Hope.","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 2:33 p.m. ET","Headline":"Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 10:31 a.m. ET","Headline":"Moderna Making Vaccine Booster Shot to Protect Against South African Covid-19 Strain","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 8:26 a.m. ET","Headline":"Merck Scraps Covid-19 Vaccine Programs","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 8:15 a.m. ET","Headline":"GameStop Stock Is Soaring Again. What\u2019s Behind Its Remarkable \u2014 and Inexplicable \u2014 Run.","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 25, 2021 at 6:53 a.m. ET","Headline":"Merck to discontinue development of COVID-19 vaccines, focus on two investigational therapies","Summary":"Merck  said Monday it is discontinuing development of its two COVID-19 vaccine candidates following disappointing trial results, and will instead focus on the development of two investigational therapeutic candidates. The ..."},{"Date":"Jan. 26, 2021 at 8:11 a.m. ET","Headline":"GE and Other Industrial Stocks Are Jumping After Earnings. Why That\u2019s Great News for the Economy.","Summary":""},{"Date":"Jan. 26, 2021 at 7:48 a.m. ET","Headline":"Johnson Johnson Just Reported Earnings. Here\u2019s the One Number to Pay Attention To.","Summary":""},{"Date":"Jan. 30, 2021 at 12:18 p.m. ET","Headline":"Sanofi Will Make Pfizer\u2019s Covid-19 Vaccine. Are More Manufacturing Partnerships Coming?","Summary":""},{"Date":"Feb. 1, 2021 at 1:11 p.m. ET","Headline":"Time for more record earnings reports from Big Tech, led by Amazon\u2019s first $100 billion quarter","Summary":""},{"Date":"Feb. 1, 2021 at 9:43 a.m. ET","Headline":"Vaccine rollout issues points to \u2018bumpier\u2019 path to normal, unnerving stock-market bulls","Summary":""},{"Date":"Feb. 4, 2021 at 4:38 p.m. ET","Headline":"S&P 500, Nasdaq close at records as U.S. jobs data, coronavirus cases and earnings improve","Summary":"Merck & Co. Inc.  said Thursday that Chief Executive Kenneth Frazier will retire, effective June 30, after 10 years in the role, and 29 years with the company. The drug maker said it elected Chief Financial Officer Robert ..."},{"Date":"Feb. 4, 2021 at 10:12 a.m. ET","Headline":"UnitedHealth Says CEO Is Leaving, Sending Shares Down","Summary":"Merck & Co. Inc.  said Thursday that Chief Executive Kenneth Frazier will retire, effective June 30, after 10 years in the role, and 29 years with the company. The drug maker said it elected Chief Financial Officer Robert ..."},{"Date":"Feb. 4, 2021 at 7:56 a.m. ET","Headline":"Merck Announces New CEO, But Reports Earnings Miss","Summary":"Merck & Co. Inc.  said Thursday that Chief Executive Kenneth Frazier will retire, effective June 30, after 10 years in the role, and 29 years with the company. The drug maker said it elected Chief Financial Officer Robert ..."},{"Date":"Feb. 4, 2021 at 7:06 a.m. ET","Headline":"Merck CEO Kenneth Frazier to retire after 10 years in the role","Summary":"Merck & Co. Inc.  said Thursday that Chief Executive Kenneth Frazier will retire, effective June 30, after 10 years in the role, and 29 years with the company. The drug maker said it elected Chief Financial Officer Robert ..."},{"Date":"Feb. 4, 2021 at 6:59 a.m. ET","Headline":"Merck misses profit expectations but beats on revenue, provides upbeat outlook","Summary":"Shares of Merck & Co. Inc.  slipped 0.2% in premarket trading Thursday, after the drug maker reported a fourth-quarter profit that missed expectations, but revenue that beat and provided and upbeat full-year outlook. The c..."},{"Date":"Feb. 3, 2021 at 7:22 p.m. ET","Headline":"A straightforward explanation why more COVID-19 vaccines can\u2019t be produced with help from \u2018dozens\u2019 of companies","Summary":""},{"Date":"Feb. 5, 2021 at 5:00 a.m. ET","Headline":"80% of S&P 500 Companies Beat Wall Street Fourth-Quarter Earnings Estimates, and Two More Numbers to Know","Summary":"Halfway through earnings season, the S&P 500 is exceeding expectations. Plus, a look at Treasury notes and three CEO retirement announcements."},{"Date":"Feb. 9, 2021 at 1:33 p.m. ET","Headline":"Sanofi CEO on the Future of Messenger RNA Vaccines \u2014 and His Company","Summary":""},{"Date":"Feb. 8, 2021 at 7:00 a.m. ET","Headline":"15 Undervalued Stocks With Strong Earnings Growth in 2021","Summary":""},{"Date":"Feb. 13, 2021 at 1:02 p.m. ET","Headline":"How the Pandemic Is Changing the Vaccine Industry","Summary":""},{"Date":"Feb. 16, 2021 at 6:26 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Bought Verizon and Chevron. Here\u2019s What Else It Traded.","Summary":""},{"Date":"Feb. 16, 2021 at 4:44 p.m. ET","Headline":"Berkshire Hathaway ups drug-stock stakes while trimming Apple","Summary":""},{"Date":"Feb. 16, 2021 at 9:36 a.m. ET","Headline":"Why Berkshire Hathaway\u2019s Mystery Stock May Be an Industrial or Commercial Company","Summary":""},{"Date":"Feb. 15, 2021 at 10:11 a.m. ET","Headline":"What Is Berkshire Hathaway\u2019s Mystery Stock? Big Investment by Warren Buffett Could Be Disclosed Today.","Summary":""},{"Date":"Feb. 17, 2021 at 12:06 p.m. ET","Headline":"5 Affordable Biopharma Stocks With Growth Potential","Summary":""},{"Date":"Feb. 17, 2021 at 8:20 a.m. ET","Headline":"Bitcoin Hits $51,000. The Run Doesn\u2019t Make Sense.","Summary":""},{"Date":"Feb. 19, 2021 at 7:30 p.m. ET","Headline":"The Argument for the Reborn Chesapeake Energy","Summary":""},{"Date":"Feb. 19, 2021 at 5:32 p.m. ET","Headline":"Blackstone Has Quietly Invested in Life Sciences for Years. Now Its Bet Could Pay Off.","Summary":""},{"Date":"Feb. 22, 2021 at 8:01 a.m. ET","Headline":"Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine","Summary":""},{"Date":"Feb. 25, 2021 at 10:50 a.m. ET","Headline":"Merck Pays Double to Buy Pandion Therapeutics","Summary":"Merck & Co.  announced an agreement Thursday to buy Pandion Therapeutics Inc.  in a deal valued at $1.85 billion. Under terms of the deal, Merck will pay $60 in cash for each Pandion share outstanding, which represents a 1..."},{"Date":"Feb. 25, 2021 at 6:57 a.m. ET","Headline":"Merck to buy Pandion Therapeutics for 134% premium","Summary":"Merck & Co.  announced an agreement Thursday to buy Pandion Therapeutics Inc.  in a deal valued at $1.85 billion. Under terms of the deal, Merck will pay $60 in cash for each Pandion share outstanding, which represents a 1..."},{"Date":"Mar. 2, 2021 at 9:25 p.m. ET","Headline":"Biden moves up timeline for when enough vaccine doses will be available for all adults: now end of May","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 2, 2021 at 4:20 p.m. ET","Headline":"Dow finishes 144 points lower after best one-day rally in months","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 2, 2021 at 3:45 p.m. ET","Headline":"Investors should do this 1 thing now to protect from a brewing market storm, says Pictet manager","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 2, 2021 at 2:36 p.m. ET","Headline":"U.S. COVID vaccine supply to be boosted by Merck helping make J&J vaccine","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 2, 2021 at 10:58 a.m. ET","Headline":"Merck Will Help Make J&J\u2019s Covid-19 Vaccine, Washington Post Reports","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 2, 2021 at 9:09 a.m. ET","Headline":"President Biden to announce later Tuesday that Merck will help make J&J vaccine: Washington Post","Summary":"President Joe Biden will announce later Tuesday that Merck & Co.  will help make Johnson & Johnson's  one-shot COVID-19 vaccine in an unusual agreement between two competitors that could lead to a significant boost in supp..."},{"Date":"Mar. 1, 2021 at 8:21 a.m. ET","Headline":"J&J\u2019s Covid-19 Vaccine Is Authorized. Here\u2019s What It Means for the Stock.","Summary":""},{"Date":"Mar. 4, 2021 at 11:20 a.m. ET","Headline":"House Passes Voting-Rights Bill in Rescheduled Vote","Summary":""},{"Date":"Mar. 4, 2021 at 10:17 a.m. ET","Headline":"Novartis Will Help Manufacture CureVac\u2019s Covid-19 Vaccine","Summary":""},{"Date":"Mar. 3, 2021 at 4:30 p.m. ET","Headline":"Dow tumbles for second day, U.S. stocks swoon as bond yields flirt with year\u2019s highs","Summary":""},{"Date":"Mar. 3, 2021 at 2:04 p.m. ET","Headline":"Expert \u2018mortified and disgusted\u2019 by Texas reopening plan; it \u2018will kill Texans,\u2019 says top Democrat","Summary":""},{"Date":"Mar. 3, 2021 at 8:53 a.m. ET","Headline":"U.S. Vaccine Shortage Could Soon End With Oversupply","Summary":""},{"Date":"Mar. 3, 2021 at 8:46 a.m. ET","Headline":"Biden Says U.S. Could Have Enough Vaccine Doses for Every American in May","Summary":""},{"Date":"Mar. 3, 2021 at 8:29 a.m. ET","Headline":"Las Vegas Sands Is Leaving Las Vegas. Here\u2019s Why.","Summary":""},{"Date":"Mar. 5, 2021 at 10:57 a.m. ET","Headline":"U.S. COVID-19 death toll tops 520,000 as Dr. Fauci cautions against reopening too soon","Summary":""},{"Date":"Mar. 8, 2021 at 8:03 a.m. ET","Headline":"Merck\u2019s Covid-19 Antiviral Shows Early Promise","Summary":""},{"Date":"Mar. 10, 2021 at 5:05 p.m. ET","Headline":"Dow ends above 32,000 milestone for first time. Here\u2019s how it got there","Summary":"President Joe Biden on Wednesday afternoon will announce plans to secure an additional 100 million doses of Johnson & Johnson's COVID-19 vaccine by year's end, according to a  citing unnamed administration officials. The g..."},{"Date":"Mar. 10, 2021 at 4:22 p.m. ET","Headline":"\u2018We want to be oversupplied\u2019: U.S. buying additional 100 million doses of J&J vaccine","Summary":"President Joe Biden on Wednesday afternoon will announce plans to secure an additional 100 million doses of Johnson & Johnson's COVID-19 vaccine by year's end, according to a  citing unnamed administration officials. The g..."},{"Date":"Mar. 10, 2021 at 2:24 p.m. ET","Headline":"Biden to buy another 100 million doses of J&J vaccine as Alaska becomes first state to open eligibility to everyone aged 16 and over","Summary":"President Joe Biden on Wednesday afternoon will announce plans to secure an additional 100 million doses of Johnson & Johnson's COVID-19 vaccine by year's end, according to a  citing unnamed administration officials. The g..."},{"Date":"Mar. 10, 2021 at 8:47 a.m. ET","Headline":"Biden to unveil plans to obtain additional 100 million doses of J&J vaccine: report","Summary":"President Joe Biden on Wednesday afternoon will announce plans to secure an additional 100 million doses of Johnson & Johnson's COVID-19 vaccine by year's end, according to a  citing unnamed administration officials. The g..."},{"Date":"Mar. 12, 2021 at 6:59 a.m. ET","Headline":"WHO declared a pandemic one year ago today","Summary":"One year after the World Health Organization declared a global pandemic, the global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 118 million,  while the death toll rose above 2.62 million..."},{"Date":"Mar. 11, 2021 at 12:40 p.m. ET","Headline":"Biden says he\u2019ll \u2018talk about what\u2019s next\u2019 in COVID response in primetime speech tonight","Summary":"One year after the World Health Organization declared a global pandemic, the global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 118 million,  while the death toll rose above 2.62 million..."},{"Date":"Mar. 11, 2021 at 6:41 a.m. ET","Headline":"Coronavirus tally one year on: Global cases of COVID-19 top 118 million and U.S. nears 530,000 fatalities","Summary":"One year after the World Health Organization declared a global pandemic, the global tally for confirmed cases of the coronavirus that causes COVID-19 climbed above 118 million,  while the death toll rose above 2.62 million..."},{"Date":"Mar. 10, 2021 at 10:15 a.m. ET","Headline":"White House Plans to Seek to Buy 100M More Doses of J&J Vaccine, Reports Say","Summary":""},{"Date":"Mar. 15, 2021 at 10:46 a.m. ET","Headline":"Merck and Gilead Will Collaborate On Long-Acting HIV Therapy","Summary":""},{"Date":"Mar. 15, 2021 at 8:43 a.m. ET","Headline":"Big Pharma Battled the Pandemic. The Stocks Are Cheap.","Summary":""},{"Date":"Mar. 18, 2021 at 9:22 a.m. ET","Headline":"Dow scores fastest 1,000-point move in history as it tops 33,000 milestone \u2014 here\u2019s what drove it there","Summary":""},{"Date":"Mar. 17, 2021 at 1:48 p.m. ET","Headline":"Biopharma Stocks Aren\u2019t Getting a Lot of Credit. Here Are 5 of the Most Undervalued.","Summary":""},{"Date":"Mar. 22, 2021 at 2:22 p.m. ET","Headline":"U.S. on track to almost triple vaccine output in March, as new variants pressure Europe and Brazil","Summary":""},{"Date":"Mar. 21, 2021 at 7:31 p.m. ET","Headline":"U.S. production of COVID-19 vaccine dramatically speeds up","Summary":""},{"Date":"Mar. 24, 2021 at 6:50 a.m. ET","Headline":"Merck names Treasurer Caroline Litchfield CFO effective April 1","Summary":"Merck  said Wednesday it has named Caroline Litchfield as its chief financial officer effective April 1, replacing Robert M. Davis, who will become president effective April 1 and chief executive on July 1. Litchfield is c..."},{"Date":"Mar. 23, 2021 at 12:42 p.m. ET","Headline":"Pfizer Will Test a Pill to Kill the Covid-19 Virus","Summary":""},{"Date":"Mar. 25, 2021 at 8:01 a.m. ET","Headline":"Vaccines are here. That\u2019s no reason to call off the hunt for effective COVID-19 treatments.","Summary":""},{"Date":"Mar. 30, 2021 at 10:21 a.m. ET","Headline":"FDA Rejects Merck Drug Keytruda for Certain Breast-Cancer Patients","Summary":""},{"Date":"Mar. 29, 2021 at 12:53 p.m. ET","Headline":"GlaxoSmithKline Will Help Manufacture Novavax\u2019s Covid-19 Vaccine for U.K.","Summary":""},{"Date":"Mar. 29, 2021 at 7:23 a.m. ET","Headline":"Here Are the Stocks to Buy Now That the Easy Money Has Been Made","Summary":""},{"Date":"Apr. 1, 2021 at 10:00 a.m. ET","Headline":"Fund Vet\u2019s Top Picks: \u2018Dogs,\u2019 Reopen Plays, REITs, and Preferreds","Summary":""},{"Date":"Apr. 11, 2021 at 4:26 p.m. ET","Headline":"Top CEOs signal they won\u2019t back down from defense of voting rights","Summary":""},{"Date":"Apr. 12, 2021 at 8:16 a.m. ET","Headline":"Powell Says Fed Will \u2018Support the Economy.\u2019 What That Means for the Stock Market.","Summary":""},{"Date":"Apr. 15, 2021 at 3:48 p.m. ET","Headline":"Merck scraps two treatments for hospitalized COVID-19 patients, will focus on antiviral for non-hospitalized patients","Summary":"Shares of Merck & Co.  were up 0.1% in premarket trading on Thursday after the drug company said the oral antiviral COVID-19 treatment it is developing with Ridgeback Biotherapeutics did not help hospitalized patients in a..."},{"Date":"Apr. 15, 2021 at 2:57 p.m. ET","Headline":"Global tally of COVID-19 cases tops 138 million as CDC committee opts to extend pause on J&J vaccine","Summary":"A group of hundreds of major U.S. companies and executives have signed a new statement opposing \"any discriminatory legislation\" that would make it harder for people to vote, and published it in on Wednesday. The companies..."},{"Date":"Apr. 14, 2021 at 6:06 p.m. ET","Headline":"Decision Delayed on Whether to Resume Johnson & Johnson Vaccine","Summary":"A group of hundreds of major U.S. companies and executives have signed a new statement opposing \"any discriminatory legislation\" that would make it harder for people to vote, and published it in on Wednesday. The companies..."},{"Date":"Apr. 14, 2021 at 4:00 p.m. ET","Headline":"\u2018We stand for democracy\u2019: Read the statement from top companies and executives opposing voting restrictions","Summary":"A group of hundreds of major U.S. companies and executives have signed a new statement opposing \"any discriminatory legislation\" that would make it harder for people to vote, and published it in on Wednesday. The companies..."},{"Date":"Apr. 14, 2021 at 8:37 a.m. ET","Headline":"Hundreds of companies and executives sign statement opposing voting restrictions in two-page ad in New York Times","Summary":"A group of hundreds of major U.S. companies and executives have signed a new statement opposing \"any discriminatory legislation\" that would make it harder for people to vote, and published it in on Wednesday. The companies..."},{"Date":"Apr. 17, 2021 at 3:42 p.m. ET","Headline":"Here\u2019s what the 30 Dow industrials companies are saying about new voting restrictions","Summary":""},{"Date":"Apr. 17, 2021 at 10:14 a.m. ET","Headline":"Long-tenured CEOs can take a business from good to great \u2014 and these companies have them","Summary":""},{"Date":"Apr. 19, 2021 at 10:03 a.m. ET","Headline":"Biogen Stock Could Rise 85%. Two Drugs Are Critical.","Summary":""},{"Date":"Apr. 21, 2021 at 5:39 p.m. ET","Headline":"Regeneron and 4 More Biopharma Stocks That Look Cheap","Summary":""},{"Date":"Apr. 23, 2021 at 12:09 p.m. ET","Headline":"Dividend Fund Vets Share Some Picks for Post-Covid Gains","Summary":""},{"Date":"Apr. 24, 2021 at 10:43 a.m. ET","Headline":"High-momentum stocks have been losing steam and this could be signaling a market top","Summary":""},{"Date":"Apr. 27, 2021 at 1:34 p.m. ET","Headline":"India\u2019s COVID surge is \u2018beyond heartbreaking,\u2019 says WHO director-general, as first relief supplies arrive","Summary":"Merck  said Tuesday it has entered voluntary licensing agreements with five Indian generic drug makers to expand access to molnupiravir, an investigational oral antiviral agent currently being studied in a Phase 3 trial fo..."},{"Date":"Apr. 27, 2021 at 11:34 a.m. ET","Headline":"Merck and Gilead Sciences Sign Deals to Aid India\u2019s Covid-19 Fight","Summary":"Merck  said Tuesday it has entered voluntary licensing agreements with five Indian generic drug makers to expand access to molnupiravir, an investigational oral antiviral agent currently being studied in a Phase 3 trial fo..."},{"Date":"Apr. 27, 2021 at 7:24 a.m. ET","Headline":"Merck in licensing deals with 5 Indian generic drug makers to expand access to COVID-19 therapy","Summary":"Merck  said Tuesday it has entered voluntary licensing agreements with five Indian generic drug makers to expand access to molnupiravir, an investigational oral antiviral agent currently being studied in a Phase 3 trial fo..."},{"Date":"Apr. 26, 2021 at 8:13 a.m. ET","Headline":"FDA to discuss whether immuno-oncology drugs with 'accelerated' approval should remain on the market","Summary":"The Food and Drug Administration advisory committee plans to hold a three-day  this week to evaluate a type of quicker approval used primarily for immuno-oncology drugs that are thought to help address unmet treatment need..."},{"Date":"Apr. 26, 2021 at 8:12 a.m. ET","Headline":"Sanofi Will Help Make Moderna Vaccine in U.S.","Summary":""},{"Date":"Apr. 29, 2021 at 6:59 p.m. ET","Headline":"What Ails Gilead\u2019s Sales","Summary":"Shares of Merck & Co. Inc.  dropped 3.4% in premarket trading Thursday, after the drug giant reported first-quarter profit and revenue that missed expectations, as the COVID-19 pandemic and loss of market exclusivity weigh..."},{"Date":"Apr. 29, 2021 at 4:19 p.m. ET","Headline":"S&P 500 ends at new record on stellar tech earnings, surge in U.S. economic growth","Summary":"Shares of Merck & Co. Inc.  dropped 3.4% in premarket trading Thursday, after the drug giant reported first-quarter profit and revenue that missed expectations, as the COVID-19 pandemic and loss of market exclusivity weigh..."},{"Date":"Apr. 29, 2021 at 9:04 a.m. ET","Headline":"Bristol Myers Squibb Stock Fell After Earnings. Here\u2019s Why.","Summary":"Shares of Merck & Co. Inc.  dropped 3.4% in premarket trading Thursday, after the drug giant reported first-quarter profit and revenue that missed expectations, as the COVID-19 pandemic and loss of market exclusivity weigh..."},{"Date":"Apr. 29, 2021 at 7:44 a.m. ET","Headline":"Merck Earnings Fell Short of Expectations. Here\u2019s What Caused the Miss.","Summary":"Shares of Merck & Co. Inc.  dropped 3.4% in premarket trading Thursday, after the drug giant reported first-quarter profit and revenue that missed expectations, as the COVID-19 pandemic and loss of market exclusivity weigh..."},{"Date":"Apr. 29, 2021 at 6:48 a.m. ET","Headline":"Merck stock drops after adjusted profit surprisingly falls, revenue comes up short","Summary":"Shares of Merck & Co. Inc.  dropped 3.4% in premarket trading Thursday, after the drug giant reported first-quarter profit and revenue that missed expectations, as the COVID-19 pandemic and loss of market exclusivity weigh..."},{"Date":"May. 3, 2021 at 1:19 p.m. ET","Headline":"Pfizer\u2019s Earnings Are Tuesday. Here\u2019s What to Expect.","Summary":""},{"Date":"May. 3, 2021 at 9:58 a.m. ET","Headline":"Moderna Is Selling Up to 500 Million Covid Vaccine Doses to COVAX. What to Know.","Summary":""},{"Date":"May. 2, 2021 at 11:50 p.m. ET","Headline":"Asian markets pull back in light trading","Summary":""},{"Date":"May. 5, 2021 at 4:44 a.m. ET","Headline":"European stocks rebound as earnings roll in, with U.S. equity futures on the rise","Summary":""},{"Date":"May. 4, 2021 at 10:24 a.m. ET","Headline":"Pfizer\u2019s Vaccine Drove a Big Earnings Beat. What It Means for the Stock.","Summary":""},{"Date":"May. 6, 2021 at 7:34 a.m. ET","Headline":"Regeneron Earnings Lift Stock. Here\u2019s Why.","Summary":"The biotech company reported financial results early Thursday. It was the details that seemed to matter."},{"Date":"May. 5, 2021 at 4:44 p.m. ET","Headline":"Investing in the Covid-19 vaccine companies? Here\u2019s the great divide in the group","Summary":""},{"Date":"May. 17, 2021 at 6:01 p.m. ET","Headline":"What this Cleveland Clinic pediatrician and vaccine expert is telling teens and their parents about getting COVID-19 shots","Summary":""},{"Date":"May. 18, 2021 at 11:00 a.m. ET","Headline":"What Berkshire Hathaway\u2019s Latest Filing Tells Us About Warren Buffett\u2019s View on Stocks","Summary":""},{"Date":"May. 17, 2021 at 5:31 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Cut Its Holdings in Chevron and Wells Fargo. Here\u2019s What It Bought.","Summary":""},{"Date":"May. 21, 2021 at 10:49 a.m. ET","Headline":"Merck Battles Pfizer in Lucrative Pediatric Vaccine Market","Summary":""},{"Date":"May. 20, 2021 at 4:17 p.m. ET","Headline":"Stocks End Higher After Improving Jobless Claims Data","Summary":""},{"Date":"May. 20, 2021 at 10:15 a.m. ET","Headline":"Cancer Biotechs Are on the Move in Advance of Big Conference","Summary":""},{"Date":"May. 20, 2021 at 9:00 a.m. ET","Headline":"Virgin Galactic Soars, Merck Falls, and Stocks Are Down Again","Summary":""},{"Date":"May. 20, 2021 at 7:00 a.m. ET","Headline":"5 Biopharma Stocks That Are Cheap and Growing","Summary":""},{"Date":"May. 24, 2021 at 10:48 a.m. ET","Headline":"Big Drug Stocks Have Rallied. Why an Analyst Says They Have More Room to Run.","Summary":""},{"Date":"May. 24, 2021 at 10:02 a.m. ET","Headline":"Pfizer Starts Another Covid-19 Booster Trial","Summary":""},{"Date":"May. 27, 2021 at 12:56 p.m. ET","Headline":"Activist Fund Elliott Management Could Give GSK Some Space: Report","Summary":""},{"Date":"May. 29, 2021 at 4:21 p.m. ET","Headline":"These cool, high-quality stocks are just right for this overheated, overvalued market","Summary":""},{"Date":"Jun. 4, 2021 at 8:50 p.m. ET","Headline":"Jobs Report Eases Worries Over Higher Interest Rates. Yet Inflation Risks Still Loom.","Summary":""},{"Date":"Jun. 7, 2021 at 6:00 a.m. ET","Headline":"This Former Merck Company Could Have Big Potential","Summary":""},{"Date":"Jun. 9, 2021 at 3:38 p.m. ET","Headline":"New daily COVID-19 cases and deaths rise again as concerns over delta variant and Biden vaccination target for July 4 increase","Summary":"Shares of Merck & Co. Inc.  rose 0.9% in premarket trading Wednesday, after the drug maker announced a supply agreement with the U.S. government for molnupiravir, its investigational oral antiviral candidate to treat mild ..."},{"Date":"Jun. 9, 2021 at 1:28 p.m. ET","Headline":"Merck Could See $1.2 Billion Covid-19 Antiviral Sale to U.S. Government","Summary":"Shares of Merck & Co. Inc.  rose 0.9% in premarket trading Wednesday, after the drug maker announced a supply agreement with the U.S. government for molnupiravir, its investigational oral antiviral candidate to treat mild ..."},{"Date":"Jun. 9, 2021 at 8:36 a.m. ET","Headline":"FDA Approves Pfizer\u2019s New Pneumococcal Vaccine, Setting Up Clash With Merck","Summary":"Shares of Merck & Co. Inc.  rose 0.9% in premarket trading Wednesday, after the drug maker announced a supply agreement with the U.S. government for molnupiravir, its investigational oral antiviral candidate to treat mild ..."},{"Date":"Jun. 9, 2021 at 7:01 a.m. ET","Headline":"Merck enters $1.2 billion agreement to supply U.S. government with potential COVID-19 treatment","Summary":"Shares of Merck & Co. Inc.  rose 0.9% in premarket trading Wednesday, after the drug maker announced a supply agreement with the U.S. government for molnupiravir, its investigational oral antiviral candidate to treat mild ..."},{"Date":"Jun. 12, 2021 at 11:37 a.m. ET","Headline":"15 momentum stocks expected to show the best sales growth over the next two years, including Carvana, Tesla and Palantir","Summary":""},{"Date":"Aug. 31, 2020 at 7:44 a.m. ET","Headline":"It\u2019s Crunch Time for Vaccine News. Brace Yourself.","Summary":""},{"Date":"Jun. 16, 2021 at 11:51 a.m. ET","Headline":"5 Undervalued Healthcare Stocks","Summary":""},{"Date":"Jun. 24, 2021 at 9:42 a.m. ET","Headline":"Arcus stock jumps 19% after announcing it will move forward with trial for lung-cancer treatment","Summary":"Shares of Arcus Biosciences Inc.  gained 19.8% in trading on Thursday, the day after the company said its experimental lung-cancer PD-L1 treatment demonstrated clinical activity in an open-label, Phase 2 clinical study. Ar..."},{"Date":"Jul. 2, 2021 at 12:27 p.m. ET","Headline":"Mizuho: Merck withdrawing Keytruda as a gastric cancer treatment won't impact the stock","Summary":"Shares of Merck & Co. Inc.  were up 0.7% in trading on Friday, the day after the company said it will voluntarily withdraw an accelerated approval for Keytruda as a third-line treatment for some patients with gastric cance..."},{"Date":"Jul. 8, 2021 at 4:15 a.m. ET","Headline":"Vaccine Maker AstraZeneca\u2019s Strong Drug Pipeline Could Lift the Stock Higher for Years","Summary":""},{"Date":"Jul. 9, 2021 at 5:00 a.m. ET","Headline":"Here Are the Cheapest Stocks in Each Sector. Some Deserve the Discount, Others Look Like Bargains.","Summary":""},{"Date":"Jul. 13, 2021 at 3:18 p.m. ET","Headline":"Pharma\u2019s defenders in Congress will blunt drug-price reform, experts say","Summary":""},{"Date":"Jul. 19, 2021 at 8:47 a.m. ET","Headline":"Big Contrarian Investor Sold Apple, Microsoft Stock, Bought Pfizer and Merck","Summary":""},{"Date":"Jul. 22, 2021 at 6:40 p.m. ET","Headline":"Absci Stock Pops 35% in its IPO, While Couchbase Rises 27%","Summary":""},{"Date":"Jul. 26, 2021 at 7:46 a.m. ET","Headline":"The main attractions arrive: Apple, Microsoft, Google, Facebook, Amazon and Tesla headline the biggest week of earnings","Summary":""},{"Date":"Jul. 27, 2021 at 6:00 a.m. ET","Headline":"Why It\u2019s Hard to Go Wrong With Bristol Myers Stock","Summary":""},{"Date":"Jul. 29, 2021 at 11:36 a.m. ET","Headline":"Merck Sales Beat Estimates, But the Stock Is Falling. Here\u2019s 1 Reason to Be Bullish.","Summary":"Shares of Merck & Co. Inc.  fell 0.9% in premarket trading Thursday, after the drug maker reported second-quarter adjusted profit that matched expectations, while sales rose above forecasts even as Keytruda sales came up s..."},{"Date":"Jul. 29, 2021 at 6:49 a.m. ET","Headline":"Merck stock slips after adjusted profit matches expectations, while revenue beats","Summary":"Shares of Merck & Co. Inc.  fell 0.9% in premarket trading Thursday, after the drug maker reported second-quarter adjusted profit that matched expectations, while sales rose above forecasts even as Keytruda sales came up s..."},{"Date":"Aug. 3, 2021 at 1:16 p.m. ET","Headline":"Translate Bio Stock Jumps After Agreeing to Be Bought by Sanofi. Why It\u2019s a Smart Deal.","Summary":""},{"Date":"Aug. 6, 2021 at 8:26 p.m. ET","Headline":"Plastics Are Still in Demand. This Stock Stands to Profit\u2014but Beware the Risks.","Summary":""},{"Date":"Aug. 11, 2021 at 12:05 p.m. ET","Headline":"Moderna shares slide 16% after bearish BofA note, putting them on track for biggest percentage decline since May 2020","Summary":"Moderna Inc. shares  tumbled 16% Wednesday to put them on track for their biggest percentage decline since May of 2020, according to Dow Jones data. The stock has now fallen for four of the past five days and has lost more..."},{"Date":"Aug. 11, 2021 at 8:25 a.m. ET","Headline":"Moderna\u2019s stock price is \u2018ridiculous,\u2019 says BofA analyst","Summary":""},{"Date":"Aug. 12, 2021 at 12:37 p.m. ET","Headline":"Merck Spinoff Organon Is Supercheap\u2014and It Just Set a 3.7% Dividend Yield","Summary":"Shares of Organon & Co.  shot up 7.1% in morning trading Thursday, after the pharmaceutical company and .  reported second-quarter profit and revenue that beat expectations, amid strength in its women's health business, an..."},{"Date":"Aug. 12, 2021 at 10:27 a.m. ET","Headline":"More Companies Are Making Diversity Data Public. But the Majority Aren\u2019t Meeting Requirements.","Summary":"Shares of Organon & Co.  shot up 7.1% in morning trading Thursday, after the pharmaceutical company and .  reported second-quarter profit and revenue that beat expectations, amid strength in its women's health business, an..."},{"Date":"Aug. 12, 2021 at 9:59 a.m. ET","Headline":"Organon stock jumps after earnings beat, initiating dividend with yield well above its peer group","Summary":"Shares of Organon & Co.  shot up 7.1% in morning trading Thursday, after the pharmaceutical company and .  reported second-quarter profit and revenue that beat expectations, amid strength in its women's health business, an..."},{"Date":"Aug. 15, 2021 at 6:24 p.m. ET","Headline":"A Peek Into Warren Buffett\u2019s Second-Quarter Stock Moves","Summary":""},{"Date":"Aug. 14, 2021 at 9:38 a.m. ET","Headline":"If you\u2019re nervous about the stock market at record highs, consider these five companies that are loved by the smart money","Summary":""},{"Date":"Aug. 17, 2021 at 2:04 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Sold Its Entire Axalta Stake","Summary":""},{"Date":"Aug. 17, 2021 at 1:37 p.m. ET","Headline":"What Will It Take to Get Warren Buffett to Buy Stocks?","Summary":""},{"Date":"Aug. 16, 2021 at 7:19 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Cuts Stakes in 3 Drugmakers and GM, Adds to Kroger","Summary":""},{"Date":"Aug. 16, 2021 at 7:14 p.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway buys Kroger, cuts stakes in drug makers","Summary":""},{"Date":"Aug. 16, 2021 at 6:31 a.m. ET","Headline":"China\u2019s Economy Is Slowing Down. The Recovery Could Be Losing Steam.","Summary":""},{"Date":"Aug. 19, 2021 at 4:26 p.m. ET","Headline":"27% of Dow Companies Have Mandated Vaccines","Summary":""},{"Date":"Aug. 21, 2021 at 1:02 p.m. ET","Headline":"Buffett\u2019s Berkshire Still Isn\u2019t Buying. Here\u2019s What It Sold.","Summary":""},{"Date":"Aug. 20, 2021 at 8:19 a.m. ET","Headline":"J&J\u2019s CEO Plans to Step Down. Analysts Expect a Smooth Transition.","Summary":""},{"Date":"Aug. 24, 2021 at 10:59 a.m. ET","Headline":"The S&P 500 Has Been Soaring. These 10 Stocks Are Still Cheap.","Summary":""},{"Date":"Aug. 30, 2021 at 12:10 p.m. ET","Headline":"If you\u2019ve got the stock market jitters, here are 20 companies in two defensive sectors","Summary":""},{"Date":"Sep. 2, 2021 at 1:02 p.m. ET","Headline":"Here\u2019s How to Marry ESG and Dividends. And 5 Picks for a Start.","Summary":"Shares of Merck & Co. Inc.  and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gaine..."},{"Date":"Sep. 2, 2021 at 6:48 a.m. ET","Headline":"Heading Into Jobs Report, It\u2019s Back to a Bad News Is Good News Market","Summary":"Shares of Merck & Co. Inc.  and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gaine..."},{"Date":"Sep. 1, 2021 at 10:27 a.m. ET","Headline":"Merck and Pfizer Are Testing Antiviral Pills. The Covid Battle Is Moving Beyond Vaccines.","Summary":"Shares of Merck & Co. Inc.  and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gaine..."},{"Date":"Sep. 1, 2021 at 6:58 a.m. ET","Headline":"Merck, Ridgeback start Phase 3 trial of oral drug to prevent COVID-19","Summary":"Shares of Merck & Co. Inc.  and Ridgeback Biotherapeutics said Wednesday that they have started a Phase 3 trial of molnupiravir, and oral antiviral therapeutics for the prevention of COVID-19 infection. Merck's stock gaine..."},{"Date":"Sep. 4, 2021 at 9:34 a.m. ET","Headline":"14 dividend stocks from a winning value manager as the broader market hits record highs","Summary":""},{"Date":"Sep. 8, 2021 at 7:19 a.m. ET","Headline":"Moderna stock extends rally after price target gets a 77% boost at Morgan Stanley","Summary":""},{"Date":"Sep. 7, 2021 at 2:05 p.m. ET","Headline":"Nasdaq Closes at a Record High. Bonds Had a Good Day, Too.","Summary":""},{"Date":"Sep. 9, 2021 at 10:55 a.m. ET","Headline":"Why Atea Could Be the Frontrunner in the Covid Antiviral Race","Summary":""},{"Date":"Sep. 9, 2021 at 9:55 a.m. ET","Headline":"White House to Announce Drug-Pricing Plan. Pharma Stocks Are Down.","Summary":""},{"Date":"Sep. 11, 2021 at 10:05 a.m. ET","Headline":"Debt limit, social spending, infrastructure battles loom in \u2018uniquely frenetic period\u2019 for Congress","Summary":""},{"Date":"Sep. 14, 2021 at 8:38 a.m. ET","Headline":"Merck CEO: Authorization of its experimental antiviral COVID-19 treatment could come by year end","Summary":"Merck & Co. Inc.  said it expects the company's experimental oral antiviral treatment for COVID-19 could get emergency authorization by the end of the year. \"We expect to be able to see clinical data here in the back half ..."},{"Date":"Sep. 20, 2021 at 4:45 p.m. ET","Headline":"Here are the worst-performing U.S. stocks as the Evergrande crisis rattles investors","Summary":""},{"Date":"Sep. 20, 2021 at 7:51 a.m. ET","Headline":"Pills to Battle Covid Are Coming. These Companies Stand to Gain.","Summary":""},{"Date":"Sep. 20, 2021 at 6:39 a.m. ET","Headline":"It\u2019s Crunchtime for Evergrande. The Market Is Worried.","Summary":""},{"Date":"Sep. 24, 2021 at 4:51 p.m. ET","Headline":"The Dow Held Steady, Bitcoin Fell\u2014and What Else Happened in the Stock Market Today","Summary":""},{"Date":"Sep. 23, 2021 at 2:22 p.m. ET","Headline":"Another Hedge Fund Joins in Criticism of GlaxoSmithKline CEO. What Investors Need to Know.","Summary":""},{"Date":"Sep. 28, 2021 at 5:27 p.m. ET","Headline":"Stocks Slid as Bond Yields Surged. The Market Finally Had Its Taper Tantrum.","Summary":""},{"Date":"Sep. 28, 2021 at 8:25 a.m. ET","Headline":"Merck Reportedly Close to Buying Acceleron Pharma","Summary":""},{"Date":"Sep. 28, 2021 at 6:46 a.m. ET","Headline":"Is energy sector now so cheap that investors will put their green preferences on a back burner?","Summary":""},{"Date":"Sep. 28, 2021 at 6:36 a.m. ET","Headline":"The Value Rotation Is Back. But for How Long?","Summary":""},{"Date":"Sep. 28, 2021 at 3:20 a.m. ET","Headline":"Merck nears deal for rare-disease-drug maker Acceleron","Summary":""},{"Date":"Sep. 27, 2021 at 9:03 a.m. ET","Headline":"Pfizer CEO Says Vaccine Data in Children Due Soon, Starts Trial of Pill to Protect Against Covid-19","Summary":""},{"Date":"Sep. 27, 2021 at 7:53 a.m. ET","Headline":"Medicine\u2019s Golden Age Is Dawning. 10 Stocks to Play the Latest Innovations.","Summary":""},{"Date":"Sep. 30, 2021 at 7:10 p.m. ET","Headline":"Merck CEO Sees \u2018Multibillion-Dollar\u2019 Opportunity With Acceleron","Summary":"Merck & Co.  said Thursday it has agreed to acquire Acceleron Pharma Inc.  in a deal with an equity value of $11.5 billion that was first reported earlier this week Merck will pay $180 in cash for each Acceleron share owne..."},{"Date":"Sep. 30, 2021 at 9:57 a.m. ET","Headline":"There\u2019s a Fight Over Pneumococcal Vaccines. Pfizer May Be Winning.","Summary":"Merck & Co.  said Thursday it has agreed to acquire Acceleron Pharma Inc.  in a deal with an equity value of $11.5 billion that was first reported earlier this week Merck will pay $180 in cash for each Acceleron share owne..."},{"Date":"Sep. 30, 2021 at 8:04 a.m. ET","Headline":"Merck and Acceleron Pharma Agree to $11.5 Billion Deal. The Shares Are Up.","Summary":"Merck & Co.  said Thursday it has agreed to acquire Acceleron Pharma Inc.  in a deal with an equity value of $11.5 billion that was first reported earlier this week Merck will pay $180 in cash for each Acceleron share owne..."},{"Date":"Sep. 30, 2021 at 7:30 a.m. ET","Headline":"Merck confirms to acquire Acceleron in a deal valued at $11.5 billion","Summary":"Merck & Co.  said Thursday it has agreed to acquire Acceleron Pharma Inc.  in a deal with an equity value of $11.5 billion that was first reported earlier this week Merck will pay $180 in cash for each Acceleron share owne..."},{"Date":"Sep. 30, 2021 at 7:07 a.m. ET","Headline":"Facebook, Alphabet and Twitter are among the worst internet stocks for investors right now. These are the best, says Citi.","Summary":""},{"Date":"Sep. 29, 2021 at 8:33 a.m. ET","Headline":"Merck Says Its Covid-19  Antiviral Pill Looks Good Against Variants","Summary":""},{"Date":"Sep. 29, 2021 at 6:09 a.m. ET","Headline":"Only 47 stocks in the S&P 500 have fallen over the past year \u2014 Wall Street predicts they will climb up to 54% in 12 months","Summary":""},{"Date":"Sep. 28, 2021 at 4:49 p.m. ET","Headline":"S&P 500 books worst daily slump in about 4 months as bond yields climb","Summary":""},{"Date":"Oct. 2, 2021 at 2:57 p.m. ET","Headline":"\u2018This is a profound game changer\u2019: Merck\u2019s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show","Summary":"The global tally for the coronavirus-borne illness climbed above 234 million on Saturday, while the death toll rose above 4.79 million, according to . The U.S. continues to lead the world with a total of 43.6 million cases..."},{"Date":"Oct. 2, 2021 at 9:36 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 234 million and U.S. death toll passes 700,000","Summary":"The global tally for the coronavirus-borne illness climbed above 234 million on Saturday, while the death toll rose above 4.79 million, according to . The U.S. continues to lead the world with a total of 43.6 million cases..."},{"Date":"Oct. 1, 2021 at 5:07 p.m. ET","Headline":"U.S. stocks finish sharply higher Friday, but S&P 500 still books biggest weekly drop since February","Summary":"U.S. stock indexes closed solidly higher Friday, with some of the upbeat mood on Wall Street to start October and the fourth quarter being attributed to an experimental COVID-19 pill from Merck & Co.  that has shown in tri..."},{"Date":"Oct. 1, 2021 at 4:26 p.m. ET","Headline":"The Dow Climbed, Merck Rose on Covid Pill\u2014and What Else Happened in the Stock Market Today","Summary":"U.S. stock indexes closed solidly higher Friday, with some of the upbeat mood on Wall Street to start October and the fourth quarter being attributed to an experimental COVID-19 pill from Merck & Co.  that has shown in tri..."},{"Date":"Oct. 1, 2021 at 4:09 p.m. ET","Headline":"Dow surges nearly 500 points as Merck's experimental COVID drug delivers dose of optimism but stocks register weekly losses","Summary":"U.S. stock indexes closed solidly higher Friday, with some of the upbeat mood on Wall Street to start October and the fourth quarter being attributed to an experimental COVID-19 pill from Merck & Co.  that has shown in tri..."},{"Date":"Oct. 1, 2021 at 12:40 p.m. ET","Headline":"Merck Covid Pill Cuts Covid Hospitalization in Half. Its Stock Is Surging.","Summary":"The global tally for the coronavirus-borne illness climbed above 233.7 million on Friday, while the death toll rose above 4.78 million, according to . The U.S. continues to lead the world with a total of 43.4 million cases..."},{"Date":"Oct. 1, 2021 at 10:08 a.m. ET","Headline":"BioNTech Starts New Cancer Vaccine Trial","Summary":"The global tally for the coronavirus-borne illness climbed above 233.7 million on Friday, while the death toll rose above 4.78 million, according to . The U.S. continues to lead the world with a total of 43.4 million cases..."},{"Date":"Oct. 1, 2021 at 8:39 a.m. ET","Headline":"Here are five places to invest for income that Wall Street is overlooking, says Fidelity manager","Summary":"The global tally for the coronavirus-borne illness climbed above 233.7 million on Friday, while the death toll rose above 4.78 million, according to . The U.S. continues to lead the world with a total of 43.4 million cases..."},{"Date":"Oct. 1, 2021 at 6:49 a.m. ET","Headline":"History Says Expect a Strong Fourth Quarter. History Can Be Wrong.","Summary":"The global tally for the coronavirus-borne illness climbed above 233.7 million on Friday, while the death toll rose above 4.78 million, according to . The U.S. continues to lead the world with a total of 43.4 million cases..."},{"Date":"Oct. 1, 2021 at 6:34 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 223.7 million and Merck says antiviral is effective as treatment","Summary":"The global tally for the coronavirus-borne illness climbed above 233.7 million on Friday, while the death toll rose above 4.78 million, according to . The U.S. continues to lead the world with a total of 43.4 million cases..."},{"Date":"Oct. 1, 2021 at 6:16 a.m. ET","Headline":"Merck shares jump 3.5% premarket after it reveals positive data in trial of COVID-19 antiviral","Summary":"Merck shares  jumped 3.5% in premarket trade Friday, after the company said the oral antiviral it developed as a treatment for COVID-19 with partner Ridgeback Biotherapeutics reduced the risk of hospitalization or death in..."},{"Date":"Oct. 4, 2021 at 8:13 p.m. ET","Headline":"Tech Stocks Are Tumbling, U.S. Political Pressures Weigh\u2014and What Else Is Happening in the Stock Market Today","Summary":"Shares of Redhill Biopharma Ltd.  gained 7.0% in premarket trading on Monday after the company said it had new data from a Phase 2\/3 clinical study evaluating its experimental oral antiviral opaganib in severely ill, hospi..."},{"Date":"Oct. 4, 2021 at 5:49 p.m. ET","Headline":"The Dow Got Clobbered Today, but These Stocks Didn\u2019t","Summary":"Shares of Redhill Biopharma Ltd.  gained 7.0% in premarket trading on Monday after the company said it had new data from a Phase 2\/3 clinical study evaluating its experimental oral antiviral opaganib in severely ill, hospi..."},{"Date":"Oct. 4, 2021 at 8:48 a.m. ET","Headline":"RedHill's stock is up 7.0% as it shares new data about experimental COVID-19 drug","Summary":"Shares of Redhill Biopharma Ltd.  gained 7.0% in premarket trading on Monday after the company said it had new data from a Phase 2\/3 clinical study evaluating its experimental oral antiviral opaganib in severely ill, hospi..."},{"Date":"Oct. 4, 2021 at 12:43 a.m. ET","Headline":"Evergrande share trading suspended as Asian markets start the week mixed","Summary":""},{"Date":"Oct. 3, 2021 at 4:47 p.m. ET","Headline":"Moderna Stock Tumbled Because Good News on a Covid Pill Is Bad News for Vaccines","Summary":""},{"Date":"Oct. 6, 2021 at 11:42 a.m. ET","Headline":"Vaccine Stocks Slip Fourth Day in a Row. Here\u2019s Why.","Summary":""},{"Date":"Oct. 6, 2021 at 8:18 a.m. ET","Headline":"Stocks will be volatile until they can prove their inflation resilience, these strategists say","Summary":""},{"Date":"Oct. 6, 2021 at 6:35 a.m. ET","Headline":"The Energy Price Surge Is Spiraling Into Other Markets","Summary":""},{"Date":"Oct. 5, 2021 at 6:59 a.m. ET","Headline":"U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000","Summary":""},{"Date":"Oct. 5, 2021 at 6:42 a.m. ET","Headline":"Tech Stocks Are Vulnerable as Fed Policy Shift Gets Priced In","Summary":""},{"Date":"Oct. 5, 2021 at 6:30 a.m. ET","Headline":"AstraZeneca Submits Covid Antibody Drug for Emergency Authorization","Summary":""},{"Date":"Oct. 8, 2021 at 6:47 a.m. ET","Headline":"Merck\u2019s Covid Pill Could Pose Serious Risks, Scientists Warn","Summary":""},{"Date":"Oct. 7, 2021 at 10:01 a.m. ET","Headline":"Pfizer and BioNTech Asked FDA to Authorize Vaccine for Children","Summary":""},{"Date":"Oct. 12, 2021 at 8:00 a.m. ET","Headline":"Merck Plans to Double Production of Covid Antiviral Pill Amid Demand: Report","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 12, 2021 at 6:35 a.m. ET","Headline":"Musk Taunts Bezos Over World\u2019s Richest Crown. But Who Will Make You Richer?","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 12, 2021 at 6:14 a.m. ET","Headline":"Merck seeks authorization for what would be first pill to treat COVID-19, and AstraZeneca reports positive results for antibody treatment","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 4:38 p.m. ET","Headline":"Dow finishes 250 points lower as stock market gains fizzle ahead of bank earnings kickoff","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 4:15 p.m. ET","Headline":"Dow Falls, Oil Prices Rally\u2014and What Else Is Happening in the Stock Market Today","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 9:59 a.m. ET","Headline":"\u2018It\u2019s not a magic pill\u2019: What Merck\u2019s antiviral pill could mean for vaccine hesitancy","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 8:27 a.m. ET","Headline":"Merck Submits Covid Pill to FDA for Emergency Approval","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 7:18 a.m. ET","Headline":"Why the new SEC sheriff could be trouble for companies like Tesla","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 6:29 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 238 million as Merck sees FDA approval for antiviral","Summary":"The global tally for the coronavirus-borne illness climbed above 237.9 million on Monday, while the death toll rose above 4.85 million, according to . The U.S. continues to lead the world with a total of 44.3 million cases..."},{"Date":"Oct. 11, 2021 at 6:23 a.m. ET","Headline":"Merck asks U.S. FDA to authorize promising anti-COVID pill","Summary":"Merck & Co. Inc.  and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) with the Food and Drug Administration for molnupiravir, their oral antiviral medicin..."},{"Date":"Oct. 11, 2021 at 6:12 a.m. ET","Headline":"Merck, Ridgeback submit EUA application for their pill to treat COVID-19","Summary":"Merck & Co. Inc.  and Ridgeback Biotherapeutics said Monday that Merck has submitted an application for Emergency Use Authorization (EUA) with the Food and Drug Administration for molnupiravir, their oral antiviral medicin..."},{"Date":"Oct. 4, 2021 at 2:58 a.m. ET","Headline":"BioNTech CEO reportedly says a different COVID vaccine may be needed by next year","Summary":""},{"Date":"Oct. 14, 2021 at 10:39 a.m. ET","Headline":"FDA Will Consider Regeneron\u2019s Covid-19 Antibody for Full Approval","Summary":""},{"Date":"Oct. 13, 2021 at 9:11 a.m. ET","Headline":"Merck\u2019s Covid-19 Antiviral Can Still Get FDA Authorization, Despite Safety Concerns, Analyst Says","Summary":""},{"Date":"Oct. 13, 2021 at 8:33 a.m. ET","Headline":"This development may fully reopen the global economy \u2014 and the stock market has mostly ignored it","Summary":""},{"Date":"Oct. 13, 2021 at 6:32 a.m. ET","Headline":"An FDA Advisory Panel Will Debate Moderna and J&J Boosters This Week","Summary":""},{"Date":"Oct. 15, 2021 at 11:04 a.m. ET","Headline":"Don\u2019t Count Out Covid-19 Monoclonal Antibody Treatments, Analyst Says. These Are the Stocks to Watch.","Summary":"Shares of Merck & Co. Inc.  were down 0.1% in premarket trading on Friday, the day after the Food and Drug Administration said it plans to convene an advisory committee on Nov. 30 to discuss the company's experimental COVI..."},{"Date":"Oct. 15, 2021 at 7:45 a.m. ET","Headline":"Why a pill you take at home could change the direction of the pandemic","Summary":"Shares of Merck & Co. Inc.  were down 0.1% in premarket trading on Friday, the day after the Food and Drug Administration said it plans to convene an advisory committee on Nov. 30 to discuss the company's experimental COVI..."},{"Date":"Oct. 15, 2021 at 7:42 a.m. ET","Headline":"FDA to hold advisory committee for Merck's experimental COVID-19 pill","Summary":"Shares of Merck & Co. Inc.  were down 0.1% in premarket trading on Friday, the day after the Food and Drug Administration said it plans to convene an advisory committee on Nov. 30 to discuss the company's experimental COVI..."},{"Date":"Oct. 18, 2021 at 12:19 a.m. ET","Headline":"\u2018I\u2019m getting compassion fatigue\u2019: My parents said they\u2019d rather quit their jobs and lose everything than get the COVID-19 vaccine","Summary":""},{"Date":"Oct. 19, 2021 at 4:57 p.m. ET","Headline":"Atea Pharma Stumbles in Race for a Covid Pill. The Stock Is Down 64%.","Summary":""},{"Date":"Oct. 19, 2021 at 1:27 p.m. ET","Headline":"Stocks Closed Up Today. The Upside of Corporate Profits.","Summary":""},{"Date":"Oct. 19, 2021 at 7:25 a.m. ET","Headline":"The success of Merck\u2019s antiviral \u2014 and other COVID-19 pills in development \u2014 may depend on how quickly people start taking them","Summary":""},{"Date":"Oct. 21, 2021 at 11:39 a.m. ET","Headline":"Merck Scores Unexpectedly in Pneumococcal Vaccine Fight With Pfizer. What It Means for the Stocks.","Summary":""},{"Date":"Oct. 26, 2021 at 8:26 a.m. ET","Headline":"Fauci says U.S. is on track to start vaccinating kids aged 5 to 11 by November, as FDA advisers prepare to meet on the matter","Summary":"Merck  and partner Ridgeback Biotherapeutics said Monday the European Medicines Agency has started a rolling review of molnupiravir, its oral antiviral treatment for COVID-19 in adults.  \"Merck plans to work with the EMA's..."},{"Date":"Oct. 25, 2021 at 9:42 a.m. ET","Headline":"Holiday earnings forecasts have been lumps of coal so far, and here come the biggest ones","Summary":"Merck  and partner Ridgeback Biotherapeutics said Monday the European Medicines Agency has started a rolling review of molnupiravir, its oral antiviral treatment for COVID-19 in adults.  \"Merck plans to work with the EMA's..."},{"Date":"Oct. 25, 2021 at 6:15 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics announce start of rolling review of COVID antiviral in Europe","Summary":"Merck  and partner Ridgeback Biotherapeutics said Monday the European Medicines Agency has started a rolling review of molnupiravir, its oral antiviral treatment for COVID-19 in adults.  \"Merck plans to work with the EMA's..."},{"Date":"Oct. 28, 2021 at 4:24 p.m. ET","Headline":"S&P 500, Nasdaq hit new records on strong earnings and progress on budget deal, despite disappointing economic growth","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker and animal health company reported third-quarter profit and revenue that rose above expectations and provided and upbeat full-year o..."},{"Date":"Oct. 28, 2021 at 8:28 a.m. ET","Headline":"Merck Stock Is Gaining. Earnings Came in Strong.","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker and animal health company reported third-quarter profit and revenue that rose above expectations and provided and upbeat full-year o..."},{"Date":"Oct. 28, 2021 at 7:07 a.m. ET","Headline":"Fund managers are tossing out their losers. Here are the bargains investors might not want to miss.","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker and animal health company reported third-quarter profit and revenue that rose above expectations and provided and upbeat full-year o..."},{"Date":"Oct. 28, 2021 at 6:43 a.m. ET","Headline":"Merck stock gains after profit and revenue rise above expectations, and upbeat full-year outlook","Summary":"Shares of Merck & Co. Inc.  rose 1.0% in premarket trading Thursday, after the drug maker and animal health company reported third-quarter profit and revenue that rose above expectations and provided and upbeat full-year o..."},{"Date":"Oct. 28, 2021 at 6:30 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 245 million and study finds cheap antidepressant has promise as treatment","Summary":"The global tally for the coronavirus-borne illness climbed above 245 million on Thursday, while the death toll edged above 4.97 million, according to . The U.S. continues to lead the world with a total of 45.7 million case..."},{"Date":"Oct. 27, 2021 at 6:51 p.m. ET","Headline":"Cheap, generic antidepressant shows promise in treating early COVID-19","Summary":""},{"Date":"Oct. 30, 2021 at 2:25 p.m. ET","Headline":"Merck to Refile Notification of Acceleron Merger Deal, Extending Deadline for Shareholders","Summary":"Shares of Apple Inc.  sank 3.7% early Friday, to pace the Dow Jones Industrial Average's  premarket decliners by a wide margin, in the wake of the technology behemoth's . The stock's implied price decline would shave about..."},{"Date":"Oct. 29, 2021 at 3:04 p.m. ET","Headline":"CDC says people with mental-health issues should get COVID-19 vaccine boosters, as U.S. vaccination rate remains stubbornly static","Summary":"Shares of Apple Inc.  sank 3.7% early Friday, to pace the Dow Jones Industrial Average's  premarket decliners by a wide margin, in the wake of the technology behemoth's . The stock's implied price decline would shave about..."},{"Date":"Oct. 29, 2021 at 1:19 p.m. ET","Headline":"Merck\u2019s Covid Antiviral Isn\u2019t Just a Quick Win. It Could Lift Revenue for Years.","Summary":"Shares of Apple Inc.  sank 3.7% early Friday, to pace the Dow Jones Industrial Average's  premarket decliners by a wide margin, in the wake of the technology behemoth's . The stock's implied price decline would shave about..."},{"Date":"Oct. 29, 2021 at 6:42 a.m. ET","Headline":"Apple's stock drop after earnings can be blamed for more than half of Dow futures' decline","Summary":"Shares of Apple Inc.  sank 3.7% early Friday, to pace the Dow Jones Industrial Average's  premarket decliners by a wide margin, in the wake of the technology behemoth's . The stock's implied price decline would shave about..."},{"Date":"Oct. 29, 2021 at 6:22 a.m. ET","Headline":"WHO is now closely tracking a delta subvariant found in 42 countries to see if it\u2019s more transmissible","Summary":""},{"Date":"Oct. 31, 2021 at 9:02 a.m. ET","Headline":"Merck\u2019s COVID-19 pill could bring in up to $7 billion in sales next year","Summary":""},{"Date":"Nov. 2, 2021 at 6:22 p.m. ET","Headline":"Democrats Reach Deal on Drug Prices, Schumer Says. Pharma Stocks Are Steady.","Summary":""},{"Date":"Nov. 2, 2021 at 4:16 p.m. ET","Headline":"Pfizer CEO Says Poor Countries Need to Order Covid Vaccines Earlier","Summary":""},{"Date":"Nov. 5, 2021 at 4:37 p.m. ET","Headline":"Dow, S&P 500, Nasdaq end at record highs, extending streak of weekly gains on Pfizer pill study, stronger-than-expected jobs report","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 4:27 p.m. ET","Headline":"Stocks Rallied to Records After Strong Jobs Report, Peloton Tumbled\u2014and What Else Happened in the Stock Market Today","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 1:16 p.m. ET","Headline":"Pfizer\u2019s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 11:58 a.m. ET","Headline":"Merck stock's biggest selloff in nearly 17 years is cutting close to 60 points off the Dow's price","Summary":"Shares of Merck & Co.  tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc.  released data on  that showed greater efficacy than Merck's. The..."},{"Date":"Nov. 5, 2021 at 9:19 a.m. ET","Headline":"Pfizer Stock Is Soaring Because Its Covid Antiviral Appears to Work Really, Really Well","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 8:40 a.m. ET","Headline":"Here\u2019s the factor that mattered most to driving stocks \u2014 and it sure wasn\u2019t interest rates","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 7:49 a.m. ET","Headline":"WHO warns Europe could see 500,000 more COVID-19 deaths by February amid uneven vaccine take-up, and U.S. starts to give kids as young as 5 their shots","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 7:28 a.m. ET","Headline":"Merck shares slide premarket as Pfizer soars on data from trial of rival COVID-19 antiviral treatment","Summary":"Merck & Co. Inc. shares  slid 10% in premarket trading Friday after Pfizer Inc.  said its oral antiviral treatment candidate for COVID-19 reduced the risk of hospitalization or death by 89% in non-hospitalized high-risk ad..."},{"Date":"Nov. 5, 2021 at 6:32 a.m. ET","Headline":"Peloton, Uber, and Airbnb Earnings All Tell Investors the Same Thing","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved molnupiravir, which is now going by the name Lagevrio. The U.K. health secretary, Sajid Javid, said it's the first country to approve an antiv..."},{"Date":"Nov. 4, 2021 at 9:19 a.m. ET","Headline":"Merck Covid Pill Gets First Authorization From U.K. Regulators. The Stock Rises.","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved molnupiravir, which is now going by the name Lagevrio. The U.K. health secretary, Sajid Javid, said it's the first country to approve an antiv..."},{"Date":"Nov. 4, 2021 at 7:15 a.m. ET","Headline":"U.K. regulator approves Merck's antiviral for home use","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved molnupiravir, which is now going by the name Lagevrio. The U.K. health secretary, Sajid Javid, said it's the first country to approve an antiv..."},{"Date":"Nov. 4, 2021 at 7:12 a.m. ET","Headline":"Three generations haven\u2019t traded through an inflationary cycle. Here are the stocks for it, one seasoned fund manager says.","Summary":""},{"Date":"Nov. 7, 2021 at 2:00 p.m. ET","Headline":"Good Jobs Report Points to Continued Good Times for Stocks","Summary":""},{"Date":"Nov. 6, 2021 at 2:35 p.m. ET","Headline":"How Long Will the Stock Market Rally? At Least Until New Year\u2019s.","Summary":""},{"Date":"Nov. 9, 2021 at 9:00 a.m. ET","Headline":"Pfizer to seek authorization of COVID-19 pill \u2018as soon as possible\u2019","Summary":"Shares of Merck & Co. Inc.  rallied 1.9% in premarket trading Tuesday, after the drug maker and partner Ridgeback Biotherapeutics said the U.S. government will exercise options to buy 1.4 million additional courses of the ..."},{"Date":"Nov. 9, 2021 at 6:14 a.m. ET","Headline":"Merck stock rallies after U.S. plans to buy 1.4 million more COVID-19 pill courses for $1 billion if authorized","Summary":"Shares of Merck & Co. Inc.  rallied 1.9% in premarket trading Tuesday, after the drug maker and partner Ridgeback Biotherapeutics said the U.S. government will exercise options to buy 1.4 million additional courses of the ..."},{"Date":"Nov. 11, 2021 at 11:42 a.m. ET","Headline":"Organon's stock slides after announcing deal with Forendo Pharma","Summary":"Shares of Organon & Co.  were down 6.7% in trading on Thursday after the company said it plans to acquire Forendo Pharma, a privately held company developing an endometriosis therapy. As part of the agreement, Organon will..."},{"Date":"Nov. 11, 2021 at 6:28 a.m. ET","Headline":"Tesla and AMC Insiders Are Selling. And They\u2019re Not the Only Ones.","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Wednesday the Japanese government has agreed to purchase $1.6 million courses of their COVID-19 antiviral molnupiravir, once it receives an authorization or approval..."},{"Date":"Nov. 10, 2021 at 8:11 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics say Japan to purchase 1.6 million courses of their COVID antiviral if it's authorized","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Wednesday the Japanese government has agreed to purchase $1.6 million courses of their COVID-19 antiviral molnupiravir, once it receives an authorization or approval..."},{"Date":"Nov. 10, 2021 at 7:20 a.m. ET","Headline":"Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day","Summary":""},{"Date":"Nov. 13, 2021 at 7:00 a.m. ET","Headline":"Shell\u2019s Pension Dropped Alibaba, Sold Pfizer, J&J, and Merck Stock","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 3:13 p.m. ET","Headline":"Some Acceleron Investors Want a Better Deal From Merck","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 7:50 a.m. ET","Headline":"Johnson & Johnson to spin off consumer health unit from medical device and drug-making division","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 12, 2021 at 6:32 a.m. ET","Headline":"J&J plans to split into two public companies and separate consumer and drug businesses","Summary":"Johnson & Johnson shares  jumped 3.6% in premarket trade Friday, after  that the company plans to split into two companies, splitting off the consumer group from the prescription drugs and medical devices business. The com..."},{"Date":"Nov. 15, 2021 at 7:44 p.m. ET","Headline":"Warren Buffett\u2019s firm trims stakes in drug makers, finance companies","Summary":""},{"Date":"Nov. 15, 2021 at 12:05 p.m. ET","Headline":"Covid Cases Are Rising Again. Booster Rollout Could Expand as a Result.","Summary":""},{"Date":"Nov. 14, 2021 at 10:03 p.m. ET","Headline":"Pfizer\u2019s Big Gamble Is Paying Off. Its Stock Is a Good Long-Term Bet.","Summary":""},{"Date":"Nov. 14, 2021 at 9:36 p.m. ET","Headline":"Will Johnson & Johnson\u2019s Split Pay Off? History Says No.","Summary":""},{"Date":"Nov. 17, 2021 at 9:30 a.m. ET","Headline":"Glaxo and Vir Report $1 Billion Sale of Covid-19 Antibody. The U.S. Is Still Buying.","Summary":"Merck  and partner privately held Ridgeback Biotherapeutics will present data from a Phase 3 trial of their COVID-19 antiviral molnupiravir at the  American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meet..."},{"Date":"Nov. 17, 2021 at 6:13 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics to present Phase 3 data from COVID antiviral at ASTMH meeting at 9. a.m.","Summary":"Merck  and partner privately held Ridgeback Biotherapeutics will present data from a Phase 3 trial of their COVID-19 antiviral molnupiravir at the  American Society of Tropical Medicine and Hygiene (ASTMH) 2021 Annual Meet..."},{"Date":"Nov. 16, 2021 at 9:18 a.m. ET","Headline":"Pfizer Signs Royalty-Free Deal to Aid Poor Nations\u2019 Access to Its Covid Pill","Summary":""},{"Date":"Nov. 16, 2021 at 9:05 a.m. ET","Headline":"Warren Buffett\u2019s Berkshire Hathaway Sells Merck Shares, Buys Royalty Pharma Stake","Summary":""},{"Date":"Nov. 16, 2021 at 6:42 a.m. ET","Headline":"Biden\u2019s Inflation Solution May Be Staring Him in the Face\u2014China","Summary":""},{"Date":"Nov. 18, 2021 at 1:09 p.m. ET","Headline":"Boeing Stock Upgraded\u2014Again. Analysts See a Turnaround Coming.","Summary":""},{"Date":"Nov. 18, 2021 at 10:11 a.m. ET","Headline":"Pfizer to Be Paid $5.29 Billion From U.S. Government for Covid-19 Oral Pill","Summary":""},{"Date":"Nov. 17, 2021 at 6:30 a.m. ET","Headline":"Nvidia Earnings Are a Big Deal. But There\u2019s Something More Important.","Summary":""},{"Date":"Nov. 20, 2021 at 1:23 p.m. ET","Headline":"Pills to treat COVID-19 will be game-changers, but the best strategy remains prevention","Summary":""},{"Date":"Nov. 23, 2021 at 9:13 a.m. ET","Headline":"Covid-19 Vaccine and Pills Will Push Pfizer\u2019s Revenue Above $100B Next Year, Analyst Says","Summary":""},{"Date":"Nov. 22, 2021 at 11:04 a.m. ET","Headline":"How Scale Went Out of Fashion in Corporate America","Summary":""},{"Date":"Nov. 22, 2021 at 9:29 a.m. ET","Headline":"Merck Closes Biggest Biotech Deal of the Year","Summary":""},{"Date":"Nov. 23, 2021 at 8:16 a.m. ET","Headline":"The Dogs of the Dow Are Ending 2021 With a Whimper. Why Next Year Could Be Better.","Summary":""},{"Date":"Nov. 26, 2021 at 8:15 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics says COVID antiviral reduced risk of hospitalization or death in at-risk adults","Summary":"Merck  and partner Ridgeback Biotherapeutics said their COVID-19 antiviral molnupiravir reduced the risk of hospitalization or death in at-risk adults with mild-to-moderate COVID to 6.8% from 9.7% in the placebo group in t..."},{"Date":"Nov. 29, 2021 at 3:08 p.m. ET","Headline":"Merck stock dives after Citi downgrades on \u2018high probability\u2019 that HIV treatment will be abandoned","Summary":""},{"Date":"Nov. 29, 2021 at 6:40 a.m. ET","Headline":"WHO warns world leaders against knee-jerk reaction to coronavirus variant from South Africa as U.K. and EU impose travel bans","Summary":""},{"Date":"Nov. 28, 2021 at 3:53 p.m. ET","Headline":"Vaccine Makers, Countries Rush to Fight Off New Covid Strain. The Latest News on Omicron.","Summary":""},{"Date":"Dec. 1, 2021 at 8:33 a.m. ET","Headline":"FDA Advisors Vote Narrowly in Favor of Merck Covid Pill","Summary":"The global tally for the coronavirus-borne illness climbed above 262.9 million on Tuesday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.6 million cas..."},{"Date":"Dec. 1, 2021 at 7:53 a.m. ET","Headline":"FDA advisers recommend Merck\u2019s COVID-19 pill in close vote","Summary":"The global tally for the coronavirus-borne illness climbed above 262.9 million on Tuesday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.6 million cas..."},{"Date":"Dec. 1, 2021 at 6:46 a.m. ET","Headline":"WHO urges calm approach to omicron variant of COVID, warns travel restrictions may undermine surveillance and tracking","Summary":"The global tally for the coronavirus-borne illness climbed above 262.9 million on Tuesday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.6 million cas..."},{"Date":"Dec. 1, 2021 at 6:31 a.m. ET","Headline":"A Volatile Fed Is the Last Thing Markets Need. Powell Has a Second Chance.","Summary":"The global tally for the coronavirus-borne illness climbed above 262.9 million on Tuesday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.6 million cas..."},{"Date":"Dec. 1, 2021 at 6:21 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 near 263 million and U.S. to revise testing rules for travelers","Summary":"The global tally for the coronavirus-borne illness climbed above 262.9 million on Tuesday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.6 million cas..."},{"Date":"Nov. 30, 2021 at 1:01 p.m. ET","Headline":"Apple stock sticks out as it jumps into record territory while the Dow and the rest of its components drop","Summary":"Shares of Apple Inc.  stuck out like a sore thumb Tuesday, as they rallied 2.0% toward a record close in afternoon trading, to be the only one of 30 Dow Jones Industrial Average  components to be gaining ground. Meanwhile,..."},{"Date":"Nov. 30, 2021 at 9:57 a.m. ET","Headline":"Stock Market Jitters Continue Over Omicron. Why It\u2019s Too Early to Panic.","Summary":"Merck & Co. Inc.  and AstraZeneca PLC  said Tuesday that their supplemental New Drug Application (sNDA) for its breast cancer treatment Lynparza has been accepted and granted priority review by the U.S. Food and Drug Admin..."},{"Date":"Nov. 30, 2021 at 8:28 a.m. ET","Headline":"Merck\u2019s Covid Pill Gets an FDA Hearing. What\u2019s at Stake for the Stock.","Summary":"Merck & Co. Inc.  and AstraZeneca PLC  said Tuesday that their supplemental New Drug Application (sNDA) for its breast cancer treatment Lynparza has been accepted and granted priority review by the U.S. Food and Drug Admin..."},{"Date":"Nov. 30, 2021 at 6:40 a.m. ET","Headline":"Merck, AstraZeneca's sNDA for breast cancer treatment granted priority review by the FDA","Summary":"Merck & Co. Inc.  and AstraZeneca PLC  said Tuesday that their supplemental New Drug Application (sNDA) for its breast cancer treatment Lynparza has been accepted and granted priority review by the U.S. Food and Drug Admin..."},{"Date":"Nov. 30, 2021 at 6:35 a.m. ET","Headline":"Coronavirus tally: Global cases of COVID-19 top 262 million as FDA panel to meet on Merck's antiviral","Summary":"The global tally for the coronavirus-borne illness climbed above 262 million on Monday, while the death toll edged above 5.21 million, according to . The U.S. continues to lead the world with a total of 48.4 million cases ..."},{"Date":"Nov. 30, 2021 at 6:32 a.m. ET","Headline":"Moderna\u2019s Omicron Warning Reignites Selloff. Get Used to Volatility.","Summary":""},{"Date":"Dec. 3, 2021 at 2:28 p.m. ET","Headline":"Merck to supply Government of Canada with up to 1 million courses molnupiravir, its COVID-19 pill","Summary":"Merck & Co. Inc.  said Friday that it has entered into an agreement to supply the Government of Canada with up to one million patient courses of its COVID-19 pill, molnupiravir, which is being developed in collaboration wi..."},{"Date":"Dec. 2, 2021 at 7:52 a.m. ET","Headline":"U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral","Summary":""},{"Date":"Dec. 5, 2021 at 8:57 p.m. ET","Headline":"Bristol Stock Is Too Cheap. Why It Could Be Ready to Rally.","Summary":""},{"Date":"Dec. 5, 2021 at 10:40 a.m. ET","Headline":"After high hopes for Merck\u2019s COVID-19 pill, Wall Street now expects a \u2018tepid\u2019 authorization","Summary":""},{"Date":"Dec. 7, 2021 at 9:05 a.m. ET","Headline":"Merck Stock Is Sinking After an Analyst Said It Would Go Nowhere Fast","Summary":""},{"Date":"Dec. 9, 2021 at 8:08 a.m. ET","Headline":"Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash","Summary":"Merck KGaA  said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment a..."},{"Date":"Dec. 8, 2021 at 1:16 p.m. ET","Headline":"This Robot Trader Sold Moderna Stock. What It Bought Instead.","Summary":"Merck KGaA  said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment a..."},{"Date":"Dec. 8, 2021 at 11:07 a.m. ET","Headline":"Merck KGaA invests nearly $700 million into venture capital arm M Ventures","Summary":"Merck KGaA  said Wednesday it will invest an additional 600 million euros (about $680 million) into its corporate venture capital arm M Ventures over the next five years. That's the third increase in financial commitment a..."},{"Date":"Dec. 12, 2021 at 12:50 p.m. ET","Headline":"Here Are the Cheapest Stocks in Each Sector of the S&P 500","Summary":""},{"Date":"Dec. 12, 2021 at 11:59 a.m. ET","Headline":"How to Find the Healthiest Dividend Stocks for Your Portfolio","Summary":""},{"Date":"Dec. 15, 2021 at 9:29 a.m. ET","Headline":"Vir and Glaxo\u2019s Drug Could Be the Last Antibody Treatment Standing Against Omicron","Summary":""},{"Date":"Dec. 14, 2021 at 8:32 a.m. ET","Headline":"Pfizer Confirms Its Covid Pill Reduces the Risk of Hospitalization or Death by Nearly 90%","Summary":""},{"Date":"Dec. 16, 2021 at 2:40 p.m. ET","Headline":"EU meets to discuss response to omicron variant as France restricts travel from UK, and CDC panel to discuss rare side effect from J&J vaccine","Summary":""},{"Date":"Dec. 16, 2021 at 7:13 a.m. ET","Headline":"Here\u2019s a list of favored dividend stocks with room to pay more for investors worried about 2022","Summary":""},{"Date":"Dec. 19, 2021 at 5:26 p.m. ET","Headline":"Omicron may sideline two leading drugs used to treat COVID-19","Summary":""},{"Date":"Dec. 21, 2021 at 11:31 a.m. ET","Headline":"Omicron Is Driving Up Demand for Rapid Tests","Summary":""},{"Date":"Dec. 9, 2021 at 7:22 a.m. ET","Headline":"Uncovering these \u2018hidden stories\u2019 has led this fund manager to stock gains that beat the S&P 500. Here are his picks","Summary":""},{"Date":"Dec. 23, 2021 at 8:24 p.m. ET","Headline":"Omicron Is Surging. Inflation Is Rising. But Investors Are Dreaming of a Santa Claus Rally.","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 3:34 p.m. ET","Headline":"Oil logs 4% weekly rise as omicron jitters fade","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 1:27 p.m. ET","Headline":"FDA adds Merck antiviral to COVID-19 tool kit for high-risk adults above 18 amid flurry of positive news on boosters","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 12:49 p.m. ET","Headline":"The S&P 500 Celebrates the Holiday Early With a New High","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 12:04 p.m. ET","Headline":"Merck\u2019s Antiviral Pill Gets Emergency Use OK for Some Covid Patients","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 23, 2021 at 9:48 a.m. ET","Headline":"FDA authorizes Merck's COVID-19 antiviral but only when other treatments are 'not accessible' or 'appropriate'","Summary":"Shares of Merck & Co. Inc.  were down 0.8% in trading on Thursday after the Food and Drug Administration authorized the company's COVID-19 antiviral for adults who have tested positive for the virus and are at high risk of..."},{"Date":"Dec. 22, 2021 at 12:50 p.m. ET","Headline":"FDA Authorizes Pfizer Antiviral Pill to Fight Covid","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Wednesday the UK government has ordered an additional 1.75 million courses of their COVID-19 antiviral molnupiravir. The new order brings the total ordered by the UK..."},{"Date":"Dec. 22, 2021 at 10:09 a.m. ET","Headline":"Why growth and dividend stocks will be hot items for 2022, along with these superproductive companies","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Wednesday the UK government has ordered an additional 1.75 million courses of their COVID-19 antiviral molnupiravir. The new order brings the total ordered by the UK..."},{"Date":"Dec. 22, 2021 at 6:18 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics say UK government has ordered additional 1.75 million doses of their COVID antiviral","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Wednesday the UK government has ordered an additional 1.75 million courses of their COVID-19 antiviral molnupiravir. The new order brings the total ordered by the UK..."},{"Date":"Dec. 22, 2021 at 5:53 a.m. ET","Headline":"Biden administration to stockpile 4 million COVID-19 therapies by end January: report","Summary":"The administration of President Joe Biden plans to have 4 million various therapies to treat COVID-19 in its pandemic arsenal by the end of January, according to a  cited sources. Included are a monoclonal antibody, preven..."},{"Date":"Dec. 25, 2021 at 9:30 a.m. ET","Headline":"Pfizer\u2019s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock.","Summary":""},{"Date":"Dec. 24, 2021 at 9:02 a.m. ET","Headline":"S&P 500 sweeps to record close, stocks end higher for 3rd day in final session before Christmas","Summary":""},{"Date":"Dec. 23, 2021 at 9:08 p.m. ET","Headline":"Omicron Who? S&P 500 Closes a Short Trading Week at a New High.","Summary":""},{"Date":"Dec. 27, 2021 at 10:17 a.m. ET","Headline":"Here Are Barron\u2019s 10 Top Stocks for the New Year","Summary":""},{"Date":"Dec. 27, 2021 at 8:11 a.m. ET","Headline":"Omicron Is Wreaking Havoc. Why Investors Are Calm.","Summary":""},{"Date":"Dec. 26, 2021 at 4:35 p.m. ET","Headline":"New easy-to-use COVID-19 pills come with a catch","Summary":""},{"Date":"Dec. 26, 2021 at 2:16 p.m. ET","Headline":"Omicron\u2019s Surge Sparks New Wave of Restrictions in Europe","Summary":""},{"Date":"Dec. 29, 2021 at 4:26 p.m. ET","Headline":"Dow, S&P 500 end at records Wednesday as stocks rally in final week of 2021","Summary":""},{"Date":"Dec. 29, 2021 at 12:22 p.m. ET","Headline":"Some ETFs mix investing with charities \u2014 should you?","Summary":""},{"Date":"Dec. 28, 2021 at 11:25 a.m. ET","Headline":"The U.S. is rolling out Pfizer and Merck\u2019s COVID-19 antivirals to states but \u2018complex\u2019 manufacturing process may limit launch","Summary":""},{"Date":"Dec. 31, 2021 at 12:02 p.m. ET","Headline":"Daily average of COVID hospitalizations rises above 80,000 for the first time in 3 months, while cases keep breaking daily records","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 11:26 a.m. ET","Headline":"U.K. Authorizes Pfizer\u2019s Antiviral Covid-19 Pill","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 7:18 a.m. ET","Headline":"These dividend-paying companies can help to fade big tech and play a broader economic recovery","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Dec. 31, 2021 at 6:41 a.m. ET","Headline":"U.K. approves Pfizer oral antiviral Paxlovid for COVID-19","Summary":"The U.K. Medicines and Healthcare products Regulatory Agency said it's approved Pfizer's  Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. T..."},{"Date":"Jan. 4, 2022 at 10:09 a.m. ET","Headline":"Vaccine Stocks Tumble Even Though Covid-19 Cases Are Soaring","Summary":"Shares of Genprex Inc.  skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug ..."},{"Date":"Jan. 4, 2022 at 8:21 a.m. ET","Headline":"Intel Joins the Dogs of the Dow. Why These Stocks Could Be a Good Strategy This Year.","Summary":"Shares of Genprex Inc.  skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug ..."},{"Date":"Jan. 3, 2022 at 2:24 p.m. ET","Headline":"Genprex stock more than doubles on very heavy volume after FTD granted for cancer treatment","Summary":"Shares of Genprex Inc.  skyrocketed 121% on massive volume in afternoon trading Monday, after the gene therapy company said its Reqorsa Immunogene Therapy was granted Fast Track Designation (FTD) by the U.S. Food and Drug ..."},{"Date":"Jan. 3, 2022 at 9:48 a.m. ET","Headline":"These are the stocks Wall Street analysts heavily favor for 2022 and also expect to rise the most","Summary":""},{"Date":"Jan. 3, 2022 at 9:20 a.m. ET","Headline":"These are the best-performing S&P 500 and Nasdaq-100 stocks of 2021","Summary":""},{"Date":"Jan. 3, 2022 at 7:53 a.m. ET","Headline":"Here Are Barron\u2019s Best Income Investments for the New Year","Summary":""},{"Date":"Jan. 6, 2022 at 10:05 a.m. ET","Headline":"Healthcare\u2019s Biggest Conference Is Next Week. What to Know.","Summary":""},{"Date":"Jan. 6, 2022 at 9:11 a.m. ET","Headline":"These Drug Companies Have Lots of Cash for Research and Product Buys","Summary":""},{"Date":"Jan. 8, 2022 at 10:41 a.m. ET","Headline":"Why the bull market will stay alive in 2022 \u2014 plus 8 cheap stocks for your money now","Summary":"Shares of Absci Corp.  skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fees and milestone payments from Merc..."},{"Date":"Jan. 7, 2022 at 8:46 a.m. ET","Headline":"Is it time to fight the Fed? This veteran strategist says the central bank won\u2019t risk a 20% drop in house prices and a 30% slide in stocks.","Summary":"Shares of Absci Corp.  skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fees and milestone payments from Merc..."},{"Date":"Jan. 7, 2022 at 8:22 a.m. ET","Headline":"Absci stock rockets after collaboration with Merck could lead to more than $600 million in payments","Summary":"Shares of Absci Corp.  skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fees and milestone payments from Merc..."},{"Date":"Jan. 10, 2022 at 8:12 a.m. ET","Headline":"This Robot Trader Is Betting on Big Gains for Tesla and Nvidia Stock. It\u2019s Been Right Before.","Summary":""},{"Date":"Jan. 9, 2022 at 6:00 a.m. ET","Headline":"Spinoffs Fared Poorly in 2021. What It Takes for These Stocks to Outperform.","Summary":""},{"Date":"Jan. 11, 2022 at 9:02 a.m. ET","Headline":"Vir Stock Jumps as U.S. Buys 600,000 More Glaxo Covid Antibody Doses","Summary":""},{"Date":"Jan. 18, 2022 at 6:53 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics to supply 3 million doses of COVID antiviral to Unicef in 2022","Summary":"Merck  and partner privately held Ridgeback Biotherapeutics said Tuesday they have won a supply agreement from the United Nations Children's Fund, or Unicef, to provide it with up to 3 million doses of their COVID-19 antiv..."},{"Date":"Jan. 20, 2022 at 8:42 a.m. ET","Headline":"NIH says Pfizer's Paxloid should be first treatment option for certain COVID-19 patients","Summary":"The National Institutes of Health on Wednesday updated its  for patients with mild to moderate forms of COVID-19 who are at high risk for disease progression. The new guidelines now include the recently authorized antivira..."},{"Date":"Jan. 19, 2022 at 7:57 a.m. ET","Headline":"Omicron cases seem to have peaked in northeastern states, but national case tally remains at record levels and hospitals are slammed","Summary":""},{"Date":"Jan. 21, 2022 at 6:19 a.m. ET","Headline":"South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing","Summary":""},{"Date":"Jan. 24, 2022 at 6:32 p.m. ET","Headline":"We should double down on COVID-10 treatments for those at high risk instead of pushing boosters and tests for everyone","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Monday after the company said the Food and Drug Administration requested additional information about its experimental cough treatment. The regulator issued a..."},{"Date":"Jan. 24, 2022 at 6:04 p.m. ET","Headline":"FDA halts use of antibody drugs that don\u2019t work against omicron","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Monday after the company said the Food and Drug Administration requested additional information about its experimental cough treatment. The regulator issued a..."},{"Date":"Jan. 24, 2022 at 5:15 p.m. ET","Headline":"Dow stages unprecedented 1,214-point intraday reversal, and all 3 major indexes end higher in tumultuous Monday","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Monday after the company said the Food and Drug Administration requested additional information about its experimental cough treatment. The regulator issued a..."},{"Date":"Jan. 24, 2022 at 7:26 a.m. ET","Headline":"Merck says FDA wants more information about its experimental cough treatment","Summary":"Shares of Merck & Co. Inc.  gained 0.4% in premarket trading on Monday after the company said the Food and Drug Administration requested additional information about its experimental cough treatment. The regulator issued a..."},{"Date":"Jan. 25, 2022 at 2:54 p.m. ET","Headline":"Pfizer and BioNTech launch study of omicron vaccine, and FDA halts use of two COVID antibody treatments","Summary":""},{"Date":"Jan. 25, 2022 at 10:10 a.m. ET","Headline":"How Omicron Is Changing Vaccine and Therapeutic Strategies","Summary":""},{"Date":"Jan. 28, 2022 at 12:44 p.m. ET","Headline":"World hits milestone of 10 billion COVID vaccine doses administered, but less than 10% of people in low-income countries have had a first jab","Summary":"Merck & Co. Inc.  and partner Ridgeback Biotherapeutics said Friday that data from six preclinical studies of its molnupiravir COVID-19 pill showed \"consisent antiviral activity\" against the omicron variant of the coronavi..."},{"Date":"Jan. 28, 2022 at 8:35 a.m. ET","Headline":"What\u2019s old is new again \u2014 the Dogs of the Dow are outperforming the stock market","Summary":"Merck & Co. Inc.  and partner Ridgeback Biotherapeutics said Friday that data from six preclinical studies of its molnupiravir COVID-19 pill showed \"consisent antiviral activity\" against the omicron variant of the coronavi..."},{"Date":"Jan. 28, 2022 at 7:09 a.m. ET","Headline":"Merck, Ridgeback says COVID-19 pill molnupiravir shows antiviral activity against omicron variant","Summary":"Merck & Co. Inc.  and partner Ridgeback Biotherapeutics said Friday that data from six preclinical studies of its molnupiravir COVID-19 pill showed \"consisent antiviral activity\" against the omicron variant of the coronavi..."},{"Date":"Jan. 27, 2022 at 2:45 p.m. ET","Headline":"U.S. daily COVID case tally now falling and hospitalizations seem to be peaking, as Moderna launches trial of omicron-specific booster","Summary":""},{"Date":"Jan. 31, 2022 at 9:43 a.m. ET","Headline":"This ARK holding and pandemic star is down 77% from its peak \u2014 why one hedge fund is starting to buy it","Summary":""},{"Date":"Feb. 3, 2022 at 10:53 a.m. ET","Headline":"Merck\u2019s Earnings Guidance for 2022 Misses Estimates. The Stock Is Falling.","Summary":"Merck & Co. shares  rose 0.8% premarket Thursday, after the drug company beat estimates for the fourth quarter after chalking up more than $950 million in sales from its COVID-19 antiviral molnupiravir. The company posted ..."},{"Date":"Feb. 3, 2022 at 6:51 a.m. ET","Headline":"Merck tops Q4 estimates as COVID antiviral chalks up $952 million of sales","Summary":"Merck & Co. shares  rose 0.8% premarket Thursday, after the drug company beat estimates for the fourth quarter after chalking up more than $950 million in sales from its COVID-19 antiviral molnupiravir. The company posted ..."},{"Date":"Feb. 7, 2022 at 8:36 a.m. ET","Headline":"Time to Lift Covid Restrictions? Some Public Health Experts Call for a Pullback Soon.","Summary":""},{"Date":"Feb. 7, 2022 at 6:51 a.m. ET","Headline":"Four drug makers raked in $14 billion in sales of COVID-19 treatments in 2021. How will they do this year?","Summary":""},{"Date":"Feb. 8, 2022 at 7:02 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics on track to make 20 million courses of COVID antiviral in 2022","Summary":"Merck & Co.  and partner privately held Ridgeback Biotherapeutics said Tuesday they have completed manufacturing of 10 million doses of their COVID antiviral molnupiravir and are on track to make at least 20 million course..."},{"Date":"Feb. 12, 2022 at 8:05 a.m. ET","Headline":"\u2018You will not believe what I\u2019ve just found.\u2019 Inside the ivermectin saga: a hacked password, mysterious websites and faulty data.","Summary":""},{"Date":"Feb. 18, 2022 at 4:12 p.m. ET","Headline":"Moderna Is Targeting Shingles, Herpes, and Cancer. The CEO Is Looking Beyond Covid.","Summary":""},{"Date":"Feb. 23, 2022 at 7:50 a.m. ET","Headline":"Facebook, Google, Amazon and more marked Black History Month with fanfare \u2014 after donating to lawmakers who blocked voting rights bills","Summary":""},{"Date":"Feb. 22, 2022 at 6:54 a.m. ET","Headline":"Markets Are on a War Footing. Here\u2019s a Worst-Case Scenario.","Summary":""},{"Date":"Feb. 24, 2022 at 10:37 a.m. ET","Headline":"These 20 S&P 500 stocks are down at least 5% after Russia invades Ukraine","Summary":""},{"Date":"Mar. 3, 2022 at 12:46 p.m. ET","Headline":"WHO adds Merck antiviral to its COVID treatments, and warns Ukraine has low vaccination rate and surging cases","Summary":"The World Health Organization said Thursday it is updating its guidelines on COVID-19 treatments to include molnupiravir, the antiviral developed by Merck & Co. . It's the first oral antirival to be added to the agency's g..."},{"Date":"Mar. 3, 2022 at 8:19 a.m. ET","Headline":"CVS, Walgreens, and Walmart part of Biden\u2019s test-to-treat COVID-19 program","Summary":"The World Health Organization said Thursday it is updating its guidelines on COVID-19 treatments to include molnupiravir, the antiviral developed by Merck & Co. . It's the first oral antirival to be added to the agency's g..."},{"Date":"Mar. 3, 2022 at 6:17 a.m. ET","Headline":"Coronavirus tally: WHO adds Merck's antiviral to its treatment guidelines for non-severe patients","Summary":"The World Health Organization said Thursday it is updating its guidelines on COVID-19 treatments to include molnupiravir, the antiviral developed by Merck & Co. . It's the first oral antirival to be added to the agency's g..."},{"Date":"Mar. 2, 2022 at 10:24 a.m. ET","Headline":"As Covid Cases Fall, Biden Says It\u2019s Time to Return to Normal Life","Summary":""},{"Date":"Mar. 9, 2022 at 9:59 a.m. ET","Headline":"Russia-Ukraine War Won\u2019t Affect Pharmaceutical Sales, but It Could Disrupt Trials, Companies Say","Summary":""},{"Date":"Mar. 11, 2022 at 8:24 p.m. ET","Headline":"Pharma Exposure to the Ukraine War? Clinical Trials","Summary":""},{"Date":"Mar. 12, 2022 at 1:39 p.m. ET","Headline":"Covid-19 Cases Climb in U.K. as BA.2 Spreads. What to Know.","Summary":""},{"Date":"Mar. 15, 2022 at 8:20 a.m. ET","Headline":"AbbVie, Scripps Research to develop COVID-19 antivirals","Summary":"AbbVie Inc.  said Tuesday that it will partner with Scripps Research to develop new COVID-19 antivirals. \"Our SARS-CoV-2 research program has the potential to impact significantly the ongoing gaps in patient needs to move ..."},{"Date":"Mar. 15, 2022 at 8:12 a.m. ET","Headline":"Merck to stop clinical trial testing Keytruda with AstraZeneca's Lynparza in prostate cancer patients","Summary":"Merck & Co. Inc.  said Tuesday that it will stop a clinical trial evaluating Keytruda with AstraZeneca's  Lynparza in advanced prostate cancer patients because the combination therapy doesn't work. The company said the dru..."},{"Date":"Mar. 14, 2022 at 8:04 a.m. ET","Headline":"12 dividend stocks paying at least 3.5% that are well-suited for high inflation","Summary":""},{"Date":"Mar. 16, 2022 at 7:11 a.m. ET","Headline":"Sewage samples signal possible increase in U.S. COVID cases in some places, even though overall cases are falling","Summary":""},{"Date":"Mar. 21, 2022 at 8:35 a.m. ET","Headline":"12 Dividend Stocks for Retirement\u2014and How to Find More","Summary":""},{"Date":"Mar. 28, 2022 at 12:41 p.m. ET","Headline":"The BA.2 Covid Variant Is Already Changing the U.S. Response to the Pandemic","Summary":""},{"Date":"Apr. 1, 2022 at 2:33 p.m. ET","Headline":"U.S. lawmakers close to agreeing on $10 billion in funding for next phase of the COVID-19 battle, as death toll tops 980,000","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Friday they will present data showing that treatment with their COVID-19 antiviral ended infectious illness more rapidly than placebo in a late-stage trial. Data on ..."},{"Date":"Apr. 1, 2022 at 7:00 a.m. ET","Headline":"Merck and Ridgeback to present data showing COVID antiviral ends infectious illness more quickly than placebo","Summary":"Merck  and privately held Ridgeback Biotherapeutics said Friday they will present data showing that treatment with their COVID-19 antiviral ended infectious illness more rapidly than placebo in a late-stage trial. Data on ..."},{"Date":"Apr. 3, 2022 at 9:41 p.m. ET","Headline":"Discovery, Merck, Carnival, Broadcom, and Other Stocks to Watch This Week","Summary":""},{"Date":"Apr. 1, 2022 at 7:30 p.m. ET","Headline":"Defense Stocks Rose With the Ukraine War. Then a Tight Proposed Budget Set Them Back.","Summary":""},{"Date":"Apr. 5, 2022 at 4:43 p.m. ET","Headline":"FDA pulls GlaxoSmithKline\u2019s COVID-19 drug as omicron subvariant dominates U.S. cases","Summary":""},{"Date":"Apr. 8, 2022 at 3:09 p.m. ET","Headline":"As COVID-19 cases decline in the U.S., White House officials face outbreak","Summary":""},{"Date":"Apr. 7, 2022 at 7:57 a.m. ET","Headline":"BA.2 subvariant of omicron accounted for almost 94% of global cases in latest week, the latest sign of how dominant it has become","Summary":""},{"Date":"Apr. 13, 2022 at 3:00 a.m. ET","Headline":"An International Stock Fund Weathers the Storm","Summary":""},{"Date":"Apr. 15, 2022 at 12:49 p.m. ET","Headline":"How well is the COVID-19 test-to-treat program working?","Summary":""},{"Date":"Apr. 20, 2022 at 7:31 p.m. ET","Headline":"6 Defensive Healthcare Stocks With Big Dividend Yields","Summary":""},{"Date":"Apr. 24, 2022 at 5:53 p.m. ET","Headline":"6 Dividend Stocks to Help You Whip Inflation Now","Summary":""},{"Date":"Apr. 25, 2022 at 11:02 a.m. ET","Headline":"Merck, Lilly, Bristol Earnings This Week Could Prove Big Pharma\u2019s Defensive Value","Summary":""},{"Date":"Apr. 28, 2022 at 4:26 p.m. ET","Headline":"The Pandemic\u2019s Impact on Merck Is Lessening, CFO Says","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 28, 2022 at 4:26 p.m. ET","Headline":"Dow, S&P 500 record best day in 7 weeks as tech stocks rally","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 28, 2022 at 3:49 p.m. ET","Headline":"Many Big Pharma Stocks Have Outperformed. It Isn\u2019t Too Late to Buy.","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 28, 2022 at 9:19 a.m. ET","Headline":"Merck Beats Earnings Estimates. The Stock Is Up.","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 28, 2022 at 9:02 a.m. ET","Headline":"How Gilead is positioning Veklury against COVID-19 antivirals like Paxlovid","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 28, 2022 at 9:00 a.m. ET","Headline":"Can a decades-old antidepressant keep COVID-19 patients out of the hospital?","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"Apr. 27, 2022 at 9:30 a.m. ET","Headline":"Moderna hires chief commercial officer","Summary":"Shares of Moderna Inc.  were down 0.4% in premarket trading on Wednesday after the company said it hired a new chief commercial officer. Arpa Garay, who is set to Moderna on May 31, most recently served as chief marketing ..."},{"Date":"May. 3, 2022 at 9:06 a.m. ET","Headline":"Pfizer Earnings and Revenue Soundly Beat Estimates, Though Paxlovid Sales Miss","Summary":""},{"Date":"Apr. 6, 2022 at 3:30 a.m. ET","Headline":"The Key to Surviving Inflation is \u2018Pricing Power.\u2019 These Companies Have It in Spades.","Summary":""},{"Date":"May. 6, 2022 at 1:07 p.m. ET","Headline":"Drug companies are making an accounting change after the SEC cracked down on Biogen","Summary":""},{"Date":"May. 6, 2022 at 9:40 a.m. ET","Headline":"Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn\u2019t Happening.","Summary":""},{"Date":"May. 10, 2022 at 7:51 p.m. ET","Headline":"Bill Gates says he has COVID-19, is experiencing mild symptoms","Summary":""},{"Date":"May. 10, 2022 at 2:26 p.m. ET","Headline":"Pfizer Is Spending $11.6 Billion on Biohaven. Its Plans Point to a Lot More M&A.","Summary":""},{"Date":"May. 11, 2022 at 10:38 a.m. ET","Headline":"New Roche Cancer Data Slams Biopharma Stocks","Summary":""},{"Date":"May. 14, 2022 at 3:45 p.m. ET","Headline":"12 stocks to consider for the next leg of the bull market","Summary":""},{"Date":"May. 22, 2022 at 7:28 p.m. ET","Headline":"\u2018I chose to take a gamble\u2019: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatment","Summary":""},{"Date":"May. 21, 2022 at 10:15 a.m. ET","Headline":"Stocks Are Ready for a Bounce Higher After S&P 500 Rallies Out of Bear Market","Summary":""},{"Date":"May. 25, 2022 at 10:45 a.m. ET","Headline":"CDC: A Paxlovid rebound may be \u2018natural\u2019 part of a COVID-19 infection","Summary":""},{"Date":"May. 25, 2022 at 8:43 a.m. ET","Headline":"An Unexpected Blue Wave Could Shake Up These Stocks","Summary":""},{"Date":"May. 31, 2022 at 10:10 a.m. ET","Headline":"Don\u2019t fall in love with stocks, they\u2019ll break your heart","Summary":""},{"Date":"May. 31, 2022 at 8:40 a.m. ET","Headline":"Buy This Pharma Stock. Its Rally Is Just Getting Started","Summary":""},{"Date":"May. 31, 2022 at 8:08 a.m. ET","Headline":"GSK to Buy U.S. Biotech Affinivax in $3.3 Billion Deal","Summary":""},{"Date":"Jun. 11, 2022 at 7:44 a.m. ET","Headline":"Energy stocks are this year\u2019s best performers \u2014 but they\u2019re not on the list of top investment newsletters","Summary":""},{"Date":"Jun. 17, 2022 at 11:18 a.m. ET","Headline":"Seagen Stock Surges on Report of Merck Interest","Summary":"Shares of Seagen Inc.  shot up 14.7% toward a seven-month high in morning trading Friday, after The Wall Street Journal reported that Merck & Co. Inc.  is looking into buying the cancer-focused biotechnology company. Meanw..."},{"Date":"Jun. 17, 2022 at 11:03 a.m. ET","Headline":"Seagen's stock surges after WSJ reports $31 billion-valued biotech is being eyed by Merck","Summary":"Shares of Seagen Inc.  shot up 14.7% toward a seven-month high in morning trading Friday, after The Wall Street Journal reported that Merck & Co. Inc.  is looking into buying the cancer-focused biotechnology company. Meanw..."},{"Date":"Jun. 17, 2022 at 9:54 a.m. ET","Headline":"It\u2019s time to let pharmacists prescribe COVID-fighting pills like Paxlovid","Summary":""},{"Date":"Jun. 15, 2022 at 5:30 p.m. ET","Headline":"5 Healthcare Stocks That Are Bucking the Bear Market","Summary":""},{"Date":"Jun. 20, 2022 at 9:44 a.m. ET","Headline":"Is Juneteenth being observed by companies in the Dow industrials? Here\u2019s how some are handling it.","Summary":""},{"Date":"Jun. 17, 2022 at 3:04 p.m. ET","Headline":"The Days of Big Pharma Are Over. What the Era of Big Biotech Means for Investors.","Summary":""},{"Date":"Jun. 23, 2022 at 9:46 a.m. ET","Headline":"Merck Clocks Wins Against Pfizer in Pneumococcal Vaccine Market","Summary":""},{"Date":"Jun. 24, 2022 at 7:05 p.m. ET","Headline":"High-Yield Bonds Look Like Bargains After an Awful First Half","Summary":""},{"Date":"Jun. 24, 2022 at 4:30 p.m. ET","Headline":"How an Income Fund Makes Stocks Safer With High-Yield Bonds","Summary":""},{"Date":"Jul. 1, 2022 at 9:07 a.m. ET","Headline":"Biotech Stocks Finally Rose in June. What Does It Mean?","Summary":"The Dow Jones Industrial Average's  is suffering a unanimous decline of 480 points, or 1.6%, as all 30 of the blue-chip barometer's components are trading lower. The biggest point drags are the shares of Salesforce Inc. , ..."},{"Date":"Jun. 30, 2022 at 9:47 a.m. ET","Headline":"All 30 Dow stocks are falling, with Goldman Sachs and Salesforce the biggest drags","Summary":"The Dow Jones Industrial Average's  is suffering a unanimous decline of 480 points, or 1.6%, as all 30 of the blue-chip barometer's components are trading lower. The biggest point drags are the shares of Salesforce Inc. , ..."},{"Date":"Jul. 7, 2022 at 4:45 p.m. ET","Headline":"Biotech Stocks Are Poised to Outperform for the Rest of 2022","Summary":""},{"Date":"Jul. 7, 2022 at 4:20 p.m. ET","Headline":"Dow Rises, GameStop Pops\u2014and What Else Happened in the Stock Market Today","Summary":""},{"Date":"Jul. 7, 2022 at 10:45 a.m. ET","Headline":"Democrats\u2019 Latest Drug-Pricing Bill Has a Chance. What It Means for Pharma Stocks.","Summary":""},{"Date":"Jul. 7, 2022 at 9:04 a.m. ET","Headline":"Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion: Report","Summary":""},{"Date":"Jul. 7, 2022 at 8:48 a.m. ET","Headline":"This strategist warned investors not to chase momentum at the top. Now he says it\u2019s time to be a contrarian.","Summary":""},{"Date":"Jul. 7, 2022 at 7:45 a.m. ET","Headline":"GameStop, Virgin Galactic, and More Thursday Morning Stock Movers.","Summary":""},{"Date":"Jul. 6, 2022 at 10:58 p.m. ET","Headline":"Merck in talks to buy cancer biotech Seagen for about $40 billion","Summary":""},{"Date":"Jul. 6, 2022 at 1:00 p.m. ET","Headline":"What\u2019s the Deal With Biotech? Investors Have the Sector All Wrong, Says Citi","Summary":""},{"Date":"Jul. 9, 2022 at 8:55 a.m. ET","Headline":"These are the dividend stocks most recommended by top-performing newsletters \u2014 and 6 yield above 4%","Summary":""},{"Date":"Jul. 13, 2022 at 6:11 a.m. ET","Headline":"Merck to pay Orion $290 million upfront to develop, commercialize prostate cancer treatment","Summary":"Merck & Co. Inc.  said Wednesday it will make a $290 million upfront payment to Orion Corp. as part of an agreement to develop and commercialize Orion's prostate cancer treatment ODM-208. Merck said the payment will be inc..."},{"Date":"Jul. 15, 2022 at 6:33 p.m. ET","Headline":"Merck deal for Seagen unlikely to be finalized ahead of earnings later this month, sources say","Summary":""},{"Date":"Jul. 21, 2022 at 10:00 a.m. ET","Headline":"Dividend ETFs Keep Getting Larger. It\u2019s Survival of the Biggest.","Summary":""},{"Date":"Jul. 11, 2022 at 10:59 a.m. ET","Headline":"Biotech Stocks Are Up by Double Digits. It\u2019s Still a Bear Market.","Summary":""},{"Date":"Jul. 27, 2022 at 7:23 p.m. ET","Headline":"Stock Futures Fall as Disappointing Meta Outlook Dampens Nasdaq\u2019s Massive Gain","Summary":"Shares of Seagen Inc.  gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in combination with Merck & Co. Inc.'s ..."},{"Date":"Jul. 27, 2022 at 7:17 a.m. ET","Headline":"Insider Trading Cases Are on the Rise. Credit the SEC\u2019s Computers.","Summary":"Shares of Seagen Inc.  gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in combination with Merck & Co. Inc.'s ..."},{"Date":"Jul. 26, 2022 at 1:37 p.m. ET","Headline":"Big Tech earnings are about to determine the direction of the market","Summary":"Shares of Seagen Inc.  gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in combination with Merck & Co. Inc.'s ..."},{"Date":"Jul. 26, 2022 at 7:30 a.m. ET","Headline":"Seagen shares positive data for bladder cancer drug; stock is up 2.5%","Summary":"Shares of Seagen Inc.  gained 2.5% in premarket trading on Tuesday after the company said an early-stage clinical trial evaluating its investigational treatment for urothelial cancer in combination with Merck & Co. Inc.'s ..."},{"Date":"Jul. 29, 2022 at 6:40 a.m. ET","Headline":"Apple and Amazon\u2019s Tech Strength Gets Bulls Buying Despite Recession on the Radar","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 4:53 p.m. ET","Headline":"Manchin Deal Lifts Odds of Drug-Price Overhaul. Pharma Stocks Might Be Unscathed.","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 12:14 p.m. ET","Headline":"Merck Tops Profit Estimates on Strong Keytruda and Gardasil Sales","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 9:30 a.m. ET","Headline":"Pfizer Earnings Beat Expectations. Vaccine and Paxlovid Sales Were Higher Than Anticipated.","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 8:59 a.m. ET","Headline":"These clean energy ETFs have been outperforming \u2014 and there\u2019s a fundamental reason why","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 7:53 a.m. ET","Headline":"Meta, Ford, Spirit and More Thursday Morning Stock Movers","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 6:45 a.m. ET","Headline":"Merck stock ticks up after profit more than triples to beat expectations","Summary":"Shares of Merck & Co. Inc.  edged up 0.1% in premarket trading Thursday, after the drug maker reported second-quarter profit and sales that rose above expectations, and raised its full-year sales outlook slightly. Net inco..."},{"Date":"Jul. 28, 2022 at 3:31 a.m. ET","Headline":"Paxlovid has been given to Biden and millions of Americans infected with COVID-19. In the U.K., it sits on the shelf.","Summary":""},{"Date":"Aug. 4, 2022 at 9:41 a.m. ET","Headline":"The Bull Market in Biotech Stocks Is Still Going Strong","Summary":""},{"Date":"Aug. 6, 2022 at 10:22 a.m. ET","Headline":"There are three reasons health care is the market\u2019s best sector today. These eight stocks are the most worry-free.","Summary":""},{"Date":"Aug. 6, 2022 at 10:17 a.m. ET","Headline":"Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal","Summary":""},{"Date":"Aug. 12, 2022 at 8:06 a.m. ET","Headline":"Get ready for more merger mania in the pharma sector for the rest of the year","Summary":""},{"Date":"Aug. 14, 2022 at 7:55 p.m. ET","Headline":"R.I.P., Bear Market. For Now, Signs Point to More Buying.","Summary":""},{"Date":"Aug. 13, 2022 at 9:34 a.m. ET","Headline":"10 defensive stocks that can also provide you with growth and dividends over the long term","Summary":""},{"Date":"Aug. 16, 2022 at 9:48 a.m. ET","Headline":"Merck Jumps Into a $3.7 Billion mRNA Collaboration","Summary":"Merck  and privately held Orna Therapeutics said Tuesday they have agreed to collaborate to discover and develop programs, including vaccines and therapeutics, in the fields of infectious disease and oncology. Under the te..."},{"Date":"Aug. 16, 2022 at 9:40 a.m. ET","Headline":"Here\u2019s what investors should do as the housing market faces tough times","Summary":"Merck  and privately held Orna Therapeutics said Tuesday they have agreed to collaborate to discover and develop programs, including vaccines and therapeutics, in the fields of infectious disease and oncology. Under the te..."},{"Date":"Aug. 16, 2022 at 7:01 a.m. ET","Headline":"Merck and Orna Therapeutics to collaborate in deal entitling Orna to up to $3.5 billion in milestone payments","Summary":"Merck  and privately held Orna Therapeutics said Tuesday they have agreed to collaborate to discover and develop programs, including vaccines and therapeutics, in the fields of infectious disease and oncology. Under the te..."},{"Date":"Aug. 15, 2022 at 10:40 a.m. ET","Headline":"Biotech Keeps Staving Off the Bear, but for How Long?","Summary":""},{"Date":"Aug. 18, 2022 at 2:37 p.m. ET","Headline":"Democrats are wrong: Allowing Medicare to negotiate some drug prices won\u2019t be a game-changer","Summary":""},{"Date":"Aug. 18, 2022 at 11:33 a.m. ET","Headline":"Now that the S&P 500 is looking overbought, watch what happens to this downtrend line that defines the bear market","Summary":""},{"Date":"Aug. 21, 2022 at 10:15 a.m. ET","Headline":"What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out","Summary":""},{"Date":"Aug. 21, 2022 at 10:10 a.m. ET","Headline":"Ivermectin among generic drugs that failed to help COVID-19 patients avoid hospitalization, large study shows","Summary":""},{"Date":"Aug. 26, 2022 at 4:13 p.m. ET","Headline":"Dow Drops 1,000 Points After Powell\u2019s Jackson Hole Speech\u2014and What Else Happened in the Stock Market Today","Summary":""},{"Date":"Aug. 26, 2022 at 2:11 p.m. ET","Headline":"Seagen Stock Falls on Report Possible Buyout by Merck Has Stalled","Summary":""},{"Date":"Aug. 26, 2022 at 7:54 a.m. ET","Headline":"Affirm, Dell, Workday, Ulta, and More Stock Market Movers Friday","Summary":""},{"Date":"Aug. 25, 2022 at 5:07 p.m. ET","Headline":"Labor board files complaint against Starbucks over withholding pay hikes, benefits","Summary":""},{"Date":"Aug. 25, 2022 at 3:25 p.m. ET","Headline":"The short-term outlook for the S&P 500 doesn\u2019t look good after a mini-rally stalled","Summary":""},{"Date":"Aug. 25, 2022 at 6:19 a.m. ET","Headline":"Study finds Pfizer COVID pill provides no benefit in younger adults","Summary":""},{"Date":"Sep. 1, 2022 at 4:07 p.m. ET","Headline":"The stock market is unrelentingly bearish but still nowhere close to triggering a \u2018buy\u2019 signal","Summary":""},{"Date":"Sep. 9, 2022 at 11:22 a.m. ET","Headline":"Moderna Wants Investors to Look Past Its Covid-19 Vaccine","Summary":""},{"Date":"Sep. 8, 2022 at 11:48 a.m. ET","Headline":"An \u2018oversold\u2019 rally in stocks may be in the works","Summary":""},{"Date":"Sep. 14, 2022 at 7:48 a.m. ET","Headline":"AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say","Summary":""},{"Date":"Sep. 16, 2022 at 11:45 a.m. ET","Headline":"The stock market\u2019s trend is relentlessly bearish, especially after this week\u2019s big daily declines","Summary":""},{"Date":"Sep. 20, 2022 at 8:34 a.m. ET","Headline":"Berkshire Made Big Bets on Citi, HP, and Paramount. They Look Like Losers.","Summary":"Merck  said Tuesday it is launching a new Phase 3 trial of once-daily islatravir for the treatment of people with HIV-1 infection. \"These new Phase 3 studies will evaluate a once-daily oral combination of doravirine 100 mg..."},{"Date":"Sep. 20, 2022 at 7:00 a.m. ET","Headline":"Merck launches new Phase 3 trial of once-daily HIV treatment, to discontinue trial of once-monthly dose","Summary":"Merck  said Tuesday it is launching a new Phase 3 trial of once-daily islatravir for the treatment of people with HIV-1 infection. \"These new Phase 3 studies will evaluate a once-daily oral combination of doravirine 100 mg..."},{"Date":"Oct. 10, 2022 at 10:17 a.m. ET","Headline":"Merck Trial Data Show Heart Drug Could Be a Winner","Summary":""},{"Date":"Oct. 10, 2022 at 8:07 a.m. ET","Headline":"Large number of U.S. COVID deaths could be prevented if patients would take Pfizer\u2019s Paxlovid, White House coordinator warns","Summary":""},{"Date":"Oct. 12, 2022 at 5:28 p.m. ET","Headline":"Moderna Stock Takes Off on Cancer Vaccine News","Summary":""},{"Date":"Oct. 12, 2022 at 4:19 p.m. ET","Headline":"U.S. stocks end lower with S&P 500 booking 6-day losing streak as investors digest Fed minutes, await CPI","Summary":""},{"Date":"Oct. 12, 2022 at 12:17 p.m. ET","Headline":"Pfizer and Moderna Stocks Jump After FDA Grants Emergency Use of Boosters for Children","Summary":""},{"Date":"Oct. 12, 2022 at 9:16 a.m. ET","Headline":"What\u2019s going to break next? Look for leverage and artificial constraints, says this fund manager","Summary":""},{"Date":"Oct. 12, 2022 at 7:47 a.m. ET","Headline":"Merck, Moderna to develop personalized cancer vaccine","Summary":""},{"Date":"Oct. 19, 2022 at 8:49 a.m. ET","Headline":"Biogen and 10 Other Healthcare Stocks Thriving in This Bear Market","Summary":"The Dow Jones Industrial Average  is headed for , with all 30 components trading higher in the premarket. The biggest gainers ahead of the open were shares of Goldman Sachs Group Inc. , which climbed 2.9% after reported , ..."},{"Date":"Oct. 18, 2022 at 7:53 a.m. ET","Headline":"All 30 Dow stocks rally, led by Goldman and Salesforce stocks","Summary":"The Dow Jones Industrial Average  is headed for , with all 30 components trading higher in the premarket. The biggest gainers ahead of the open were shares of Goldman Sachs Group Inc. , which climbed 2.9% after reported , ..."},{"Date":"Oct. 27, 2022 at 4:21 p.m. ET","Headline":"U.S. stocks end mixed despite strong GDP data, Nasdaq down 1.6% with tech stocks hit by Meta results ahead of Apple, Amazon earnings","Summary":"The Dow Jones Industrial Average's  components that reported quarterly results ahead of Thursday's provided the bulk of the index's early gains after all beat profit expectations. The combined implied shares price gains of..."},{"Date":"Oct. 27, 2022 at 9:37 a.m. ET","Headline":"Why the rout for big tech companies may just be getting started","Summary":"The Dow Jones Industrial Average's  components that reported quarterly results ahead of Thursday's provided the bulk of the index's early gains after all beat profit expectations. The combined implied shares price gains of..."},{"Date":"Oct. 27, 2022 at 8:59 a.m. ET","Headline":"Dow futures getting a more than 160-point boost from its earnings reporters","Summary":"The Dow Jones Industrial Average's  components that reported quarterly results ahead of Thursday's provided the bulk of the index's early gains after all beat profit expectations. The combined implied shares price gains of..."},{"Date":"Oct. 27, 2022 at 6:46 a.m. ET","Headline":"Merck stock rises after profit and sales beat, raised outlook","Summary":"Shares of Merck & Co. Inc.  rose 1.4% in premarket trading Thursday, after the drug giant reported third-quarter profit and sale that beat expectations and raised its full-year outlook, as sales of the company's top 3 sell..."},{"Date":"Oct. 28, 2022 at 6:26 a.m. ET","Headline":"Lockheed, Nvidia, and Others Have Pricing Power. Their Profit Margins Prove It.","Summary":""},{"Date":"Oct. 27, 2022 at 2:20 p.m. ET","Headline":"Merck\u2019s CFO Says Biotech Deals are Getting Done","Summary":""},{"Date":"Nov. 2, 2022 at 3:30 a.m. ET","Headline":"6 Stocks With Healthy Dividends and Solid Returns","Summary":""},{"Date":"Nov. 1, 2022 at 1:15 a.m. ET","Headline":"3 Things to Watch When Pfizer Announces Earnings","Summary":""},{"Date":"Nov. 3, 2022 at 1:45 p.m. ET","Headline":"Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion","Summary":""},{"Date":"Nov. 5, 2022 at 10:04 a.m. ET","Headline":"20 dividend stocks that may be safest if the Federal Reserve causes a recession","Summary":""},{"Date":"Nov. 1, 2022 at 3:59 p.m. ET","Headline":"Podcast: Expert Market Forecaster Jim Stack Sees More Pain Before a Big Buying Opportunity","Summary":""},{"Date":"Nov. 10, 2022 at 9:03 a.m. ET","Headline":"All 30 Dow stocks rising, led by tech giants Salesforce, Microsoft and Apple","Summary":"The early 774-point surge in futures  of the Dow Jones Industrial Average  was unanimous, with all 30 components gaining ground premarket, in the wake of . The biggest gainers were shares of customer relationship managemen..."},{"Date":"Nov. 9, 2022 at 12:37 p.m. ET","Headline":"Clovis Oncology stock slides 75% after biotech warns it will run out of cash by January of 2023","Summary":"Clovis Oncology Inc. shares  plunged 75% Wednesday, after the Colorado-based biotech said it will not have sufficient liquidity to maintain operations beyond January of 2023. The company said recent regulatory developments..."},{"Date":"Nov. 21, 2022 at 4:32 p.m. ET","Headline":"U.S. stocks finish lower as China COVID-19 fears resurface","Summary":"Shares of Imago BioSciences Inc.  soared 104.9% into record territory in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other bone marrow dis..."},{"Date":"Nov. 21, 2022 at 8:57 a.m. ET","Headline":"Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech","Summary":"Shares of Imago BioSciences Inc.  soared 104.9% into record territory in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and other bone marrow dis..."},{"Date":"Nov. 23, 2022 at 8:31 a.m. ET","Headline":"China\u2019s three-week COVID case tally tops 253,000 and daily average is rising, government says","Summary":""},{"Date":"Nov. 21, 2022 at 1:22 p.m. ET","Headline":"Imago BioSciences Stock Surges. It\u2019s Being Bought by Merck.","Summary":""},{"Date":"Nov. 26, 2022 at 8:35 a.m. ET","Headline":"Stephen King: Twitter\u2019s only advertiser will soon be MyPillow. Here\u2019s Elon Musk\u2019s response.","Summary":""},{"Date":"Nov. 25, 2022 at 7:50 p.m. ET","Headline":"Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven","Summary":""},{"Date":"Nov. 25, 2022 at 7:53 p.m. ET","Headline":"Bye-Bye, Bear Market? The Worst Could Be Over for Stocks.","Summary":""},{"Date":"Dec. 2, 2022 at 7:06 p.m. ET","Headline":"Buy AbbVie Stock. The Pharma Giant Is Still Worth Owning Even as Humira Fades.","Summary":""},{"Date":"Dec. 1, 2022 at 2:26 p.m. ET","Headline":"What Bear Market? The Dow Is Down Just Over 5% in 2022.","Summary":""},{"Date":"Dec. 1, 2022 at 9:30 a.m. ET","Headline":"It\u2019s Rough Out There. Stick With Dividend Stocks to Stay Afloat.","Summary":""},{"Date":"Dec. 1, 2022 at 8:37 a.m. ET","Headline":"The Stock Market Keeps Going Up. How to Protect Yourself From Another Drop.","Summary":""},{"Date":"Dec. 3, 2022 at 7:30 a.m. ET","Headline":"McCormick, PulteGroup, and Merck Boost Dividends","Summary":""},{"Date":"Dec. 6, 2022 at 8:19 a.m. ET","Headline":"Gossamer Bio's stock falls 64% on findings for Phase 2 study for hypertension drug","Summary":"Shares of Gossamer Bio Inc.  plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase 2 clinical trial. Though Gossamer ..."},{"Date":"Dec. 9, 2022 at 4:13 p.m. ET","Headline":"The Dow industrials are on the verge of a \u2018golden cross,\u2019 even as BlackRock predicts recession like no other","Summary":""},{"Date":"Dec. 14, 2022 at 1:32 p.m. ET","Headline":"Moderna Stock Soared on Good News About Cancer Vaccine. Why One Analyst Downgraded the Stock.","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 14, 2022 at 6:51 a.m. ET","Headline":"Moderna\u2019s Cancer Vaccine Reduces Deaths in Melanoma Patients. The Stock Is Gaining.","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 14, 2022 at 6:46 a.m. ET","Headline":"Falling Inflation Is Good News for the Fed. Just Don\u2019t Get Too Excited.","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 13, 2022 at 4:36 p.m. ET","Headline":"Dow ends 100 points higher, stocks book back-to-back gains as Wall Street gauges cooler inflation report, awaits Fed rate decision","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 13, 2022 at 4:12 p.m. ET","Headline":"Stocks Moving the Most Today: Moderna, Pinterest, Trimble, and More","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 13, 2022 at 7:34 a.m. ET","Headline":"Merck, Moderna say mRNA vaccine and Keytruda lowers the risk of death in melanoma patients","Summary":"Merck & Co. Inc.  and Moderna Inc.  said Tuesday that their experimental mRNA-based cancer vaccine reduced the risk of recurrence or death when used with Merck's Keytruda in patients with late-stage melanoma. Merck's stock..."},{"Date":"Dec. 16, 2022 at 8:27 a.m. ET","Headline":"BioNTech upgraded to buy on high hopes for combined flu\/COVID vaccine and oncology pipeline","Summary":""},{"Date":"Dec. 17, 2022 at 7:41 a.m. ET","Headline":"This momentum-stock strategy can be a winner regardless of whether the Federal Reserve pivots","Summary":""},{"Date":"Dec. 20, 2022 at 1:10 p.m. ET","Headline":"Gilead Data Raise New Questions About Cancer Therapy","Summary":""},{"Date":"Dec. 19, 2022 at 9:47 a.m. ET","Headline":"Moderna Stock Is Upgraded on Growth Opportunities Not Related to Covid","Summary":""},{"Date":"Dec. 22, 2022 at 9:41 a.m. ET","Headline":"Merck, Sichuan Kelun enter cancer collaboration, with milestone payments up to $9.3 billion","Summary":"Merck & Co. Inc.  said Thursday that it entered into an agreement with Sichuan Kelun Pharmaceutical Co. Ltd.  to develop seven new cancer therapies. Merck will pay the Chinse biotech an upfront payment of $175 million, wit..."},{"Date":"Dec. 21, 2022 at 12:00 p.m. ET","Headline":"PepsiCo, Kellogg, and Other Stocks That Can Thrive During a Recession","Summary":""},{"Date":"Dec. 24, 2022 at 8:26 a.m. ET","Headline":"As COVID cases rise, how to steer clear of viruses during the holiday season","Summary":""},{"Date":"Dec. 30, 2022 at 4:42 p.m. ET","Headline":"These Stocks Moved the Most Today: Novavax, Micron, Biogen, and More","Summary":""},{"Date":"Dec. 30, 2022 at 1:47 p.m. ET","Headline":"COVID-related ICU patients rise to 5-month high above 5,000\u2014are new cases really falling?","Summary":""},{"Date":"Dec. 30, 2022 at 10:36 a.m. ET","Headline":"China\u2019s Covid Reopening Will Be Bumpy. Deaths Could Peak at 25,000 a Day.","Summary":""},{"Date":"Dec. 30, 2022 at 9:12 a.m. ET","Headline":"China COVID cases could double next month, as Merck antiviral gets approval","Summary":""},{"Date":"Dec. 30, 2022 at 6:15 a.m. ET","Headline":"Dow Dogs, Led by Chevron and Merck, Beat the Dow Industrials in 2022","Summary":""},{"Date":"Dec. 29, 2022 at 10:33 a.m. ET","Headline":"All 30 Dow stocks rise, led by Disney and Apple, the previous session\u2019s worst performers","Summary":""},{"Date":"Dec. 31, 2022 at 8:49 a.m. ET","Headline":"Best stock picks for 2023: Here are Wall Street analysts\u2019 most heavily favored choices","Summary":""},{"Date":"Dec. 31, 2022 at 8:17 a.m. ET","Headline":"These 20 stocks were the biggest winners of 2022","Summary":""},{"Date":"Jan. 3, 2023 at 8:14 a.m. ET","Headline":"Evaxion's stock soars after getting FDA approval for mid-stage cancer trial","Summary":"U.S.-listed shares of Evaxion Biotech A\/S  jumped about 17% in premarket trading on Tuesday after the company said the Food and Drug Administration has allowed a Phase 2b clinical trial testing its experimental cancer vacc..."},{"Date":"Jan. 4, 2023 at 10:01 a.m. ET","Headline":"Moderna Bolsters Its Vaccine Pipeline With $85 Million Deal for Biotech Firm OriCiro","Summary":""},{"Date":"Jan. 7, 2023 at 9:12 a.m. ET","Headline":"XBB.1.5, which makes up 28% of new COVID cases in the U.S., fuels worries about a winter wave","Summary":""},{"Date":"Jan. 3, 2023 at 2:56 a.m. ET","Headline":"Here Are Barron\u2019s 12 Best Income Investments for the New Year","Summary":""},{"Date":"Jan. 9, 2023 at 4:30 p.m. ET","Headline":"Dow erases 300-point gain as stocks end mostly lower","Summary":""},{"Date":"Jan. 9, 2023 at 8:44 a.m. ET","Headline":"The Year\u2019s Biggest Healthcare Conference Starts Monday. What to Expect.","Summary":""},{"Date":"Jan. 8, 2023 at 6:32 p.m. ET","Headline":"It\u2019s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.","Summary":""},{"Date":"Jan. 10, 2023 at 4:32 p.m. ET","Headline":"Healthcare Stocks, a Star in 2022, Are Going Nowhere in 2023","Summary":""},{"Date":"Jan. 20, 2023 at 9:03 a.m. ET","Headline":"Price Negotiations Are About to Reshape the Drug Industry","Summary":""},{"Date":"Jan. 31, 2023 at 4:47 p.m. ET","Headline":"These 20 stocks led the January rally","Summary":""},{"Date":"Jan. 27, 2023 at 9:17 a.m. ET","Headline":"Here Are the Best-Performing ESG Funds","Summary":""},{"Date":"Feb. 2, 2023 at 5:47 p.m. ET","Headline":"What\u2019s Ailing the Dow This Year? UnitedHealth, Chevron, J&J, Amgen.","Summary":""},{"Date":"Feb. 2, 2023 at 4:33 p.m. ET","Headline":"These Stocks Are Moving the Most Today: Meta, Align, Coinbase, Harley, Okta, and More","Summary":""},{"Date":"Feb. 2, 2023 at 4:29 p.m. ET","Headline":"S&P 500 surges to end at over five-month high, Nasdaq closes up 3.3% as Meta leads rally in tech sector stocks","Summary":""},{"Date":"Feb. 2, 2023 at 6:52 a.m. ET","Headline":"Merck Tops Quarterly Profit Estimates but Sees Weaker 2023 Revenue on Lagevrio Sales Drop","Summary":""},{"Date":"Feb. 2, 2023 at 6:42 a.m. ET","Headline":"Merck stock falls after quarterly earnings top expectations but profit outlook disappoints","Summary":""},{"Date":"Feb. 3, 2023 at 6:32 a.m. ET","Headline":"Apple Is Not the Economy. Why the Fed\u2019s More Bullish Than Tech.","Summary":""},{"Date":"Feb. 6, 2023 at 4:34 p.m. ET","Headline":"These 5 timely stocks from a top international fund manager can help your portfolio take on the world","Summary":""},{"Date":"Feb. 15, 2023 at 5:22 p.m. ET","Headline":"Berkshire Churns Through Stocks.  Warren Buffett Moves on From Buy and Hold.","Summary":""},{"Date":"Feb. 22, 2023 at 5:23 p.m. ET","Headline":"Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation","Summary":""},{"Date":"Feb. 22, 2023 at 11:41 a.m. ET","Headline":"Intel\u2019s dividend cut shows the need for quality. Here are 20 dividend stocks screened by UBS.","Summary":""},{"Date":"Feb. 24, 2023 at 1:41 p.m. ET","Headline":"WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants","Summary":""},{"Date":"Feb. 24, 2023 at 7:09 a.m. ET","Headline":"Moderna\u2019s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales","Summary":""},{"Date":"Feb. 24, 2023 at 7:03 a.m. ET","Headline":"Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator\u2019s decision to recommend refusing authorization of their COVID antiviral","Summary":""},{"Date":"Feb. 23, 2023 at 8:49 a.m. ET","Headline":"Moderna Stock Drops on Disappointing Earnings, Falling Covid-19 Vaccine Sales","Summary":""},{"Date":"Feb. 21, 2023 at 6:48 p.m. ET","Headline":"\u2018Biosimilars\u2019 Were Supposed to Tame Costs for Drugs Like Humira. It Isn\u2019t Working.","Summary":""},{"Date":"Feb. 26, 2023 at 10:26 p.m. ET","Headline":"Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion","Summary":""},{"Date":"Feb. 28, 2023 at 9:03 a.m. ET","Headline":"Moderna\u2019s Covid Boom Is Ending. Why the Outlook Isn\u2019t All Grim.","Summary":""},{"Date":"Feb. 27, 2023 at 10:21 a.m. ET","Headline":"Pfizer in Talks to Buy Seagen for $30 Billion or More","Summary":""},{"Date":"Mar. 2, 2023 at 1:00 a.m. ET","Headline":"Biotech Has Fallen Hard. Now Could Be a Good Time to Buy.","Summary":""},{"Date":"Mar. 1, 2023 at 6:06 a.m. ET","Headline":"The 20 worst U.S. stocks in February: the biggest loser dropped 35%","Summary":""},{"Date":"Mar. 3, 2023 at 5:56 p.m. ET","Headline":"The 100 Most Sustainable U.S. Companies Right Now","Summary":""},{"Date":"Mar. 7, 2023 at 4:59 p.m. ET","Headline":"These stocks fared the worst as Powell pushed the market down Tuesday","Summary":""},{"Date":"Mar. 10, 2023 at 1:15 a.m. ET","Headline":"Johnson & Johnson, Kellogg, and 2 Other Spinoffs to Watch in 2023","Summary":""},{"Date":"Mar. 3, 2023 at 7:55 p.m. ET","Headline":"U.S. Oil Will Grow Only 3% This Year. One Reason: Executive Compensation.","Summary":""},{"Date":"Mar. 13, 2023 at 10:07 a.m. ET","Headline":"Pfizer Rolls the Dice on Seagen in $43 Billion Deal. The Risks It Faces.","Summary":""},{"Date":"Mar. 17, 2023 at 8:08 a.m. ET","Headline":"Merck\u2019s combination therapy in lung cancer fails a Phase 2 clinical trial","Summary":""},{"Date":"Apr. 1, 2023 at 8:41 a.m. ET","Headline":"Here are the 20 best performing stocks of March \u2014 and the 20 worst","Summary":""},{"Date":"Apr. 7, 2023 at 7:02 a.m. ET","Headline":"Merck and Eisai report disappointing results from trials of combination treatment for melanoma and colorectal cancer","Summary":""},{"Date":"Apr. 8, 2023 at 9:48 a.m. ET","Headline":"Bird Flu Is Threatening Chickens. Why Farmers Don\u2019t Want a Vaccine.","Summary":""},{"Date":"Apr. 11, 2023 at 3:51 p.m. ET","Headline":"Antivaccine Groups See Hope in Abortion-Pill Ruling. What It Means for Pharma.","Summary":""},{"Date":"Apr. 13, 2023 at 6:20 a.m. ET","Headline":"Merck\u2019s stock leads the Dow\u2019s early gainers after Citi turns bullish, raises price target by 24%","Summary":""},{"Date":"Apr. 14, 2023 at 2:45 p.m. ET","Headline":"The FDA Is Resuming Drug Lab Inspections in China. These Biotechs Could Benefit.","Summary":""},{"Date":"Apr. 17, 2023 at 4:28 p.m. ET","Headline":"U.S. stocks end slightly higher with earnings season set to pick up steam","Summary":""},{"Date":"Apr. 17, 2023 at 4:21 p.m. ET","Headline":"These Stocks Are Moving the Most Today: State Street, Alphabet, Prometheus, Roblox, Moderna, Enphase, and More","Summary":""},{"Date":"Apr. 17, 2023 at 3:02 p.m. ET","Headline":"Moderna Cancer-Therapy Sees More Upbeat Data","Summary":""},{"Date":"Apr. 17, 2023 at 2:45 p.m. ET","Headline":"Healthcare Is Back. But Is It Here to Stay?","Summary":""},{"Date":"Apr. 17, 2023 at 2:14 p.m. ET","Headline":"Prometheus Biosciences, XPeng, Alphabet, Roblox and other stocks on the move Monday","Summary":""},{"Date":"Apr. 17, 2023 at 11:58 a.m. ET","Headline":"Merck\u2019s Deal for Prometheus Expected to Generate Billions in Additional Sales","Summary":""},{"Date":"Apr. 17, 2023 at 9:58 a.m. ET","Headline":"\u2018Gradually, then suddenly.\u2019 Earnings expectations may be about to drop, says Morgan Stanley strategist.","Summary":""},{"Date":"Apr. 17, 2023 at 7:31 a.m. ET","Headline":"Merck to buy Prometheus Biosciences for $10.8 billion","Summary":""},{"Date":"Apr. 17, 2023 at 7:30 a.m. ET","Headline":"Moderna, Merck combo cancer-vaccine treatment shows \u2018significant\u2019 promise","Summary":""},{"Date":"Apr. 17, 2023 at 6:11 a.m. ET","Headline":"Big Bank Earnings Won\u2019t Reveal If the Turmoil Is Over. Here\u2019s What Will.","Summary":""},{"Date":"Apr. 19, 2023 at 11:13 a.m. ET","Headline":"8 Defensive Plays as Healthcare Stocks Stumble","Summary":""},{"Date":"Apr. 18, 2023 at 9:04 a.m. ET","Headline":"Merck\u2019s $10.8 billion takeover of Prometheus is a good strategic move that gives it a foothold in immunology","Summary":""},{"Date":"Apr. 21, 2023 at 3:30 a.m. ET","Headline":"These 6 Income Funds Use Options to Pump Up Their Yields","Summary":""},{"Date":"Apr. 21, 2023 at 2:00 a.m. ET","Headline":"Biopharma Deals Are Hot. There\u2019s More to Come\u2014and These Stocks Can Benefit.","Summary":""},{"Date":"Apr. 24, 2023 at 11:06 a.m. ET","Headline":"Two breakthroughs on dementia \u2014 one that\u2019s useful right now","Summary":""},{"Date":"Apr. 27, 2023 at 5:18 p.m. ET","Headline":"Dow, S&P 500 post biggest gains since January after earnings from Meta and other big-tech names","Summary":""},{"Date":"Apr. 27, 2023 at 1:29 p.m. ET","Headline":"Cisco, Caterpillar and More Fortress Stocks to Buy in a Messy Market","Summary":""},{"Date":"Apr. 27, 2023 at 9:34 a.m. ET","Headline":"Merck\u2019s First-Quarter Earnings Beat Estimates. The Stock Is Rising.","Summary":""},{"Date":"Apr. 27, 2023 at 9:33 a.m. ET","Headline":"An undiscovered universe of stocks is trading at \u2018near generational lows,\u2019 asset manager says","Summary":""},{"Date":"Apr. 26, 2023 at 4:29 p.m. ET","Headline":"Dow ends down 220 points as First Republic worries overshadow upbeat Big Tech earnings","Summary":""},{"Date":"Apr. 28, 2023 at 8:30 a.m. ET","Headline":"Merck\u2019s first-quarter earnings beat estimates, even as COVID-19 treatment sales plummet","Summary":""},{"Date":"Apr. 28, 2023 at 7:01 a.m. ET","Headline":"First Republic Bank Faces a Critical Weekend. What to Expect.","Summary":""},{"Date":"May. 3, 2023 at 6:25 a.m. ET","Headline":"Fed Holds an Ace to Calm Banking Turmoil. Why It\u2019s Not Playing It.","Summary":""},{"Date":"May. 3, 2023 at 3:30 a.m. ET","Headline":"Biotech Stocks Are Heavily Shorted. They Could Be Winners.","Summary":""},{"Date":"May. 2, 2023 at 5:19 p.m. ET","Headline":"Kenvue, Acelyrin Go Public This Week. Why the Biotech IPO Window Isn\u2019t Open Yet.","Summary":""},{"Date":"Apr. 27, 2023 at 1:30 a.m. ET","Headline":"13 Moves to Make Before the Market Wakes Up to All the Risk That\u2019s Out There","Summary":""},{"Date":"May. 4, 2023 at 9:16 a.m. ET","Headline":"Moderna Posts Earnings Beat. There\u2019s Good News on Covid Vaccines Too.","Summary":""},{"Date":"May. 8, 2023 at 9:02 a.m. ET","Headline":"You Can Have Dividends and Growth. Here\u2019s How.","Summary":""},{"Date":"May. 17, 2023 at 12:38 p.m. ET","Headline":"Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider","Summary":""},{"Date":"May. 17, 2023 at 8:29 a.m. ET","Headline":"FTC sues to block Amgen\u2019s acquisition of Horizon Therapeutics","Summary":""},{"Date":"May. 19, 2023 at 7:24 p.m. ET","Headline":"Berkshire Stock Buys Still Get a Buffett Bounce\u2014but Maybe Not the Expected Results","Summary":""},{"Date":"May. 16, 2023 at 12:29 p.m. ET","Headline":"Beware of Warren Buffett\u2019s Stock Buys. They Usually Fall Flat.","Summary":""},{"Date":"May. 26, 2023 at 11:42 a.m. ET","Headline":"Drugmakers Released a Ton of New Cancer Treatment Data. The Biggest Developments.","Summary":""},{"Date":"Dec. 31, 2018 at 6:00 a.m. ET","Headline":"Visa Stock Was a 2018 Winner Despite a Rough End to the Year","Summary":""},{"Date":"Jun. 6, 2023 at 3:54 p.m. ET","Headline":"Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say","Summary":""},{"Date":"Jun. 6, 2023 at 2:14 p.m. ET","Headline":"Merck Is Fighting Medicare Drug-Price Negotiations in Court","Summary":""},{"Date":"Jun. 6, 2023 at 10:42 a.m. ET","Headline":"Coinbase, Apple stocks falls while GitLab, Thor shares rally, and other stocks on the move","Summary":""},{"Date":"Jun. 5, 2023 at 1:09 p.m. ET","Headline":"Moderna and Merck reveal new data on individualized cancer treatment","Summary":""},{"Date":"Jun. 9, 2023 at 8:38 a.m. ET","Headline":"White House signals no pause on Medicare drug price negotiations after Merck lawsuit","Summary":""},{"Date":"Jun. 13, 2023 at 5:48 p.m. ET","Headline":"Merck says court ruled in its favor over patent-infringement suit","Summary":""},{"Date":"Jun. 16, 2023 at 5:02 p.m. ET","Headline":"Bristol Myers Squibb sues federal government over Medicare drug negotiations: report","Summary":""},{"Date":"Jun. 17, 2023 at 8:20 a.m. ET","Headline":"Biotech stocks could soon get a M&A boost. Here are 3 likely takeover plays.","Summary":""},{"Date":"Jun. 28, 2023 at 3:50 p.m. ET","Headline":"After \u2018transformative\u2019 year, Roivant aims to challenge bigger rivals in inflammation and immunology","Summary":""},{"Date":"Dec. 30, 2018 at 10:00 a.m. ET","Headline":"How Nike Stock Beat the Dow in 2018","Summary":""},{"Date":"Jul. 1, 2023 at 8:16 a.m. ET","Headline":"These are the best-performing stocks in the 2023 bull market \u2014 and the worst","Summary":""},{"Date":"Jul. 13, 2023 at 11:50 a.m. ET","Headline":"Big Pharma Ramps Up Fight Against Medicare Price Negotiations","Summary":""},{"Date":"Jul. 18, 2023 at 4:40 p.m. ET","Headline":"Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program","Summary":""},{"Date":"Jul. 20, 2023 at 1:53 p.m. ET","Headline":"Johnson & Johnson Stock Jumps on Earnings Beat. But Talc Worries Loom.","Summary":""},{"Date":"Jul. 19, 2023 at 7:06 a.m. ET","Headline":"Merck Phase 3 Keytruda Study Hits Key Goal in Early Cervical Cancer >MRK","Summary":""},{"Date":"Jul. 19, 2023 at 3:31 a.m. ET","Headline":"5 Beaten-Down Healthcare Stocks With Potential for a Rebound","Summary":""},{"Date":"Jul. 21, 2023 at 8:03 a.m. ET","Headline":"Merck Gets CHMP Backing for Expanded Keytruda Use in Gastrointestinal Cancers >MRK","Summary":""},{"Date":"Jul. 21, 2023 at 5:05 a.m. ET","Headline":"As Ozempic\/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion","Summary":""},{"Date":"Jul. 26, 2023 at 6:55 a.m. ET","Headline":"Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma","Summary":""},{"Date":"Jul. 28, 2023 at 7:24 a.m. ET","Headline":"Merck Phase 3 Keytruda Study Hits Key Goal in Early High-Risk Breast Cancer >MRK","Summary":""},{"Date":"Aug. 1, 2023 at 6:31 a.m. ET","Headline":"Merck Earnings Top Expectations. More M&A Could Be Next.","Summary":""},{"Date":"Jul. 31, 2023 at 12:30 p.m. ET","Headline":"Drugmakers Want to Crush Medicare\u2019s Pricing Power. They\u2019ll Probably Succeed.","Summary":""},{"Date":"Aug. 3, 2023 at 10:37 a.m. ET","Headline":"Moderna Raises Hope, Concern, With Update on Sales of Covid-19 Vaccine","Summary":""},{"Date":"Aug. 2, 2023 at 4:33 p.m. ET","Headline":"S&P 500 slumps nearly 1.4% in worst day since April as Nasdaq falls over 2% after Fitch lowers U.S. credit rating","Summary":""},{"Date":"Aug. 2, 2023 at 7:43 a.m. ET","Headline":"Merck swings to loss as it books charge on $10.8 billion acquisition of Prometheus Biosciences","Summary":""},{"Date":"Aug. 2, 2023 at 7:41 a.m. ET","Headline":"Pfizer\u2019s stock drops as earnings fall sharply amid lower sales for its COVID products","Summary":""},{"Date":"Aug. 2, 2023 at 6:33 a.m. ET","Headline":"Fitch\u2019s U.S. Credit Downgrade Is a Bad Look. Why It\u2019s Not a Disaster.","Summary":""},{"Date":"Aug. 7, 2023 at 7:23 a.m. ET","Headline":"Ginkgo Bioworks stock pops as company plans Merck collaboration","Summary":""},{"Date":"Aug. 8, 2023 at 12:05 p.m. ET","Headline":"Eli Lilly\u2019s stock soars toward best day in 23 years after strong earnings, upbeat Mounjaro outlook","Summary":""},{"Date":"Aug. 18, 2023 at 5:02 p.m. ET","Headline":"Buy Moderna and BioNTech Stock. Both Pharmas Have Strong Drug Pipelines and Plenty of Cash.","Summary":""},{"Date":"Aug. 18, 2023 at 7:11 a.m. ET","Headline":"Merck Phase 3 Welireg Study Hits Key Endpoint in Renal Cell Carcinoma >MRK","Summary":""},{"Date":"Aug. 25, 2023 at 6:55 a.m. ET","Headline":"Merck Launches Phase 3 for MK-0616 Oral Cholesterol Drug >MRK","Summary":""},{"Date":"Aug. 25, 2023 at 6:52 a.m. ET","Headline":"Merck and Eisai say late-stage trial of treatment for head and neck cancer did not meet goals","Summary":""},{"Date":"Aug. 26, 2023 at 1:07 p.m. ET","Headline":"As Medicare picks 10 drugs for price negotiations, 50 million people stand to benefit \u2014 even if their drugs aren\u2019t on the list","Summary":""},{"Date":"Aug. 26, 2023 at 9:44 a.m. ET","Headline":"Stock buybacks spur wealth inequality and stifle innovation. Should they be banned?","Summary":""},{"Date":"Aug. 26, 2023 at 8:53 a.m. ET","Headline":"\u2018The sharks are still there.\u2019 Stock market\u2019s decline is just beginning, this top fund manager says","Summary":""},{"Date":"Aug. 29, 2023 at 3:26 p.m. ET","Headline":"Eli Lilly and Other Pharma Stocks Are Ignoring Medicare\u2019s 10 Drug List","Summary":""},{"Date":"Aug. 29, 2023 at 3:22 p.m. ET","Headline":"Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations","Summary":""},{"Date":"Aug. 29, 2023 at 9:33 a.m. ET","Headline":"After calling the S&P 500\u2019s climb this year, this strategist says hang on, the gains aren\u2019t over.","Summary":""},{"Date":"Aug. 28, 2023 at 3:00 a.m. ET","Headline":"Biden Administration to Reveal Which Pharma Blockbusters Medicare Will Pay Less For","Summary":""},{"Date":"Aug. 30, 2023 at 3:56 p.m. ET","Headline":"Medicare\u2019s Plan to Negotiate Drug Discounts Won\u2019t Hit Pharma Hard, Analysts say","Summary":""},{"Date":"Aug. 30, 2023 at 6:46 a.m. ET","Headline":"Crypto Scores Big Win Over the SEC. Why the Battle\u2019s Far From Over.","Summary":""},{"Date":"Sep. 9, 2023 at 8:42 a.m. ET","Headline":"How one big stock-market investor is positioning for a decade of inflation","Summary":""},{"Date":"Sep. 9, 2023 at 8:13 a.m. ET","Headline":"These four Dow stocks take top prizes for dividend growth","Summary":""},{"Date":"Sep. 13, 2023 at 12:19 p.m. ET","Headline":"Moderna Rises on Positive Results From Flu Vaccine,  and Other Plans to Move Beyond Covid","Summary":""},{"Date":"Sep. 13, 2023 at 6:32 a.m. ET","Headline":"Moderna aims to prove it\u2019s \u2018more than a COVID company\u2019","Summary":""},{"Date":"Sep. 15, 2023 at 9:33 a.m. ET","Headline":"Merck Gets CHMP Backing for Keytruda as Non-Small Cell Lung Cancer Adjuvant >MRK","Summary":""},{"Date":"Sep. 18, 2023 at 6:33 a.m. ET","Headline":"Strikes, Dot Plots, Energy Prices. How the Fed\u2019s Inflation Battle Is Getting Tougher.","Summary":""},{"Date":"Sep. 17, 2023 at 2:26 p.m. ET","Headline":"New Cancer Drugs Are Changing the Odds. The Latest on Treatments.","Summary":""},{"Date":"Sep. 20, 2023 at 7:50 a.m. ET","Headline":"Exscientia\u2019s stock rockets toward a record gain after AI-driven drug discovery collaboration with Germany\u2019s Merck KGaA","Summary":""},{"Date":"Sep. 20, 2023 at 7:12 a.m. ET","Headline":"Merck Gets FDA Priority Review for New Keytruda Cervical Cancer Indication >MRK","Summary":""},{"Date":"Sep. 19, 2023 at 6:57 a.m. ET","Headline":"Merck Gets FDA Priority Review of Welireg in Advanced Renal Cell Carcinoma >MRK","Summary":""},{"Date":"Sep. 14, 2023 at 12:30 a.m. ET","Headline":"\u2018This Is Not a Covid Vaccine Company,\u2019 Moderna CEO Says","Summary":""},{"Date":"Sep. 28, 2023 at 10:14 a.m. ET","Headline":"Dow's 84-point rally led by gains for UnitedHealth, JPMorgan Chase shares","Summary":""},{"Date":"Sep. 28, 2023 at 7:11 a.m. ET","Headline":"Merck Gets FDA Priority Review of Sotatercept in Pulmonary Arterial Hypertension >MRK","Summary":""},{"Date":"Sep. 27, 2023 at 3:53 p.m. ET","Headline":"Dow down 88 points on losses for shares of Verizon, McDonald's","Summary":""},{"Date":"Sep. 27, 2023 at 2:29 p.m. ET","Headline":"Dow down nearly 175 points on losses for shares of McDonald's, Verizon","Summary":""},{"Date":"Sep. 27, 2023 at 1:27 p.m. ET","Headline":"Dow's 270-point fall led by losses in shares of Walgreens Boots, Johnson & Johnson","Summary":""},{"Date":"Sep. 27, 2023 at 12:06 p.m. ET","Headline":"Johnson & Johnson, Verizon share losses contribute to Dow's 186-point fall","Summary":""},{"Date":"Sep. 27, 2023 at 10:53 a.m. ET","Headline":"Dow falls nearly 100 points on losses for Walgreens Boots, Johnson & Johnson stocks","Summary":""},{"Date":"Sep. 27, 2023 at 7:28 a.m. ET","Headline":"Merck\u2019s COVID antiviral may be linked to virus mutations, study finds","Summary":""},{"Date":"Sep. 29, 2023 at 3:51 p.m. ET","Headline":"Travelers, Walmart share losses contribute to Dow's nearly 100-point drop","Summary":""},{"Date":"Sep. 29, 2023 at 1:50 p.m. ET","Headline":"Dow drops 184 points on losses in shares of Travelers, Walmart","Summary":""},{"Date":"Sep. 29, 2023 at 12:49 p.m. ET","Headline":"Travelers, Walmart share losses lead Dow's 90-point drop","Summary":""},{"Date":"Sep. 29, 2023 at 10:20 a.m. ET","Headline":"As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment","Summary":""},{"Date":"Oct. 2, 2023 at 12:43 p.m. ET","Headline":"Big Pharma Can\u2019t Stop the Price-Negotiation Program. What\u2019s Next.","Summary":""},{"Date":"Oct. 2, 2023 at 12:28 p.m. ET","Headline":"This fund shows that industry expertise can help you make a lot of money in the stock market","Summary":""}]